#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Dynamic functional connectivity impairments in early schizophrenia and clinical high-risk for psychosis
#Text=Individuals at clinical high-risk (CHR) for psychosis are characterized by attenuated psychotic symptoms.
1-1	0-7	Dynamic	_	
1-2	8-18	functional	_	
1-3	19-31	connectivity	_	
1-4	32-43	impairments	_	
1-5	44-46	in	_	
1-6	47-52	early	_	
1-7	53-66	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
1-8	67-70	and	_	
1-9	71-79	clinical	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[1]	
1-10	80-89	high-risk	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[1]	
1-11	90-93	for	_	
1-12	94-103	psychosis	_	
1-13	104-115	Individuals	_	
1-14	116-118	at	_	
1-15	119-127	clinical	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[2]	
1-16	128-137	high-risk	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[2]	
1-17	138-139	(	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[2]	
1-18	139-142	CHR	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[2]	
1-19	142-143	)	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[2]	
1-20	144-147	for	_	
1-21	148-157	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder	
1-22	158-161	are	_	
1-23	162-175	characterized	_	
1-24	176-178	by	_	
1-25	179-189	attenuated	_	
1-26	190-199	psychotic	_	
1-27	200-208	symptoms	_	
1-28	208-209	.	_	

#Text=Only a minority of CHR individuals convert to full-blown psychosis.
2-1	210-214	Only	_	
2-2	215-216	a	_	
2-3	217-225	minority	_	
2-4	226-228	of	_	
2-5	229-232	CHR	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk	
2-6	233-244	individuals	_	
2-7	245-252	convert	_	
2-8	253-255	to	_	
2-9	256-266	full-blown	_	
2-10	267-276	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder	
2-11	276-277	.	_	

#Text=Therefore, there is a strong interest in identifying neurobiological abnormalities underlying the psychosis risk syndrome.
3-1	278-287	Therefore	_	
3-2	287-288	,	_	
3-3	289-294	there	_	
3-4	295-297	is	_	
3-5	298-299	a	_	
3-6	300-306	strong	_	
3-7	307-315	interest	_	
3-8	316-318	in	_	
3-9	319-330	identifying	_	
3-10	331-346	neurobiological	_	
3-11	347-360	abnormalities	_	
3-12	361-371	underlying	_	
3-13	372-375	the	_	
3-14	376-385	psychosis	_	
3-15	386-390	risk	_	
3-16	391-399	syndrome	_	
3-17	399-400	.	_	

#Text=Dynamic functional connectivity (DFC) captures time-varying connectivity over short time scales, and has the potential to reveal complex brain functional organization.
4-1	401-408	Dynamic	_	
4-2	409-419	functional	_	
4-3	420-432	connectivity	_	
4-4	433-434	(	_	
4-5	434-437	DFC	_	
4-6	437-438	)	_	
4-7	439-447	captures	_	
4-8	448-460	time-varying	_	
4-9	461-473	connectivity	_	
4-10	474-478	over	_	
4-11	479-484	short	_	
4-12	485-489	time	_	
4-13	490-496	scales	_	
4-14	496-497	,	_	
4-15	498-501	and	_	
4-16	502-505	has	_	
4-17	506-509	the	_	
4-18	510-519	potential	_	
4-19	520-522	to	_	
4-20	523-529	reveal	_	
4-21	530-537	complex	_	
4-22	538-543	brain	_	
4-23	544-554	functional	_	
4-24	555-567	organization	_	
4-25	567-568	.	_	

#Text=Based on resting-state functional magnetic resonance imaging (fMRI) data from 70 healthy controls (HCs), 53 CHR individuals, and 58 early illness schizophrenia (ESZ) patients, we applied a novel group information guided ICA (GIG-ICA) to estimate inherent connectivity states from DFC, and then investigated group differences.
5-1	569-574	Based	_	
5-2	575-577	on	_	
5-3	578-591	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[3]	
5-4	592-602	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[3]	
5-5	603-611	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[3]	
5-6	612-621	resonance	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[3]	
5-7	622-629	imaging	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[3]	
5-8	630-631	(	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[3]	
5-9	631-635	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[3]	
5-10	635-636	)	_	
5-11	637-641	data	_	
5-12	642-646	from	_	
5-13	647-649	70	_	
5-14	650-657	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[4]	
5-15	658-666	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[4]	
5-16	667-668	(	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[4]	
5-17	668-671	HCs	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[4]	
5-18	671-672	)	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[4]	
5-19	672-673	,	_	
5-20	674-676	53	_	
5-21	677-680	CHR	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk	
5-22	681-692	individuals	_	
5-23	692-693	,	_	
5-24	694-697	and	_	
5-25	698-700	58	_	
5-26	701-706	early	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]	
5-27	707-714	illness	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]	
5-28	715-728	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]	
5-29	729-730	(	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]	
5-30	730-733	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]	
5-31	733-734	)	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]	
5-32	735-743	patients	_	
5-33	743-744	,	_	
5-34	745-747	we	_	
5-35	748-755	applied	_	
5-36	756-757	a	_	
5-37	758-763	novel	_	
5-38	764-769	group	_	
5-39	770-781	information	_	
5-40	782-788	guided	_	
5-41	789-792	ICA	_	
5-42	793-794	(	_	
5-43	794-801	GIG-ICA	_	
5-44	801-802	)	_	
5-45	803-805	to	_	
5-46	806-814	estimate	_	
5-47	815-823	inherent	_	
5-48	824-836	connectivity	_	
5-49	837-843	states	_	
5-50	844-848	from	_	
5-51	849-852	DFC	_	
5-52	852-853	,	_	
5-53	854-857	and	_	
5-54	858-862	then	_	
5-55	863-875	investigated	_	
5-56	876-881	group	_	
5-57	882-893	differences	_	
5-58	893-894	.	_	

#Text=We found that ESZ patients showed more aberrant connectivities and greater alterations than CHR individuals.
6-1	895-897	We	_	
6-2	898-903	found	_	
6-3	904-908	that	_	
6-4	909-912	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
6-5	913-921	patients	_	
6-6	922-928	showed	_	
6-7	929-933	more	_	
6-8	934-942	aberrant	_	
6-9	943-957	connectivities	_	
6-10	958-961	and	_	
6-11	962-969	greater	_	
6-12	970-981	alterations	_	
6-13	982-986	than	_	
6-14	987-990	CHR	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk	
6-15	991-1002	individuals	_	
6-16	1002-1003	.	_	

#Text=Results also suggested that disease-related connectivity states occurred in CHR and ESZ groups.
7-1	1004-1011	Results	_	
7-2	1012-1016	also	_	
7-3	1017-1026	suggested	_	
7-4	1027-1031	that	_	
7-5	1032-1047	disease-related	_	
7-6	1048-1060	connectivity	_	
7-7	1061-1067	states	_	
7-8	1068-1076	occurred	_	
7-9	1077-1079	in	_	
7-10	1080-1083	CHR	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk	
7-11	1084-1087	and	_	
7-12	1088-1091	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
7-13	1092-1098	groups	_	
7-14	1098-1099	.	_	

#Text=Regarding the dominant state with the highest contribution to dynamic connectivity, ESZ patients exhibited greater impairments than CHR individuals primarily in the cerebellum, frontal cortex, thalamus and temporal cortex, while CHR and ESZ populations shared common aberrances mainly in the supplementary motor area, parahippocampal gyrus and postcentral cortex.
8-1	1100-1109	Regarding	_	
8-2	1110-1113	the	_	
8-3	1114-1122	dominant	_	
8-4	1123-1128	state	_	
8-5	1129-1133	with	_	
8-6	1134-1137	the	_	
8-7	1138-1145	highest	_	
8-8	1146-1158	contribution	_	
8-9	1159-1161	to	_	
8-10	1162-1169	dynamic	_	
8-11	1170-1182	connectivity	_	
8-12	1182-1183	,	_	
8-13	1184-1187	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
8-14	1188-1196	patients	_	
8-15	1197-1206	exhibited	_	
8-16	1207-1214	greater	_	
8-17	1215-1226	impairments	_	
8-18	1227-1231	than	_	
8-19	1232-1235	CHR	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk	
8-20	1236-1247	individuals	_	
8-21	1248-1257	primarily	_	
8-22	1258-1260	in	_	
8-23	1261-1264	the	_	
8-24	1265-1275	cerebellum	_	
8-25	1275-1276	,	_	
8-26	1277-1284	frontal	_	
8-27	1285-1291	cortex	_	
8-28	1291-1292	,	_	
8-29	1293-1301	thalamus	_	
8-30	1302-1305	and	_	
8-31	1306-1314	temporal	_	
8-32	1315-1321	cortex	_	
8-33	1321-1322	,	_	
8-34	1323-1328	while	_	
8-35	1329-1332	CHR	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk	
8-36	1333-1336	and	_	
8-37	1337-1340	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
8-38	1341-1352	populations	_	
8-39	1353-1359	shared	_	
8-40	1360-1366	common	_	
8-41	1367-1377	aberrances	_	
8-42	1378-1384	mainly	_	
8-43	1385-1387	in	_	
8-44	1388-1391	the	_	
8-45	1392-1405	supplementary	_	
8-46	1406-1411	motor	_	
8-47	1412-1416	area	_	
8-48	1416-1417	,	_	
8-49	1418-1433	parahippocampal	_	
8-50	1434-1439	gyrus	_	
8-51	1440-1443	and	_	
8-52	1444-1455	postcentral	_	
8-53	1456-1462	cortex	_	
8-54	1462-1463	.	_	

#Text=CHR-specific changes were also found in the connections between the superior frontal gyrus and calcarine cortex in the dominant state.
9-1	1464-1476	CHR-specific	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk	
9-2	1477-1484	changes	_	
9-3	1485-1489	were	_	
9-4	1490-1494	also	_	
9-5	1495-1500	found	_	
9-6	1501-1503	in	_	
9-7	1504-1507	the	_	
9-8	1508-1519	connections	_	
9-9	1520-1527	between	_	
9-10	1528-1531	the	_	
9-11	1532-1540	superior	_	
9-12	1541-1548	frontal	_	
9-13	1549-1554	gyrus	_	
9-14	1555-1558	and	_	
9-15	1559-1568	calcarine	_	
9-16	1569-1575	cortex	_	
9-17	1576-1578	in	_	
9-18	1579-1582	the	_	
9-19	1583-1591	dominant	_	
9-20	1592-1597	state	_	
9-21	1597-1598	.	_	

#Text=Our findings show that CHR individuals generally show an intermediate functional connectivity pattern between HCs and SZ patients but also have unique connectivity alterations.
#Text=1.
10-1	1599-1602	Our	_	
10-2	1603-1611	findings	_	
10-3	1612-1616	show	_	
10-4	1617-1621	that	_	
10-5	1622-1625	CHR	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk	
10-6	1626-1637	individuals	_	
10-7	1638-1647	generally	_	
10-8	1648-1652	show	_	
10-9	1653-1655	an	_	
10-10	1656-1668	intermediate	_	
10-11	1669-1679	functional	_	
10-12	1680-1692	connectivity	_	
10-13	1693-1700	pattern	_	
10-14	1701-1708	between	_	
10-15	1709-1712	HCs	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
10-16	1713-1716	and	_	
10-17	1717-1719	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
10-18	1720-1728	patients	_	
10-19	1729-1732	but	_	
10-20	1733-1737	also	_	
10-21	1738-1742	have	_	
10-22	1743-1749	unique	_	
10-23	1750-1762	connectivity	_	
10-24	1763-1774	alterations	_	
10-25	1774-1775	.	_	
10-26	1776-1777	1	_	
10-27	1777-1778	.	_	

#Text=Introduction
#Text=In many patients with schizophrenia, a prodromal phase is evident before the onset of the full syndrome, characterized by attenuated psychotic symptoms and deterioration in functioning.
11-1	1779-1791	Introduction	_	
11-2	1792-1794	In	_	
11-3	1795-1799	many	_	
11-4	1800-1808	patients	_	
11-5	1809-1813	with	_	
11-6	1814-1827	schizophrenia	_	
11-7	1827-1828	,	_	
11-8	1829-1830	a	_	
11-9	1831-1840	prodromal	_	
11-10	1841-1846	phase	_	
11-11	1847-1849	is	_	
11-12	1850-1857	evident	_	
11-13	1858-1864	before	_	
11-14	1865-1868	the	_	
11-15	1869-1874	onset	_	
11-16	1875-1877	of	_	
11-17	1878-1881	the	_	
11-18	1882-1886	full	_	
11-19	1887-1895	syndrome	_	
11-20	1895-1896	,	_	
11-21	1897-1910	characterized	_	
11-22	1911-1913	by	_	
11-23	1914-1924	attenuated	_	
11-24	1925-1934	psychotic	_	
11-25	1935-1943	symptoms	_	
11-26	1944-1947	and	_	
11-27	1948-1961	deterioration	_	
11-28	1962-1964	in	_	
11-29	1965-1976	functioning	_	
11-30	1976-1977	.	_	

#Text=Clinical criteria have been developed to identify individuals exhibiting these putatively prodromal symptoms, and individuals meeting these criteria have been shown to be at clinical high risk (CHR) for development of a full-blown psychotic disorder.
12-1	1978-1986	Clinical	_	
12-2	1987-1995	criteria	_	
12-3	1996-2000	have	_	
12-4	2001-2005	been	_	
12-5	2006-2015	developed	_	
12-6	2016-2018	to	_	
12-7	2019-2027	identify	_	
12-8	2028-2039	individuals	_	
12-9	2040-2050	exhibiting	_	
12-10	2051-2056	these	_	
12-11	2057-2067	putatively	_	
12-12	2068-2077	prodromal	_	
12-13	2078-2086	symptoms	_	
12-14	2086-2087	,	_	
12-15	2088-2091	and	_	
12-16	2092-2103	individuals	_	
12-17	2104-2111	meeting	_	
12-18	2112-2117	these	_	
12-19	2118-2126	criteria	_	
12-20	2127-2131	have	_	
12-21	2132-2136	been	_	
12-22	2137-2142	shown	_	
12-23	2143-2145	to	_	
12-24	2146-2148	be	_	
12-25	2149-2151	at	_	
12-26	2152-2160	clinical	_	
12-27	2161-2165	high	_	
12-28	2166-2170	risk	_	
12-29	2171-2172	(	_	
12-30	2172-2175	CHR	_	
12-31	2175-2176	)	_	
12-32	2177-2180	for	_	
12-33	2181-2192	development	_	
12-34	2193-2195	of	_	
12-35	2196-2197	a	_	
12-36	2198-2208	full-blown	_	
12-37	2209-2218	psychotic	_	
12-38	2219-2227	disorder	_	
12-39	2227-2228	.	_	

#Text=Among CHR individuals, a subset (about 35%) converts to full-blown psychosis within 2.5 years of initial recruitment into longitudinal study protocols.
13-1	2229-2234	Among	_	
13-2	2235-2238	CHR	_	
13-3	2239-2250	individuals	_	
13-4	2250-2251	,	_	
13-5	2252-2253	a	_	
13-6	2254-2260	subset	_	
13-7	2261-2262	(	_	
13-8	2262-2267	about	_	
13-9	2268-2271	35%	_	
13-10	2271-2272	)	_	
13-11	2273-2281	converts	_	
13-12	2282-2284	to	_	
13-13	2285-2295	full-blown	_	
13-14	2296-2305	psychosis	_	
13-15	2306-2312	within	_	
13-16	2313-2316	2.5	_	
13-17	2317-2322	years	_	
13-18	2323-2325	of	_	
13-19	2326-2333	initial	_	
13-20	2334-2345	recruitment	_	
13-21	2346-2350	into	_	
13-22	2351-2363	longitudinal	_	
13-23	2364-2369	study	_	
13-24	2370-2379	protocols	_	
13-25	2379-2380	.	_	

#Text=CHR individuals are generally in some clinical distress and help-seeking, underscoring the fact that they are currently symptomatic and not simply at risk for future psychosis.
14-1	2381-2384	CHR	_	
14-2	2385-2396	individuals	_	
14-3	2397-2400	are	_	
14-4	2401-2410	generally	_	
14-5	2411-2413	in	_	
14-6	2414-2418	some	_	
14-7	2419-2427	clinical	_	
14-8	2428-2436	distress	_	
14-9	2437-2440	and	_	
14-10	2441-2453	help-seeking	_	
14-11	2453-2454	,	_	
14-12	2455-2467	underscoring	_	
14-13	2468-2471	the	_	
14-14	2472-2476	fact	_	
14-15	2477-2481	that	_	
14-16	2482-2486	they	_	
14-17	2487-2490	are	_	
14-18	2491-2500	currently	_	
14-19	2501-2512	symptomatic	_	
14-20	2513-2516	and	_	
14-21	2517-2520	not	_	
14-22	2521-2527	simply	_	
14-23	2528-2530	at	_	
14-24	2531-2535	risk	_	
14-25	2536-2539	for	_	
14-26	2540-2546	future	_	
14-27	2547-2556	psychosis	_	
14-28	2556-2557	.	_	

#Text=The neural substrates associated with the CHR syndrome are just beginning to be characterized, and research efforts are underway to elucidate brain abnormalities underlying this syndrome as well as to improve identification of which CHR individuals will later develop a psychotic disorder.
15-1	2558-2561	The	_	
15-2	2562-2568	neural	_	
15-3	2569-2579	substrates	_	
15-4	2580-2590	associated	_	
15-5	2591-2595	with	_	
15-6	2596-2599	the	_	
15-7	2600-2603	CHR	_	
15-8	2604-2612	syndrome	_	
15-9	2613-2616	are	_	
15-10	2617-2621	just	_	
15-11	2622-2631	beginning	_	
15-12	2632-2634	to	_	
15-13	2635-2637	be	_	
15-14	2638-2651	characterized	_	
15-15	2651-2652	,	_	
15-16	2653-2656	and	_	
15-17	2657-2665	research	_	
15-18	2666-2673	efforts	_	
15-19	2674-2677	are	_	
15-20	2678-2686	underway	_	
15-21	2687-2689	to	_	
15-22	2690-2699	elucidate	_	
15-23	2700-2705	brain	_	
15-24	2706-2719	abnormalities	_	
15-25	2720-2730	underlying	_	
15-26	2731-2735	this	_	
15-27	2736-2744	syndrome	_	
15-28	2745-2747	as	_	
15-29	2748-2752	well	_	
15-30	2753-2755	as	_	
15-31	2756-2758	to	_	
15-32	2759-2766	improve	_	
15-33	2767-2781	identification	_	
15-34	2782-2784	of	_	
15-35	2785-2790	which	_	
15-36	2791-2794	CHR	_	
15-37	2795-2806	individuals	_	
15-38	2807-2811	will	_	
15-39	2812-2817	later	_	
15-40	2818-2825	develop	_	
15-41	2826-2827	a	_	
15-42	2828-2837	psychotic	_	
15-43	2838-2846	disorder	_	
15-44	2846-2847	.	_	

#Text=There has been research using structural and functional imaging data to study CHR individuals.
16-1	2848-2853	There	_	
16-2	2854-2857	has	_	
16-3	2858-2862	been	_	
16-4	2863-2871	research	_	
16-5	2872-2877	using	_	
16-6	2878-2888	structural	_	
16-7	2889-2892	and	_	
16-8	2893-2903	functional	_	
16-9	2904-2911	imaging	_	
16-10	2912-2916	data	_	
16-11	2917-2919	to	_	
16-12	2920-2925	study	_	
16-13	2926-2929	CHR	_	
16-14	2930-2941	individuals	_	
16-15	2941-2942	.	_	

#Text=Both task-based and resting-state functional magnetic resonance imaging (fMRI) data have been employed to investigate functional activation and connectivity in CHR individuals.
17-1	2943-2947	Both	_	
17-2	2948-2958	task-based	_	
17-3	2959-2962	and	_	
17-4	2963-2976	resting-state	_	
17-5	2977-2987	functional	_	
17-6	2988-2996	magnetic	_	
17-7	2997-3006	resonance	_	
17-8	3007-3014	imaging	_	
17-9	3015-3016	(	_	
17-10	3016-3020	fMRI	_	
17-11	3020-3021	)	_	
17-12	3022-3026	data	_	
17-13	3027-3031	have	_	
17-14	3032-3036	been	_	
17-15	3037-3045	employed	_	
17-16	3046-3048	to	_	
17-17	3049-3060	investigate	_	
17-18	3061-3071	functional	_	
17-19	3072-3082	activation	_	
17-20	3083-3086	and	_	
17-21	3087-3099	connectivity	_	
17-22	3100-3102	in	_	
17-23	3103-3106	CHR	_	
17-24	3107-3118	individuals	_	
17-25	3118-3119	.	_	

#Text=Reported differences using fMRI in CHR individuals, relative to healthy controls (HCs), have mainly involved the prefrontal, temporal, anterior cingulate and cerebellar regions that also showed abnormalities in patients with first episode psychosis.
18-1	3120-3128	Reported	_	
18-2	3129-3140	differences	_	
18-3	3141-3146	using	_	
18-4	3147-3151	fMRI	_	
18-5	3152-3154	in	_	
18-6	3155-3158	CHR	_	
18-7	3159-3170	individuals	_	
18-8	3170-3171	,	_	
18-9	3172-3180	relative	_	
18-10	3181-3183	to	_	
18-11	3184-3191	healthy	_	
18-12	3192-3200	controls	_	
18-13	3201-3202	(	_	
18-14	3202-3205	HCs	_	
18-15	3205-3206	)	_	
18-16	3206-3207	,	_	
18-17	3208-3212	have	_	
18-18	3213-3219	mainly	_	
18-19	3220-3228	involved	_	
18-20	3229-3232	the	_	
18-21	3233-3243	prefrontal	_	
18-22	3243-3244	,	_	
18-23	3245-3253	temporal	_	
18-24	3253-3254	,	_	
18-25	3255-3263	anterior	_	
18-26	3264-3273	cingulate	_	
18-27	3274-3277	and	_	
18-28	3278-3288	cerebellar	_	
18-29	3289-3296	regions	_	
18-30	3297-3301	that	_	
18-31	3302-3306	also	_	
18-32	3307-3313	showed	_	
18-33	3314-3327	abnormalities	_	
18-34	3328-3330	in	_	
18-35	3331-3339	patients	_	
18-36	3340-3344	with	_	
18-37	3345-3350	first	_	
18-38	3351-3358	episode	_	
18-39	3359-3368	psychosis	_	
18-40	3368-3369	.	_	

#Text=Functional connectivity (FC) derived from resting-state fMRI reflects the functionally integrated relationship between spatially separated brain regions, and may provide biomarkers for mental disorders.
19-1	3370-3380	Functional	_	
19-2	3381-3393	connectivity	_	
19-3	3394-3395	(	_	
19-4	3395-3397	FC	_	
19-5	3397-3398	)	_	
19-6	3399-3406	derived	_	
19-7	3407-3411	from	_	
19-8	3412-3425	resting-state	_	
19-9	3426-3430	fMRI	_	
19-10	3431-3439	reflects	_	
19-11	3440-3443	the	_	
19-12	3444-3456	functionally	_	
19-13	3457-3467	integrated	_	
19-14	3468-3480	relationship	_	
19-15	3481-3488	between	_	
19-16	3489-3498	spatially	_	
19-17	3499-3508	separated	_	
19-18	3509-3514	brain	_	
19-19	3515-3522	regions	_	
19-20	3522-3523	,	_	
19-21	3524-3527	and	_	
19-22	3528-3531	may	_	
19-23	3532-3539	provide	_	
19-24	3540-3550	biomarkers	_	
19-25	3551-3554	for	_	
19-26	3555-3561	mental	_	
19-27	3562-3571	disorders	_	
19-28	3571-3572	.	_	

#Text=Most previous FC studies including CHR individuals have investigated networks seeded from a priori defined regions of interest (ROIs) (e.g., thalamus, superior temporal gyrus, posterior cingulate cortex and cerebellum) by computing connectivity between a specific ROI and other voxels in whole brain.
20-1	3573-3577	Most	_	
20-2	3578-3586	previous	_	
20-3	3587-3589	FC	_	
20-4	3590-3597	studies	_	
20-5	3598-3607	including	_	
20-6	3608-3611	CHR	_	
20-7	3612-3623	individuals	_	
20-8	3624-3628	have	_	
20-9	3629-3641	investigated	_	
20-10	3642-3650	networks	_	
20-11	3651-3657	seeded	_	
20-12	3658-3662	from	_	
20-13	3663-3664	a	_	
20-14	3665-3671	priori	_	
20-15	3672-3679	defined	_	
20-16	3680-3687	regions	_	
20-17	3688-3690	of	_	
20-18	3691-3699	interest	_	
20-19	3700-3701	(	_	
20-20	3701-3705	ROIs	_	
20-21	3705-3706	)	_	
20-22	3707-3708	(	_	
20-23	3708-3711	e.g	_	
20-24	3711-3712	.	_	
20-25	3712-3713	,	_	
20-26	3714-3722	thalamus	_	
20-27	3722-3723	,	_	
20-28	3724-3732	superior	_	
20-29	3733-3741	temporal	_	
20-30	3742-3747	gyrus	_	
20-31	3747-3748	,	_	
20-32	3749-3758	posterior	_	
20-33	3759-3768	cingulate	_	
20-34	3769-3775	cortex	_	
20-35	3776-3779	and	_	
20-36	3780-3790	cerebellum	_	
20-37	3790-3791	)	_	
20-38	3792-3794	by	_	
20-39	3795-3804	computing	_	
20-40	3805-3817	connectivity	_	
20-41	3818-3825	between	_	
20-42	3826-3827	a	_	
20-43	3828-3836	specific	_	
20-44	3837-3840	ROI	_	
20-45	3841-3844	and	_	
20-46	3845-3850	other	_	
20-47	3851-3857	voxels	_	
20-48	3858-3860	in	_	
20-49	3861-3866	whole	_	
20-50	3867-3872	brain	_	
20-51	3872-3873	.	_	

#Text=To our knowledge, no prior work has investigated whole-brain pair-wise FCs in CHR individuals using resting-state fMRI data.
21-1	3874-3876	To	_	
21-2	3877-3880	our	_	
21-3	3881-3890	knowledge	_	
21-4	3890-3891	,	_	
21-5	3892-3894	no	_	
21-6	3895-3900	prior	_	
21-7	3901-3905	work	_	
21-8	3906-3909	has	_	
21-9	3910-3922	investigated	_	
21-10	3923-3934	whole-brain	_	
21-11	3935-3944	pair-wise	_	
21-12	3945-3948	FCs	_	
21-13	3949-3951	in	_	
21-14	3952-3955	CHR	_	
21-15	3956-3967	individuals	_	
21-16	3968-3973	using	_	
21-17	3974-3987	resting-state	_	
21-18	3988-3992	fMRI	_	
21-19	3993-3997	data	_	
21-20	3997-3998	.	_	

#Text=Moreover, the above mentioned research employed static FC (SFC) analyses, which assume that FC is unchanging across the scan acquisition period.
22-1	3999-4007	Moreover	_	
22-2	4007-4008	,	_	
22-3	4009-4012	the	_	
22-4	4013-4018	above	_	
22-5	4019-4028	mentioned	_	
22-6	4029-4037	research	_	
22-7	4038-4046	employed	_	
22-8	4047-4053	static	_	
22-9	4054-4056	FC	_	
22-10	4057-4058	(	_	
22-11	4058-4061	SFC	_	
22-12	4061-4062	)	_	
22-13	4063-4071	analyses	_	
22-14	4071-4072	,	_	
22-15	4073-4078	which	_	
22-16	4079-4085	assume	_	
22-17	4086-4090	that	_	
22-18	4091-4093	FC	_	
22-19	4094-4096	is	_	
22-20	4097-4107	unchanging	_	
22-21	4108-4114	across	_	
22-22	4115-4118	the	_	
22-23	4119-4123	scan	_	
22-24	4124-4135	acquisition	_	
22-25	4136-4142	period	_	
22-26	4142-4143	.	_	

#Text=However, recent studies have provided evidence that FC can be time-varying over periods of tens of seconds, evident during a few minutes of scans.
23-1	4144-4151	However	_	
23-2	4151-4152	,	_	
23-3	4153-4159	recent	_	
23-4	4160-4167	studies	_	
23-5	4168-4172	have	_	
23-6	4173-4181	provided	_	
23-7	4182-4190	evidence	_	
23-8	4191-4195	that	_	
23-9	4196-4198	FC	_	
23-10	4199-4202	can	_	
23-11	4203-4205	be	_	
23-12	4206-4218	time-varying	_	
23-13	4219-4223	over	_	
23-14	4224-4231	periods	_	
23-15	4232-4234	of	_	
23-16	4235-4239	tens	_	
23-17	4240-4242	of	_	
23-18	4243-4250	seconds	_	
23-19	4250-4251	,	_	
23-20	4252-4259	evident	_	
23-21	4260-4266	during	_	
23-22	4267-4268	a	_	
23-23	4269-4272	few	_	
23-24	4273-4280	minutes	_	
23-25	4281-4283	of	_	
23-26	4284-4289	scans	_	
23-27	4289-4290	.	_	

#Text=Here we report the first study to examine whole-brain dynamic FC (DFC) in CHR individuals and patients in the early stages of schizophrenia using resting-state fMRI data.
24-1	4291-4295	Here	_	
24-2	4296-4298	we	_	
24-3	4299-4305	report	_	
24-4	4306-4309	the	_	
24-5	4310-4315	first	_	
24-6	4316-4321	study	_	
24-7	4322-4324	to	_	
24-8	4325-4332	examine	_	
24-9	4333-4344	whole-brain	_	
24-10	4345-4352	dynamic	_	
24-11	4353-4355	FC	_	
24-12	4356-4357	(	_	
24-13	4357-4360	DFC	_	
24-14	4360-4361	)	_	
24-15	4362-4364	in	_	
24-16	4365-4368	CHR	_	
24-17	4369-4380	individuals	_	
24-18	4381-4384	and	_	
24-19	4385-4393	patients	_	
24-20	4394-4396	in	_	
24-21	4397-4400	the	_	
24-22	4401-4406	early	_	
24-23	4407-4413	stages	_	
24-24	4414-4416	of	_	
24-25	4417-4430	schizophrenia	_	
24-26	4431-4436	using	_	
24-27	4437-4450	resting-state	_	
24-28	4451-4455	fMRI	_	
24-29	4456-4460	data	_	
24-30	4460-4461	.	_	

#Text=DFC can be captured using a sliding time-window method.
25-1	4462-4465	DFC	_	
25-2	4466-4469	can	_	
25-3	4470-4472	be	_	
25-4	4473-4481	captured	_	
25-5	4482-4487	using	_	
25-6	4488-4489	a	_	
25-7	4490-4497	sliding	_	
25-8	4498-4509	time-window	_	
25-9	4510-4516	method	_	
25-10	4516-4517	.	_	

#Text=Different connectivity states, reflecting specific configurations of connected regions, can be revealed by post-hoc analyses of DFC, so alterations in connectivity states among different clinical populations might provide unique or additional biomarkers of disorders not detectable with SFC measures.
26-1	4518-4527	Different	_	
26-2	4528-4540	connectivity	_	
26-3	4541-4547	states	_	
26-4	4547-4548	,	_	
26-5	4549-4559	reflecting	_	
26-6	4560-4568	specific	_	
26-7	4569-4583	configurations	_	
26-8	4584-4586	of	_	
26-9	4587-4596	connected	_	
26-10	4597-4604	regions	_	
26-11	4604-4605	,	_	
26-12	4606-4609	can	_	
26-13	4610-4612	be	_	
26-14	4613-4621	revealed	_	
26-15	4622-4624	by	_	
26-16	4625-4633	post-hoc	_	
26-17	4634-4642	analyses	_	
26-18	4643-4645	of	_	
26-19	4646-4649	DFC	_	
26-20	4649-4650	,	_	
26-21	4651-4653	so	_	
26-22	4654-4665	alterations	_	
26-23	4666-4668	in	_	
26-24	4669-4681	connectivity	_	
26-25	4682-4688	states	_	
26-26	4689-4694	among	_	
26-27	4695-4704	different	_	
26-28	4705-4713	clinical	_	
26-29	4714-4725	populations	_	
26-30	4726-4731	might	_	
26-31	4732-4739	provide	_	
26-32	4740-4746	unique	_	
26-33	4747-4749	or	_	
26-34	4750-4760	additional	_	
26-35	4761-4771	biomarkers	_	
26-36	4772-4774	of	_	
26-37	4775-4784	disorders	_	
26-38	4785-4788	not	_	
26-39	4789-4799	detectable	_	
26-40	4800-4804	with	_	
26-41	4805-4808	SFC	_	
26-42	4809-4817	measures	_	
26-43	4817-4818	.	_	

#Text=There has been considerable work using DFC analyses to investigate impairments in schizophrenia-spectrum disorders and mood disorders as well as classifying individual patients based on DFC measures.
27-1	4819-4824	There	_	
27-2	4825-4828	has	_	
27-3	4829-4833	been	_	
27-4	4834-4846	considerable	_	
27-5	4847-4851	work	_	
27-6	4852-4857	using	_	
27-7	4858-4861	DFC	_	
27-8	4862-4870	analyses	_	
27-9	4871-4873	to	_	
27-10	4874-4885	investigate	_	
27-11	4886-4897	impairments	_	
27-12	4898-4900	in	_	
27-13	4901-4923	schizophrenia-spectrum	_	
27-14	4924-4933	disorders	_	
27-15	4934-4937	and	_	
27-16	4938-4942	mood	_	
27-17	4943-4952	disorders	_	
27-18	4953-4955	as	_	
27-19	4956-4960	well	_	
27-20	4961-4963	as	_	
27-21	4964-4975	classifying	_	
27-22	4976-4986	individual	_	
27-23	4987-4995	patients	_	
27-24	4996-5001	based	_	
27-25	5002-5004	on	_	
27-26	5005-5008	DFC	_	
27-27	5009-5017	measures	_	
27-28	5017-5018	.	_	

#Text=Researchers have applied clustering, principal components analysis (PCA), Fisher discrimination dictionary learning (FDDL), and spatial and temporal independent components analysis (ICA) to extract connectivity states.
28-1	5019-5030	Researchers	_	
28-2	5031-5035	have	_	
28-3	5036-5043	applied	_	
28-4	5044-5054	clustering	_	
28-5	5054-5055	,	_	
28-6	5056-5065	principal	_	
28-7	5066-5076	components	_	
28-8	5077-5085	analysis	_	
28-9	5086-5087	(	_	
28-10	5087-5090	PCA	_	
28-11	5090-5091	)	_	
28-12	5091-5092	,	_	
28-13	5093-5099	Fisher	_	
28-14	5100-5114	discrimination	_	
28-15	5115-5125	dictionary	_	
28-16	5126-5134	learning	_	
28-17	5135-5136	(	_	
28-18	5136-5140	FDDL	_	
28-19	5140-5141	)	_	
28-20	5141-5142	,	_	
28-21	5143-5146	and	_	
28-22	5147-5154	spatial	_	
28-23	5155-5158	and	_	
28-24	5159-5167	temporal	_	
28-25	5168-5179	independent	_	
28-26	5180-5190	components	_	
28-27	5191-5199	analysis	_	
28-28	5200-5201	(	_	
28-29	5201-5204	ICA	_	
28-30	5204-5205	)	_	
28-31	5206-5208	to	_	
28-32	5209-5216	extract	_	
28-33	5217-5229	connectivity	_	
28-34	5230-5236	states	_	
28-35	5236-5237	.	_	

#Text=These methods typically estimate connectivity states with discrepant patterns due to their different assumptions.
29-1	5238-5243	These	_	
29-2	5244-5251	methods	_	
29-3	5252-5261	typically	_	
29-4	5262-5270	estimate	_	
29-5	5271-5283	connectivity	_	
29-6	5284-5290	states	_	
29-7	5291-5295	with	_	
29-8	5296-5306	discrepant	_	
29-9	5307-5315	patterns	_	
29-10	5316-5319	due	_	
29-11	5320-5322	to	_	
29-12	5323-5328	their	_	
29-13	5329-5338	different	_	
29-14	5339-5350	assumptions	_	
29-15	5350-5351	.	_	

#Text=Clustering approaches may fail to converge when working on “noisy” data that do not necessarily have desirable distributions.
30-1	5352-5362	Clustering	_	
30-2	5363-5373	approaches	_	
30-3	5374-5377	may	_	
30-4	5378-5382	fail	_	
30-5	5383-5385	to	_	
30-6	5386-5394	converge	_	
30-7	5395-5399	when	_	
30-8	5400-5407	working	_	
30-9	5408-5410	on	_	
30-10	5411-5412	“	_	
30-11	5412-5417	noisy	_	
30-12	5417-5418	”	_	
30-13	5419-5423	data	_	
30-14	5424-5428	that	_	
30-15	5429-5431	do	_	
30-16	5432-5435	not	_	
30-17	5436-5447	necessarily	_	
30-18	5448-5452	have	_	
30-19	5453-5462	desirable	_	
30-20	5463-5476	distributions	_	
30-21	5476-5477	.	_	

#Text=A more serious shortcoming of clustering is that the method always can yield a partition with any given number of clusters, regardless if the used features show patterns indicating clusters.
31-1	5478-5479	A	_	
31-2	5480-5484	more	_	
31-3	5485-5492	serious	_	
31-4	5493-5504	shortcoming	_	
31-5	5505-5507	of	_	
31-6	5508-5518	clustering	_	
31-7	5519-5521	is	_	
31-8	5522-5526	that	_	
31-9	5527-5530	the	_	
31-10	5531-5537	method	_	
31-11	5538-5544	always	_	
31-12	5545-5548	can	_	
31-13	5549-5554	yield	_	
31-14	5555-5556	a	_	
31-15	5557-5566	partition	_	
31-16	5567-5571	with	_	
31-17	5572-5575	any	_	
31-18	5576-5581	given	_	
31-19	5582-5588	number	_	
31-20	5589-5591	of	_	
31-21	5592-5600	clusters	_	
31-22	5600-5601	,	_	
31-23	5602-5612	regardless	_	
31-24	5613-5615	if	_	
31-25	5616-5619	the	_	
31-26	5620-5624	used	_	
31-27	5625-5633	features	_	
31-28	5634-5638	show	_	
31-29	5639-5647	patterns	_	
31-30	5648-5658	indicating	_	
31-31	5659-5667	clusters	_	
31-32	5667-5668	.	_	

#Text=Most previous decomposition-based work has focused on group-level connectivity states that are common across subjects.
32-1	5669-5673	Most	_	
32-2	5674-5682	previous	_	
32-3	5683-5702	decomposition-based	_	
32-4	5703-5707	work	_	
32-5	5708-5711	has	_	
32-6	5712-5719	focused	_	
32-7	5720-5722	on	_	
32-8	5723-5734	group-level	_	
32-9	5735-5747	connectivity	_	
32-10	5748-5754	states	_	
32-11	5755-5759	that	_	
32-12	5760-5763	are	_	
32-13	5764-5770	common	_	
32-14	5771-5777	across	_	
32-15	5778-5786	subjects	_	
32-16	5786-5787	.	_	

#Text=To overcome some of the methodological limitations of the traditional DFC approaches, we have developed a novel group information guided ICA (GIG-ICA) framework to analyze DFC.
33-1	5788-5790	To	_	
33-2	5791-5799	overcome	_	
33-3	5800-5804	some	_	
33-4	5805-5807	of	_	
33-5	5808-5811	the	_	
33-6	5812-5826	methodological	_	
33-7	5827-5838	limitations	_	
33-8	5839-5841	of	_	
33-9	5842-5845	the	_	
33-10	5846-5857	traditional	_	
33-11	5858-5861	DFC	_	
33-12	5862-5872	approaches	_	
33-13	5872-5873	,	_	
33-14	5874-5876	we	_	
33-15	5877-5881	have	_	
33-16	5882-5891	developed	_	
33-17	5892-5893	a	_	
33-18	5894-5899	novel	_	
33-19	5900-5905	group	_	
33-20	5906-5917	information	_	
33-21	5918-5924	guided	_	
33-22	5925-5928	ICA	_	
33-23	5929-5930	(	_	
33-24	5930-5937	GIG-ICA	_	
33-25	5937-5938	)	_	
33-26	5939-5948	framework	_	
33-27	5949-5951	to	_	
33-28	5952-5959	analyze	_	
33-29	5960-5963	DFC	_	
33-30	5963-5964	.	_	

#Text=Guided by the group-level connectivity states, our method can extract the subject-specific connectivity states using a multiple-objective optimization framework.
34-1	5965-5971	Guided	_	
34-2	5972-5974	by	_	
34-3	5975-5978	the	_	
34-4	5979-5990	group-level	_	
34-5	5991-6003	connectivity	_	
34-6	6004-6010	states	_	
34-7	6010-6011	,	_	
34-8	6012-6015	our	_	
34-9	6016-6022	method	_	
34-10	6023-6026	can	_	
34-11	6027-6034	extract	_	
34-12	6035-6038	the	_	
34-13	6039-6055	subject-specific	_	
34-14	6056-6068	connectivity	_	
34-15	6069-6075	states	_	
34-16	6076-6081	using	_	
34-17	6082-6083	a	_	
34-18	6084-6102	multiple-objective	_	
34-19	6103-6115	optimization	_	
34-20	6116-6125	framework	_	
34-21	6125-6126	.	_	

#Text=The subject-specific states are directly comparable across subjects, which benefits the exploration of disease biomarkers.
35-1	6127-6130	The	_	
35-2	6131-6147	subject-specific	_	
35-3	6148-6154	states	_	
35-4	6155-6158	are	_	
35-5	6159-6167	directly	_	
35-6	6168-6178	comparable	_	
35-7	6179-6185	across	_	
35-8	6186-6194	subjects	_	
35-9	6194-6195	,	_	
35-10	6196-6201	which	_	
35-11	6202-6210	benefits	_	
35-12	6211-6214	the	_	
35-13	6215-6226	exploration	_	
35-14	6227-6229	of	_	
35-15	6230-6237	disease	_	
35-16	6238-6248	biomarkers	_	
35-17	6248-6249	.	_	

#Text=In our previous work using the proposed method, we detected group differences among a spectrum of symptomatically-related disorders including bipolar disorder with psychosis, schizoaffective disorder and schizophrenia, suggesting that our dynamic connectivity analysis method is able to identify potential biomarkers that were not evident using the conventional static connectivity analysis.
36-1	6250-6252	In	_	
36-2	6253-6256	our	_	
36-3	6257-6265	previous	_	
36-4	6266-6270	work	_	
36-5	6271-6276	using	_	
36-6	6277-6280	the	_	
36-7	6281-6289	proposed	_	
36-8	6290-6296	method	_	
36-9	6296-6297	,	_	
36-10	6298-6300	we	_	
36-11	6301-6309	detected	_	
36-12	6310-6315	group	_	
36-13	6316-6327	differences	_	
36-14	6328-6333	among	_	
36-15	6334-6335	a	_	
36-16	6336-6344	spectrum	_	
36-17	6345-6347	of	_	
36-18	6348-6371	symptomatically-related	_	
36-19	6372-6381	disorders	_	
36-20	6382-6391	including	_	
36-21	6392-6399	bipolar	_	
36-22	6400-6408	disorder	_	
36-23	6409-6413	with	_	
36-24	6414-6423	psychosis	_	
36-25	6423-6424	,	_	
36-26	6425-6440	schizoaffective	_	
36-27	6441-6449	disorder	_	
36-28	6450-6453	and	_	
36-29	6454-6467	schizophrenia	_	
36-30	6467-6468	,	_	
36-31	6469-6479	suggesting	_	
36-32	6480-6484	that	_	
36-33	6485-6488	our	_	
36-34	6489-6496	dynamic	_	
36-35	6497-6509	connectivity	_	
36-36	6510-6518	analysis	_	
36-37	6519-6525	method	_	
36-38	6526-6528	is	_	
36-39	6529-6533	able	_	
36-40	6534-6536	to	_	
36-41	6537-6545	identify	_	
36-42	6546-6555	potential	_	
36-43	6556-6566	biomarkers	_	
36-44	6567-6571	that	_	
36-45	6572-6576	were	_	
36-46	6577-6580	not	_	
36-47	6581-6588	evident	_	
36-48	6589-6594	using	_	
36-49	6595-6598	the	_	
36-50	6599-6611	conventional	_	
36-51	6612-6618	static	_	
36-52	6619-6631	connectivity	_	
36-53	6632-6640	analysis	_	
36-54	6640-6641	.	_	

#Text=Both hypo-connectivities and hyper-connectivities were observed for those diagnoses, and interestingly the connections’ strengths had reasonable associations with the symptom scores.
37-1	6642-6646	Both	_	
37-2	6647-6666	hypo-connectivities	_	
37-3	6667-6670	and	_	
37-4	6671-6691	hyper-connectivities	_	
37-5	6692-6696	were	_	
37-6	6697-6705	observed	_	
37-7	6706-6709	for	_	
37-8	6710-6715	those	_	
37-9	6716-6725	diagnoses	_	
37-10	6725-6726	,	_	
37-11	6727-6730	and	_	
37-12	6731-6744	interestingly	_	
37-13	6745-6748	the	_	
37-14	6749-6760	connections	_	
37-15	6760-6761	’	_	
37-16	6762-6771	strengths	_	
37-17	6772-6775	had	_	
37-18	6776-6786	reasonable	_	
37-19	6787-6799	associations	_	
37-20	6800-6804	with	_	
37-21	6805-6808	the	_	
37-22	6809-6816	symptom	_	
37-23	6817-6823	scores	_	
37-24	6823-6824	.	_	

#Text=In the present study, we applied the method to the resting-state fMRI data of HCs, CHR individuals and early illness schizophrenia (ESZ) patients, aiming to find DFC characteristics that differentiate these groups.
38-1	6825-6827	In	_	
38-2	6828-6831	the	_	
38-3	6832-6839	present	_	
38-4	6840-6845	study	_	
38-5	6845-6846	,	_	
38-6	6847-6849	we	_	
38-7	6850-6857	applied	_	
38-8	6858-6861	the	_	
38-9	6862-6868	method	_	
38-10	6869-6871	to	_	
38-11	6872-6875	the	_	
38-12	6876-6889	resting-state	_	
38-13	6890-6894	fMRI	_	
38-14	6895-6899	data	_	
38-15	6900-6902	of	_	
38-16	6903-6906	HCs	_	
38-17	6906-6907	,	_	
38-18	6908-6911	CHR	_	
38-19	6912-6923	individuals	_	
38-20	6924-6927	and	_	
38-21	6928-6933	early	_	
38-22	6934-6941	illness	_	
38-23	6942-6955	schizophrenia	_	
38-24	6956-6957	(	_	
38-25	6957-6960	ESZ	_	
38-26	6960-6961	)	_	
38-27	6962-6970	patients	_	
38-28	6970-6971	,	_	
38-29	6972-6978	aiming	_	
38-30	6979-6981	to	_	
38-31	6982-6986	find	_	
38-32	6987-6990	DFC	_	
38-33	6991-7006	characteristics	_	
38-34	7007-7011	that	_	
38-35	7012-7025	differentiate	_	
38-36	7026-7031	these	_	
38-37	7032-7038	groups	_	
38-38	7038-7039	.	_	

#Text=We hypothesized that CHR subjects would share several of DFC alterations apparent in ESZ, but would show intermediate changes between the HC and ESZ groups.
#Text=2.
39-1	7040-7042	We	_	
39-2	7043-7055	hypothesized	_	
39-3	7056-7060	that	_	
39-4	7061-7064	CHR	_	
39-5	7065-7073	subjects	_	
39-6	7074-7079	would	_	
39-7	7080-7085	share	_	
39-8	7086-7093	several	_	
39-9	7094-7096	of	_	
39-10	7097-7100	DFC	_	
39-11	7101-7112	alterations	_	
39-12	7113-7121	apparent	_	
39-13	7122-7124	in	_	
39-14	7125-7128	ESZ	_	
39-15	7128-7129	,	_	
39-16	7130-7133	but	_	
39-17	7134-7139	would	_	
39-18	7140-7144	show	_	
39-19	7145-7157	intermediate	_	
39-20	7158-7165	changes	_	
39-21	7166-7173	between	_	
39-22	7174-7177	the	_	
39-23	7178-7180	HC	_	
39-24	7181-7184	and	_	
39-25	7185-7188	ESZ	_	
39-26	7189-7195	groups	_	
39-27	7195-7196	.	_	
39-28	7197-7198	2	_	
39-29	7198-7199	.	_	

#Text=Materials and methods
#Text=2.1.
40-1	7200-7209	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[6]	
40-2	7210-7213	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[6]	
40-3	7214-7221	methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[6]	
40-4	7222-7225	2.1	_	
40-5	7225-7226	.	_	

#Text=Materials
#Text=Resting-state fMRI data from 70 HCs, 53 CHR individuals, and 58 ESZ patients were analyzed.
41-1	7227-7236	Materials	_	
41-2	7237-7250	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[8]	
41-3	7251-7255	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[8]	
41-4	7256-7260	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
41-5	7261-7265	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
41-6	7266-7268	70	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
41-7	7269-7272	HCs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[9]	
41-8	7272-7273	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
41-9	7274-7276	53	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
41-10	7277-7280	CHR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[10]	
41-11	7281-7292	individuals	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
41-12	7292-7293	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
41-13	7294-7297	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
41-14	7298-7300	58	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
41-15	7301-7304	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[11]	
41-16	7305-7313	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
41-17	7314-7318	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
41-18	7319-7327	analyzed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
41-19	7327-7328	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	

#Text=Table 1 shows the demographic and clinical information.
42-1	7329-7334	Table	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
42-2	7335-7336	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
42-3	7337-7342	shows	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
42-4	7343-7346	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
42-5	7347-7358	demographic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
42-6	7359-7362	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
42-7	7363-7371	clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
42-8	7372-7383	information	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
42-9	7383-7384	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	

#Text=There are no significant differences among the three groups on age or gender (p-value = 0.7 for gender examined by Chi Square test; p-value = 0.2 for age examined by analysis of variance).
43-1	7385-7390	There	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-2	7391-7394	are	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-3	7395-7397	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-4	7398-7409	significant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-5	7410-7421	differences	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-6	7422-7427	among	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-7	7428-7431	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-8	7432-7437	three	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-9	7438-7444	groups	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-10	7445-7447	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-11	7448-7451	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-12	7452-7454	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-13	7455-7461	gender	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-14	7462-7463	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-15	7463-7470	p-value	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-16	7471-7472	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-17	7473-7476	0.7	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-18	7477-7480	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-19	7481-7487	gender	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-20	7488-7496	examined	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-21	7497-7499	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-22	7500-7503	Chi	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-23	7504-7510	Square	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-24	7511-7515	test	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-25	7515-7516	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-26	7517-7524	p-value	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-27	7525-7526	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-28	7527-7530	0.2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-29	7531-7534	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-30	7535-7538	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-31	7539-7547	examined	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-32	7548-7550	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-33	7551-7559	analysis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-34	7560-7562	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-35	7563-7571	variance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-36	7571-7572	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
43-37	7572-7573	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	

#Text=CHR individuals were recruited from the University of California, San Francisco’s (UCSF) Prodromal Assessment, Research, and Treatment Clinic.
44-1	7574-7577	CHR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[12]	
44-2	7578-7589	individuals	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-3	7590-7594	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-4	7595-7604	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-5	7605-7609	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-6	7610-7613	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-7	7614-7624	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-8	7625-7627	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-9	7628-7638	California	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-10	7638-7639	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-11	7640-7643	San	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-12	7644-7653	Francisco	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-13	7653-7654	’	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-14	7654-7655	s	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-15	7656-7657	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-16	7657-7661	UCSF	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-17	7661-7662	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-18	7663-7672	Prodromal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-19	7673-7683	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-20	7683-7684	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-21	7685-7693	Research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-22	7693-7694	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-23	7695-7698	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-24	7699-7708	Treatment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-25	7709-7715	Clinic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
44-26	7715-7716	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	

#Text=Individuals recruited to the CHR group met the Criteria of Prodromal Syndromes (COPS) based on a Structured Interview for Prodromal Syndromes (SIPS).
45-1	7717-7728	Individuals	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-2	7729-7738	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-3	7739-7741	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-4	7742-7745	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-5	7746-7749	CHR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[13]	
45-6	7750-7755	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-7	7756-7759	met	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-8	7760-7763	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-9	7764-7772	Criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-10	7773-7775	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-11	7776-7785	Prodromal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-12	7786-7795	Syndromes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-13	7796-7797	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-14	7797-7801	COPS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-15	7801-7802	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-16	7803-7808	based	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-17	7809-7811	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-18	7812-7813	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
45-19	7814-7824	Structured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale[14]	
45-20	7825-7834	Interview	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale[14]	
45-21	7835-7838	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale[14]	
45-22	7839-7848	Prodromal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale[14]	
45-23	7849-7858	Syndromes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale[14]	
45-24	7859-7860	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale[14]	
45-25	7860-7864	SIPS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale[14]	
45-26	7864-7865	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale[14]	
45-27	7865-7866	.	_	

#Text=The COPS comprises three non-mutually exclusive syndromes: Attenuated Positive Symptom Syndrome (APSS), Brief Intermittent Psychotic Syndrome (BIPS), and/or Genetic Risk and Deterioration Syndrome (GRD).
46-1	7867-7870	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-2	7871-7875	COPS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-3	7876-7885	comprises	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-4	7886-7891	three	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-5	7892-7904	non-mutually	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-6	7905-7914	exclusive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-7	7915-7924	syndromes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-8	7924-7925	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-9	7926-7936	Attenuated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-10	7937-7945	Positive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-11	7946-7953	Symptom	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-12	7954-7962	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-13	7963-7964	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-14	7964-7968	APSS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-15	7968-7969	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-16	7969-7970	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-17	7971-7976	Brief	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome[16]	
46-18	7977-7989	Intermittent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome[16]	
46-19	7990-7999	Psychotic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome[16]	
46-20	8000-8008	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome[16]	
46-21	8009-8010	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome[16]	
46-22	8010-8014	BIPS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome[16]	
46-23	8014-8015	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome[16]	
46-24	8015-8016	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-25	8017-8020	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-26	8020-8021	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-27	8021-8023	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-28	8024-8031	Genetic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-29	8032-8036	Risk	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-30	8037-8040	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-31	8041-8054	Deterioration	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-32	8055-8063	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-33	8064-8065	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-34	8065-8068	GRD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-35	8068-8069	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
46-36	8069-8070	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=The majority (92.5%) of CHR subjects met COPS criteria for APSS.
47-1	8071-8074	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
47-2	8075-8083	majority	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
47-3	8084-8085	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
47-4	8085-8090	92.5%	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
47-5	8090-8091	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
47-6	8092-8094	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
47-7	8095-8098	CHR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[18]	
47-8	8099-8107	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
47-9	8108-8111	met	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
47-10	8112-8116	COPS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
47-11	8117-8125	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
47-12	8126-8129	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
47-13	8130-8134	APSS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
47-14	8134-8135	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	

#Text=Supplementary Table S1 shows the number and percentage of CHR subjects with each syndrome.
48-1	8136-8149	Supplementary	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-2	8150-8155	Table	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-3	8156-8158	S1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-4	8159-8164	shows	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-5	8165-8168	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-6	8169-8175	number	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-7	8176-8179	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-8	8180-8190	percentage	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-9	8191-8193	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-10	8194-8197	CHR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[19]	
48-11	8198-8206	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-12	8207-8211	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-13	8212-8216	each	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-14	8217-8225	syndrome	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-15	8225-8226	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=Clinical ratings of symptom severity in CHR individuals were obtained using the Scale of Prodromal Symptoms (SOPS), an embedded scale within the SIPS.
49-1	8227-8235	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-2	8236-8243	ratings	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-3	8244-8246	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-4	8247-8254	symptom	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-5	8255-8263	severity	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-6	8264-8266	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-7	8267-8270	CHR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[20]	
49-8	8271-8282	individuals	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-9	8283-8287	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-10	8288-8296	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-11	8297-8302	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-12	8303-8306	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-13	8307-8312	Scale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-14	8313-8315	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-15	8316-8325	Prodromal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-16	8326-8334	Symptoms	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-17	8335-8336	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-18	8336-8340	SOPS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-19	8340-8341	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-20	8341-8342	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-21	8343-8345	an	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-22	8346-8354	embedded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-23	8355-8360	scale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-24	8361-8367	within	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-25	8368-8371	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
49-26	8372-8376	SIPS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale[21]	
49-27	8376-8377	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=Most of the CHR subjects (41/53; 77%) were antipsychotic medication-naive at the time of scanning.
50-1	8378-8382	Most	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-2	8383-8385	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-3	8386-8389	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-4	8390-8393	CHR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[22]	
50-5	8394-8402	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-6	8403-8404	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-7	8404-8406	41	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-8	8406-8407	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-9	8407-8409	53	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-10	8409-8410	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-11	8411-8414	77%	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-12	8414-8415	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-13	8416-8420	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-14	8421-8434	antipsychotic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-15	8435-8451	medication-naive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-16	8452-8454	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-17	8455-8458	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-18	8459-8463	time	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-19	8464-8466	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-20	8467-8475	scanning	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
50-21	8475-8476	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=ESZ patients within mean ± standard deviation = 2.08 ± 1.37 years of illness onset were recruited from an early psychosis clinic at UCSF and from community clinics.
51-1	8477-8480	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[23]	
51-2	8481-8489	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-3	8490-8496	within	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-4	8497-8501	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-5	8502-8503	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-6	8504-8512	standard	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-7	8513-8522	deviation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-8	8523-8524	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-9	8525-8529	2.08	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-10	8530-8531	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-11	8532-8536	1.37	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-12	8537-8542	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-13	8543-8545	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-14	8546-8553	illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-15	8554-8559	onset	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-16	8560-8564	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-17	8565-8574	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-18	8575-8579	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-19	8580-8582	an	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-20	8583-8588	early	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-21	8589-8598	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-22	8599-8605	clinic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-23	8606-8608	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-24	8609-8613	UCSF	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-25	8614-8617	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-26	8618-8622	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-27	8623-8632	community	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-28	8633-8640	clinics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-29	8640-8641	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=Diagnosis of schizophrenia or schizoaffective disorder in ESZ participants was verified using the Structured Clinical Interview for DSM-IV (SCID), and symptom severity was assessed using the Positive and Negative Syndrome Scale (PANSS).
52-1	8642-8651	Diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-2	8652-8654	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-3	8655-8668	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[24]	
52-4	8669-8671	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-5	8672-8687	schizoaffective	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder[25]	
52-6	8688-8696	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder[25]	
52-7	8697-8699	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-8	8700-8703	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[26]	
52-9	8704-8716	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-10	8717-8720	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-11	8721-8729	verified	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-12	8730-8735	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-13	8736-8739	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-14	8740-8750	Structured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[27]	
52-15	8751-8759	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[27]	
52-16	8760-8769	Interview	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[27]	
52-17	8770-8773	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[27]	
52-18	8774-8780	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[27]	
52-19	8781-8782	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[27]	
52-20	8782-8786	SCID	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[27]	
52-21	8786-8787	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[27]	
52-22	8787-8788	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-23	8789-8792	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-24	8793-8800	symptom	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-25	8801-8809	severity	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-26	8810-8813	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-27	8814-8822	assessed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-28	8823-8828	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-29	8829-8832	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-30	8833-8841	Positive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[28]	
52-31	8842-8845	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[28]	
52-32	8846-8854	Negative	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[28]	
52-33	8855-8863	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[28]	
52-34	8864-8869	Scale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[28]	
52-35	8870-8871	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[28]	
52-36	8871-8876	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[28]	
52-37	8876-8877	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[28]	
52-38	8877-8878	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=Most ESZ patients (53/58; 91%) were taking antipsychotic medication at the time of testing.
53-1	8879-8883	Most	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-2	8884-8887	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[29]	
53-3	8888-8896	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-4	8897-8898	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-5	8898-8900	53	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-6	8900-8901	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-7	8901-8903	58	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-8	8903-8904	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-9	8905-8908	91%	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-10	8908-8909	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-11	8910-8914	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-12	8915-8921	taking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-13	8922-8935	antipsychotic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-14	8936-8946	medication	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-15	8947-8949	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-16	8950-8953	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-17	8954-8958	time	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-18	8959-8961	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-19	8962-8969	testing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
53-20	8969-8970	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=HCs were recruited from the community and did not meet criteria for any Axis I diagnosis based on the SCID.
54-1	8971-8974	HCs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[30]	
54-2	8975-8979	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-3	8980-8989	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-4	8990-8994	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-5	8995-8998	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-6	8999-9008	community	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-7	9009-9012	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-8	9013-9016	did	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-9	9017-9020	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-10	9021-9025	meet	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-11	9026-9034	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-12	9035-9038	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-13	9039-9042	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-14	9043-9047	Axis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-15	9048-9049	I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-16	9050-9059	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-17	9060-9065	based	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-18	9066-9068	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-19	9069-9072	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
54-20	9073-9077	SCID	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[31]	
54-21	9077-9078	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=Written informed consent was obtained from study participants under protocols approved by the Institutional Review Board at UCSF.
55-1	9079-9086	Written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-2	9087-9095	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-3	9096-9103	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-4	9104-9107	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-5	9108-9116	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-6	9117-9121	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-7	9122-9127	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-8	9128-9140	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-9	9141-9146	under	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-10	9147-9156	protocols	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-11	9157-9165	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-12	9166-9168	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-13	9169-9172	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-14	9173-9186	Institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-15	9187-9193	Review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-16	9194-9199	Board	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-17	9200-9202	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-18	9203-9207	UCSF	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
55-19	9207-9208	.	_	

#Text=All brain images were acquired on a 3T TIM TRIO scanner at the UCSF Neuroimaging Center.
56-1	9209-9212	All	_	
56-2	9213-9218	brain	_	
56-3	9219-9225	images	_	
56-4	9226-9230	were	_	
56-5	9231-9239	acquired	_	
56-6	9240-9242	on	_	
56-7	9243-9244	a	_	
56-8	9245-9247	3T	_	
56-9	9248-9251	TIM	_	
56-10	9252-9256	TRIO	_	
56-11	9257-9264	scanner	_	
56-12	9265-9267	at	_	
56-13	9268-9271	the	_	
56-14	9272-9276	UCSF	_	
56-15	9277-9289	Neuroimaging	_	
56-16	9290-9296	Center	_	
56-17	9296-9297	.	_	

#Text=Resting-state scans were acquired using high-speed whole-brain echo-planar imaging (EPI) sequences.
57-1	9298-9311	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging	
57-2	9312-9317	scans	_	
57-3	9318-9322	were	_	
57-4	9323-9331	acquired	_	
57-5	9332-9337	using	_	
57-6	9338-9348	high-speed	_	
57-7	9349-9360	whole-brain	_	
57-8	9361-9372	echo-planar	_	
57-9	9373-9380	imaging	_	
57-10	9381-9382	(	_	
57-11	9382-9385	EPI	_	
57-12	9385-9386	)	_	
57-13	9387-9396	sequences	_	
57-14	9396-9397	.	_	

#Text=Rest scans lasted six minutes, during which 180 functional images were obtained (32 axial slices, 3.5 mm slice thickness, 1.05 mm inter-slice gap, TR = 2 s, TE = 29 ms, flip angle = 75°, FOV = 24 cm, 64 × 64 matrix).
58-1	9398-9402	Rest	_	
58-2	9403-9408	scans	_	
58-3	9409-9415	lasted	_	
58-4	9416-9419	six	_	
58-5	9420-9427	minutes	_	
58-6	9427-9428	,	_	
58-7	9429-9435	during	_	
58-8	9436-9441	which	_	
58-9	9442-9445	180	_	
58-10	9446-9456	functional	_	
58-11	9457-9463	images	_	
58-12	9464-9468	were	_	
58-13	9469-9477	obtained	_	
58-14	9478-9479	(	_	
58-15	9479-9481	32	_	
58-16	9482-9487	axial	_	
58-17	9488-9494	slices	_	
58-18	9494-9495	,	_	
58-19	9496-9499	3.5	_	
58-20	9500-9502	mm	_	
58-21	9503-9508	slice	_	
58-22	9509-9518	thickness	_	
58-23	9518-9519	,	_	
58-24	9520-9524	1.05	_	
58-25	9525-9527	mm	_	
58-26	9528-9539	inter-slice	_	
58-27	9540-9543	gap	_	
58-28	9543-9544	,	_	
58-29	9545-9547	TR	_	
58-30	9548-9549	=	_	
58-31	9550-9551	2	_	
58-32	9552-9553	s	_	
58-33	9553-9554	,	_	
58-34	9555-9557	TE	_	
58-35	9558-9559	=	_	
58-36	9560-9562	29	_	
58-37	9563-9565	ms	_	
58-38	9565-9566	,	_	
58-39	9567-9571	flip	_	
58-40	9572-9577	angle	_	
58-41	9578-9579	=	_	
58-42	9580-9582	75	_	
58-43	9582-9583	°	_	
58-44	9583-9584	,	_	
58-45	9585-9588	FOV	_	
58-46	9589-9590	=	_	
58-47	9591-9593	24	_	
58-48	9594-9596	cm	_	
58-49	9596-9597	,	_	
58-50	9598-9600	64	_	
58-51	9601-9602	×	_	
58-52	9603-9605	64	_	
58-53	9606-9612	matrix	_	
58-54	9612-9613	)	_	
58-55	9613-9614	.	_	

#Text=Participants were instructed to rest with eyes closed and stay awake.
59-1	9615-9627	Participants	_	
59-2	9628-9632	were	_	
59-3	9633-9643	instructed	_	
59-4	9644-9646	to	_	
59-5	9647-9651	rest	_	
59-6	9652-9656	with	_	
59-7	9657-9661	eyes	_	
59-8	9662-9668	closed	_	
59-9	9669-9672	and	_	
59-10	9673-9677	stay	_	
59-11	9678-9683	awake	_	
59-12	9683-9684	.	_	

#Text=FMRI data of each subject were preprocessed using the Data Processing Assistant for Resting-State fMRI (DPARSF) toolbox based on Statistical Parametric Mapping (SPM8) (http://www.fil.ion.ucl.ac.uk/spm).
60-1	9685-9689	FMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
60-2	9690-9694	data	_	
60-3	9695-9697	of	_	
60-4	9698-9702	each	_	
60-5	9703-9710	subject	_	
60-6	9711-9715	were	_	
60-7	9716-9728	preprocessed	_	
60-8	9729-9734	using	_	
60-9	9735-9738	the	_	
60-10	9739-9743	Data	_	
60-11	9744-9754	Processing	_	
60-12	9755-9764	Assistant	_	
60-13	9765-9768	for	_	
60-14	9769-9782	Resting-State	_	
60-15	9783-9787	fMRI	_	
60-16	9788-9789	(	_	
60-17	9789-9795	DPARSF	_	
60-18	9795-9796	)	_	
60-19	9797-9804	toolbox	_	
60-20	9805-9810	based	_	
60-21	9811-9813	on	_	
60-22	9814-9825	Statistical	_	
60-23	9826-9836	Parametric	_	
60-24	9837-9844	Mapping	_	
60-25	9845-9846	(	_	
60-26	9846-9850	SPM8	_	
60-27	9850-9851	)	_	
60-28	9852-9853	(	_	
60-29	9853-9857	http	_	
60-30	9857-9858	:	_	
60-31	9858-9859	/	_	
60-32	9859-9860	/	_	
60-33	9860-9881	www.fil.ion.ucl.ac.uk	_	
60-34	9881-9882	/	_	
60-35	9882-9885	spm	_	
60-36	9885-9886	)	_	
60-37	9886-9887	.	_	

#Text=The first 10 volumes were discarded, and then the remaining images were slice-time corrected and realigned for head-motion correction.
61-1	9888-9891	The	_	
61-2	9892-9897	first	_	
61-3	9898-9900	10	_	
61-4	9901-9908	volumes	_	
61-5	9909-9913	were	_	
61-6	9914-9923	discarded	_	
61-7	9923-9924	,	_	
61-8	9925-9928	and	_	
61-9	9929-9933	then	_	
61-10	9934-9937	the	_	
61-11	9938-9947	remaining	_	
61-12	9948-9954	images	_	
61-13	9955-9959	were	_	
61-14	9960-9970	slice-time	_	
61-15	9971-9980	corrected	_	
61-16	9981-9984	and	_	
61-17	9985-9994	realigned	_	
61-18	9995-9998	for	_	
61-19	9999-10010	head-motion	_	
61-20	10011-10021	correction	_	
61-21	10021-10022	.	_	

#Text=For each subject, the translation of head motion was less than 4 mm and the rotation of head motion did not exceed 4 degrees in all axes through the whole scanning process.
62-1	10023-10026	For	_	
62-2	10027-10031	each	_	
62-3	10032-10039	subject	_	
62-4	10039-10040	,	_	
62-5	10041-10044	the	_	
62-6	10045-10056	translation	_	
62-7	10057-10059	of	_	
62-8	10060-10064	head	_	
62-9	10065-10071	motion	_	
62-10	10072-10075	was	_	
62-11	10076-10080	less	_	
62-12	10081-10085	than	_	
62-13	10086-10087	4	_	
62-14	10088-10090	mm	_	
62-15	10091-10094	and	_	
62-16	10095-10098	the	_	
62-17	10099-10107	rotation	_	
62-18	10108-10110	of	_	
62-19	10111-10115	head	_	
62-20	10116-10122	motion	_	
62-21	10123-10126	did	_	
62-22	10127-10130	not	_	
62-23	10131-10137	exceed	_	
62-24	10138-10139	4	_	
62-25	10140-10147	degrees	_	
62-26	10148-10150	in	_	
62-27	10151-10154	all	_	
62-28	10155-10159	axes	_	
62-29	10160-10167	through	_	
62-30	10168-10171	the	_	
62-31	10172-10177	whole	_	
62-32	10178-10186	scanning	_	
62-33	10187-10194	process	_	
62-34	10194-10195	.	_	

#Text=The mean and standard deviation of the summarized head motion measures across subjects are reported for each group in Table 1.
63-1	10196-10199	The	_	
63-2	10200-10204	mean	_	
63-3	10205-10208	and	_	
63-4	10209-10217	standard	_	
63-5	10218-10227	deviation	_	
63-6	10228-10230	of	_	
63-7	10231-10234	the	_	
63-8	10235-10245	summarized	_	
63-9	10246-10250	head	_	
63-10	10251-10257	motion	_	
63-11	10258-10266	measures	_	
63-12	10267-10273	across	_	
63-13	10274-10282	subjects	_	
63-14	10283-10286	are	_	
63-15	10287-10295	reported	_	
63-16	10296-10299	for	_	
63-17	10300-10304	each	_	
63-18	10305-10310	group	_	
63-19	10311-10313	in	_	
63-20	10314-10319	Table	_	
63-21	10320-10321	1	_	
63-22	10321-10322	.	_	

#Text=Analysis of variance (p < 0.05) showed no significant group difference in either the maximum translation motion displacement or the maximum rotation motion displacement.
64-1	10323-10331	Analysis	_	
64-2	10332-10334	of	_	
64-3	10335-10343	variance	_	
64-4	10344-10345	(	_	
64-5	10345-10346	p	_	
64-6	10347-10348	<	_	
64-7	10349-10353	0.05	_	
64-8	10353-10354	)	_	
64-9	10355-10361	showed	_	
64-10	10362-10364	no	_	
64-11	10365-10376	significant	_	
64-12	10377-10382	group	_	
64-13	10383-10393	difference	_	
64-14	10394-10396	in	_	
64-15	10397-10403	either	_	
64-16	10404-10407	the	_	
64-17	10408-10415	maximum	_	
64-18	10416-10427	translation	_	
64-19	10428-10434	motion	_	
64-20	10435-10447	displacement	_	
64-21	10448-10450	or	_	
64-22	10451-10454	the	_	
64-23	10455-10462	maximum	_	
64-24	10463-10471	rotation	_	
64-25	10472-10478	motion	_	
64-26	10479-10491	displacement	_	
64-27	10491-10492	.	_	

#Text=Subsequently, the images were spatially normalized to the Montreal Neurological Institute (MNI) EPI template, resliced to 3 mm × 3 mm × 3 mm voxels, and smoothed with a Gaussian kernel with a full-width at half-maximum (FWHM) of 6 mm.
65-1	10493-10505	Subsequently	_	
65-2	10505-10506	,	_	
65-3	10507-10510	the	_	
65-4	10511-10517	images	_	
65-5	10518-10522	were	_	
65-6	10523-10532	spatially	_	
65-7	10533-10543	normalized	_	
65-8	10544-10546	to	_	
65-9	10547-10550	the	_	
65-10	10551-10559	Montreal	_	
65-11	10560-10572	Neurological	_	
65-12	10573-10582	Institute	_	
65-13	10583-10584	(	_	
65-14	10584-10587	MNI	_	
65-15	10587-10588	)	_	
65-16	10589-10592	EPI	_	
65-17	10593-10601	template	_	
65-18	10601-10602	,	_	
65-19	10603-10611	resliced	_	
65-20	10612-10614	to	_	
65-21	10615-10616	3	_	
65-22	10617-10619	mm	_	
65-23	10620-10621	×	_	
65-24	10622-10623	3	_	
65-25	10624-10626	mm	_	
65-26	10627-10628	×	_	
65-27	10629-10630	3	_	
65-28	10631-10633	mm	_	
65-29	10634-10640	voxels	_	
65-30	10640-10641	,	_	
65-31	10642-10645	and	_	
65-32	10646-10654	smoothed	_	
65-33	10655-10659	with	_	
65-34	10660-10661	a	_	
65-35	10662-10670	Gaussian	_	
65-36	10671-10677	kernel	_	
65-37	10678-10682	with	_	
65-38	10683-10684	a	_	
65-39	10685-10695	full-width	_	
65-40	10696-10698	at	_	
65-41	10699-10711	half-maximum	_	
65-42	10712-10713	(	_	
65-43	10713-10717	FWHM	_	
65-44	10717-10718	)	_	
65-45	10719-10721	of	_	
65-46	10722-10723	6	_	
65-47	10724-10726	mm	_	
65-48	10726-10727	.	_	

#Text=Detrending and band-pass filtering (0.01Hz–0.08Hz) were then performed to remove higher frequency physiological noise and lower frequency scanner drift.
66-1	10728-10738	Detrending	_	
66-2	10739-10742	and	_	
66-3	10743-10752	band-pass	_	
66-4	10753-10762	filtering	_	
66-5	10763-10764	(	_	
66-6	10764-10770	0.01Hz	_	
66-7	10770-10771	–	_	
66-8	10771-10777	0.08Hz	_	
66-9	10777-10778	)	_	
66-10	10779-10783	were	_	
66-11	10784-10788	then	_	
66-12	10789-10798	performed	_	
66-13	10799-10801	to	_	
66-14	10802-10808	remove	_	
66-15	10809-10815	higher	_	
66-16	10816-10825	frequency	_	
66-17	10826-10839	physiological	_	
66-18	10840-10845	noise	_	
66-19	10846-10849	and	_	
66-20	10850-10855	lower	_	
66-21	10856-10865	frequency	_	
66-22	10866-10873	scanner	_	
66-23	10874-10879	drift	_	
66-24	10879-10880	.	_	

#Text=Finally, nuisance covariates including six head motion parameters, white matter signal, cerebrospinal fluid signal, and global mean signal were regressed out, and then residual images were saved for subsequent analyses.
67-1	10881-10888	Finally	_	
67-2	10888-10889	,	_	
67-3	10890-10898	nuisance	_	
67-4	10899-10909	covariates	_	
67-5	10910-10919	including	_	
67-6	10920-10923	six	_	
67-7	10924-10928	head	_	
67-8	10929-10935	motion	_	
67-9	10936-10946	parameters	_	
67-10	10946-10947	,	_	
67-11	10948-10953	white	_	
67-12	10954-10960	matter	_	
67-13	10961-10967	signal	_	
67-14	10967-10968	,	_	
67-15	10969-10982	cerebrospinal	_	
67-16	10983-10988	fluid	_	
67-17	10989-10995	signal	_	
67-18	10995-10996	,	_	
67-19	10997-11000	and	_	
67-20	11001-11007	global	_	
67-21	11008-11012	mean	_	
67-22	11013-11019	signal	_	
67-23	11020-11024	were	_	
67-24	11025-11034	regressed	_	
67-25	11035-11038	out	_	
67-26	11038-11039	,	_	
67-27	11040-11043	and	_	
67-28	11044-11048	then	_	
67-29	11049-11057	residual	_	
67-30	11058-11064	images	_	
67-31	11065-11069	were	_	
67-32	11070-11075	saved	_	
67-33	11076-11079	for	_	
67-34	11080-11090	subsequent	_	
67-35	11091-11099	analyses	_	
67-36	11099-11100	.	_	

#Text=Note: the white matter signal, cerebrospinal fluid signal and global mean signal used as covariates were obtained after the detrending and band-pass filtering processing.
#Text=2.2.
68-1	11101-11105	Note	_	
68-2	11105-11106	:	_	
68-3	11107-11110	the	_	
68-4	11111-11116	white	_	
68-5	11117-11123	matter	_	
68-6	11124-11130	signal	_	
68-7	11130-11131	,	_	
68-8	11132-11145	cerebrospinal	_	
68-9	11146-11151	fluid	_	
68-10	11152-11158	signal	_	
68-11	11159-11162	and	_	
68-12	11163-11169	global	_	
68-13	11170-11174	mean	_	
68-14	11175-11181	signal	_	
68-15	11182-11186	used	_	
68-16	11187-11189	as	_	
68-17	11190-11200	covariates	_	
68-18	11201-11205	were	_	
68-19	11206-11214	obtained	_	
68-20	11215-11220	after	_	
68-21	11221-11224	the	_	
68-22	11225-11235	detrending	_	
68-23	11236-11239	and	_	
68-24	11240-11249	band-pass	_	
68-25	11250-11259	filtering	_	
68-26	11260-11270	processing	_	
68-27	11270-11271	.	_	
68-28	11272-11275	2.2	_	
68-29	11275-11276	.	_	

#Text=Methods
#Text=Firstly, time-varying functional connectivity was estimated using a sliding time-window method, and then inherent connectivity states can be computed using our proposed decomposition-based method.
69-1	11277-11284	Methods	_	
69-2	11285-11292	Firstly	_	
69-3	11292-11293	,	_	
69-4	11294-11306	time-varying	_	
69-5	11307-11317	functional	_	
69-6	11318-11330	connectivity	_	
69-7	11331-11334	was	_	
69-8	11335-11344	estimated	_	
69-9	11345-11350	using	_	
69-10	11351-11352	a	_	
69-11	11353-11360	sliding	_	
69-12	11361-11372	time-window	_	
69-13	11373-11379	method	_	
69-14	11379-11380	,	_	
69-15	11381-11384	and	_	
69-16	11385-11389	then	_	
69-17	11390-11398	inherent	_	
69-18	11399-11411	connectivity	_	
69-19	11412-11418	states	_	
69-20	11419-11422	can	_	
69-21	11423-11425	be	_	
69-22	11426-11434	computed	_	
69-23	11435-11440	using	_	
69-24	11441-11444	our	_	
69-25	11445-11453	proposed	_	
69-26	11454-11473	decomposition-based	_	
69-27	11474-11480	method	_	
69-28	11480-11481	.	_	

#Text=The overall framework of estimating dynamic connectivity and connectivity states is shown in Fig. 1.
70-1	11482-11485	The	_	
70-2	11486-11493	overall	_	
70-3	11494-11503	framework	_	
70-4	11504-11506	of	_	
70-5	11507-11517	estimating	_	
70-6	11518-11525	dynamic	_	
70-7	11526-11538	connectivity	_	
70-8	11539-11542	and	_	
70-9	11543-11555	connectivity	_	
70-10	11556-11562	states	_	
70-11	11563-11565	is	_	
70-12	11566-11571	shown	_	
70-13	11572-11574	in	_	
70-14	11575-11578	Fig	_	
70-15	11578-11579	.	_	
70-16	11580-11581	1	_	
70-17	11581-11582	.	_	

#Text=Detailed procedures are explained in the following subsections.
71-1	11583-11591	Detailed	_	
71-2	11592-11602	procedures	_	
71-3	11603-11606	are	_	
71-4	11607-11616	explained	_	
71-5	11617-11619	in	_	
71-6	11620-11623	the	_	
71-7	11624-11633	following	_	
71-8	11634-11645	subsections	_	
71-9	11645-11646	.	_	

#Text=Finally, we investigated group differences based on the individual-subject’s connectivity states, aiming to reveal potential biomarkers.
#Text=2.2.1.
72-1	11647-11654	Finally	_	
72-2	11654-11655	,	_	
72-3	11656-11658	we	_	
72-4	11659-11671	investigated	_	
72-5	11672-11677	group	_	
72-6	11678-11689	differences	_	
72-7	11690-11695	based	_	
72-8	11696-11698	on	_	
72-9	11699-11702	the	_	
72-10	11703-11721	individual-subject	_	
72-11	11721-11722	’	_	
72-12	11722-11723	s	_	
72-13	11724-11736	connectivity	_	
72-14	11737-11743	states	_	
72-15	11743-11744	,	_	
72-16	11745-11751	aiming	_	
72-17	11752-11754	to	_	
72-18	11755-11761	reveal	_	
72-19	11762-11771	potential	_	
72-20	11772-11782	biomarkers	_	
72-21	11782-11783	.	_	
72-22	11784-11789	2.2.1	_	
72-23	11789-11790	.	_	

#Text=Estimating dynamic functional connectivity
#Text=As shown in Fig. 1A, using the sliding time-window method, we computed whole-brain DFC for each subject based on 116 ROIs from the automated anatomical labeling (AAL) template.
73-1	11791-11801	Estimating	_	
73-2	11802-11809	dynamic	_	
73-3	11810-11820	functional	_	
73-4	11821-11833	connectivity	_	
73-5	11834-11836	As	_	
73-6	11837-11842	shown	_	
73-7	11843-11845	in	_	
73-8	11846-11849	Fig	_	
73-9	11849-11850	.	_	
73-10	11851-11853	1A	_	
73-11	11853-11854	,	_	
73-12	11855-11860	using	_	
73-13	11861-11864	the	_	
73-14	11865-11872	sliding	_	
73-15	11873-11884	time-window	_	
73-16	11885-11891	method	_	
73-17	11891-11892	,	_	
73-18	11893-11895	we	_	
73-19	11896-11904	computed	_	
73-20	11905-11916	whole-brain	_	
73-21	11917-11920	DFC	_	
73-22	11921-11924	for	_	
73-23	11925-11929	each	_	
73-24	11930-11937	subject	_	
73-25	11938-11943	based	_	
73-26	11944-11946	on	_	
73-27	11947-11950	116	_	
73-28	11951-11955	ROIs	_	
73-29	11956-11960	from	_	
73-30	11961-11964	the	_	
73-31	11965-11974	automated	_	
73-32	11975-11985	anatomical	_	
73-33	11986-11994	labeling	_	
73-34	11995-11996	(	_	
73-35	11996-11999	AAL	_	
73-36	11999-12000	)	_	
73-37	12001-12009	template	_	
73-38	12009-12010	.	_	

#Text=The index (ID) and name of each ROI can be found in supplementary Table S2.
74-1	12011-12014	The	_	
74-2	12015-12020	index	_	
74-3	12021-12022	(	_	
74-4	12022-12024	ID	_	
74-5	12024-12025	)	_	
74-6	12026-12029	and	_	
74-7	12030-12034	name	_	
74-8	12035-12037	of	_	
74-9	12038-12042	each	_	
74-10	12043-12046	ROI	_	
74-11	12047-12050	can	_	
74-12	12051-12053	be	_	
74-13	12054-12059	found	_	
74-14	12060-12062	in	_	
74-15	12063-12076	supplementary	_	
74-16	12077-12082	Table	_	
74-17	12083-12085	S2	_	
74-18	12085-12086	.	_	

#Text=For the averaged time-series within each ROI, we segmented it using a sliding time-window that was created by convolving a rectangle (width = 20 TRs) with a Gaussian (σ = 3 TRs).
75-1	12087-12090	For	_	
75-2	12091-12094	the	_	
75-3	12095-12103	averaged	_	
75-4	12104-12115	time-series	_	
75-5	12116-12122	within	_	
75-6	12123-12127	each	_	
75-7	12128-12131	ROI	_	
75-8	12131-12132	,	_	
75-9	12133-12135	we	_	
75-10	12136-12145	segmented	_	
75-11	12146-12148	it	_	
75-12	12149-12154	using	_	
75-13	12155-12156	a	_	
75-14	12157-12164	sliding	_	
75-15	12165-12176	time-window	_	
75-16	12177-12181	that	_	
75-17	12182-12185	was	_	
75-18	12186-12193	created	_	
75-19	12194-12196	by	_	
75-20	12197-12207	convolving	_	
75-21	12208-12209	a	_	
75-22	12210-12219	rectangle	_	
75-23	12220-12221	(	_	
75-24	12221-12226	width	_	
75-25	12227-12228	=	_	
75-26	12229-12231	20	_	
75-27	12232-12235	TRs	_	
75-28	12235-12236	)	_	
75-29	12237-12241	with	_	
75-30	12242-12243	a	_	
75-31	12244-12252	Gaussian	_	
75-32	12253-12254	(	_	
75-33	12254-12255	σ	_	
75-34	12256-12257	=	_	
75-35	12258-12259	3	_	
75-36	12260-12263	TRs	_	
75-37	12263-12264	)	_	
75-38	12264-12265	.	_	

#Text=The window length was 40 s (2 s × 20), which has extensively evaluated and shown to be suitable for capturing dynamics in FCs.
76-1	12266-12269	The	_	
76-2	12270-12276	window	_	
76-3	12277-12283	length	_	
76-4	12284-12287	was	_	
76-5	12288-12290	40	_	
76-6	12291-12292	s	_	
76-7	12293-12294	(	_	
76-8	12294-12295	2	_	
76-9	12296-12297	s	_	
76-10	12298-12299	×	_	
76-11	12300-12302	20	_	
76-12	12302-12303	)	_	
76-13	12303-12304	,	_	
76-14	12305-12310	which	_	
76-15	12311-12314	has	_	
76-16	12315-12326	extensively	_	
76-17	12327-12336	evaluated	_	
76-18	12337-12340	and	_	
76-19	12341-12346	shown	_	
76-20	12347-12349	to	_	
76-21	12350-12352	be	_	
76-22	12353-12361	suitable	_	
76-23	12362-12365	for	_	
76-24	12366-12375	capturing	_	
76-25	12376-12384	dynamics	_	
76-26	12385-12387	in	_	
76-27	12388-12391	FCs	_	
76-28	12391-12392	.	_	

#Text=The window slid in steps of 1 TR, resulting in 151 short time-series for each ROI.
77-1	12393-12396	The	_	
77-2	12397-12403	window	_	
77-3	12404-12408	slid	_	
77-4	12409-12411	in	_	
77-5	12412-12417	steps	_	
77-6	12418-12420	of	_	
77-7	12421-12422	1	_	
77-8	12423-12425	TR	_	
77-9	12425-12426	,	_	
77-10	12427-12436	resulting	_	
77-11	12437-12439	in	_	
77-12	12440-12443	151	_	
77-13	12444-12449	short	_	
77-14	12450-12461	time-series	_	
77-15	12462-12465	for	_	
77-16	12466-12470	each	_	
77-17	12471-12474	ROI	_	
77-18	12474-12475	.	_	

#Text=Afterwards, regarding each window, a 116 × 116 connectivity matrix was calculated based on the associated short time-series of all ROIs.
78-1	12476-12486	Afterwards	_	
78-2	12486-12487	,	_	
78-3	12488-12497	regarding	_	
78-4	12498-12502	each	_	
78-5	12503-12509	window	_	
78-6	12509-12510	,	_	
78-7	12511-12512	a	_	
78-8	12513-12516	116	_	
78-9	12517-12518	×	_	
78-10	12519-12522	116	_	
78-11	12523-12535	connectivity	_	
78-12	12536-12542	matrix	_	
78-13	12543-12546	was	_	
78-14	12547-12557	calculated	_	
78-15	12558-12563	based	_	
78-16	12564-12566	on	_	
78-17	12567-12570	the	_	
78-18	12571-12581	associated	_	
78-19	12582-12587	short	_	
78-20	12588-12599	time-series	_	
78-21	12600-12602	of	_	
78-22	12603-12606	all	_	
78-23	12607-12611	ROIs	_	
78-24	12611-12612	.	_	

#Text=Each connectivity matrix reflecting the temporal correlations among ROIs within one window was estimated from a regularized inverse covariance matrix using a graphical LASSO framework.
79-1	12613-12617	Each	_	
79-2	12618-12630	connectivity	_	
79-3	12631-12637	matrix	_	
79-4	12638-12648	reflecting	_	
79-5	12649-12652	the	_	
79-6	12653-12661	temporal	_	
79-7	12662-12674	correlations	_	
79-8	12675-12680	among	_	
79-9	12681-12685	ROIs	_	
79-10	12686-12692	within	_	
79-11	12693-12696	one	_	
79-12	12697-12703	window	_	
79-13	12704-12707	was	_	
79-14	12708-12717	estimated	_	
79-15	12718-12722	from	_	
79-16	12723-12724	a	_	
79-17	12725-12736	regularized	_	
79-18	12737-12744	inverse	_	
79-19	12745-12755	covariance	_	
79-20	12756-12762	matrix	_	
79-21	12763-12768	using	_	
79-22	12769-12770	a	_	
79-23	12771-12780	graphical	_	
79-24	12781-12786	LASSO	_	
79-25	12787-12796	framework	_	
79-26	12796-12797	.	_	

#Text=LASSO imposed sparsity by placing an L1 norm penalty on the inverse covariance matrix to decrease noise effect of short time series.
80-1	12798-12803	LASSO	_	
80-2	12804-12811	imposed	_	
80-3	12812-12820	sparsity	_	
80-4	12821-12823	by	_	
80-5	12824-12831	placing	_	
80-6	12832-12834	an	_	
80-7	12835-12837	L1	_	
80-8	12838-12842	norm	_	
80-9	12843-12850	penalty	_	
80-10	12851-12853	on	_	
80-11	12854-12857	the	_	
80-12	12858-12865	inverse	_	
80-13	12866-12876	covariance	_	
80-14	12877-12883	matrix	_	
80-15	12884-12886	to	_	
80-16	12887-12895	decrease	_	
80-17	12896-12901	noise	_	
80-18	12902-12908	effect	_	
80-19	12909-12911	of	_	
80-20	12912-12917	short	_	
80-21	12918-12922	time	_	
80-22	12923-12929	series	_	
80-23	12929-12930	.	_	

#Text=After obtaining the regularized inverse covariance matrix, its corresponding covariance matrix was calculated and then transformed into a correlation matrix, representing the functional connectivity matrix.
81-1	12931-12936	After	_	
81-2	12937-12946	obtaining	_	
81-3	12947-12950	the	_	
81-4	12951-12962	regularized	_	
81-5	12963-12970	inverse	_	
81-6	12971-12981	covariance	_	
81-7	12982-12988	matrix	_	
81-8	12988-12989	,	_	
81-9	12990-12993	its	_	
81-10	12994-13007	corresponding	_	
81-11	13008-13018	covariance	_	
81-12	13019-13025	matrix	_	
81-13	13026-13029	was	_	
81-14	13030-13040	calculated	_	
81-15	13041-13044	and	_	
81-16	13045-13049	then	_	
81-17	13050-13061	transformed	_	
81-18	13062-13066	into	_	
81-19	13067-13068	a	_	
81-20	13069-13080	correlation	_	
81-21	13081-13087	matrix	_	
81-22	13087-13088	,	_	
81-23	13089-13101	representing	_	
81-24	13102-13105	the	_	
81-25	13106-13116	functional	_	
81-26	13117-13129	connectivity	_	
81-27	13130-13136	matrix	_	
81-28	13136-13137	.	_	

#Text=Thus, for each subject, 151 connectivity matrices were obtained, reflecting time-varying functional connectivity between paired ROIs.
82-1	13138-13142	Thus	_	
82-2	13142-13143	,	_	
82-3	13144-13147	for	_	
82-4	13148-13152	each	_	
82-5	13153-13160	subject	_	
82-6	13160-13161	,	_	
82-7	13162-13165	151	_	
82-8	13166-13178	connectivity	_	
82-9	13179-13187	matrices	_	
82-10	13188-13192	were	_	
82-11	13193-13201	obtained	_	
82-12	13201-13202	,	_	
82-13	13203-13213	reflecting	_	
82-14	13214-13226	time-varying	_	
82-15	13227-13237	functional	_	
82-16	13238-13250	connectivity	_	
82-17	13251-13258	between	_	
82-18	13259-13265	paired	_	
82-19	13266-13270	ROIs	_	
82-20	13270-13271	.	_	

#Text=Due to the symmetry of connectivity matrix within each window, the upper half 6670 unique elements can reflect connectivity strengths among 116 ROIs.
83-1	13272-13275	Due	_	
83-2	13276-13278	to	_	
83-3	13279-13282	the	_	
83-4	13283-13291	symmetry	_	
83-5	13292-13294	of	_	
83-6	13295-13307	connectivity	_	
83-7	13308-13314	matrix	_	
83-8	13315-13321	within	_	
83-9	13322-13326	each	_	
83-10	13327-13333	window	_	
83-11	13333-13334	,	_	
83-12	13335-13338	the	_	
83-13	13339-13344	upper	_	
83-14	13345-13349	half	_	
83-15	13350-13354	6670	_	
83-16	13355-13361	unique	_	
83-17	13362-13370	elements	_	
83-18	13371-13374	can	_	
83-19	13375-13382	reflect	_	
83-20	13383-13395	connectivity	_	
83-21	13396-13405	strengths	_	
83-22	13406-13411	among	_	
83-23	13412-13415	116	_	
83-24	13416-13420	ROIs	_	
83-25	13420-13421	.	_	

#Text=Taking the kth subject for an example, its dynamic connectivity can be denoted by a window-by-connectivity matrix Xk (size: 151 × 6670).
84-1	13422-13428	Taking	_	
84-2	13429-13432	the	_	
84-3	13433-13436	kth	_	
84-4	13437-13444	subject	_	
84-5	13445-13448	for	_	
84-6	13449-13451	an	_	
84-7	13452-13459	example	_	
84-8	13459-13460	,	_	
84-9	13461-13464	its	_	
84-10	13465-13472	dynamic	_	
84-11	13473-13485	connectivity	_	
84-12	13486-13489	can	_	
84-13	13490-13492	be	_	
84-14	13493-13500	denoted	_	
84-15	13501-13503	by	_	
84-16	13504-13505	a	_	
84-17	13506-13528	window-by-connectivity	_	
84-18	13529-13535	matrix	_	
84-19	13536-13538	Xk	_	
84-20	13539-13540	(	_	
84-21	13540-13544	size	_	
84-22	13544-13545	:	_	
84-23	13546-13549	151	_	
84-24	13550-13551	×	_	
84-25	13552-13556	6670	_	
84-26	13556-13557	)	_	
84-27	13557-13558	.	_	

#Text=We then performed a r-to-z Fisher transformation on Xk.
#Text=2.2.2.
85-1	13559-13561	We	_	
85-2	13562-13566	then	_	
85-3	13567-13576	performed	_	
85-4	13577-13578	a	_	
85-5	13579-13585	r-to-z	_	
85-6	13586-13592	Fisher	_	
85-7	13593-13607	transformation	_	
85-8	13608-13610	on	_	
85-9	13611-13613	Xk	_	
85-10	13613-13614	.	_	
85-11	13615-13620	2.2.2	_	
85-12	13620-13621	.	_	

#Text=Estimating functional connectivity states
#Text=Previous work has shown that multiple connectivity states exist in the time-varying connectivity.
86-1	13622-13632	Estimating	_	
86-2	13633-13643	functional	_	
86-3	13644-13656	connectivity	_	
86-4	13657-13663	states	_	
86-5	13664-13672	Previous	_	
86-6	13673-13677	work	_	
86-7	13678-13681	has	_	
86-8	13682-13687	shown	_	
86-9	13688-13692	that	_	
86-10	13693-13701	multiple	_	
86-11	13702-13714	connectivity	_	
86-12	13715-13721	states	_	
86-13	13722-13727	exist	_	
86-14	13728-13730	in	_	
86-15	13731-13734	the	_	
86-16	13735-13747	time-varying	_	
86-17	13748-13760	connectivity	_	
86-18	13760-13761	.	_	

#Text=In the study, we sought to investigate whether HC, CHR and ESZ groups showed differences in the connectivity states; and if true, whether these changes showed a progressive trend from the healthy condition to psychosis risk to early schizophrenia.
87-1	13762-13764	In	_	
87-2	13765-13768	the	_	
87-3	13769-13774	study	_	
87-4	13774-13775	,	_	
87-5	13776-13778	we	_	
87-6	13779-13785	sought	_	
87-7	13786-13788	to	_	
87-8	13789-13800	investigate	_	
87-9	13801-13808	whether	_	
87-10	13809-13811	HC	_	
87-11	13811-13812	,	_	
87-12	13813-13816	CHR	_	
87-13	13817-13820	and	_	
87-14	13821-13824	ESZ	_	
87-15	13825-13831	groups	_	
87-16	13832-13838	showed	_	
87-17	13839-13850	differences	_	
87-18	13851-13853	in	_	
87-19	13854-13857	the	_	
87-20	13858-13870	connectivity	_	
87-21	13871-13877	states	_	
87-22	13877-13878	;	_	
87-23	13879-13882	and	_	
87-24	13883-13885	if	_	
87-25	13886-13890	true	_	
87-26	13890-13891	,	_	
87-27	13892-13899	whether	_	
87-28	13900-13905	these	_	
87-29	13906-13913	changes	_	
87-30	13914-13920	showed	_	
87-31	13921-13922	a	_	
87-32	13923-13934	progressive	_	
87-33	13935-13940	trend	_	
87-34	13941-13945	from	_	
87-35	13946-13949	the	_	
87-36	13950-13957	healthy	_	
87-37	13958-13967	condition	_	
87-38	13968-13970	to	_	
87-39	13971-13980	psychosis	_	
87-40	13981-13985	risk	_	
87-41	13986-13988	to	_	
87-42	13989-13994	early	_	
87-43	13995-14008	schizophrenia	_	
87-44	14008-14009	.	_	

#Text=Our recently proposed dynamic connectivity analysis method was applied to estimate the connectivity states.
88-1	14010-14013	Our	_	
88-2	14014-14022	recently	_	
88-3	14023-14031	proposed	_	
88-4	14032-14039	dynamic	_	
88-5	14040-14052	connectivity	_	
88-6	14053-14061	analysis	_	
88-7	14062-14068	method	_	
88-8	14069-14072	was	_	
88-9	14073-14080	applied	_	
88-10	14081-14083	to	_	
88-11	14084-14092	estimate	_	
88-12	14093-14096	the	_	
88-13	14097-14109	connectivity	_	
88-14	14110-14116	states	_	
88-15	14116-14117	.	_	

#Text=In our method, the connectivity states are decoded by the independent components (ICs), and the loadings of ICs represent the fluctuations of connectivity states.
89-1	14118-14120	In	_	
89-2	14121-14124	our	_	
89-3	14125-14131	method	_	
89-4	14131-14132	,	_	
89-5	14133-14136	the	_	
89-6	14137-14149	connectivity	_	
89-7	14150-14156	states	_	
89-8	14157-14160	are	_	
89-9	14161-14168	decoded	_	
89-10	14169-14171	by	_	
89-11	14172-14175	the	_	
89-12	14176-14187	independent	_	
89-13	14188-14198	components	_	
89-14	14199-14200	(	_	
89-15	14200-14203	ICs	_	
89-16	14203-14204	)	_	
89-17	14204-14205	,	_	
89-18	14206-14209	and	_	
89-19	14210-14213	the	_	
89-20	14214-14222	loadings	_	
89-21	14223-14225	of	_	
89-22	14226-14229	ICs	_	
89-23	14230-14239	represent	_	
89-24	14240-14243	the	_	
89-25	14244-14256	fluctuations	_	
89-26	14257-14259	of	_	
89-27	14260-14272	connectivity	_	
89-28	14273-14279	states	_	
89-29	14279-14280	.	_	

#Text=Considering there are probably connectivity states with group-specific patterns among the three groups, we extracted connectivity states for each group.
90-1	14281-14292	Considering	_	
90-2	14293-14298	there	_	
90-3	14299-14302	are	_	
90-4	14303-14311	probably	_	
90-5	14312-14324	connectivity	_	
90-6	14325-14331	states	_	
90-7	14332-14336	with	_	
90-8	14337-14351	group-specific	_	
90-9	14352-14360	patterns	_	
90-10	14361-14366	among	_	
90-11	14367-14370	the	_	
90-12	14371-14376	three	_	
90-13	14377-14383	groups	_	
90-14	14383-14384	,	_	
90-15	14385-14387	we	_	
90-16	14388-14397	extracted	_	
90-17	14398-14410	connectivity	_	
90-18	14411-14417	states	_	
90-19	14418-14421	for	_	
90-20	14422-14426	each	_	
90-21	14427-14432	group	_	
90-22	14432-14433	.	_	

#Text=The following processing steps were implemented for each group separately.
91-1	14434-14437	The	_	
91-2	14438-14447	following	_	
91-3	14448-14458	processing	_	
91-4	14459-14464	steps	_	
91-5	14465-14469	were	_	
91-6	14470-14481	implemented	_	
91-7	14482-14485	for	_	
91-8	14486-14490	each	_	
91-9	14491-14496	group	_	
91-10	14497-14507	separately	_	
91-11	14507-14508	.	_	

#Text=We concatenated the window-by-connectivity matrices of all subjects along the window direction and obtained a matrix X= [X1;…;Xk;…;XN], (k = 1,…,N), where N was the number of subjects.
92-1	14509-14511	We	_	
92-2	14512-14524	concatenated	_	
92-3	14525-14528	the	_	
92-4	14529-14551	window-by-connectivity	_	
92-5	14552-14560	matrices	_	
92-6	14561-14563	of	_	
92-7	14564-14567	all	_	
92-8	14568-14576	subjects	_	
92-9	14577-14582	along	_	
92-10	14583-14586	the	_	
92-11	14587-14593	window	_	
92-12	14594-14603	direction	_	
92-13	14604-14607	and	_	
92-14	14608-14616	obtained	_	
92-15	14617-14618	a	_	
92-16	14619-14625	matrix	_	
92-17	14626-14627	X	_	
92-18	14627-14628	=	_	
92-19	14629-14630	[	_	
92-20	14630-14632	X1	_	
92-21	14632-14633	;	_	
92-22	14633-14634	…	_	
92-23	14634-14635	;	_	
92-24	14635-14637	Xk	_	
92-25	14637-14638	;	_	
92-26	14638-14639	…	_	
92-27	14639-14640	;	_	
92-28	14640-14642	XN	_	
92-29	14642-14643	]	_	
92-30	14643-14644	,	_	
92-31	14645-14646	(	_	
92-32	14646-14647	k	_	
92-33	14648-14649	=	_	
92-34	14650-14651	1	_	
92-35	14651-14652	,	_	
92-36	14652-14653	…	_	
92-37	14653-14654	,	_	
92-38	14654-14655	N	_	
92-39	14655-14656	)	_	
92-40	14656-14657	,	_	
92-41	14658-14663	where	_	
92-42	14664-14665	N	_	
92-43	14666-14669	was	_	
92-44	14670-14673	the	_	
92-45	14674-14680	number	_	
92-46	14681-14683	of	_	
92-47	14684-14692	subjects	_	
92-48	14692-14693	.	_	

#Text=As shown in Fig. 1B, we performed ICA using ICASSO technique on the whole dynamic connectivity matrix (i.e., X) to compute the reliable group-level connectivity states (GSs).
93-1	14694-14696	As	_	
93-2	14697-14702	shown	_	
93-3	14703-14705	in	_	
93-4	14706-14709	Fig	_	
93-5	14709-14710	.	_	
93-6	14711-14713	1B	_	
93-7	14713-14714	,	_	
93-8	14715-14717	we	_	
93-9	14718-14727	performed	_	
93-10	14728-14731	ICA	_	
93-11	14732-14737	using	_	
93-12	14738-14744	ICASSO	_	
93-13	14745-14754	technique	_	
93-14	14755-14757	on	_	
93-15	14758-14761	the	_	
93-16	14762-14767	whole	_	
93-17	14768-14775	dynamic	_	
93-18	14776-14788	connectivity	_	
93-19	14789-14795	matrix	_	
93-20	14796-14797	(	_	
93-21	14797-14800	i.e	_	
93-22	14800-14801	.	_	
93-23	14801-14802	,	_	
93-24	14803-14804	X	_	
93-25	14804-14805	)	_	
93-26	14806-14808	to	_	
93-27	14809-14816	compute	_	
93-28	14817-14820	the	_	
93-29	14821-14829	reliable	_	
93-30	14830-14841	group-level	_	
93-31	14842-14854	connectivity	_	
93-32	14855-14861	states	_	
93-33	14862-14863	(	_	
93-34	14863-14866	GSs	_	
93-35	14866-14867	)	_	
93-36	14867-14868	.	_	

#Text=Before ICA, subject-level PCAs and a following group-level PCA were used to reduce the dimensionality of the window direction.
94-1	14869-14875	Before	_	
94-2	14876-14879	ICA	_	
94-3	14879-14880	,	_	
94-4	14881-14894	subject-level	_	
94-5	14895-14899	PCAs	_	
94-6	14900-14903	and	_	
94-7	14904-14905	a	_	
94-8	14906-14915	following	_	
94-9	14916-14927	group-level	_	
94-10	14928-14931	PCA	_	
94-11	14932-14936	were	_	
94-12	14937-14941	used	_	
94-13	14942-14944	to	_	
94-14	14945-14951	reduce	_	
94-15	14952-14955	the	_	
94-16	14956-14970	dimensionality	_	
94-17	14971-14973	of	_	
94-18	14974-14977	the	_	
94-19	14978-14984	window	_	
94-20	14985-14994	direction	_	
94-21	14994-14995	.	_	

#Text=Thus, we had X = A·S, where S = [S1;…; Sl;…;SM] included all group-level ICs.
95-1	14996-15000	Thus	_	
95-2	15000-15001	,	_	
95-3	15002-15004	we	_	
95-4	15005-15008	had	_	
95-5	15009-15010	X	_	
95-6	15011-15012	=	_	
95-7	15013-15014	A	_	
95-8	15014-15015	·	_	
95-9	15015-15016	S	_	
95-10	15016-15017	,	_	
95-11	15018-15023	where	_	
95-12	15024-15025	S	_	
95-13	15026-15027	=	_	
95-14	15028-15029	[	_	
95-15	15029-15031	S1	_	
95-16	15031-15032	;	_	
95-17	15032-15033	…	_	
95-18	15033-15034	;	_	
95-19	15035-15037	Sl	_	
95-20	15037-15038	;	_	
95-21	15038-15039	…	_	
95-22	15039-15040	;	_	
95-23	15040-15042	SM	_	
95-24	15042-15043	]	_	
95-25	15044-15052	included	_	
95-26	15053-15056	all	_	
95-27	15057-15068	group-level	_	
95-28	15069-15072	ICs	_	
95-29	15072-15073	.	_	

#Text=Sl can represent information of the lth GS.
96-1	15074-15076	Sl	_	
96-2	15077-15080	can	_	
96-3	15081-15090	represent	_	
96-4	15091-15102	information	_	
96-5	15103-15105	of	_	
96-6	15106-15109	the	_	
96-7	15110-15113	lth	_	
96-8	15114-15116	GS	_	
96-9	15116-15117	.	_	

#Text=Although it is hard to determine an optimal setting for the number of components, many prior studies suggested five connectivity states to estimate in dynamic connectivity analysis.
97-1	15118-15126	Although	_	
97-2	15127-15129	it	_	
97-3	15130-15132	is	_	
97-4	15133-15137	hard	_	
97-5	15138-15140	to	_	
97-6	15141-15150	determine	_	
97-7	15151-15153	an	_	
97-8	15154-15161	optimal	_	
97-9	15162-15169	setting	_	
97-10	15170-15173	for	_	
97-11	15174-15177	the	_	
97-12	15178-15184	number	_	
97-13	15185-15187	of	_	
97-14	15188-15198	components	_	
97-15	15198-15199	,	_	
97-16	15200-15204	many	_	
97-17	15205-15210	prior	_	
97-18	15211-15218	studies	_	
97-19	15219-15228	suggested	_	
97-20	15229-15233	five	_	
97-21	15234-15246	connectivity	_	
97-22	15247-15253	states	_	
97-23	15254-15256	to	_	
97-24	15257-15265	estimate	_	
97-25	15266-15268	in	_	
97-26	15269-15276	dynamic	_	
97-27	15277-15289	connectivity	_	
97-28	15290-15298	analysis	_	
97-29	15298-15299	.	_	

#Text=So, consistent to previous work, M was set to 5 in this study.
98-1	15300-15302	So	_	
98-2	15302-15303	,	_	
98-3	15304-15314	consistent	_	
98-4	15315-15317	to	_	
98-5	15318-15326	previous	_	
98-6	15327-15331	work	_	
98-7	15331-15332	,	_	
98-8	15333-15334	M	_	
98-9	15335-15338	was	_	
98-10	15339-15342	set	_	
98-11	15343-15345	to	_	
98-12	15346-15347	5	_	
98-13	15348-15350	in	_	
98-14	15351-15355	this	_	
98-15	15356-15361	study	_	
98-16	15361-15362	.	_	

#Text=Using this setting, the mean of preserved variances was 76% in subject-level PCAs and reliable performance of ICASSO with 20 ICA runs was achieved (see supplementary Fig.
99-1	15363-15368	Using	_	
99-2	15369-15373	this	_	
99-3	15374-15381	setting	_	
99-4	15381-15382	,	_	
99-5	15383-15386	the	_	
99-6	15387-15391	mean	_	
99-7	15392-15394	of	_	
99-8	15395-15404	preserved	_	
99-9	15405-15414	variances	_	
99-10	15415-15418	was	_	
99-11	15419-15422	76%	_	
99-12	15423-15425	in	_	
99-13	15426-15439	subject-level	_	
99-14	15440-15444	PCAs	_	
99-15	15445-15448	and	_	
99-16	15449-15457	reliable	_	
99-17	15458-15469	performance	_	
99-18	15470-15472	of	_	
99-19	15473-15479	ICASSO	_	
99-20	15480-15484	with	_	
99-21	15485-15487	20	_	
99-22	15488-15491	ICA	_	
99-23	15492-15496	runs	_	
99-24	15497-15500	was	_	
99-25	15501-15509	achieved	_	
99-26	15510-15511	(	_	
99-27	15511-15514	see	_	
99-28	15515-15528	supplementary	_	
99-29	15529-15532	Fig	_	
99-30	15532-15533	.	_	

#Text=S1).
100-1	15534-15536	S1	_	
100-2	15536-15537	)	_	
100-3	15537-15538	.	_	

#Text=Each GS (i.e., one row of S) was z-scored to zero mean and unit variance for consequent processing.
101-1	15539-15543	Each	_	
101-2	15544-15546	GS	_	
101-3	15547-15548	(	_	
101-4	15548-15551	i.e	_	
101-5	15551-15552	.	_	
101-6	15552-15553	,	_	
101-7	15554-15557	one	_	
101-8	15558-15561	row	_	
101-9	15562-15564	of	_	
101-10	15565-15566	S	_	
101-11	15566-15567	)	_	
101-12	15568-15571	was	_	
101-13	15572-15580	z-scored	_	
101-14	15581-15583	to	_	
101-15	15584-15588	zero	_	
101-16	15589-15593	mean	_	
101-17	15594-15597	and	_	
101-18	15598-15602	unit	_	
101-19	15603-15611	variance	_	
101-20	15612-15615	for	_	
101-21	15616-15626	consequent	_	
101-22	15627-15637	processing	_	
101-23	15637-15638	.	_	

#Text=According to ICA, A= [A1;…;Ak;…;AN] included the mixing coefficient matrices of all subjects.
102-1	15639-15648	According	_	
102-2	15649-15651	to	_	
102-3	15652-15655	ICA	_	
102-4	15655-15656	,	_	
102-5	15657-15658	A	_	
102-6	15658-15659	=	_	
102-7	15660-15661	[	_	
102-8	15661-15663	A1	_	
102-9	15663-15664	;	_	
102-10	15664-15665	…	_	
102-11	15665-15666	;	_	
102-12	15666-15668	Ak	_	
102-13	15668-15669	;	_	
102-14	15669-15670	…	_	
102-15	15670-15671	;	_	
102-16	15671-15673	AN	_	
102-17	15673-15674	]	_	
102-18	15675-15683	included	_	
102-19	15684-15687	the	_	
102-20	15688-15694	mixing	_	
102-21	15695-15706	coefficient	_	
102-22	15707-15715	matrices	_	
102-23	15716-15718	of	_	
102-24	15719-15722	all	_	
102-25	15723-15731	subjects	_	
102-26	15731-15732	.	_	

#Text=Ak represented the temporal fluctuations of all connectivity states for the kth subject, and each column of Ak reflected the subject-specific fluctuation (SF) of one state for the kth subject.
103-1	15733-15735	Ak	_	
103-2	15736-15747	represented	_	
103-3	15748-15751	the	_	
103-4	15752-15760	temporal	_	
103-5	15761-15773	fluctuations	_	
103-6	15774-15776	of	_	
103-7	15777-15780	all	_	
103-8	15781-15793	connectivity	_	
103-9	15794-15800	states	_	
103-10	15801-15804	for	_	
103-11	15805-15808	the	_	
103-12	15809-15812	kth	_	
103-13	15813-15820	subject	_	
103-14	15820-15821	,	_	
103-15	15822-15825	and	_	
103-16	15826-15830	each	_	
103-17	15831-15837	column	_	
103-18	15838-15840	of	_	
103-19	15841-15843	Ak	_	
103-20	15844-15853	reflected	_	
103-21	15854-15857	the	_	
103-22	15858-15874	subject-specific	_	
103-23	15875-15886	fluctuation	_	
103-24	15887-15888	(	_	
103-25	15888-15890	SF	_	
103-26	15890-15891	)	_	
103-27	15892-15894	of	_	
103-28	15895-15898	one	_	
103-29	15899-15904	state	_	
103-30	15905-15908	for	_	
103-31	15909-15912	the	_	
103-32	15913-15916	kth	_	
103-33	15917-15924	subject	_	
103-34	15924-15925	.	_	

#Text=Afterwards, we assessed the contribution of each GS to the dynamic connectivity.
104-1	15926-15936	Afterwards	_	
104-2	15936-15937	,	_	
104-3	15938-15940	we	_	
104-4	15941-15949	assessed	_	
104-5	15950-15953	the	_	
104-6	15954-15966	contribution	_	
104-7	15967-15969	of	_	
104-8	15970-15974	each	_	
104-9	15975-15977	GS	_	
104-10	15978-15980	to	_	
104-11	15981-15984	the	_	
104-12	15985-15992	dynamic	_	
104-13	15993-16005	connectivity	_	
104-14	16005-16006	.	_	

#Text=The contribution of the lth GS was measured using  , where al was the lth column of A.
105-1	16007-16010	The	_	
105-2	16011-16023	contribution	_	
105-3	16024-16026	of	_	
105-4	16027-16030	the	_	
105-5	16031-16034	lth	_	
105-6	16035-16037	GS	_	
105-7	16038-16041	was	_	
105-8	16042-16050	measured	_	
105-9	16051-16056	using	_	
105-10	16058-16059	,	_	
105-11	16060-16065	where	_	
105-12	16066-16068	al	_	
105-13	16069-16072	was	_	
105-14	16073-16076	the	_	
105-15	16077-16080	lth	_	
105-16	16081-16087	column	_	
105-17	16088-16090	of	_	
105-18	16091-16092	A	_	
105-19	16092-16093	.	_	

#Text=The measure reflected the percentage of the loading of each GS in all GSs’ loading sum.
106-1	16094-16097	The	_	
106-2	16098-16105	measure	_	
106-3	16106-16115	reflected	_	
106-4	16116-16119	the	_	
106-5	16120-16130	percentage	_	
106-6	16131-16133	of	_	
106-7	16134-16137	the	_	
106-8	16138-16145	loading	_	
106-9	16146-16148	of	_	
106-10	16149-16153	each	_	
106-11	16154-16156	GS	_	
106-12	16157-16159	in	_	
106-13	16160-16163	all	_	
106-14	16164-16167	GSs	_	
106-15	16167-16168	’	_	
106-16	16169-16176	loading	_	
106-17	16177-16180	sum	_	
106-18	16180-16181	.	_	

#Text=Consequently, the first-rank GS was identified as the dominant GS (e.g., Sl), which included the most information across entire dynamic connectivity stream of all subjects.
107-1	16182-16194	Consequently	_	
107-2	16194-16195	,	_	
107-3	16196-16199	the	_	
107-4	16200-16210	first-rank	_	
107-5	16211-16213	GS	_	
107-6	16214-16217	was	_	
107-7	16218-16228	identified	_	
107-8	16229-16231	as	_	
107-9	16232-16235	the	_	
107-10	16236-16244	dominant	_	
107-11	16245-16247	GS	_	
107-12	16248-16249	(	_	
107-13	16249-16252	e.g	_	
107-14	16252-16253	.	_	
107-15	16253-16254	,	_	
107-16	16255-16257	Sl	_	
107-17	16257-16258	)	_	
107-18	16258-16259	,	_	
107-19	16260-16265	which	_	
107-20	16266-16274	included	_	
107-21	16275-16278	the	_	
107-22	16279-16283	most	_	
107-23	16284-16295	information	_	
107-24	16296-16302	across	_	
107-25	16303-16309	entire	_	
107-26	16310-16317	dynamic	_	
107-27	16318-16330	connectivity	_	
107-28	16331-16337	stream	_	
107-29	16338-16340	of	_	
107-30	16341-16344	all	_	
107-31	16345-16353	subjects	_	
107-32	16353-16354	.	_	

#Text=Subsequently, based on the identified dominant GS and the individual-subject’s Fisher-transformed dynamic connectivity matrix (e.g., Xk), we estimated the corresponding dominant subject-specific state (SS) using a multiple-objective function optimization (see the following formula (1)).
108-1	16355-16367	Subsequently	_	
108-2	16367-16368	,	_	
108-3	16369-16374	based	_	
108-4	16375-16377	on	_	
108-5	16378-16381	the	_	
108-6	16382-16392	identified	_	
108-7	16393-16401	dominant	_	
108-8	16402-16404	GS	_	
108-9	16405-16408	and	_	
108-10	16409-16412	the	_	
108-11	16413-16431	individual-subject	_	
108-12	16431-16432	’	_	
108-13	16432-16433	s	_	
108-14	16434-16452	Fisher-transformed	_	
108-15	16453-16460	dynamic	_	
108-16	16461-16473	connectivity	_	
108-17	16474-16480	matrix	_	
108-18	16481-16482	(	_	
108-19	16482-16485	e.g	_	
108-20	16485-16486	.	_	
108-21	16486-16487	,	_	
108-22	16488-16490	Xk	_	
108-23	16490-16491	)	_	
108-24	16491-16492	,	_	
108-25	16493-16495	we	_	
108-26	16496-16505	estimated	_	
108-27	16506-16509	the	_	
108-28	16510-16523	corresponding	_	
108-29	16524-16532	dominant	_	
108-30	16533-16549	subject-specific	_	
108-31	16550-16555	state	_	
108-32	16556-16557	(	_	
108-33	16557-16559	SS	_	
108-34	16559-16560	)	_	
108-35	16561-16566	using	_	
108-36	16567-16568	a	_	
108-37	16569-16587	multiple-objective	_	
108-38	16588-16596	function	_	
108-39	16597-16609	optimization	_	
108-40	16610-16611	(	_	
108-41	16611-16614	see	_	
108-42	16615-16618	the	_	
108-43	16619-16628	following	_	
108-44	16629-16636	formula	_	
108-45	16637-16638	(	_	
108-46	16638-16639	1	_	
108-47	16639-16640	)	_	
108-48	16640-16641	)	_	
108-49	16641-16642	.	_	

#Text=Fig. 1C shows the schematic drawing of the step.
109-1	16643-16646	Fig	_	
109-2	16646-16647	.	_	
109-3	16648-16650	1C	_	
109-4	16651-16656	shows	_	
109-5	16657-16660	the	_	
109-6	16661-16670	schematic	_	
109-7	16671-16678	drawing	_	
109-8	16679-16681	of	_	
109-9	16682-16685	the	_	
109-10	16686-16690	step	_	
109-11	16690-16691	.	_	

#Text=In the procedure, the independence of the dominant SS as well as the correspondence between the dominant SS and the dominant GS were simultaneously optimized, resulting in accurate individual-level connectivity states that can be directly comparable across subjects.
110-1	16692-16694	In	_	
110-2	16695-16698	the	_	
110-3	16699-16708	procedure	_	
110-4	16708-16709	,	_	
110-5	16710-16713	the	_	
110-6	16714-16726	independence	_	
110-7	16727-16729	of	_	
110-8	16730-16733	the	_	
110-9	16734-16742	dominant	_	
110-10	16743-16745	SS	_	
110-11	16746-16748	as	_	
110-12	16749-16753	well	_	
110-13	16754-16756	as	_	
110-14	16757-16760	the	_	
110-15	16761-16775	correspondence	_	
110-16	16776-16783	between	_	
110-17	16784-16787	the	_	
110-18	16788-16796	dominant	_	
110-19	16797-16799	SS	_	
110-20	16800-16803	and	_	
110-21	16804-16807	the	_	
110-22	16808-16816	dominant	_	
110-23	16817-16819	GS	_	
110-24	16820-16824	were	_	
110-25	16825-16839	simultaneously	_	
110-26	16840-16849	optimized	_	
110-27	16849-16850	,	_	
110-28	16851-16860	resulting	_	
110-29	16861-16863	in	_	
110-30	16864-16872	accurate	_	
110-31	16873-16889	individual-level	_	
110-32	16890-16902	connectivity	_	
110-33	16903-16909	states	_	
110-34	16910-16914	that	_	
110-35	16915-16918	can	_	
110-36	16919-16921	be	_	
110-37	16922-16930	directly	_	
110-38	16931-16941	comparable	_	
110-39	16942-16948	across	_	
110-40	16949-16957	subjects	_	
110-41	16957-16958	.	_	

#Text=The optimization can directly yield Z-scored individual-level states with zero mean and unit variance.
111-1	16959-16962	The	_	
111-2	16963-16975	optimization	_	
111-3	16976-16979	can	_	
111-4	16980-16988	directly	_	
111-5	16989-16994	yield	_	
111-6	16995-17003	Z-scored	_	
111-7	17004-17020	individual-level	_	
111-8	17021-17027	states	_	
111-9	17028-17032	with	_	
111-10	17033-17037	zero	_	
111-11	17038-17042	mean	_	
111-12	17043-17046	and	_	
111-13	17047-17051	unit	_	
111-14	17052-17060	variance	_	
111-15	17060-17061	.	_	

#Text=In (1),   represents the estimated dominant SS of the kth subject, where   is the whitened Xk;   is the unmixing column vector.
112-1	17063-17065	In	_	
112-2	17066-17067	(	_	
112-3	17067-17068	1	_	
112-4	17068-17069	)	_	
112-5	17069-17070	,	_	
112-6	17073-17083	represents	_	
112-7	17084-17087	the	_	
112-8	17088-17097	estimated	_	
112-9	17098-17106	dominant	_	
112-10	17107-17109	SS	_	
112-11	17110-17112	of	_	
112-12	17113-17116	the	_	
112-13	17117-17120	kth	_	
112-14	17121-17128	subject	_	
112-15	17128-17129	,	_	
112-16	17130-17135	where	_	
112-17	17138-17140	is	_	
112-18	17141-17144	the	_	
112-19	17145-17153	whitened	_	
112-20	17154-17156	Xk	_	
112-21	17156-17157	;	_	
112-22	17160-17162	is	_	
112-23	17163-17166	the	_	
112-24	17167-17175	unmixing	_	
112-25	17176-17182	column	_	
112-26	17183-17189	vector	_	
112-27	17189-17190	.	_	

#Text=The first function is for optimizing the independence measure of  .
113-1	17191-17194	The	_	
113-2	17195-17200	first	_	
113-3	17201-17209	function	_	
113-4	17210-17212	is	_	
113-5	17213-17216	for	_	
113-6	17217-17227	optimizing	_	
113-7	17228-17231	the	_	
113-8	17232-17244	independence	_	
113-9	17245-17252	measure	_	
113-10	17253-17255	of	_	
113-11	17257-17258	.	_	

#Text=In our method,  , the negentropy of  , is used to reflect independence of  .
114-1	17259-17261	In	_	
114-2	17262-17265	our	_	
114-3	17266-17272	method	_	
114-4	17272-17273	,	_	
114-5	17275-17276	,	_	
114-6	17277-17280	the	_	
114-7	17281-17291	negentropy	_	
114-8	17292-17294	of	_	
114-9	17296-17297	,	_	
114-10	17298-17300	is	_	
114-11	17301-17305	used	_	
114-12	17306-17308	to	_	
114-13	17309-17316	reflect	_	
114-14	17317-17329	independence	_	
114-15	17330-17332	of	_	
114-16	17334-17335	.	_	

#Text=Here, ν is a is a Gaussian variable with zero mean and unit variance; G (·)is a nonquadratic function.
115-1	17336-17340	Here	_	
115-2	17340-17341	,	_	
115-3	17342-17343	ν	_	
115-4	17344-17346	is	_	
115-5	17347-17348	a	_	
115-6	17349-17351	is	_	
115-7	17352-17353	a	_	
115-8	17354-17362	Gaussian	_	
115-9	17363-17371	variable	_	
115-10	17372-17376	with	_	
115-11	17377-17381	zero	_	
115-12	17382-17386	mean	_	
115-13	17387-17390	and	_	
115-14	17391-17395	unit	_	
115-15	17396-17404	variance	_	
115-16	17404-17405	;	_	
115-17	17406-17407	G	_	
115-18	17408-17409	(	_	
115-19	17409-17410	·	_	
115-20	17410-17411	)	_	
115-21	17411-17413	is	_	
115-22	17414-17415	a	_	
115-23	17416-17428	nonquadratic	_	
115-24	17429-17437	function	_	
115-25	17437-17438	.	_	

#Text=The second function   is used to measure the similarity (i.e., correspondence) between Sl. and  .
116-1	17439-17442	The	_	
116-2	17443-17449	second	_	
116-3	17450-17458	function	_	
116-4	17461-17463	is	_	
116-5	17464-17468	used	_	
116-6	17469-17471	to	_	
116-7	17472-17479	measure	_	
116-8	17480-17483	the	_	
116-9	17484-17494	similarity	_	
116-10	17495-17496	(	_	
116-11	17496-17499	i.e	_	
116-12	17499-17500	.	_	
116-13	17500-17501	,	_	
116-14	17502-17516	correspondence	_	
116-15	17516-17517	)	_	
116-16	17518-17525	between	_	
116-17	17526-17528	Sl	_	
116-18	17528-17529	.	_	
116-19	17530-17533	and	_	
116-20	17535-17536	.	_	

#Text=E[ ] denotes the expectation of variable.
117-1	17537-17538	E	_	
117-2	17538-17539	[	_	
117-3	17540-17541	]	_	
117-4	17542-17549	denotes	_	
117-5	17550-17553	the	_	
117-6	17554-17565	expectation	_	
117-7	17566-17568	of	_	
117-8	17569-17577	variable	_	
117-9	17577-17578	.	_	

#Text=By derivation,   equals to Pearson correlation between Sl and  .
118-1	17579-17581	By	_	
118-2	17582-17592	derivation	_	
118-3	17592-17593	,	_	
118-4	17596-17602	equals	_	
118-5	17603-17605	to	_	
118-6	17606-17613	Pearson	_	
118-7	17614-17625	correlation	_	
118-8	17626-17633	between	_	
118-9	17634-17636	Sl	_	
118-10	17637-17640	and	_	
118-11	17642-17643	.	_	

#Text=To solve the multiple-objective function optimization, a linear weighted sum method was applied to combine the two objectives.
119-1	17644-17646	To	_	
119-2	17647-17652	solve	_	
119-3	17653-17656	the	_	
119-4	17657-17675	multiple-objective	_	
119-5	17676-17684	function	_	
119-6	17685-17697	optimization	_	
119-7	17697-17698	,	_	
119-8	17699-17700	a	_	
119-9	17701-17707	linear	_	
119-10	17708-17716	weighted	_	
119-11	17717-17720	sum	_	
119-12	17721-17727	method	_	
119-13	17728-17731	was	_	
119-14	17732-17739	applied	_	
119-15	17740-17742	to	_	
119-16	17743-17750	combine	_	
119-17	17751-17754	the	_	
119-18	17755-17758	two	_	
119-19	17759-17769	objectives	_	
119-20	17769-17770	.	_	

#Text=After the optimization, the dominant subject-specific states were obtained.
120-1	17771-17776	After	_	
120-2	17777-17780	the	_	
120-3	17781-17793	optimization	_	
120-4	17793-17794	,	_	
120-5	17795-17798	the	_	
120-6	17799-17807	dominant	_	
120-7	17808-17824	subject-specific	_	
120-8	17825-17831	states	_	
120-9	17832-17836	were	_	
120-10	17837-17845	obtained	_	
120-11	17845-17846	.	_	

#Text=Derived from the above mentioned analyses, each of the group-level and individual-subject connectivity states is denoted by a Z-scored component (size: 1 × 6670).
121-1	17847-17854	Derived	_	
121-2	17855-17859	from	_	
121-3	17860-17863	the	_	
121-4	17864-17869	above	_	
121-5	17870-17879	mentioned	_	
121-6	17880-17888	analyses	_	
121-7	17888-17889	,	_	
121-8	17890-17894	each	_	
121-9	17895-17897	of	_	
121-10	17898-17901	the	_	
121-11	17902-17913	group-level	_	
121-12	17914-17917	and	_	
121-13	17918-17936	individual-subject	_	
121-14	17937-17949	connectivity	_	
121-15	17950-17956	states	_	
121-16	17957-17959	is	_	
121-17	17960-17967	denoted	_	
121-18	17968-17970	by	_	
121-19	17971-17972	a	_	
121-20	17973-17981	Z-scored	_	
121-21	17982-17991	component	_	
121-22	17992-17993	(	_	
121-23	17993-17997	size	_	
121-24	17997-17998	:	_	
121-25	17999-18000	1	_	
121-26	18001-18002	×	_	
121-27	18003-18007	6670	_	
121-28	18007-18008	)	_	
121-29	18008-18009	.	_	

#Text=We then converted each component to a 116 × 116 symmetric matrix, so each element of the symmetric matrix reflects the relationship between one pair of ROIs.
122-1	18010-18012	We	_	
122-2	18013-18017	then	_	
122-3	18018-18027	converted	_	
122-4	18028-18032	each	_	
122-5	18033-18042	component	_	
122-6	18043-18045	to	_	
122-7	18046-18047	a	_	
122-8	18048-18051	116	_	
122-9	18052-18053	×	_	
122-10	18054-18057	116	_	
122-11	18058-18067	symmetric	_	
122-12	18068-18074	matrix	_	
122-13	18074-18075	,	_	
122-14	18076-18078	so	_	
122-15	18079-18083	each	_	
122-16	18084-18091	element	_	
122-17	18092-18094	of	_	
122-18	18095-18098	the	_	
122-19	18099-18108	symmetric	_	
122-20	18109-18115	matrix	_	
122-21	18116-18124	reflects	_	
122-22	18125-18128	the	_	
122-23	18129-18141	relationship	_	
122-24	18142-18149	between	_	
122-25	18150-18153	one	_	
122-26	18154-18158	pair	_	
122-27	18159-18161	of	_	
122-28	18162-18166	ROIs	_	
122-29	18166-18167	.	_	

#Text=It is worth pointing out that the positive and negative values in the symmetric matrix of each GS should be interpreted along with the state’s loadings (i.e., SFs) due to the ambiguity of the signs of components (i.e., states).
123-1	18168-18170	It	_	
123-2	18171-18173	is	_	
123-3	18174-18179	worth	_	
123-4	18180-18188	pointing	_	
123-5	18189-18192	out	_	
123-6	18193-18197	that	_	
123-7	18198-18201	the	_	
123-8	18202-18210	positive	_	
123-9	18211-18214	and	_	
123-10	18215-18223	negative	_	
123-11	18224-18230	values	_	
123-12	18231-18233	in	_	
123-13	18234-18237	the	_	
123-14	18238-18247	symmetric	_	
123-15	18248-18254	matrix	_	
123-16	18255-18257	of	_	
123-17	18258-18262	each	_	
123-18	18263-18265	GS	_	
123-19	18266-18272	should	_	
123-20	18273-18275	be	_	
123-21	18276-18287	interpreted	_	
123-22	18288-18293	along	_	
123-23	18294-18298	with	_	
123-24	18299-18302	the	_	
123-25	18303-18308	state	_	
123-26	18308-18309	’	_	
123-27	18309-18310	s	_	
123-28	18311-18319	loadings	_	
123-29	18320-18321	(	_	
123-30	18321-18324	i.e	_	
123-31	18324-18325	.	_	
123-32	18325-18326	,	_	
123-33	18327-18330	SFs	_	
123-34	18330-18331	)	_	
123-35	18332-18335	due	_	
123-36	18336-18338	to	_	
123-37	18339-18342	the	_	
123-38	18343-18352	ambiguity	_	
123-39	18353-18355	of	_	
123-40	18356-18359	the	_	
123-41	18360-18365	signs	_	
123-42	18366-18368	of	_	
123-43	18369-18379	components	_	
123-44	18380-18381	(	_	
123-45	18381-18384	i.e	_	
123-46	18384-18385	.	_	
123-47	18385-18386	,	_	
123-48	18387-18393	states	_	
123-49	18393-18394	)	_	
123-50	18394-18395	.	_	

#Text=If one state’s SF values are positive, it means that its contribution to time-varying connectivity is positive.
124-1	18396-18398	If	_	
124-2	18399-18402	one	_	
124-3	18403-18408	state	_	
124-4	18408-18409	’	_	
124-5	18409-18410	s	_	
124-6	18411-18413	SF	_	
124-7	18414-18420	values	_	
124-8	18421-18424	are	_	
124-9	18425-18433	positive	_	
124-10	18433-18434	,	_	
124-11	18435-18437	it	_	
124-12	18438-18443	means	_	
124-13	18444-18448	that	_	
124-14	18449-18452	its	_	
124-15	18453-18465	contribution	_	
124-16	18466-18468	to	_	
124-17	18469-18481	time-varying	_	
124-18	18482-18494	connectivity	_	
124-19	18495-18497	is	_	
124-20	18498-18506	positive	_	
124-21	18506-18507	.	_	

#Text=So, the positive/negative values in the state (i.e., the positive/negative values in the symmetric matrix) reflect the positive/negative connectivity strengths between ROIs.
125-1	18508-18510	So	_	
125-2	18510-18511	,	_	
125-3	18512-18515	the	_	
125-4	18516-18524	positive	_	
125-5	18524-18525	/	_	
125-6	18525-18533	negative	_	
125-7	18534-18540	values	_	
125-8	18541-18543	in	_	
125-9	18544-18547	the	_	
125-10	18548-18553	state	_	
125-11	18554-18555	(	_	
125-12	18555-18558	i.e	_	
125-13	18558-18559	.	_	
125-14	18559-18560	,	_	
125-15	18561-18564	the	_	
125-16	18565-18573	positive	_	
125-17	18573-18574	/	_	
125-18	18574-18582	negative	_	
125-19	18583-18589	values	_	
125-20	18590-18592	in	_	
125-21	18593-18596	the	_	
125-22	18597-18606	symmetric	_	
125-23	18607-18613	matrix	_	
125-24	18613-18614	)	_	
125-25	18615-18622	reflect	_	
125-26	18623-18626	the	_	
125-27	18627-18635	positive	_	
125-28	18635-18636	/	_	
125-29	18636-18644	negative	_	
125-30	18645-18657	connectivity	_	
125-31	18658-18667	strengths	_	
125-32	18668-18675	between	_	
125-33	18676-18680	ROIs	_	
125-34	18680-18681	.	_	

#Text=If one state’s SF values have both positive and negative values, the values in the symmetric matrix don’t directly correspond to the connectivity strengths.
126-1	18682-18684	If	_	
126-2	18685-18688	one	_	
126-3	18689-18694	state	_	
126-4	18694-18695	’	_	
126-5	18695-18696	s	_	
126-6	18697-18699	SF	_	
126-7	18700-18706	values	_	
126-8	18707-18711	have	_	
126-9	18712-18716	both	_	
126-10	18717-18725	positive	_	
126-11	18726-18729	and	_	
126-12	18730-18738	negative	_	
126-13	18739-18745	values	_	
126-14	18745-18746	,	_	
126-15	18747-18750	the	_	
126-16	18751-18757	values	_	
126-17	18758-18760	in	_	
126-18	18761-18764	the	_	
126-19	18765-18774	symmetric	_	
126-20	18775-18781	matrix	_	
126-21	18782-18785	don	_	
126-22	18785-18786	’	_	
126-23	18786-18787	t	_	
126-24	18788-18796	directly	_	
126-25	18797-18807	correspond	_	
126-26	18808-18810	to	_	
126-27	18811-18814	the	_	
126-28	18815-18827	connectivity	_	
126-29	18828-18837	strengths	_	
126-30	18837-18838	.	_	

#Text=In that case, the positive (or negative) value in SF means that the state (or anti-state) exists in the corresponding window’s functional connectivity.
#Text=2.2.3.
127-1	18839-18841	In	_	
127-2	18842-18846	that	_	
127-3	18847-18851	case	_	
127-4	18851-18852	,	_	
127-5	18853-18856	the	_	
127-6	18857-18865	positive	_	
127-7	18866-18867	(	_	
127-8	18867-18869	or	_	
127-9	18870-18878	negative	_	
127-10	18878-18879	)	_	
127-11	18880-18885	value	_	
127-12	18886-18888	in	_	
127-13	18889-18891	SF	_	
127-14	18892-18897	means	_	
127-15	18898-18902	that	_	
127-16	18903-18906	the	_	
127-17	18907-18912	state	_	
127-18	18913-18914	(	_	
127-19	18914-18916	or	_	
127-20	18917-18927	anti-state	_	
127-21	18927-18928	)	_	
127-22	18929-18935	exists	_	
127-23	18936-18938	in	_	
127-24	18939-18942	the	_	
127-25	18943-18956	corresponding	_	
127-26	18957-18963	window	_	
127-27	18963-18964	’	_	
127-28	18964-18965	s	_	
127-29	18966-18976	functional	_	
127-30	18977-18989	connectivity	_	
127-31	18989-18990	.	_	
127-32	18991-18996	2.2.3	_	
127-33	18996-18997	.	_	

#Text=Investigating group differences in the functional connectivity states
#Text=In the section, we focus on investigating group differences in the connectivity states, aiming to explore whether CHR individuals tend to be intermediate between HC subjects and ESZ patients and what measures could be employed as potential biomarkers for CHR and ESZ.
128-1	18998-19011	Investigating	_	
128-2	19012-19017	group	_	
128-3	19018-19029	differences	_	
128-4	19030-19032	in	_	
128-5	19033-19036	the	_	
128-6	19037-19047	functional	_	
128-7	19048-19060	connectivity	_	
128-8	19061-19067	states	_	
128-9	19068-19070	In	_	
128-10	19071-19074	the	_	
128-11	19075-19082	section	_	
128-12	19082-19083	,	_	
128-13	19084-19086	we	_	
128-14	19087-19092	focus	_	
128-15	19093-19095	on	_	
128-16	19096-19109	investigating	_	
128-17	19110-19115	group	_	
128-18	19116-19127	differences	_	
128-19	19128-19130	in	_	
128-20	19131-19134	the	_	
128-21	19135-19147	connectivity	_	
128-22	19148-19154	states	_	
128-23	19154-19155	,	_	
128-24	19156-19162	aiming	_	
128-25	19163-19165	to	_	
128-26	19166-19173	explore	_	
128-27	19174-19181	whether	_	
128-28	19182-19185	CHR	_	
128-29	19186-19197	individuals	_	
128-30	19198-19202	tend	_	
128-31	19203-19205	to	_	
128-32	19206-19208	be	_	
128-33	19209-19221	intermediate	_	
128-34	19222-19229	between	_	
128-35	19230-19232	HC	_	
128-36	19233-19241	subjects	_	
128-37	19242-19245	and	_	
128-38	19246-19249	ESZ	_	
128-39	19250-19258	patients	_	
128-40	19259-19262	and	_	
128-41	19263-19267	what	_	
128-42	19268-19276	measures	_	
128-43	19277-19282	could	_	
128-44	19283-19285	be	_	
128-45	19286-19294	employed	_	
128-46	19295-19297	as	_	
128-47	19298-19307	potential	_	
128-48	19308-19318	biomarkers	_	
128-49	19319-19322	for	_	
128-50	19323-19326	CHR	_	
128-51	19327-19330	and	_	
128-52	19331-19334	ESZ	_	
128-53	19334-19335	.	_	

#Text=Similar to our previous work, we matched results among the three groups in order to compare the corresponding states.
129-1	19336-19343	Similar	_	
129-2	19344-19346	to	_	
129-3	19347-19350	our	_	
129-4	19351-19359	previous	_	
129-5	19360-19364	work	_	
129-6	19364-19365	,	_	
129-7	19366-19368	we	_	
129-8	19369-19376	matched	_	
129-9	19377-19384	results	_	
129-10	19385-19390	among	_	
129-11	19391-19394	the	_	
129-12	19395-19400	three	_	
129-13	19401-19407	groups	_	
129-14	19408-19410	in	_	
129-15	19411-19416	order	_	
129-16	19417-19419	to	_	
129-17	19420-19427	compare	_	
129-18	19428-19431	the	_	
129-19	19432-19445	corresponding	_	
129-20	19446-19452	states	_	
129-21	19452-19453	.	_	

#Text=The detailed matching method is described in the supplementary materials.
130-1	19454-19457	The	_	
130-2	19458-19466	detailed	_	
130-3	19467-19475	matching	_	
130-4	19476-19482	method	_	
130-5	19483-19485	is	_	
130-6	19486-19495	described	_	
130-7	19496-19498	in	_	
130-8	19499-19502	the	_	
130-9	19503-19516	supplementary	_	
130-10	19517-19526	materials	_	
130-11	19526-19527	.	_	

#Text=After that, we visualized each of GSs using the BrainNet Viewer toolbox to reflect the related connectivity pattern among ROIs.
131-1	19528-19533	After	_	
131-2	19534-19538	that	_	
131-3	19538-19539	,	_	
131-4	19540-19542	we	_	
131-5	19543-19553	visualized	_	
131-6	19554-19558	each	_	
131-7	19559-19561	of	_	
131-8	19562-19565	GSs	_	
131-9	19566-19571	using	_	
131-10	19572-19575	the	_	
131-11	19576-19584	BrainNet	_	
131-12	19585-19591	Viewer	_	
131-13	19592-19599	toolbox	_	
131-14	19600-19602	to	_	
131-15	19603-19610	reflect	_	
131-16	19611-19614	the	_	
131-17	19615-19622	related	_	
131-18	19623-19635	connectivity	_	
131-19	19636-19643	pattern	_	
131-20	19644-19649	among	_	
131-21	19650-19654	ROIs	_	
131-22	19654-19655	.	_	

#Text=Next, to assess the relationship (similarity or disparity) of the matched GSs across the three groups, we computed Pearson correlation coefficient between any pair of GSs, resulting in a correlation matrix (size: 3 × 3).
132-1	19656-19660	Next	_	
132-2	19660-19661	,	_	
132-3	19662-19664	to	_	
132-4	19665-19671	assess	_	
132-5	19672-19675	the	_	
132-6	19676-19688	relationship	_	
132-7	19689-19690	(	_	
132-8	19690-19700	similarity	_	
132-9	19701-19703	or	_	
132-10	19704-19713	disparity	_	
132-11	19713-19714	)	_	
132-12	19715-19717	of	_	
132-13	19718-19721	the	_	
132-14	19722-19729	matched	_	
132-15	19730-19733	GSs	_	
132-16	19734-19740	across	_	
132-17	19741-19744	the	_	
132-18	19745-19750	three	_	
132-19	19751-19757	groups	_	
132-20	19757-19758	,	_	
132-21	19759-19761	we	_	
132-22	19762-19770	computed	_	
132-23	19771-19778	Pearson	_	
132-24	19779-19790	correlation	_	
132-25	19791-19802	coefficient	_	
132-26	19803-19810	between	_	
132-27	19811-19814	any	_	
132-28	19815-19819	pair	_	
132-29	19820-19822	of	_	
132-30	19823-19826	GSs	_	
132-31	19826-19827	,	_	
132-32	19828-19837	resulting	_	
132-33	19838-19840	in	_	
132-34	19841-19842	a	_	
132-35	19843-19854	correlation	_	
132-36	19855-19861	matrix	_	
132-37	19862-19863	(	_	
132-38	19863-19867	size	_	
132-39	19867-19868	:	_	
132-40	19869-19870	3	_	
132-41	19871-19872	×	_	
132-42	19873-19874	3	_	
132-43	19874-19875	)	_	
132-44	19875-19876	.	_	

#Text=The upper triangular elements of the correlation matrix include rHC–CHR, rHC–ESZ, and rCHR–ESZ.
133-1	19877-19880	The	_	
133-2	19881-19886	upper	_	
133-3	19887-19897	triangular	_	
133-4	19898-19906	elements	_	
133-5	19907-19909	of	_	
133-6	19910-19913	the	_	
133-7	19914-19925	correlation	_	
133-8	19926-19932	matrix	_	
133-9	19933-19940	include	_	
133-10	19941-19948	rHC–CHR	_	
133-11	19948-19949	,	_	
133-12	19950-19957	rHC–ESZ	_	
133-13	19957-19958	,	_	
133-14	19959-19962	and	_	
133-15	19963-19971	rCHR–ESZ	_	
133-16	19971-19972	.	_	

#Text=Here, rHC–CHR denotes the correlation between the GS of HC group and the GS of CHR group.
134-1	19973-19977	Here	_	
134-2	19977-19978	,	_	
134-3	19979-19986	rHC–CHR	_	
134-4	19987-19994	denotes	_	
134-5	19995-19998	the	_	
134-6	19999-20010	correlation	_	
134-7	20011-20018	between	_	
134-8	20019-20022	the	_	
134-9	20023-20025	GS	_	
134-10	20026-20028	of	_	
134-11	20029-20031	HC	_	
134-12	20032-20037	group	_	
134-13	20038-20041	and	_	
134-14	20042-20045	the	_	
134-15	20046-20048	GS	_	
134-16	20049-20051	of	_	
134-17	20052-20055	CHR	_	
134-18	20056-20061	group	_	
134-19	20061-20062	.	_	

#Text=Then, we took the mean of the absolute correlations in the similarity matrix as the overall similarity measure of the matched GSs.
135-1	20063-20067	Then	_	
135-2	20067-20068	,	_	
135-3	20069-20071	we	_	
135-4	20072-20076	took	_	
135-5	20077-20080	the	_	
135-6	20081-20085	mean	_	
135-7	20086-20088	of	_	
135-8	20089-20092	the	_	
135-9	20093-20101	absolute	_	
135-10	20102-20114	correlations	_	
135-11	20115-20117	in	_	
135-12	20118-20121	the	_	
135-13	20122-20132	similarity	_	
135-14	20133-20139	matrix	_	
135-15	20140-20142	as	_	
135-16	20143-20146	the	_	
135-17	20147-20154	overall	_	
135-18	20155-20165	similarity	_	
135-19	20166-20173	measure	_	
135-20	20174-20176	of	_	
135-21	20177-20180	the	_	
135-22	20181-20188	matched	_	
135-23	20189-20192	GSs	_	
135-24	20192-20193	.	_	

#Text=Furthermore, we examined if the inter-group relationships of GSs are statistically significant using multiple permutation runs.
136-1	20194-20205	Furthermore	_	
136-2	20205-20206	,	_	
136-3	20207-20209	we	_	
136-4	20210-20218	examined	_	
136-5	20219-20221	if	_	
136-6	20222-20225	the	_	
136-7	20226-20237	inter-group	_	
136-8	20238-20251	relationships	_	
136-9	20252-20254	of	_	
136-10	20255-20258	GSs	_	
136-11	20259-20262	are	_	
136-12	20263-20276	statistically	_	
136-13	20277-20288	significant	_	
136-14	20289-20294	using	_	
136-15	20295-20303	multiple	_	
136-16	20304-20315	permutation	_	
136-17	20316-20320	runs	_	
136-18	20320-20321	.	_	

#Text=For each group, we generated 100 permutations, each of which randomly included 85% samples of the original subjects.
137-1	20322-20325	For	_	
137-2	20326-20330	each	_	
137-3	20331-20336	group	_	
137-4	20336-20337	,	_	
137-5	20338-20340	we	_	
137-6	20341-20350	generated	_	
137-7	20351-20354	100	_	
137-8	20355-20367	permutations	_	
137-9	20367-20368	,	_	
137-10	20369-20373	each	_	
137-11	20374-20376	of	_	
137-12	20377-20382	which	_	
137-13	20383-20391	randomly	_	
137-14	20392-20400	included	_	
137-15	20401-20404	85%	_	
137-16	20405-20412	samples	_	
137-17	20413-20415	of	_	
137-18	20416-20419	the	_	
137-19	20420-20428	original	_	
137-20	20429-20437	subjects	_	
137-21	20437-20438	.	_	

#Text=In each permutation run, the group-level ICA (shown in Fig. 1B) was applied to analyze the selected subjects’ dynamic connectivity, resulting in new GSs of the group.
138-1	20439-20441	In	_	
138-2	20442-20446	each	_	
138-3	20447-20458	permutation	_	
138-4	20459-20462	run	_	
138-5	20462-20463	,	_	
138-6	20464-20467	the	_	
138-7	20468-20479	group-level	_	
138-8	20480-20483	ICA	_	
138-9	20484-20485	(	_	
138-10	20485-20490	shown	_	
138-11	20491-20493	in	_	
138-12	20494-20497	Fig	_	
138-13	20497-20498	.	_	
138-14	20499-20501	1B	_	
138-15	20501-20502	)	_	
138-16	20503-20506	was	_	
138-17	20507-20514	applied	_	
138-18	20515-20517	to	_	
138-19	20518-20525	analyze	_	
138-20	20526-20529	the	_	
138-21	20530-20538	selected	_	
138-22	20539-20547	subjects	_	
138-23	20547-20548	’	_	
138-24	20549-20556	dynamic	_	
138-25	20557-20569	connectivity	_	
138-26	20569-20570	,	_	
138-27	20571-20580	resulting	_	
138-28	20581-20583	in	_	
138-29	20584-20587	new	_	
138-30	20588-20591	GSs	_	
138-31	20592-20594	of	_	
138-32	20595-20598	the	_	
138-33	20599-20604	group	_	
138-34	20604-20605	.	_	

#Text=For each group, we then matched the new GSs from each permutation run with the GSs obtained from the original samples using a greedy search rule.
139-1	20606-20609	For	_	
139-2	20610-20614	each	_	
139-3	20615-20620	group	_	
139-4	20620-20621	,	_	
139-5	20622-20624	we	_	
139-6	20625-20629	then	_	
139-7	20630-20637	matched	_	
139-8	20638-20641	the	_	
139-9	20642-20645	new	_	
139-10	20646-20649	GSs	_	
139-11	20650-20654	from	_	
139-12	20655-20659	each	_	
139-13	20660-20671	permutation	_	
139-14	20672-20675	run	_	
139-15	20676-20680	with	_	
139-16	20681-20684	the	_	
139-17	20685-20688	GSs	_	
139-18	20689-20697	obtained	_	
139-19	20698-20702	from	_	
139-20	20703-20706	the	_	
139-21	20707-20715	original	_	
139-22	20716-20723	samples	_	
139-23	20724-20729	using	_	
139-24	20730-20731	a	_	
139-25	20732-20738	greedy	_	
139-26	20739-20745	search	_	
139-27	20746-20750	rule	_	
139-28	20750-20751	.	_	

#Text=So, the new GSs from each permutation run were re-sorted to provide correspondence across the three groups.
140-1	20752-20754	So	_	
140-2	20754-20755	,	_	
140-3	20756-20759	the	_	
140-4	20760-20763	new	_	
140-5	20764-20767	GSs	_	
140-6	20768-20772	from	_	
140-7	20773-20777	each	_	
140-8	20778-20789	permutation	_	
140-9	20790-20793	run	_	
140-10	20794-20798	were	_	
140-11	20799-20808	re-sorted	_	
140-12	20809-20811	to	_	
140-13	20812-20819	provide	_	
140-14	20820-20834	correspondence	_	
140-15	20835-20841	across	_	
140-16	20842-20845	the	_	
140-17	20846-20851	three	_	
140-18	20852-20858	groups	_	
140-19	20858-20859	.	_	

#Text=Regarding each of 100 runs, a 3 × 3 correlation matrix associated with one state can be computed, representing the inter-group relationship of GSs in the run.
141-1	20860-20869	Regarding	_	
141-2	20870-20874	each	_	
141-3	20875-20877	of	_	
141-4	20878-20881	100	_	
141-5	20882-20886	runs	_	
141-6	20886-20887	,	_	
141-7	20888-20889	a	_	
141-8	20890-20891	3	_	
141-9	20892-20893	×	_	
141-10	20894-20895	3	_	
141-11	20896-20907	correlation	_	
141-12	20908-20914	matrix	_	
141-13	20915-20925	associated	_	
141-14	20926-20930	with	_	
141-15	20931-20934	one	_	
141-16	20935-20940	state	_	
141-17	20941-20944	can	_	
141-18	20945-20947	be	_	
141-19	20948-20956	computed	_	
141-20	20956-20957	,	_	
141-21	20958-20970	representing	_	
141-22	20971-20974	the	_	
141-23	20975-20986	inter-group	_	
141-24	20987-20999	relationship	_	
141-25	21000-21002	of	_	
141-26	21003-21006	GSs	_	
141-27	21007-21009	in	_	
141-28	21010-21013	the	_	
141-29	21014-21017	run	_	
141-30	21017-21018	.	_	

#Text=Finally, for each state, we investigated if rHC–CHR, rHC–ESZ, and rCHR–ESZ had significant differences by performing two-tailed two-sample t-tests between rHC–CHR and rHC–ESZ, between rCHR–ESZ. and rHC–CHR, as well as between rCHR–ESZ and rHR–ESZ based on the values from 100 permutation runs.
142-1	21019-21026	Finally	_	
142-2	21026-21027	,	_	
142-3	21028-21031	for	_	
142-4	21032-21036	each	_	
142-5	21037-21042	state	_	
142-6	21042-21043	,	_	
142-7	21044-21046	we	_	
142-8	21047-21059	investigated	_	
142-9	21060-21062	if	_	
142-10	21063-21070	rHC–CHR	_	
142-11	21070-21071	,	_	
142-12	21072-21079	rHC–ESZ	_	
142-13	21079-21080	,	_	
142-14	21081-21084	and	_	
142-15	21085-21093	rCHR–ESZ	_	
142-16	21094-21097	had	_	
142-17	21098-21109	significant	_	
142-18	21110-21121	differences	_	
142-19	21122-21124	by	_	
142-20	21125-21135	performing	_	
142-21	21136-21146	two-tailed	_	
142-22	21147-21157	two-sample	_	
142-23	21158-21165	t-tests	_	
142-24	21166-21173	between	_	
142-25	21174-21181	rHC–CHR	_	
142-26	21182-21185	and	_	
142-27	21186-21193	rHC–ESZ	_	
142-28	21193-21194	,	_	
142-29	21195-21202	between	_	
142-30	21203-21211	rCHR–ESZ	_	
142-31	21211-21212	.	_	
142-32	21213-21216	and	_	
142-33	21217-21224	rHC–CHR	_	
142-34	21224-21225	,	_	
142-35	21226-21228	as	_	
142-36	21229-21233	well	_	
142-37	21234-21236	as	_	
142-38	21237-21244	between	_	
142-39	21245-21253	rCHR–ESZ	_	
142-40	21254-21257	and	_	
142-41	21258-21265	rHR–ESZ	_	
142-42	21266-21271	based	_	
142-43	21272-21274	on	_	
142-44	21275-21278	the	_	
142-45	21279-21285	values	_	
142-46	21286-21290	from	_	
142-47	21291-21294	100	_	
142-48	21295-21306	permutation	_	
142-49	21307-21311	runs	_	
142-50	21311-21312	.	_	

#Text=Significant level was set to p < 0.01 with Bonferroni correction (i.e., p < 0.01/15).
143-1	21313-21324	Significant	_	
143-2	21325-21330	level	_	
143-3	21331-21334	was	_	
143-4	21335-21338	set	_	
143-5	21339-21341	to	_	
143-6	21342-21343	p	_	
143-7	21344-21345	<	_	
143-8	21346-21350	0.01	_	
143-9	21351-21355	with	_	
143-10	21356-21366	Bonferroni	_	
143-11	21367-21377	correction	_	
143-12	21378-21379	(	_	
143-13	21379-21382	i.e	_	
143-14	21382-21383	.	_	
143-15	21383-21384	,	_	
143-16	21385-21386	p	_	
143-17	21387-21388	<	_	
143-18	21389-21393	0.01	_	
143-19	21393-21394	/	_	
143-20	21394-21396	15	_	
143-21	21396-21397	)	_	
143-22	21397-21398	.	_	

#Text=Due to the importance of the dominant state (with the most contribution to the dynamic connectivity), we investigated its group differences in detail.
144-1	21399-21402	Due	_	
144-2	21403-21405	to	_	
144-3	21406-21409	the	_	
144-4	21410-21420	importance	_	
144-5	21421-21423	of	_	
144-6	21424-21427	the	_	
144-7	21428-21436	dominant	_	
144-8	21437-21442	state	_	
144-9	21443-21444	(	_	
144-10	21444-21448	with	_	
144-11	21449-21452	the	_	
144-12	21453-21457	most	_	
144-13	21458-21470	contribution	_	
144-14	21471-21473	to	_	
144-15	21474-21477	the	_	
144-16	21478-21485	dynamic	_	
144-17	21486-21498	connectivity	_	
144-18	21498-21499	)	_	
144-19	21499-21500	,	_	
144-20	21501-21503	we	_	
144-21	21504-21516	investigated	_	
144-22	21517-21520	its	_	
144-23	21521-21526	group	_	
144-24	21527-21538	differences	_	
144-25	21539-21541	in	_	
144-26	21542-21548	detail	_	
144-27	21548-21549	.	_	

#Text=First, we averaged the dominant SSs across subjects for each group to see if the connectivity patterns are disparate (or consistent) across groups.
145-1	21550-21555	First	_	
145-2	21555-21556	,	_	
145-3	21557-21559	we	_	
145-4	21560-21568	averaged	_	
145-5	21569-21572	the	_	
145-6	21573-21581	dominant	_	
145-7	21582-21585	SSs	_	
145-8	21586-21592	across	_	
145-9	21593-21601	subjects	_	
145-10	21602-21605	for	_	
145-11	21606-21610	each	_	
145-12	21611-21616	group	_	
145-13	21617-21619	to	_	
145-14	21620-21623	see	_	
145-15	21624-21626	if	_	
145-16	21627-21630	the	_	
145-17	21631-21643	connectivity	_	
145-18	21644-21652	patterns	_	
145-19	21653-21656	are	_	
145-20	21657-21666	disparate	_	
145-21	21667-21668	(	_	
145-22	21668-21670	or	_	
145-23	21671-21681	consistent	_	
145-24	21681-21682	)	_	
145-25	21683-21689	across	_	
145-26	21690-21696	groups	_	
145-27	21696-21697	.	_	

#Text=Then, analysis of covariance (ANCOVA) with age and gender as covariates was performed on each connection’s strengths in the dominant SSs to investigate the group difference of three groups.
146-1	21698-21702	Then	_	
146-2	21702-21703	,	_	
146-3	21704-21712	analysis	_	
146-4	21713-21715	of	_	
146-5	21716-21726	covariance	_	
146-6	21727-21728	(	_	
146-7	21728-21734	ANCOVA	_	
146-8	21734-21735	)	_	
146-9	21736-21740	with	_	
146-10	21741-21744	age	_	
146-11	21745-21748	and	_	
146-12	21749-21755	gender	_	
146-13	21756-21758	as	_	
146-14	21759-21769	covariates	_	
146-15	21770-21773	was	_	
146-16	21774-21783	performed	_	
146-17	21784-21786	on	_	
146-18	21787-21791	each	_	
146-19	21792-21802	connection	_	
146-20	21802-21803	’	_	
146-21	21803-21804	s	_	
146-22	21805-21814	strengths	_	
146-23	21815-21817	in	_	
146-24	21818-21821	the	_	
146-25	21822-21830	dominant	_	
146-26	21831-21834	SSs	_	
146-27	21835-21837	to	_	
146-28	21838-21849	investigate	_	
146-29	21850-21853	the	_	
146-30	21854-21859	group	_	
146-31	21860-21870	difference	_	
146-32	21871-21873	of	_	
146-33	21874-21879	three	_	
146-34	21880-21886	groups	_	
146-35	21886-21887	.	_	

#Text=Afterwards, based on each connectivity showing group differences identified by ANCOVA (p < 0.05 with Bonferroni correction), we applied a two-tailed two-sample t-test (p < 0.05 with Bonferroni correction) to assess differences in connectivity strength between any pair of groups.
147-1	21888-21898	Afterwards	_	
147-2	21898-21899	,	_	
147-3	21900-21905	based	_	
147-4	21906-21908	on	_	
147-5	21909-21913	each	_	
147-6	21914-21926	connectivity	_	
147-7	21927-21934	showing	_	
147-8	21935-21940	group	_	
147-9	21941-21952	differences	_	
147-10	21953-21963	identified	_	
147-11	21964-21966	by	_	
147-12	21967-21973	ANCOVA	_	
147-13	21974-21975	(	_	
147-14	21975-21976	p	_	
147-15	21977-21978	<	_	
147-16	21979-21983	0.05	_	
147-17	21984-21988	with	_	
147-18	21989-21999	Bonferroni	_	
147-19	22000-22010	correction	_	
147-20	22010-22011	)	_	
147-21	22011-22012	,	_	
147-22	22013-22015	we	_	
147-23	22016-22023	applied	_	
147-24	22024-22025	a	_	
147-25	22026-22036	two-tailed	_	
147-26	22037-22047	two-sample	_	
147-27	22048-22054	t-test	_	
147-28	22055-22056	(	_	
147-29	22056-22057	p	_	
147-30	22058-22059	<	_	
147-31	22060-22064	0.05	_	
147-32	22065-22069	with	_	
147-33	22070-22080	Bonferroni	_	
147-34	22081-22091	correction	_	
147-35	22091-22092	)	_	
147-36	22093-22095	to	_	
147-37	22096-22102	assess	_	
147-38	22103-22114	differences	_	
147-39	22115-22117	in	_	
147-40	22118-22130	connectivity	_	
147-41	22131-22139	strength	_	
147-42	22140-22147	between	_	
147-43	22148-22151	any	_	
147-44	22152-22156	pair	_	
147-45	22157-22159	of	_	
147-46	22160-22166	groups	_	
147-47	22166-22167	.	_	

#Text=Finally, for each connection with significant group difference, Pearson correlation coefficients between the connectivity strengths and symptom severity scores (shown in Table 1) were computed for the CHR and ESZ groups, respectively, in order to explore the associations between potential biomarkers and clinical symptoms.
148-1	22168-22175	Finally	_	
148-2	22175-22176	,	_	
148-3	22177-22180	for	_	
148-4	22181-22185	each	_	
148-5	22186-22196	connection	_	
148-6	22197-22201	with	_	
148-7	22202-22213	significant	_	
148-8	22214-22219	group	_	
148-9	22220-22230	difference	_	
148-10	22230-22231	,	_	
148-11	22232-22239	Pearson	_	
148-12	22240-22251	correlation	_	
148-13	22252-22264	coefficients	_	
148-14	22265-22272	between	_	
148-15	22273-22276	the	_	
148-16	22277-22289	connectivity	_	
148-17	22290-22299	strengths	_	
148-18	22300-22303	and	_	
148-19	22304-22311	symptom	_	
148-20	22312-22320	severity	_	
148-21	22321-22327	scores	_	
148-22	22328-22329	(	_	
148-23	22329-22334	shown	_	
148-24	22335-22337	in	_	
148-25	22338-22343	Table	_	
148-26	22344-22345	1	_	
148-27	22345-22346	)	_	
148-28	22347-22351	were	_	
148-29	22352-22360	computed	_	
148-30	22361-22364	for	_	
148-31	22365-22368	the	_	
148-32	22369-22372	CHR	_	
148-33	22373-22376	and	_	
148-34	22377-22380	ESZ	_	
148-35	22381-22387	groups	_	
148-36	22387-22388	,	_	
148-37	22389-22401	respectively	_	
148-38	22401-22402	,	_	
148-39	22403-22405	in	_	
148-40	22406-22411	order	_	
148-41	22412-22414	to	_	
148-42	22415-22422	explore	_	
148-43	22423-22426	the	_	
148-44	22427-22439	associations	_	
148-45	22440-22447	between	_	
148-46	22448-22457	potential	_	
148-47	22458-22468	biomarkers	_	
148-48	22469-22472	and	_	
148-49	22473-22481	clinical	_	
148-50	22482-22490	symptoms	_	
148-51	22490-22491	.	_	

#Text=The correlation analyses were restricted to the subjects rated within a month of the scan session.
149-1	22492-22495	The	_	
149-2	22496-22507	correlation	_	
149-3	22508-22516	analyses	_	
149-4	22517-22521	were	_	
149-5	22522-22532	restricted	_	
149-6	22533-22535	to	_	
149-7	22536-22539	the	_	
149-8	22540-22548	subjects	_	
149-9	22549-22554	rated	_	
149-10	22555-22561	within	_	
149-11	22562-22563	a	_	
149-12	22564-22569	month	_	
149-13	22570-22572	of	_	
149-14	22573-22576	the	_	
149-15	22577-22581	scan	_	
149-16	22582-22589	session	_	
149-17	22589-22590	.	_	

#Text=The significance level was set to p < 0.05 (without correction) for correlation analyses.
150-1	22591-22594	The	_	
150-2	22595-22607	significance	_	
150-3	22608-22613	level	_	
150-4	22614-22617	was	_	
150-5	22618-22621	set	_	
150-6	22622-22624	to	_	
150-7	22625-22626	p	_	
150-8	22627-22628	<	_	
150-9	22629-22633	0.05	_	
150-10	22634-22635	(	_	
150-11	22635-22642	without	_	
150-12	22643-22653	correction	_	
150-13	22653-22654	)	_	
150-14	22655-22658	for	_	
150-15	22659-22670	correlation	_	
150-16	22671-22679	analyses	_	
150-17	22679-22680	.	_	

#Text=In our work, the connectivity states were estimated from each group’s time-varying connectivity, separately.
151-1	22681-22683	In	_	
151-2	22684-22687	our	_	
151-3	22688-22692	work	_	
151-4	22692-22693	,	_	
151-5	22694-22697	the	_	
151-6	22698-22710	connectivity	_	
151-7	22711-22717	states	_	
151-8	22718-22722	were	_	
151-9	22723-22732	estimated	_	
151-10	22733-22737	from	_	
151-11	22738-22742	each	_	
151-12	22743-22748	group	_	
151-13	22748-22749	’	_	
151-14	22749-22750	s	_	
151-15	22751-22763	time-varying	_	
151-16	22764-22776	connectivity	_	
151-17	22776-22777	,	_	
151-18	22778-22788	separately	_	
151-19	22788-22789	.	_	

#Text=Since this strategy may raise concerns on whether the identified group differences were due to the grouping, we performed a permutation test (including 1000 permutation runs) to verify the effectiveness.
152-1	22790-22795	Since	_	
152-2	22796-22800	this	_	
152-3	22801-22809	strategy	_	
152-4	22810-22813	may	_	
152-5	22814-22819	raise	_	
152-6	22820-22828	concerns	_	
152-7	22829-22831	on	_	
152-8	22832-22839	whether	_	
152-9	22840-22843	the	_	
152-10	22844-22854	identified	_	
152-11	22855-22860	group	_	
152-12	22861-22872	differences	_	
152-13	22873-22877	were	_	
152-14	22878-22881	due	_	
152-15	22882-22884	to	_	
152-16	22885-22888	the	_	
152-17	22889-22897	grouping	_	
152-18	22897-22898	,	_	
152-19	22899-22901	we	_	
152-20	22902-22911	performed	_	
152-21	22912-22913	a	_	
152-22	22914-22925	permutation	_	
152-23	22926-22930	test	_	
152-24	22931-22932	(	_	
152-25	22932-22941	including	_	
152-26	22942-22946	1000	_	
152-27	22947-22958	permutation	_	
152-28	22959-22963	runs	_	
152-29	22963-22964	)	_	
152-30	22965-22967	to	_	
152-31	22968-22974	verify	_	
152-32	22975-22978	the	_	
152-33	22979-22992	effectiveness	_	
152-34	22992-22993	.	_	

#Text=Regarding each of 1000 permutations, we performed the following three steps. (1) We generated three dummy groups by randomly rearranging all subjects of the original three groups (i.e., HC, CHR and ESZ groups).
153-1	22994-23003	Regarding	_	
153-2	23004-23008	each	_	
153-3	23009-23011	of	_	
153-4	23012-23016	1000	_	
153-5	23017-23029	permutations	_	
153-6	23029-23030	,	_	
153-7	23031-23033	we	_	
153-8	23034-23043	performed	_	
153-9	23044-23047	the	_	
153-10	23048-23057	following	_	
153-11	23058-23063	three	_	
153-12	23064-23069	steps	_	
153-13	23069-23070	.	_	
153-14	23071-23072	(	_	
153-15	23072-23073	1	_	
153-16	23073-23074	)	_	
153-17	23075-23077	We	_	
153-18	23078-23087	generated	_	
153-19	23088-23093	three	_	
153-20	23094-23099	dummy	_	
153-21	23100-23106	groups	_	
153-22	23107-23109	by	_	
153-23	23110-23118	randomly	_	
153-24	23119-23130	rearranging	_	
153-25	23131-23134	all	_	
153-26	23135-23143	subjects	_	
153-27	23144-23146	of	_	
153-28	23147-23150	the	_	
153-29	23151-23159	original	_	
153-30	23160-23165	three	_	
153-31	23166-23172	groups	_	
153-32	23173-23174	(	_	
153-33	23174-23177	i.e	_	
153-34	23177-23178	.	_	
153-35	23178-23179	,	_	
153-36	23180-23182	HC	_	
153-37	23182-23183	,	_	
153-38	23184-23187	CHR	_	
153-39	23188-23191	and	_	
153-40	23192-23195	ESZ	_	
153-41	23196-23202	groups	_	
153-42	23202-23203	)	_	
153-43	23203-23204	.	_	

#Text=Each of the dummy group had the same number of subjects with the original group. (2) Consistent with the processing on the original groups, we first estimated the group-level states by performing ICA on the dynamic connectivity of each dummy group, and then identified the dominant group-level state, finally computed the corresponding dominant subject-specific states. (3) We employed ANCOVA on each FC’s strengths of the dominant subject-specific states for the three dummy groups.
154-1	23205-23209	Each	_	
154-2	23210-23212	of	_	
154-3	23213-23216	the	_	
154-4	23217-23222	dummy	_	
154-5	23223-23228	group	_	
154-6	23229-23232	had	_	
154-7	23233-23236	the	_	
154-8	23237-23241	same	_	
154-9	23242-23248	number	_	
154-10	23249-23251	of	_	
154-11	23252-23260	subjects	_	
154-12	23261-23265	with	_	
154-13	23266-23269	the	_	
154-14	23270-23278	original	_	
154-15	23279-23284	group	_	
154-16	23284-23285	.	_	
154-17	23286-23287	(	_	
154-18	23287-23288	2	_	
154-19	23288-23289	)	_	
154-20	23290-23300	Consistent	_	
154-21	23301-23305	with	_	
154-22	23306-23309	the	_	
154-23	23310-23320	processing	_	
154-24	23321-23323	on	_	
154-25	23324-23327	the	_	
154-26	23328-23336	original	_	
154-27	23337-23343	groups	_	
154-28	23343-23344	,	_	
154-29	23345-23347	we	_	
154-30	23348-23353	first	_	
154-31	23354-23363	estimated	_	
154-32	23364-23367	the	_	
154-33	23368-23379	group-level	_	
154-34	23380-23386	states	_	
154-35	23387-23389	by	_	
154-36	23390-23400	performing	_	
154-37	23401-23404	ICA	_	
154-38	23405-23407	on	_	
154-39	23408-23411	the	_	
154-40	23412-23419	dynamic	_	
154-41	23420-23432	connectivity	_	
154-42	23433-23435	of	_	
154-43	23436-23440	each	_	
154-44	23441-23446	dummy	_	
154-45	23447-23452	group	_	
154-46	23452-23453	,	_	
154-47	23454-23457	and	_	
154-48	23458-23462	then	_	
154-49	23463-23473	identified	_	
154-50	23474-23477	the	_	
154-51	23478-23486	dominant	_	
154-52	23487-23498	group-level	_	
154-53	23499-23504	state	_	
154-54	23504-23505	,	_	
154-55	23506-23513	finally	_	
154-56	23514-23522	computed	_	
154-57	23523-23526	the	_	
154-58	23527-23540	corresponding	_	
154-59	23541-23549	dominant	_	
154-60	23550-23566	subject-specific	_	
154-61	23567-23573	states	_	
154-62	23573-23574	.	_	
154-63	23575-23576	(	_	
154-64	23576-23577	3	_	
154-65	23577-23578	)	_	
154-66	23579-23581	We	_	
154-67	23582-23590	employed	_	
154-68	23591-23597	ANCOVA	_	
154-69	23598-23600	on	_	
154-70	23601-23605	each	_	
154-71	23606-23608	FC	_	
154-72	23608-23609	’	_	
154-73	23609-23610	s	_	
154-74	23611-23620	strengths	_	
154-75	23621-23623	of	_	
154-76	23624-23627	the	_	
154-77	23628-23636	dominant	_	
154-78	23637-23653	subject-specific	_	
154-79	23654-23660	states	_	
154-80	23661-23664	for	_	
154-81	23665-23668	the	_	
154-82	23669-23674	three	_	
154-83	23675-23680	dummy	_	
154-84	23681-23687	groups	_	
154-85	23687-23688	.	_	

#Text=While performing ANCOVA, the used age and gender information of each subject was the subject’s real information.
155-1	23689-23694	While	_	
155-2	23695-23705	performing	_	
155-3	23706-23712	ANCOVA	_	
155-4	23712-23713	,	_	
155-5	23714-23717	the	_	
155-6	23718-23722	used	_	
155-7	23723-23726	age	_	
155-8	23727-23730	and	_	
155-9	23731-23737	gender	_	
155-10	23738-23749	information	_	
155-11	23750-23752	of	_	
155-12	23753-23757	each	_	
155-13	23758-23765	subject	_	
155-14	23766-23769	was	_	
155-15	23770-23773	the	_	
155-16	23774-23781	subject	_	
155-17	23781-23782	’	_	
155-18	23782-23783	s	_	
155-19	23784-23788	real	_	
155-20	23789-23800	information	_	
155-21	23800-23801	.	_	

#Text=After the 1000 permutation runs, we summarized the permutation test’s result by calculating the occurring frequency of the case where the p-value obtained from ANCOVA using rearranged groups (i.e., the dummy groups) was smaller than the corresponding p-value obtained from ANCOVA using the original (i.e., real) groups.
156-1	23802-23807	After	_	
156-2	23808-23811	the	_	
156-3	23812-23816	1000	_	
156-4	23817-23828	permutation	_	
156-5	23829-23833	runs	_	
156-6	23833-23834	,	_	
156-7	23835-23837	we	_	
156-8	23838-23848	summarized	_	
156-9	23849-23852	the	_	
156-10	23853-23864	permutation	_	
156-11	23865-23869	test	_	
156-12	23869-23870	’	_	
156-13	23870-23871	s	_	
156-14	23872-23878	result	_	
156-15	23879-23881	by	_	
156-16	23882-23893	calculating	_	
156-17	23894-23897	the	_	
156-18	23898-23907	occurring	_	
156-19	23908-23917	frequency	_	
156-20	23918-23920	of	_	
156-21	23921-23924	the	_	
156-22	23925-23929	case	_	
156-23	23930-23935	where	_	
156-24	23936-23939	the	_	
156-25	23940-23947	p-value	_	
156-26	23948-23956	obtained	_	
156-27	23957-23961	from	_	
156-28	23962-23968	ANCOVA	_	
156-29	23969-23974	using	_	
156-30	23975-23985	rearranged	_	
156-31	23986-23992	groups	_	
156-32	23993-23994	(	_	
156-33	23994-23997	i.e	_	
156-34	23997-23998	.	_	
156-35	23998-23999	,	_	
156-36	24000-24003	the	_	
156-37	24004-24009	dummy	_	
156-38	24010-24016	groups	_	
156-39	24016-24017	)	_	
156-40	24018-24021	was	_	
156-41	24022-24029	smaller	_	
156-42	24030-24034	than	_	
156-43	24035-24038	the	_	
156-44	24039-24052	corresponding	_	
156-45	24053-24060	p-value	_	
156-46	24061-24069	obtained	_	
156-47	24070-24074	from	_	
156-48	24075-24081	ANCOVA	_	
156-49	24082-24087	using	_	
156-50	24088-24091	the	_	
156-51	24092-24100	original	_	
156-52	24101-24102	(	_	
156-53	24102-24105	i.e	_	
156-54	24105-24106	.	_	
156-55	24106-24107	,	_	
156-56	24108-24112	real	_	
156-57	24112-24113	)	_	
156-58	24114-24120	groups	_	
156-59	24120-24121	.	_	

#Text=The frequency (i.e., the tail probability computed from 1000 permutations) reflects the significance level of the identified group difference.
157-1	24122-24125	The	_	
157-2	24126-24135	frequency	_	
157-3	24136-24137	(	_	
157-4	24137-24140	i.e	_	
157-5	24140-24141	.	_	
157-6	24141-24142	,	_	
157-7	24143-24146	the	_	
157-8	24147-24151	tail	_	
157-9	24152-24163	probability	_	
157-10	24164-24172	computed	_	
157-11	24173-24177	from	_	
157-12	24178-24182	1000	_	
157-13	24183-24195	permutations	_	
157-14	24195-24196	)	_	
157-15	24197-24205	reflects	_	
157-16	24206-24209	the	_	
157-17	24210-24222	significance	_	
157-18	24223-24228	level	_	
157-19	24229-24231	of	_	
157-20	24232-24235	the	_	
157-21	24236-24246	identified	_	
157-22	24247-24252	group	_	
157-23	24253-24263	difference	_	
157-24	24263-24264	.	_	

#Text=Smaller tail probability corresponds to lower possibility of false positives of the identified group difference. (4) In order to identify FCs showing significant group differences in the permutation test, we further performed a step-down minP method proposed by Westfall & Young (; Peter H.
158-1	24265-24272	Smaller	_	
158-2	24273-24277	tail	_	
158-3	24278-24289	probability	_	
158-4	24290-24301	corresponds	_	
158-5	24302-24304	to	_	
158-6	24305-24310	lower	_	
158-7	24311-24322	possibility	_	
158-8	24323-24325	of	_	
158-9	24326-24331	false	_	
158-10	24332-24341	positives	_	
158-11	24342-24344	of	_	
158-12	24345-24348	the	_	
158-13	24349-24359	identified	_	
158-14	24360-24365	group	_	
158-15	24366-24376	difference	_	
158-16	24376-24377	.	_	
158-17	24378-24379	(	_	
158-18	24379-24380	4	_	
158-19	24380-24381	)	_	
158-20	24382-24384	In	_	
158-21	24385-24390	order	_	
158-22	24391-24393	to	_	
158-23	24394-24402	identify	_	
158-24	24403-24406	FCs	_	
158-25	24407-24414	showing	_	
158-26	24415-24426	significant	_	
158-27	24427-24432	group	_	
158-28	24433-24444	differences	_	
158-29	24445-24447	in	_	
158-30	24448-24451	the	_	
158-31	24452-24463	permutation	_	
158-32	24464-24468	test	_	
158-33	24468-24469	,	_	
158-34	24470-24472	we	_	
158-35	24473-24480	further	_	
158-36	24481-24490	performed	_	
158-37	24491-24492	a	_	
158-38	24493-24502	step-down	_	
158-39	24503-24507	minP	_	
158-40	24508-24514	method	_	
158-41	24515-24523	proposed	_	
158-42	24524-24526	by	_	
158-43	24527-24535	Westfall	_	
158-44	24536-24537	&	_	
158-45	24538-24543	Young	_	
158-46	24544-24545	(	_	
158-47	24545-24546	;	_	
158-48	24547-24552	Peter	_	
158-49	24553-24554	H	_	
158-50	24554-24555	.	_	

#Text=Westfall and Young, 1993) for multiple comparison corrections based on the p-values from 1000 permutations.
159-1	24556-24564	Westfall	_	
159-2	24565-24568	and	_	
159-3	24569-24574	Young	_	
159-4	24574-24575	,	_	
159-5	24576-24580	1993	_	
159-6	24580-24581	)	_	
159-7	24582-24585	for	_	
159-8	24586-24594	multiple	_	
159-9	24595-24605	comparison	_	
159-10	24606-24617	corrections	_	
159-11	24618-24623	based	_	
159-12	24624-24626	on	_	
159-13	24627-24630	the	_	
159-14	24631-24639	p-values	_	
159-15	24640-24644	from	_	
159-16	24645-24649	1000	_	
159-17	24650-24662	permutations	_	
159-18	24662-24663	.	_	

#Text=After obtaining the adjusted p-values for all FCs, FCs with significant group differences can be identified.
#Text=3.
160-1	24664-24669	After	_	
160-2	24670-24679	obtaining	_	
160-3	24680-24683	the	_	
160-4	24684-24692	adjusted	_	
160-5	24693-24701	p-values	_	
160-6	24702-24705	for	_	
160-7	24706-24709	all	_	
160-8	24710-24713	FCs	_	
160-9	24713-24714	,	_	
160-10	24715-24718	FCs	_	
160-11	24719-24723	with	_	
160-12	24724-24735	significant	_	
160-13	24736-24741	group	_	
160-14	24742-24753	differences	_	
160-15	24754-24757	can	_	
160-16	24758-24760	be	_	
160-17	24761-24771	identified	_	
160-18	24771-24772	.	_	
160-19	24773-24774	3	_	
160-20	24774-24775	.	_	

#Text=Results
#Text=3.1.
161-1	24776-24783	Results	_	
161-2	24784-24787	3.1	_	
161-3	24787-24788	.	_	

#Text=Group differences in the group-level functional connectivity states
#Text=After the state matching, the corresponding group-level connectivity states of the three groups are shown in the matrix form (size: 116 × 116) in Fig. 2.
162-1	24789-24794	Group	_	
162-2	24795-24806	differences	_	
162-3	24807-24809	in	_	
162-4	24810-24813	the	_	
162-5	24814-24825	group-level	_	
162-6	24826-24836	functional	_	
162-7	24837-24849	connectivity	_	
162-8	24850-24856	states	_	
162-9	24857-24862	After	_	
162-10	24863-24866	the	_	
162-11	24867-24872	state	_	
162-12	24873-24881	matching	_	
162-13	24881-24882	,	_	
162-14	24883-24886	the	_	
162-15	24887-24900	corresponding	_	
162-16	24901-24912	group-level	_	
162-17	24913-24925	connectivity	_	
162-18	24926-24932	states	_	
162-19	24933-24935	of	_	
162-20	24936-24939	the	_	
162-21	24940-24945	three	_	
162-22	24946-24952	groups	_	
162-23	24953-24956	are	_	
162-24	24957-24962	shown	_	
162-25	24963-24965	in	_	
162-26	24966-24969	the	_	
162-27	24970-24976	matrix	_	
162-28	24977-24981	form	_	
162-29	24982-24983	(	_	
162-30	24983-24987	size	_	
162-31	24987-24988	:	_	
162-32	24989-24992	116	_	
162-33	24993-24994	×	_	
162-34	24995-24998	116	_	
162-35	24998-24999	)	_	
162-36	25000-25002	in	_	
162-37	25003-25006	Fig	_	
162-38	25006-25007	.	_	
162-39	25008-25009	2	_	
162-40	25009-25010	.	_	

#Text=Together, we also display the rendered connectivity patterns of those states.
163-1	25011-25019	Together	_	
163-2	25019-25020	,	_	
163-3	25021-25023	we	_	
163-4	25024-25028	also	_	
163-5	25029-25036	display	_	
163-6	25037-25040	the	_	
163-7	25041-25049	rendered	_	
163-8	25050-25062	connectivity	_	
163-9	25063-25071	patterns	_	
163-10	25072-25074	of	_	
163-11	25075-25080	those	_	
163-12	25081-25087	states	_	
163-13	25087-25088	.	_	

#Text=As expected, the dominant GS had the highest contribution (49%, 45% and 47% for the HC, CHR and ESZ groups, respectively) to the dynamic connectivity, while each of the other four states’ contributions were around 10%.
164-1	25089-25091	As	_	
164-2	25092-25100	expected	_	
164-3	25100-25101	,	_	
164-4	25102-25105	the	_	
164-5	25106-25114	dominant	_	
164-6	25115-25117	GS	_	
164-7	25118-25121	had	_	
164-8	25122-25125	the	_	
164-9	25126-25133	highest	_	
164-10	25134-25146	contribution	_	
164-11	25147-25148	(	_	
164-12	25148-25151	49%	_	
164-13	25151-25152	,	_	
164-14	25153-25156	45%	_	
164-15	25157-25160	and	_	
164-16	25161-25164	47%	_	
164-17	25165-25168	for	_	
164-18	25169-25172	the	_	
164-19	25173-25175	HC	_	
164-20	25175-25176	,	_	
164-21	25177-25180	CHR	_	
164-22	25181-25184	and	_	
164-23	25185-25188	ESZ	_	
164-24	25189-25195	groups	_	
164-25	25195-25196	,	_	
164-26	25197-25209	respectively	_	
164-27	25209-25210	)	_	
164-28	25211-25213	to	_	
164-29	25214-25217	the	_	
164-30	25218-25225	dynamic	_	
164-31	25226-25238	connectivity	_	
164-32	25238-25239	,	_	
164-33	25240-25245	while	_	
164-34	25246-25250	each	_	
164-35	25251-25253	of	_	
164-36	25254-25257	the	_	
164-37	25258-25263	other	_	
164-38	25264-25268	four	_	
164-39	25269-25275	states	_	
164-40	25275-25276	’	_	
164-41	25277-25290	contributions	_	
164-42	25291-25295	were	_	
164-43	25296-25302	around	_	
164-44	25303-25306	10%	_	
164-45	25306-25307	.	_	

#Text=Similarity measures between the matched GSs were computed to investigate their relationship between the three groups.
165-1	25308-25318	Similarity	_	
165-2	25319-25327	measures	_	
165-3	25328-25335	between	_	
165-4	25336-25339	the	_	
165-5	25340-25347	matched	_	
165-6	25348-25351	GSs	_	
165-7	25352-25356	were	_	
165-8	25357-25365	computed	_	
165-9	25366-25368	to	_	
165-10	25369-25380	investigate	_	
165-11	25381-25386	their	_	
165-12	25387-25399	relationship	_	
165-13	25400-25407	between	_	
165-14	25408-25411	the	_	
165-15	25412-25417	three	_	
165-16	25418-25424	groups	_	
165-17	25424-25425	.	_	

#Text=The similarity matrices shown in the last row of Fig. 2 indicate that the dominant GSs were very consistent across groups (similarity measure = 0.94), however, the remaining four GSs were discrepant (similarity measures = 0.64, 0.59, 0.55 and 0.44, respectively).
166-1	25426-25429	The	_	
166-2	25430-25440	similarity	_	
166-3	25441-25449	matrices	_	
166-4	25450-25455	shown	_	
166-5	25456-25458	in	_	
166-6	25459-25462	the	_	
166-7	25463-25467	last	_	
166-8	25468-25471	row	_	
166-9	25472-25474	of	_	
166-10	25475-25478	Fig	_	
166-11	25478-25479	.	_	
166-12	25480-25481	2	_	
166-13	25482-25490	indicate	_	
166-14	25491-25495	that	_	
166-15	25496-25499	the	_	
166-16	25500-25508	dominant	_	
166-17	25509-25512	GSs	_	
166-18	25513-25517	were	_	
166-19	25518-25522	very	_	
166-20	25523-25533	consistent	_	
166-21	25534-25540	across	_	
166-22	25541-25547	groups	_	
166-23	25548-25549	(	_	
166-24	25549-25559	similarity	_	
166-25	25560-25567	measure	_	
166-26	25568-25569	=	_	
166-27	25570-25574	0.94	_	
166-28	25574-25575	)	_	
166-29	25575-25576	,	_	
166-30	25577-25584	however	_	
166-31	25584-25585	,	_	
166-32	25586-25589	the	_	
166-33	25590-25599	remaining	_	
166-34	25600-25604	four	_	
166-35	25605-25608	GSs	_	
166-36	25609-25613	were	_	
166-37	25614-25624	discrepant	_	
166-38	25625-25626	(	_	
166-39	25626-25636	similarity	_	
166-40	25637-25645	measures	_	
166-41	25646-25647	=	_	
166-42	25648-25652	0.64	_	
166-43	25652-25653	,	_	
166-44	25654-25658	0.59	_	
166-45	25658-25659	,	_	
166-46	25660-25664	0.55	_	
166-47	25665-25668	and	_	
166-48	25669-25673	0.44	_	
166-49	25673-25674	,	_	
166-50	25675-25687	respectively	_	
166-51	25687-25688	)	_	
166-52	25688-25689	.	_	

#Text=Furthermore, the correlation matrices indicate that compared to the HC group, the CHR and ESZ groups had greater inter-group similarity in the non-dominant states, indicating that these states could be disease-related.
167-1	25690-25701	Furthermore	_	
167-2	25701-25702	,	_	
167-3	25703-25706	the	_	
167-4	25707-25718	correlation	_	
167-5	25719-25727	matrices	_	
167-6	25728-25736	indicate	_	
167-7	25737-25741	that	_	
167-8	25742-25750	compared	_	
167-9	25751-25753	to	_	
167-10	25754-25757	the	_	
167-11	25758-25760	HC	_	
167-12	25761-25766	group	_	
167-13	25766-25767	,	_	
167-14	25768-25771	the	_	
167-15	25772-25775	CHR	_	
167-16	25776-25779	and	_	
167-17	25780-25783	ESZ	_	
167-18	25784-25790	groups	_	
167-19	25791-25794	had	_	
167-20	25795-25802	greater	_	
167-21	25803-25814	inter-group	_	
167-22	25815-25825	similarity	_	
167-23	25826-25828	in	_	
167-24	25829-25832	the	_	
167-25	25833-25845	non-dominant	_	
167-26	25846-25852	states	_	
167-27	25852-25853	,	_	
167-28	25854-25864	indicating	_	
167-29	25865-25869	that	_	
167-30	25870-25875	these	_	
167-31	25876-25882	states	_	
167-32	25883-25888	could	_	
167-33	25889-25891	be	_	
167-34	25892-25907	disease-related	_	
167-35	25907-25908	.	_	

#Text=As mentioned in the method section, we further calculated GSs and their relationships across groups by implementing 100 permutation runs.
168-1	25909-25911	As	_	
168-2	25912-25921	mentioned	_	
168-3	25922-25924	in	_	
168-4	25925-25928	the	_	
168-5	25929-25935	method	_	
168-6	25936-25943	section	_	
168-7	25943-25944	,	_	
168-8	25945-25947	we	_	
168-9	25948-25955	further	_	
168-10	25956-25966	calculated	_	
168-11	25967-25970	GSs	_	
168-12	25971-25974	and	_	
168-13	25975-25980	their	_	
168-14	25981-25994	relationships	_	
168-15	25995-26001	across	_	
168-16	26002-26008	groups	_	
168-17	26009-26011	by	_	
168-18	26012-26024	implementing	_	
168-19	26025-26028	100	_	
168-20	26029-26040	permutation	_	
168-21	26041-26045	runs	_	
168-22	26045-26046	.	_	

#Text=Based on the correlation matrices associated with one state (e.g., GS 1) from 100 permutation runs, we averaged those matrices to yield a mean correlation matrix.
169-1	26047-26052	Based	_	
169-2	26053-26055	on	_	
169-3	26056-26059	the	_	
169-4	26060-26071	correlation	_	
169-5	26072-26080	matrices	_	
169-6	26081-26091	associated	_	
169-7	26092-26096	with	_	
169-8	26097-26100	one	_	
169-9	26101-26106	state	_	
169-10	26107-26108	(	_	
169-11	26108-26111	e.g	_	
169-12	26111-26112	.	_	
169-13	26112-26113	,	_	
169-14	26114-26116	GS	_	
169-15	26117-26118	1	_	
169-16	26118-26119	)	_	
169-17	26120-26124	from	_	
169-18	26125-26128	100	_	
169-19	26129-26140	permutation	_	
169-20	26141-26145	runs	_	
169-21	26145-26146	,	_	
169-22	26147-26149	we	_	
169-23	26150-26158	averaged	_	
169-24	26159-26164	those	_	
169-25	26165-26173	matrices	_	
169-26	26174-26176	to	_	
169-27	26177-26182	yield	_	
169-28	26183-26184	a	_	
169-29	26185-26189	mean	_	
169-30	26190-26201	correlation	_	
169-31	26202-26208	matrix	_	
169-32	26208-26209	.	_	

#Text=Fig. 3 shows that each mean correlation matrix showed a quite similar pattern with that in Fig. 2.
170-1	26210-26213	Fig	_	
170-2	26213-26214	.	_	
170-3	26215-26216	3	_	
170-4	26217-26222	shows	_	
170-5	26223-26227	that	_	
170-6	26228-26232	each	_	
170-7	26233-26237	mean	_	
170-8	26238-26249	correlation	_	
170-9	26250-26256	matrix	_	
170-10	26257-26263	showed	_	
170-11	26264-26265	a	_	
170-12	26266-26271	quite	_	
170-13	26272-26279	similar	_	
170-14	26280-26287	pattern	_	
170-15	26288-26292	with	_	
170-16	26293-26297	that	_	
170-17	26298-26300	in	_	
170-18	26301-26304	Fig	_	
170-19	26304-26305	.	_	
170-20	26306-26307	2	_	
170-21	26307-26308	.	_	

#Text=Also, we examined the differences in the inter-group similarity (e.g., the difference between rCHR–ESZ and rHC–CHR) of GSs by performing two-sample t-tests on the values from 100 runs.
171-1	26309-26313	Also	_	
171-2	26313-26314	,	_	
171-3	26315-26317	we	_	
171-4	26318-26326	examined	_	
171-5	26327-26330	the	_	
171-6	26331-26342	differences	_	
171-7	26343-26345	in	_	
171-8	26346-26349	the	_	
171-9	26350-26361	inter-group	_	
171-10	26362-26372	similarity	_	
171-11	26373-26374	(	_	
171-12	26374-26377	e.g	_	
171-13	26377-26378	.	_	
171-14	26378-26379	,	_	
171-15	26380-26383	the	_	
171-16	26384-26394	difference	_	
171-17	26395-26402	between	_	
171-18	26403-26411	rCHR–ESZ	_	
171-19	26412-26415	and	_	
171-20	26416-26423	rHC–CHR	_	
171-21	26423-26424	)	_	
171-22	26425-26427	of	_	
171-23	26428-26431	GSs	_	
171-24	26432-26434	by	_	
171-25	26435-26445	performing	_	
171-26	26446-26456	two-sample	_	
171-27	26457-26464	t-tests	_	
171-28	26465-26467	on	_	
171-29	26468-26471	the	_	
171-30	26472-26478	values	_	
171-31	26479-26483	from	_	
171-32	26484-26487	100	_	
171-33	26488-26492	runs	_	
171-34	26492-26493	.	_	

#Text=The statistical results are summarized in Table 2.
172-1	26494-26497	The	_	
172-2	26498-26509	statistical	_	
172-3	26510-26517	results	_	
172-4	26518-26521	are	_	
172-5	26522-26532	summarized	_	
172-6	26533-26535	in	_	
172-7	26536-26541	Table	_	
172-8	26542-26543	2	_	
172-9	26543-26544	.	_	

#Text=The results support that there were no differences among rCHR–ESZ, rHC–CHR and rHC–ESZ for GS 1.
173-1	26545-26548	The	_	
173-2	26549-26556	results	_	
173-3	26557-26564	support	_	
173-4	26565-26569	that	_	
173-5	26570-26575	there	_	
173-6	26576-26580	were	_	
173-7	26581-26583	no	_	
173-8	26584-26595	differences	_	
173-9	26596-26601	among	_	
173-10	26602-26610	rCHR–ESZ	_	
173-11	26610-26611	,	_	
173-12	26612-26619	rHC–CHR	_	
173-13	26620-26623	and	_	
173-14	26624-26631	rHC–ESZ	_	
173-15	26632-26635	for	_	
173-16	26636-26638	GS	_	
173-17	26639-26640	1	_	
173-18	26640-26641	.	_	

#Text=Regarding GS 2, GS 3, GS 4, and GS 5, both the difference between rCHR–ESZ and rHC–CHR and the difference between rCHR–ESZ and rHC–ESZ were statistically significant.
174-1	26642-26651	Regarding	_	
174-2	26652-26654	GS	_	
174-3	26655-26656	2	_	
174-4	26656-26657	,	_	
174-5	26658-26660	GS	_	
174-6	26661-26662	3	_	
174-7	26662-26663	,	_	
174-8	26664-26666	GS	_	
174-9	26667-26668	4	_	
174-10	26668-26669	,	_	
174-11	26670-26673	and	_	
174-12	26674-26676	GS	_	
174-13	26677-26678	5	_	
174-14	26678-26679	,	_	
174-15	26680-26684	both	_	
174-16	26685-26688	the	_	
174-17	26689-26699	difference	_	
174-18	26700-26707	between	_	
174-19	26708-26716	rCHR–ESZ	_	
174-20	26717-26720	and	_	
174-21	26721-26728	rHC–CHR	_	
174-22	26729-26732	and	_	
174-23	26733-26736	the	_	
174-24	26737-26747	difference	_	
174-25	26748-26755	between	_	
174-26	26756-26764	rCHR–ESZ	_	
174-27	26765-26768	and	_	
174-28	26769-26776	rHC–ESZ	_	
174-29	26777-26781	were	_	
174-30	26782-26795	statistically	_	
174-31	26796-26807	significant	_	
174-32	26807-26808	.	_	

#Text=The difference between rHC–CHR and rHC–ESZ was not significant for GS 2, GS 4 and GS 5, but significant for GS 3.
175-1	26809-26812	The	_	
175-2	26813-26823	difference	_	
175-3	26824-26831	between	_	
175-4	26832-26839	rHC–CHR	_	
175-5	26840-26843	and	_	
175-6	26844-26851	rHC–ESZ	_	
175-7	26852-26855	was	_	
175-8	26856-26859	not	_	
175-9	26860-26871	significant	_	
175-10	26872-26875	for	_	
175-11	26876-26878	GS	_	
175-12	26879-26880	2	_	
175-13	26880-26881	,	_	
175-14	26882-26884	GS	_	
175-15	26885-26886	4	_	
175-16	26887-26890	and	_	
175-17	26891-26893	GS	_	
175-18	26894-26895	5	_	
175-19	26895-26896	,	_	
175-20	26897-26900	but	_	
175-21	26901-26912	significant	_	
175-22	26913-26916	for	_	
175-23	26917-26919	GS	_	
175-24	26920-26921	3	_	
175-25	26921-26922	.	_	

#Text=The results suggest that CHR and ESZ groups showed more similarity in GS 2, GS 4 and GS 5 than any other pairs.
176-1	26923-26926	The	_	
176-2	26927-26934	results	_	
176-3	26935-26942	suggest	_	
176-4	26943-26947	that	_	
176-5	26948-26951	CHR	_	
176-6	26952-26955	and	_	
176-7	26956-26959	ESZ	_	
176-8	26960-26966	groups	_	
176-9	26967-26973	showed	_	
176-10	26974-26978	more	_	
176-11	26979-26989	similarity	_	
176-12	26990-26992	in	_	
176-13	26993-26995	GS	_	
176-14	26996-26997	2	_	
176-15	26997-26998	,	_	
176-16	26999-27001	GS	_	
176-17	27002-27003	4	_	
176-18	27004-27007	and	_	
176-19	27008-27010	GS	_	
176-20	27011-27012	5	_	
176-21	27013-27017	than	_	
176-22	27018-27021	any	_	
176-23	27022-27027	other	_	
176-24	27028-27033	pairs	_	
176-25	27033-27034	.	_	

#Text=GS 3 was different in all the three groups, while CHR and ESZ were relatively closer.
177-1	27035-27037	GS	_	
177-2	27038-27039	3	_	
177-3	27040-27043	was	_	
177-4	27044-27053	different	_	
177-5	27054-27056	in	_	
177-6	27057-27060	all	_	
177-7	27061-27064	the	_	
177-8	27065-27070	three	_	
177-9	27071-27077	groups	_	
177-10	27077-27078	,	_	
177-11	27079-27084	while	_	
177-12	27085-27088	CHR	_	
177-13	27089-27092	and	_	
177-14	27093-27096	ESZ	_	
177-15	27097-27101	were	_	
177-16	27102-27112	relatively	_	
177-17	27113-27119	closer	_	
177-18	27119-27120	.	_	

#Text=The results support our above conclusion that the non-dominant states could be disease-related.
178-1	27121-27124	The	_	
178-2	27125-27132	results	_	
178-3	27133-27140	support	_	
178-4	27141-27144	our	_	
178-5	27145-27150	above	_	
178-6	27151-27161	conclusion	_	
178-7	27162-27166	that	_	
178-8	27167-27170	the	_	
178-9	27171-27183	non-dominant	_	
178-10	27184-27190	states	_	
178-11	27191-27196	could	_	
178-12	27197-27199	be	_	
178-13	27200-27215	disease-related	_	
178-14	27215-27216	.	_	

#Text=For each state, the associated SFs across all windows of all subjects are demonstrated in Fig. 4.
179-1	27217-27220	For	_	
179-2	27221-27225	each	_	
179-3	27226-27231	state	_	
179-4	27231-27232	,	_	
179-5	27233-27236	the	_	
179-6	27237-27247	associated	_	
179-7	27248-27251	SFs	_	
179-8	27252-27258	across	_	
179-9	27259-27262	all	_	
179-10	27263-27270	windows	_	
179-11	27271-27273	of	_	
179-12	27274-27277	all	_	
179-13	27278-27286	subjects	_	
179-14	27287-27290	are	_	
179-15	27291-27303	demonstrated	_	
179-16	27304-27306	in	_	
179-17	27307-27310	Fig	_	
179-18	27310-27311	.	_	
179-19	27312-27313	4	_	
179-20	27313-27314	.	_	

#Text=It illustrates that the dominant state had relatively higher values of SFs for most windows.
180-1	27315-27317	It	_	
180-2	27318-27329	illustrates	_	
180-3	27330-27334	that	_	
180-4	27335-27338	the	_	
180-5	27339-27347	dominant	_	
180-6	27348-27353	state	_	
180-7	27354-27357	had	_	
180-8	27358-27368	relatively	_	
180-9	27369-27375	higher	_	
180-10	27376-27382	values	_	
180-11	27383-27385	of	_	
180-12	27386-27389	SFs	_	
180-13	27390-27393	for	_	
180-14	27394-27398	most	_	
180-15	27399-27406	windows	_	
180-16	27406-27407	.	_	

#Text=Since the dominant state only had positive SFs (Fig. 4), the positive/negative values in the dominant state (i.e., the positive/negative values in the matrix of GS 1) reflected the positive/negative connectivity strengths between ROIs.
181-1	27408-27413	Since	_	
181-2	27414-27417	the	_	
181-3	27418-27426	dominant	_	
181-4	27427-27432	state	_	
181-5	27433-27437	only	_	
181-6	27438-27441	had	_	
181-7	27442-27450	positive	_	
181-8	27451-27454	SFs	_	
181-9	27455-27456	(	_	
181-10	27456-27459	Fig	_	
181-11	27459-27460	.	_	
181-12	27461-27462	4	_	
181-13	27462-27463	)	_	
181-14	27463-27464	,	_	
181-15	27465-27468	the	_	
181-16	27469-27477	positive	_	
181-17	27477-27478	/	_	
181-18	27478-27486	negative	_	
181-19	27487-27493	values	_	
181-20	27494-27496	in	_	
181-21	27497-27500	the	_	
181-22	27501-27509	dominant	_	
181-23	27510-27515	state	_	
181-24	27516-27517	(	_	
181-25	27517-27520	i.e	_	
181-26	27520-27521	.	_	
181-27	27521-27522	,	_	
181-28	27523-27526	the	_	
181-29	27527-27535	positive	_	
181-30	27535-27536	/	_	
181-31	27536-27544	negative	_	
181-32	27545-27551	values	_	
181-33	27552-27554	in	_	
181-34	27555-27558	the	_	
181-35	27559-27565	matrix	_	
181-36	27566-27568	of	_	
181-37	27569-27571	GS	_	
181-38	27572-27573	1	_	
181-39	27573-27574	)	_	
181-40	27575-27584	reflected	_	
181-41	27585-27588	the	_	
181-42	27589-27597	positive	_	
181-43	27597-27598	/	_	
181-44	27598-27606	negative	_	
181-45	27607-27619	connectivity	_	
181-46	27620-27629	strengths	_	
181-47	27630-27637	between	_	
181-48	27638-27642	ROIs	_	
181-49	27642-27643	.	_	

#Text=For the dominant state, the positive connectivities (reflecting positive correlations among ROIs) primarily involved connections within the default mode network, the sensory-motor network, the vision-related network and within-cerebellum connections, while negative connectivities linking cerebellar crus and other cortices (including rolandic, insula, Heschl’s gyrus and superior temporal lobe).
182-1	27644-27647	For	_	
182-2	27648-27651	the	_	
182-3	27652-27660	dominant	_	
182-4	27661-27666	state	_	
182-5	27666-27667	,	_	
182-6	27668-27671	the	_	
182-7	27672-27680	positive	_	
182-8	27681-27695	connectivities	_	
182-9	27696-27697	(	_	
182-10	27697-27707	reflecting	_	
182-11	27708-27716	positive	_	
182-12	27717-27729	correlations	_	
182-13	27730-27735	among	_	
182-14	27736-27740	ROIs	_	
182-15	27740-27741	)	_	
182-16	27742-27751	primarily	_	
182-17	27752-27760	involved	_	
182-18	27761-27772	connections	_	
182-19	27773-27779	within	_	
182-20	27780-27783	the	_	
182-21	27784-27791	default	_	
182-22	27792-27796	mode	_	
182-23	27797-27804	network	_	
182-24	27804-27805	,	_	
182-25	27806-27809	the	_	
182-26	27810-27823	sensory-motor	_	
182-27	27824-27831	network	_	
182-28	27831-27832	,	_	
182-29	27833-27836	the	_	
182-30	27837-27851	vision-related	_	
182-31	27852-27859	network	_	
182-32	27860-27863	and	_	
182-33	27864-27881	within-cerebellum	_	
182-34	27882-27893	connections	_	
182-35	27893-27894	,	_	
182-36	27895-27900	while	_	
182-37	27901-27909	negative	_	
182-38	27910-27924	connectivities	_	
182-39	27925-27932	linking	_	
182-40	27933-27943	cerebellar	_	
182-41	27944-27948	crus	_	
182-42	27949-27952	and	_	
182-43	27953-27958	other	_	
182-44	27959-27967	cortices	_	
182-45	27968-27969	(	_	
182-46	27969-27978	including	_	
182-47	27979-27987	rolandic	_	
182-48	27987-27988	,	_	
182-49	27989-27995	insula	_	
182-50	27995-27996	,	_	
182-51	27997-28003	Heschl	_	
182-52	28003-28004	’	_	
182-53	28004-28005	s	_	
182-54	28006-28011	gyrus	_	
182-55	28012-28015	and	_	
182-56	28016-28024	superior	_	
182-57	28025-28033	temporal	_	
182-58	28034-28038	lobe	_	
182-59	28038-28039	)	_	
182-60	28039-28040	.	_	

#Text=For each of the non-dominant states, both positive and negative values occurred in SFs (Fig. 4).
183-1	28041-28044	For	_	
183-2	28045-28049	each	_	
183-3	28050-28052	of	_	
183-4	28053-28056	the	_	
183-5	28057-28069	non-dominant	_	
183-6	28070-28076	states	_	
183-7	28076-28077	,	_	
183-8	28078-28082	both	_	
183-9	28083-28091	positive	_	
183-10	28092-28095	and	_	
183-11	28096-28104	negative	_	
183-12	28105-28111	values	_	
183-13	28112-28120	occurred	_	
183-14	28121-28123	in	_	
183-15	28124-28127	SFs	_	
183-16	28128-28129	(	_	
183-17	28129-28132	Fig	_	
183-18	28132-28133	.	_	
183-19	28134-28135	4	_	
183-20	28135-28136	)	_	
183-21	28136-28137	.	_	

#Text=Hence, the positive/negative values of the non-dominant states didn’t directly reflect the connectivity strengths.
#Text=3.2.
184-1	28138-28143	Hence	_	
184-2	28143-28144	,	_	
184-3	28145-28148	the	_	
184-4	28149-28157	positive	_	
184-5	28157-28158	/	_	
184-6	28158-28166	negative	_	
184-7	28167-28173	values	_	
184-8	28174-28176	of	_	
184-9	28177-28180	the	_	
184-10	28181-28193	non-dominant	_	
184-11	28194-28200	states	_	
184-12	28201-28205	didn	_	
184-13	28205-28206	’	_	
184-14	28206-28207	t	_	
184-15	28208-28216	directly	_	
184-16	28217-28224	reflect	_	
184-17	28225-28228	the	_	
184-18	28229-28241	connectivity	_	
184-19	28242-28251	strengths	_	
184-20	28251-28252	.	_	
184-21	28253-28256	3.2	_	
184-22	28256-28257	.	_	

#Text=Group differences in the dominant subject-specific functional connectivity state
#Text=Regarding the dominant individual-level connectivity state of each subject, we averaged them in each group.
185-1	28258-28263	Group	_	
185-2	28264-28275	differences	_	
185-3	28276-28278	in	_	
185-4	28279-28282	the	_	
185-5	28283-28291	dominant	_	
185-6	28292-28308	subject-specific	_	
185-7	28309-28319	functional	_	
185-8	28320-28332	connectivity	_	
185-9	28333-28338	state	_	
185-10	28339-28348	Regarding	_	
185-11	28349-28352	the	_	
185-12	28353-28361	dominant	_	
185-13	28362-28378	individual-level	_	
185-14	28379-28391	connectivity	_	
185-15	28392-28397	state	_	
185-16	28398-28400	of	_	
185-17	28401-28405	each	_	
185-18	28406-28413	subject	_	
185-19	28413-28414	,	_	
185-20	28415-28417	we	_	
185-21	28418-28426	averaged	_	
185-22	28427-28431	them	_	
185-23	28432-28434	in	_	
185-24	28435-28439	each	_	
185-25	28440-28445	group	_	
185-26	28445-28446	.	_	

#Text=The matrices and rendered view of the mean dominant SSs (Fig. 5A–C) show that the three groups showed a similar pattern in terms of the most important connectivity state, with the CHR group being intermediate between HC and ESZ groups.
186-1	28447-28450	The	_	
186-2	28451-28459	matrices	_	
186-3	28460-28463	and	_	
186-4	28464-28472	rendered	_	
186-5	28473-28477	view	_	
186-6	28478-28480	of	_	
186-7	28481-28484	the	_	
186-8	28485-28489	mean	_	
186-9	28490-28498	dominant	_	
186-10	28499-28502	SSs	_	
186-11	28503-28504	(	_	
186-12	28504-28507	Fig	_	
186-13	28507-28508	.	_	
186-14	28509-28513	5A–C	_	
186-15	28513-28514	)	_	
186-16	28515-28519	show	_	
186-17	28520-28524	that	_	
186-18	28525-28528	the	_	
186-19	28529-28534	three	_	
186-20	28535-28541	groups	_	
186-21	28542-28548	showed	_	
186-22	28549-28550	a	_	
186-23	28551-28558	similar	_	
186-24	28559-28566	pattern	_	
186-25	28567-28569	in	_	
186-26	28570-28575	terms	_	
186-27	28576-28578	of	_	
186-28	28579-28582	the	_	
186-29	28583-28587	most	_	
186-30	28588-28597	important	_	
186-31	28598-28610	connectivity	_	
186-32	28611-28616	state	_	
186-33	28616-28617	,	_	
186-34	28618-28622	with	_	
186-35	28623-28626	the	_	
186-36	28627-28630	CHR	_	
186-37	28631-28636	group	_	
186-38	28637-28642	being	_	
186-39	28643-28655	intermediate	_	
186-40	28656-28663	between	_	
186-41	28664-28666	HC	_	
186-42	28667-28670	and	_	
186-43	28671-28674	ESZ	_	
186-44	28675-28681	groups	_	
186-45	28681-28682	.	_	

#Text=Furthermore, 30 FCs (see Fig. 5D and the supplementary Table 3) with significant group difference were identified by comparing the dominant SSs across the three groups using ANCOVA.
187-1	28683-28694	Furthermore	_	
187-2	28694-28695	,	_	
187-3	28696-28698	30	_	
187-4	28699-28702	FCs	_	
187-5	28703-28704	(	_	
187-6	28704-28707	see	_	
187-7	28708-28711	Fig	_	
187-8	28711-28712	.	_	
187-9	28713-28715	5D	_	
187-10	28716-28719	and	_	
187-11	28720-28723	the	_	
187-12	28724-28737	supplementary	_	
187-13	28738-28743	Table	_	
187-14	28744-28745	3	_	
187-15	28745-28746	)	_	
187-16	28747-28751	with	_	
187-17	28752-28763	significant	_	
187-18	28764-28769	group	_	
187-19	28770-28780	difference	_	
187-20	28781-28785	were	_	
187-21	28786-28796	identified	_	
187-22	28797-28799	by	_	
187-23	28800-28809	comparing	_	
187-24	28810-28813	the	_	
187-25	28814-28822	dominant	_	
187-26	28823-28826	SSs	_	
187-27	28827-28833	across	_	
187-28	28834-28837	the	_	
187-29	28838-28843	three	_	
187-30	28844-28850	groups	_	
187-31	28851-28856	using	_	
187-32	28857-28863	ANCOVA	_	
187-33	28863-28864	.	_	

#Text=Those aberrant connections mainly lay within cerebellum, between temporal cortex and cerebellum, between frontal cortex and thalamus, between supplementary motor area and parahippocampal gyrus, between supplementary motor area and temporal cortex, between postcentral and temporal cortex, between parahippocampal gyrus and temporal cortex, and between Hesch1’s gyrus and cerebellum.
188-1	28865-28870	Those	_	
188-2	28871-28879	aberrant	_	
188-3	28880-28891	connections	_	
188-4	28892-28898	mainly	_	
188-5	28899-28902	lay	_	
188-6	28903-28909	within	_	
188-7	28910-28920	cerebellum	_	
188-8	28920-28921	,	_	
188-9	28922-28929	between	_	
188-10	28930-28938	temporal	_	
188-11	28939-28945	cortex	_	
188-12	28946-28949	and	_	
188-13	28950-28960	cerebellum	_	
188-14	28960-28961	,	_	
188-15	28962-28969	between	_	
188-16	28970-28977	frontal	_	
188-17	28978-28984	cortex	_	
188-18	28985-28988	and	_	
188-19	28989-28997	thalamus	_	
188-20	28997-28998	,	_	
188-21	28999-29006	between	_	
188-22	29007-29020	supplementary	_	
188-23	29021-29026	motor	_	
188-24	29027-29031	area	_	
188-25	29032-29035	and	_	
188-26	29036-29051	parahippocampal	_	
188-27	29052-29057	gyrus	_	
188-28	29057-29058	,	_	
188-29	29059-29066	between	_	
188-30	29067-29080	supplementary	_	
188-31	29081-29086	motor	_	
188-32	29087-29091	area	_	
188-33	29092-29095	and	_	
188-34	29096-29104	temporal	_	
188-35	29105-29111	cortex	_	
188-36	29111-29112	,	_	
188-37	29113-29120	between	_	
188-38	29121-29132	postcentral	_	
188-39	29133-29136	and	_	
188-40	29137-29145	temporal	_	
188-41	29146-29152	cortex	_	
188-42	29152-29153	,	_	
188-43	29154-29161	between	_	
188-44	29162-29177	parahippocampal	_	
188-45	29178-29183	gyrus	_	
188-46	29184-29187	and	_	
188-47	29188-29196	temporal	_	
188-48	29197-29203	cortex	_	
188-49	29203-29204	,	_	
188-50	29205-29208	and	_	
188-51	29209-29216	between	_	
188-52	29217-29223	Hesch1	_	
188-53	29223-29224	’	_	
188-54	29224-29225	s	_	
188-55	29226-29231	gyrus	_	
188-56	29232-29235	and	_	
188-57	29236-29246	cerebellum	_	
188-58	29246-29247	.	_	

#Text=Among the 30 FCs showing significant group difference, the mean connectivity strength of the CHR group fell in between the HC and ESZ groups for 25 FCs (see Fig. 6A), indicating that high risk stage tended to show an intermediate trend in connectivity between healthy condition and disease phase.
189-1	29248-29253	Among	_	
189-2	29254-29257	the	_	
189-3	29258-29260	30	_	
189-4	29261-29264	FCs	_	
189-5	29265-29272	showing	_	
189-6	29273-29284	significant	_	
189-7	29285-29290	group	_	
189-8	29291-29301	difference	_	
189-9	29301-29302	,	_	
189-10	29303-29306	the	_	
189-11	29307-29311	mean	_	
189-12	29312-29324	connectivity	_	
189-13	29325-29333	strength	_	
189-14	29334-29336	of	_	
189-15	29337-29340	the	_	
189-16	29341-29344	CHR	_	
189-17	29345-29350	group	_	
189-18	29351-29355	fell	_	
189-19	29356-29358	in	_	
189-20	29359-29366	between	_	
189-21	29367-29370	the	_	
189-22	29371-29373	HC	_	
189-23	29374-29377	and	_	
189-24	29378-29381	ESZ	_	
189-25	29382-29388	groups	_	
189-26	29389-29392	for	_	
189-27	29393-29395	25	_	
189-28	29396-29399	FCs	_	
189-29	29400-29401	(	_	
189-30	29401-29404	see	_	
189-31	29405-29408	Fig	_	
189-32	29408-29409	.	_	
189-33	29410-29412	6A	_	
189-34	29412-29413	)	_	
189-35	29413-29414	,	_	
189-36	29415-29425	indicating	_	
189-37	29426-29430	that	_	
189-38	29431-29435	high	_	
189-39	29436-29440	risk	_	
189-40	29441-29446	stage	_	
189-41	29447-29453	tended	_	
189-42	29454-29456	to	_	
189-43	29457-29461	show	_	
189-44	29462-29464	an	_	
189-45	29465-29477	intermediate	_	
189-46	29478-29483	trend	_	
189-47	29484-29486	in	_	
189-48	29487-29499	connectivity	_	
189-49	29500-29507	between	_	
189-50	29508-29515	healthy	_	
189-51	29516-29525	condition	_	
189-52	29526-29529	and	_	
189-53	29530-29537	disease	_	
189-54	29538-29543	phase	_	
189-55	29543-29544	.	_	

#Text=Two-sample t-test results (Fig. 6A) further suggest that 16 FCs in the ESZ group showed significant alterations compared to both the HC and CHR groups, indicating that ESZ patients had greater connectivity abnormality than CHR individuals in these FCs.
190-1	29545-29555	Two-sample	_	
190-2	29556-29562	t-test	_	
190-3	29563-29570	results	_	
190-4	29571-29572	(	_	
190-5	29572-29575	Fig	_	
190-6	29575-29576	.	_	
190-7	29577-29579	6A	_	
190-8	29579-29580	)	_	
190-9	29581-29588	further	_	
190-10	29589-29596	suggest	_	
190-11	29597-29601	that	_	
190-12	29602-29604	16	_	
190-13	29605-29608	FCs	_	
190-14	29609-29611	in	_	
190-15	29612-29615	the	_	
190-16	29616-29619	ESZ	_	
190-17	29620-29625	group	_	
190-18	29626-29632	showed	_	
190-19	29633-29644	significant	_	
190-20	29645-29656	alterations	_	
190-21	29657-29665	compared	_	
190-22	29666-29668	to	_	
190-23	29669-29673	both	_	
190-24	29674-29677	the	_	
190-25	29678-29680	HC	_	
190-26	29681-29684	and	_	
190-27	29685-29688	CHR	_	
190-28	29689-29695	groups	_	
190-29	29695-29696	,	_	
190-30	29697-29707	indicating	_	
190-31	29708-29712	that	_	
190-32	29713-29716	ESZ	_	
190-33	29717-29725	patients	_	
190-34	29726-29729	had	_	
190-35	29730-29737	greater	_	
190-36	29738-29750	connectivity	_	
190-37	29751-29762	abnormality	_	
190-38	29763-29767	than	_	
190-39	29768-29771	CHR	_	
190-40	29772-29783	individuals	_	
190-41	29784-29786	in	_	
190-42	29787-29792	these	_	
190-43	29793-29796	FCs	_	
190-44	29796-29797	.	_	

#Text=The 16 FCs were associated with the cerebellum, temporal cortex, frontal gyri, and thalamus.
191-1	29798-29801	The	_	
191-2	29802-29804	16	_	
191-3	29805-29808	FCs	_	
191-4	29809-29813	were	_	
191-5	29814-29824	associated	_	
191-6	29825-29829	with	_	
191-7	29830-29833	the	_	
191-8	29834-29844	cerebellum	_	
191-9	29844-29845	,	_	
191-10	29846-29854	temporal	_	
191-11	29855-29861	cortex	_	
191-12	29861-29862	,	_	
191-13	29863-29870	frontal	_	
191-14	29871-29875	gyri	_	
191-15	29875-29876	,	_	
191-16	29877-29880	and	_	
191-17	29881-29889	thalamus	_	
191-18	29889-29890	.	_	

#Text=Furthermore, 12 FCs involving the supplementary motor area, parahippocampal gyrus, temporal cortex, postcentral gyrus, cerebellum, frontal gyri and thalamus were significantly different between the HC group and the other two groups, suggesting that the CHR and ESZ groups showing similar changes in these FCs.
192-1	29891-29902	Furthermore	_	
192-2	29902-29903	,	_	
192-3	29904-29906	12	_	
192-4	29907-29910	FCs	_	
192-5	29911-29920	involving	_	
192-6	29921-29924	the	_	
192-7	29925-29938	supplementary	_	
192-8	29939-29944	motor	_	
192-9	29945-29949	area	_	
192-10	29949-29950	,	_	
192-11	29951-29966	parahippocampal	_	
192-12	29967-29972	gyrus	_	
192-13	29972-29973	,	_	
192-14	29974-29982	temporal	_	
192-15	29983-29989	cortex	_	
192-16	29989-29990	,	_	
192-17	29991-30002	postcentral	_	
192-18	30003-30008	gyrus	_	
192-19	30008-30009	,	_	
192-20	30010-30020	cerebellum	_	
192-21	30020-30021	,	_	
192-22	30022-30029	frontal	_	
192-23	30030-30034	gyri	_	
192-24	30035-30038	and	_	
192-25	30039-30047	thalamus	_	
192-26	30048-30052	were	_	
192-27	30053-30066	significantly	_	
192-28	30067-30076	different	_	
192-29	30077-30084	between	_	
192-30	30085-30088	the	_	
192-31	30089-30091	HC	_	
192-32	30092-30097	group	_	
192-33	30098-30101	and	_	
192-34	30102-30105	the	_	
192-35	30106-30111	other	_	
192-36	30112-30115	two	_	
192-37	30116-30122	groups	_	
192-38	30122-30123	,	_	
192-39	30124-30134	suggesting	_	
192-40	30135-30139	that	_	
192-41	30140-30143	the	_	
192-42	30144-30147	CHR	_	
192-43	30148-30151	and	_	
192-44	30152-30155	ESZ	_	
192-45	30156-30162	groups	_	
192-46	30163-30170	showing	_	
192-47	30171-30178	similar	_	
192-48	30179-30186	changes	_	
192-49	30187-30189	in	_	
192-50	30190-30195	these	_	
192-51	30196-30199	FCs	_	
192-52	30199-30200	.	_	

#Text=For the remaining two FCs linking the medial part of the superior frontal gyrus and calcarine cortex, the CHR group differed from both the HC and ESZ groups, reflecting a CHR-specific change.
193-1	30201-30204	For	_	
193-2	30205-30208	the	_	
193-3	30209-30218	remaining	_	
193-4	30219-30222	two	_	
193-5	30223-30226	FCs	_	
193-6	30227-30234	linking	_	
193-7	30235-30238	the	_	
193-8	30239-30245	medial	_	
193-9	30246-30250	part	_	
193-10	30251-30253	of	_	
193-11	30254-30257	the	_	
193-12	30258-30266	superior	_	
193-13	30267-30274	frontal	_	
193-14	30275-30280	gyrus	_	
193-15	30281-30284	and	_	
193-16	30285-30294	calcarine	_	
193-17	30295-30301	cortex	_	
193-18	30301-30302	,	_	
193-19	30303-30306	the	_	
193-20	30307-30310	CHR	_	
193-21	30311-30316	group	_	
193-22	30317-30325	differed	_	
193-23	30326-30330	from	_	
193-24	30331-30335	both	_	
193-25	30336-30339	the	_	
193-26	30340-30342	HC	_	
193-27	30343-30346	and	_	
193-28	30347-30350	ESZ	_	
193-29	30351-30357	groups	_	
193-30	30357-30358	,	_	
193-31	30359-30369	reflecting	_	
193-32	30370-30371	a	_	
193-33	30372-30384	CHR-specific	_	
193-34	30385-30391	change	_	
193-35	30391-30392	.	_	

#Text=Therefore, our results generally show that the ESZ patients had the greatest number and most severe changes, while CHR individuals tended to fall intermediately between the ESZ and HC groups.
194-1	30393-30402	Therefore	_	
194-2	30402-30403	,	_	
194-3	30404-30407	our	_	
194-4	30408-30415	results	_	
194-5	30416-30425	generally	_	
194-6	30426-30430	show	_	
194-7	30431-30435	that	_	
194-8	30436-30439	the	_	
194-9	30440-30443	ESZ	_	
194-10	30444-30452	patients	_	
194-11	30453-30456	had	_	
194-12	30457-30460	the	_	
194-13	30461-30469	greatest	_	
194-14	30470-30476	number	_	
194-15	30477-30480	and	_	
194-16	30481-30485	most	_	
194-17	30486-30492	severe	_	
194-18	30493-30500	changes	_	
194-19	30500-30501	,	_	
194-20	30502-30507	while	_	
194-21	30508-30511	CHR	_	
194-22	30512-30523	individuals	_	
194-23	30524-30530	tended	_	
194-24	30531-30533	to	_	
194-25	30534-30538	fall	_	
194-26	30539-30553	intermediately	_	
194-27	30554-30561	between	_	
194-28	30562-30565	the	_	
194-29	30566-30569	ESZ	_	
194-30	30570-30573	and	_	
194-31	30574-30576	HC	_	
194-32	30577-30583	groups	_	
194-33	30583-30584	.	_	

#Text=Additionally, the CHR group exhibited a distinct FC alteration not evident in the ESZ group.
195-1	30585-30597	Additionally	_	
195-2	30597-30598	,	_	
195-3	30599-30602	the	_	
195-4	30603-30606	CHR	_	
195-5	30607-30612	group	_	
195-6	30613-30622	exhibited	_	
195-7	30623-30624	a	_	
195-8	30625-30633	distinct	_	
195-9	30634-30636	FC	_	
195-10	30637-30647	alteration	_	
195-11	30648-30651	not	_	
195-12	30652-30659	evident	_	
195-13	30660-30662	in	_	
195-14	30663-30666	the	_	
195-15	30667-30670	ESZ	_	
195-16	30671-30676	group	_	
195-17	30676-30677	.	_	

#Text=Several FCs’ strengths were associated with the symptom scores.
196-1	30678-30685	Several	_	
196-2	30686-30689	FCs	_	
196-3	30689-30690	’	_	
196-4	30691-30700	strengths	_	
196-5	30701-30705	were	_	
196-6	30706-30716	associated	_	
196-7	30717-30721	with	_	
196-8	30722-30725	the	_	
196-9	30726-30733	symptom	_	
196-10	30734-30740	scores	_	
196-11	30740-30741	.	_	

#Text=The FC linking right supplementary motor area and left parahippocampal gyrus as well as the FC linking right parahippocampal gyrus and right temporal pole (superior temporal gyrus) showed a decreasing trend across HC, CHR and ESZ groups; meanwhile the two FCs were negatively correlated with SOPS positive symptom severity scores in the CHR group (Fig. 6B).
197-1	30742-30745	The	_	
197-2	30746-30748	FC	_	
197-3	30749-30756	linking	_	
197-4	30757-30762	right	_	
197-5	30763-30776	supplementary	_	
197-6	30777-30782	motor	_	
197-7	30783-30787	area	_	
197-8	30788-30791	and	_	
197-9	30792-30796	left	_	
197-10	30797-30812	parahippocampal	_	
197-11	30813-30818	gyrus	_	
197-12	30819-30821	as	_	
197-13	30822-30826	well	_	
197-14	30827-30829	as	_	
197-15	30830-30833	the	_	
197-16	30834-30836	FC	_	
197-17	30837-30844	linking	_	
197-18	30845-30850	right	_	
197-19	30851-30866	parahippocampal	_	
197-20	30867-30872	gyrus	_	
197-21	30873-30876	and	_	
197-22	30877-30882	right	_	
197-23	30883-30891	temporal	_	
197-24	30892-30896	pole	_	
197-25	30897-30898	(	_	
197-26	30898-30906	superior	_	
197-27	30907-30915	temporal	_	
197-28	30916-30921	gyrus	_	
197-29	30921-30922	)	_	
197-30	30923-30929	showed	_	
197-31	30930-30931	a	_	
197-32	30932-30942	decreasing	_	
197-33	30943-30948	trend	_	
197-34	30949-30955	across	_	
197-35	30956-30958	HC	_	
197-36	30958-30959	,	_	
197-37	30960-30963	CHR	_	
197-38	30964-30967	and	_	
197-39	30968-30971	ESZ	_	
197-40	30972-30978	groups	_	
197-41	30978-30979	;	_	
197-42	30980-30989	meanwhile	_	
197-43	30990-30993	the	_	
197-44	30994-30997	two	_	
197-45	30998-31001	FCs	_	
197-46	31002-31006	were	_	
197-47	31007-31017	negatively	_	
197-48	31018-31028	correlated	_	
197-49	31029-31033	with	_	
197-50	31034-31038	SOPS	_	
197-51	31039-31047	positive	_	
197-52	31048-31055	symptom	_	
197-53	31056-31064	severity	_	
197-54	31065-31071	scores	_	
197-55	31072-31074	in	_	
197-56	31075-31078	the	_	
197-57	31079-31082	CHR	_	
197-58	31083-31088	group	_	
197-59	31089-31090	(	_	
197-60	31090-31093	Fig	_	
197-61	31093-31094	.	_	
197-62	31095-31097	6B	_	
197-63	31097-31098	)	_	
197-64	31098-31099	.	_	

#Text=The connection between right temporal pole (middle temporal gyrus) and left cerebellum exhibited increasing strength from the HC to the CHR to the ESZ groups, while its connectivity strength was positively correlated with PANSS negative symptom severity scores in the ESZ group (Fig. 6B).
198-1	31100-31103	The	_	
198-2	31104-31114	connection	_	
198-3	31115-31122	between	_	
198-4	31123-31128	right	_	
198-5	31129-31137	temporal	_	
198-6	31138-31142	pole	_	
198-7	31143-31144	(	_	
198-8	31144-31150	middle	_	
198-9	31151-31159	temporal	_	
198-10	31160-31165	gyrus	_	
198-11	31165-31166	)	_	
198-12	31167-31170	and	_	
198-13	31171-31175	left	_	
198-14	31176-31186	cerebellum	_	
198-15	31187-31196	exhibited	_	
198-16	31197-31207	increasing	_	
198-17	31208-31216	strength	_	
198-18	31217-31221	from	_	
198-19	31222-31225	the	_	
198-20	31226-31228	HC	_	
198-21	31229-31231	to	_	
198-22	31232-31235	the	_	
198-23	31236-31239	CHR	_	
198-24	31240-31242	to	_	
198-25	31243-31246	the	_	
198-26	31247-31250	ESZ	_	
198-27	31251-31257	groups	_	
198-28	31257-31258	,	_	
198-29	31259-31264	while	_	
198-30	31265-31268	its	_	
198-31	31269-31281	connectivity	_	
198-32	31282-31290	strength	_	
198-33	31291-31294	was	_	
198-34	31295-31305	positively	_	
198-35	31306-31316	correlated	_	
198-36	31317-31321	with	_	
198-37	31322-31327	PANSS	_	
198-38	31328-31336	negative	_	
198-39	31337-31344	symptom	_	
198-40	31345-31353	severity	_	
198-41	31354-31360	scores	_	
198-42	31361-31363	in	_	
198-43	31364-31367	the	_	
198-44	31368-31371	ESZ	_	
198-45	31372-31377	group	_	
198-46	31378-31379	(	_	
198-47	31379-31382	Fig	_	
198-48	31382-31383	.	_	
198-49	31384-31386	6B	_	
198-50	31386-31387	)	_	
198-51	31387-31388	.	_	

#Text=The results support the clinical relevance of the connectivity-based measures.
199-1	31389-31392	The	_	
199-2	31393-31400	results	_	
199-3	31401-31408	support	_	
199-4	31409-31412	the	_	
199-5	31413-31421	clinical	_	
199-6	31422-31431	relevance	_	
199-7	31432-31434	of	_	
199-8	31435-31438	the	_	
199-9	31439-31457	connectivity-based	_	
199-10	31458-31466	measures	_	
199-11	31466-31467	.	_	

#Text=As described in section 2.2.3, we also performed a permutation test to examine the validity of the identified group differences.
200-1	31468-31470	As	_	
200-2	31471-31480	described	_	
200-3	31481-31483	in	_	
200-4	31484-31491	section	_	
200-5	31492-31497	2.2.3	_	
200-6	31497-31498	,	_	
200-7	31499-31501	we	_	
200-8	31502-31506	also	_	
200-9	31507-31516	performed	_	
200-10	31517-31518	a	_	
200-11	31519-31530	permutation	_	
200-12	31531-31535	test	_	
200-13	31536-31538	to	_	
200-14	31539-31546	examine	_	
200-15	31547-31550	the	_	
200-16	31551-31559	validity	_	
200-17	31560-31562	of	_	
200-18	31563-31566	the	_	
200-19	31567-31577	identified	_	
200-20	31578-31583	group	_	
200-21	31584-31595	differences	_	
200-22	31595-31596	.	_	

#Text=Fig. 7A shows all connections’ p-values obtained by performing ANCOVA on each connection’s strengths in the dominant subject-specific states based on the original samples of the three groups.
201-1	31597-31600	Fig	_	
201-2	31600-31601	.	_	
201-3	31602-31604	7A	_	
201-4	31605-31610	shows	_	
201-5	31611-31614	all	_	
201-6	31615-31626	connections	_	
201-7	31626-31627	’	_	
201-8	31628-31636	p-values	_	
201-9	31637-31645	obtained	_	
201-10	31646-31648	by	_	
201-11	31649-31659	performing	_	
201-12	31660-31666	ANCOVA	_	
201-13	31667-31669	on	_	
201-14	31670-31674	each	_	
201-15	31675-31685	connection	_	
201-16	31685-31686	’	_	
201-17	31686-31687	s	_	
201-18	31688-31697	strengths	_	
201-19	31698-31700	in	_	
201-20	31701-31704	the	_	
201-21	31705-31713	dominant	_	
201-22	31714-31730	subject-specific	_	
201-23	31731-31737	states	_	
201-24	31738-31743	based	_	
201-25	31744-31746	on	_	
201-26	31747-31750	the	_	
201-27	31751-31759	original	_	
201-28	31760-31767	samples	_	
201-29	31768-31770	of	_	
201-30	31771-31774	the	_	
201-31	31775-31780	three	_	
201-32	31781-31787	groups	_	
201-33	31787-31788	.	_	

#Text=Fig. 7B and C display all connections’ associated −log10 (p) values and p-values (i.e., the frequencies or tail probabilities) that were computed based on ANCOVA results of the dominant state from 1000 permutations.
202-1	31789-31792	Fig	_	
202-2	31792-31793	.	_	
202-3	31794-31796	7B	_	
202-4	31797-31800	and	_	
202-5	31801-31802	C	_	
202-6	31803-31810	display	_	
202-7	31811-31814	all	_	
202-8	31815-31826	connections	_	
202-9	31826-31827	’	_	
202-10	31828-31838	associated	_	
202-11	31839-31840	−	_	
202-12	31840-31845	log10	_	
202-13	31846-31847	(	_	
202-14	31847-31848	p	_	
202-15	31848-31849	)	_	
202-16	31850-31856	values	_	
202-17	31857-31860	and	_	
202-18	31861-31869	p-values	_	
202-19	31870-31871	(	_	
202-20	31871-31874	i.e	_	
202-21	31874-31875	.	_	
202-22	31875-31876	,	_	
202-23	31877-31880	the	_	
202-24	31881-31892	frequencies	_	
202-25	31893-31895	or	_	
202-26	31896-31900	tail	_	
202-27	31901-31914	probabilities	_	
202-28	31914-31915	)	_	
202-29	31916-31920	that	_	
202-30	31921-31925	were	_	
202-31	31926-31934	computed	_	
202-32	31935-31940	based	_	
202-33	31941-31943	on	_	
202-34	31944-31950	ANCOVA	_	
202-35	31951-31958	results	_	
202-36	31959-31961	of	_	
202-37	31962-31965	the	_	
202-38	31966-31974	dominant	_	
202-39	31975-31980	state	_	
202-40	31981-31985	from	_	
202-41	31986-31990	1000	_	
202-42	31991-32003	permutations	_	
202-43	32003-32004	.	_	

#Text=By comparing Fig. 7A with Fig. 7B (and C), we found that the statistical results were quite comparable between the original ANCOVA and the permutation test.
203-1	32005-32007	By	_	
203-2	32008-32017	comparing	_	
203-3	32018-32021	Fig	_	
203-4	32021-32022	.	_	
203-5	32023-32025	7A	_	
203-6	32026-32030	with	_	
203-7	32031-32034	Fig	_	
203-8	32034-32035	.	_	
203-9	32036-32038	7B	_	
203-10	32039-32040	(	_	
203-11	32040-32043	and	_	
203-12	32044-32045	C	_	
203-13	32045-32046	)	_	
203-14	32046-32047	,	_	
203-15	32048-32050	we	_	
203-16	32051-32056	found	_	
203-17	32057-32061	that	_	
203-18	32062-32065	the	_	
203-19	32066-32077	statistical	_	
203-20	32078-32085	results	_	
203-21	32086-32090	were	_	
203-22	32091-32096	quite	_	
203-23	32097-32107	comparable	_	
203-24	32108-32115	between	_	
203-25	32116-32119	the	_	
203-26	32120-32128	original	_	
203-27	32129-32135	ANCOVA	_	
203-28	32136-32139	and	_	
203-29	32140-32143	the	_	
203-30	32144-32155	permutation	_	
203-31	32156-32160	test	_	
203-32	32160-32161	.	_	

#Text=As shown in Fig. 7C, the identified 30 FCs presenting group differences among the original three groups showed zero (i.e., < 0.001) p-values in the permutation test.
204-1	32162-32164	As	_	
204-2	32165-32170	shown	_	
204-3	32171-32173	in	_	
204-4	32174-32177	Fig	_	
204-5	32177-32178	.	_	
204-6	32179-32181	7C	_	
204-7	32181-32182	,	_	
204-8	32183-32186	the	_	
204-9	32187-32197	identified	_	
204-10	32198-32200	30	_	
204-11	32201-32204	FCs	_	
204-12	32205-32215	presenting	_	
204-13	32216-32221	group	_	
204-14	32222-32233	differences	_	
204-15	32234-32239	among	_	
204-16	32240-32243	the	_	
204-17	32244-32252	original	_	
204-18	32253-32258	three	_	
204-19	32259-32265	groups	_	
204-20	32266-32272	showed	_	
204-21	32273-32277	zero	_	
204-22	32278-32279	(	_	
204-23	32279-32282	i.e	_	
204-24	32282-32283	.	_	
204-25	32283-32284	,	_	
204-26	32285-32286	<	_	
204-27	32287-32292	0.001	_	
204-28	32292-32293	)	_	
204-29	32294-32302	p-values	_	
204-30	32303-32305	in	_	
204-31	32306-32309	the	_	
204-32	32310-32321	permutation	_	
204-33	32322-32326	test	_	
204-34	32326-32327	.	_	

#Text=It can be observed from Fig. 7D that the adjusted p-value map (using the step-down minP method proposed by Westfall & Young) based on 1000 permutations had a similar pattern with the p-value map using the original groups.
205-1	32328-32330	It	_	
205-2	32331-32334	can	_	
205-3	32335-32337	be	_	
205-4	32338-32346	observed	_	
205-5	32347-32351	from	_	
205-6	32352-32355	Fig	_	
205-7	32355-32356	.	_	
205-8	32357-32359	7D	_	
205-9	32360-32364	that	_	
205-10	32365-32368	the	_	
205-11	32369-32377	adjusted	_	
205-12	32378-32385	p-value	_	
205-13	32386-32389	map	_	
205-14	32390-32391	(	_	
205-15	32391-32396	using	_	
205-16	32397-32400	the	_	
205-17	32401-32410	step-down	_	
205-18	32411-32415	minP	_	
205-19	32416-32422	method	_	
205-20	32423-32431	proposed	_	
205-21	32432-32434	by	_	
205-22	32435-32443	Westfall	_	
205-23	32444-32445	&	_	
205-24	32446-32451	Young	_	
205-25	32451-32452	)	_	
205-26	32453-32458	based	_	
205-27	32459-32461	on	_	
205-28	32462-32466	1000	_	
205-29	32467-32479	permutations	_	
205-30	32480-32483	had	_	
205-31	32484-32485	a	_	
205-32	32486-32493	similar	_	
205-33	32494-32501	pattern	_	
205-34	32502-32506	with	_	
205-35	32507-32510	the	_	
205-36	32511-32518	p-value	_	
205-37	32519-32522	map	_	
205-38	32523-32528	using	_	
205-39	32529-32532	the	_	
205-40	32533-32541	original	_	
205-41	32542-32548	groups	_	
205-42	32548-32549	.	_	

#Text=Fig. 7E shows the 30 FCs reflecting a group effect using the original groups after Bonferroni correction (p < 0.05).
206-1	32550-32553	Fig	_	
206-2	32553-32554	.	_	
206-3	32555-32557	7E	_	
206-4	32558-32563	shows	_	
206-5	32564-32567	the	_	
206-6	32568-32570	30	_	
206-7	32571-32574	FCs	_	
206-8	32575-32585	reflecting	_	
206-9	32586-32587	a	_	
206-10	32588-32593	group	_	
206-11	32594-32600	effect	_	
206-12	32601-32606	using	_	
206-13	32607-32610	the	_	
206-14	32611-32619	original	_	
206-15	32620-32626	groups	_	
206-16	32627-32632	after	_	
206-17	32633-32643	Bonferroni	_	
206-18	32644-32654	correction	_	
206-19	32655-32656	(	_	
206-20	32656-32657	p	_	
206-21	32658-32659	<	_	
206-22	32660-32664	0.05	_	
206-23	32664-32665	)	_	
206-24	32665-32666	.	_	

#Text=Fig. 7F and G show the FCs with significant group differences after correcting the adjusted p-values in the permutation test, resulting in 357 FCs using p < 0.05 and 58 FCs using p < 0.01.
207-1	32667-32670	Fig	_	
207-2	32670-32671	.	_	
207-3	32672-32674	7F	_	
207-4	32675-32678	and	_	
207-5	32679-32680	G	_	
207-6	32681-32685	show	_	
207-7	32686-32689	the	_	
207-8	32690-32693	FCs	_	
207-9	32694-32698	with	_	
207-10	32699-32710	significant	_	
207-11	32711-32716	group	_	
207-12	32717-32728	differences	_	
207-13	32729-32734	after	_	
207-14	32735-32745	correcting	_	
207-15	32746-32749	the	_	
207-16	32750-32758	adjusted	_	
207-17	32759-32767	p-values	_	
207-18	32768-32770	in	_	
207-19	32771-32774	the	_	
207-20	32775-32786	permutation	_	
207-21	32787-32791	test	_	
207-22	32791-32792	,	_	
207-23	32793-32802	resulting	_	
207-24	32803-32805	in	_	
207-25	32806-32809	357	_	
207-26	32810-32813	FCs	_	
207-27	32814-32819	using	_	
207-28	32820-32821	p	_	
207-29	32822-32823	<	_	
207-30	32824-32828	0.05	_	
207-31	32829-32832	and	_	
207-32	32833-32835	58	_	
207-33	32836-32839	FCs	_	
207-34	32840-32845	using	_	
207-35	32846-32847	p	_	
207-36	32848-32849	<	_	
207-37	32850-32854	0.01	_	
207-38	32854-32855	.	_	

#Text=Importantly, Fig. 7 E–G demonstrate that all the 30 functional connections showing group differences using the original method were found to be significantly different among groups using the permutation test (after multiple comparison corrections).
208-1	32856-32867	Importantly	_	
208-2	32867-32868	,	_	
208-3	32869-32872	Fig	_	
208-4	32872-32873	.	_	
208-5	32874-32875	7	_	
208-6	32876-32879	E–G	_	
208-7	32880-32891	demonstrate	_	
208-8	32892-32896	that	_	
208-9	32897-32900	all	_	
208-10	32901-32904	the	_	
208-11	32905-32907	30	_	
208-12	32908-32918	functional	_	
208-13	32919-32930	connections	_	
208-14	32931-32938	showing	_	
208-15	32939-32944	group	_	
208-16	32945-32956	differences	_	
208-17	32957-32962	using	_	
208-18	32963-32966	the	_	
208-19	32967-32975	original	_	
208-20	32976-32982	method	_	
208-21	32983-32987	were	_	
208-22	32988-32993	found	_	
208-23	32994-32996	to	_	
208-24	32997-32999	be	_	
208-25	33000-33013	significantly	_	
208-26	33014-33023	different	_	
208-27	33024-33029	among	_	
208-28	33030-33036	groups	_	
208-29	33037-33042	using	_	
208-30	33043-33046	the	_	
208-31	33047-33058	permutation	_	
208-32	33059-33063	test	_	
208-33	33064-33065	(	_	
208-34	33065-33070	after	_	
208-35	33071-33079	multiple	_	
208-36	33080-33090	comparison	_	
208-37	33091-33102	corrections	_	
208-38	33102-33103	)	_	
208-39	33103-33104	.	_	

#Text=In summary, our results support that the 30 connectivities shown in Fig. 6D were driven by diseases rather than grouping.
#Text=4.
209-1	33105-33107	In	_	
209-2	33108-33115	summary	_	
209-3	33115-33116	,	_	
209-4	33117-33120	our	_	
209-5	33121-33128	results	_	
209-6	33129-33136	support	_	
209-7	33137-33141	that	_	
209-8	33142-33145	the	_	
209-9	33146-33148	30	_	
209-10	33149-33163	connectivities	_	
209-11	33164-33169	shown	_	
209-12	33170-33172	in	_	
209-13	33173-33176	Fig	_	
209-14	33176-33177	.	_	
209-15	33178-33180	6D	_	
209-16	33181-33185	were	_	
209-17	33186-33192	driven	_	
209-18	33193-33195	by	_	
209-19	33196-33204	diseases	_	
209-20	33205-33211	rather	_	
209-21	33212-33216	than	_	
209-22	33217-33225	grouping	_	
209-23	33225-33226	.	_	
209-24	33227-33228	4	_	
209-25	33228-33229	.	_	

#Text=Discussions and conclusion
#Text=Clinical high risk individuals have an increased risk of developing a psychotic disorder.
210-1	33230-33241	Discussions	_	
210-2	33242-33245	and	_	
210-3	33246-33256	conclusion	_	
210-4	33257-33265	Clinical	_	
210-5	33266-33270	high	_	
210-6	33271-33275	risk	_	
210-7	33276-33287	individuals	_	
210-8	33288-33292	have	_	
210-9	33293-33295	an	_	
210-10	33296-33305	increased	_	
210-11	33306-33310	risk	_	
210-12	33311-33313	of	_	
210-13	33314-33324	developing	_	
210-14	33325-33326	a	_	
210-15	33327-33336	psychotic	_	
210-16	33337-33345	disorder	_	
210-17	33345-33346	.	_	

#Text=Measures identified from neuroimaging data are expected to reveal the neural mechanism of CHR and schizophrenia.
211-1	33347-33355	Measures	_	
211-2	33356-33366	identified	_	
211-3	33367-33371	from	_	
211-4	33372-33384	neuroimaging	_	
211-5	33385-33389	data	_	
211-6	33390-33393	are	_	
211-7	33394-33402	expected	_	
211-8	33403-33405	to	_	
211-9	33406-33412	reveal	_	
211-10	33413-33416	the	_	
211-11	33417-33423	neural	_	
211-12	33424-33433	mechanism	_	
211-13	33434-33436	of	_	
211-14	33437-33440	CHR	_	
211-15	33441-33444	and	_	
211-16	33445-33458	schizophrenia	_	
211-17	33458-33459	.	_	

#Text=Recently, dynamic functional connectivity has shown sensitivity in investigating disease biomarker for schizophrenia.
212-1	33460-33468	Recently	_	
212-2	33468-33469	,	_	
212-3	33470-33477	dynamic	_	
212-4	33478-33488	functional	_	
212-5	33489-33501	connectivity	_	
212-6	33502-33505	has	_	
212-7	33506-33511	shown	_	
212-8	33512-33523	sensitivity	_	
212-9	33524-33526	in	_	
212-10	33527-33540	investigating	_	
212-11	33541-33548	disease	_	
212-12	33549-33558	biomarker	_	
212-13	33559-33562	for	_	
212-14	33563-33576	schizophrenia	_	
212-15	33576-33577	.	_	

#Text=The current study is the first to examine DFC in a CHR sample, although prior SFC-based work has observed aberrant connectivity in CHR individuals.
213-1	33578-33581	The	_	
213-2	33582-33589	current	_	
213-3	33590-33595	study	_	
213-4	33596-33598	is	_	
213-5	33599-33602	the	_	
213-6	33603-33608	first	_	
213-7	33609-33611	to	_	
213-8	33612-33619	examine	_	
213-9	33620-33623	DFC	_	
213-10	33624-33626	in	_	
213-11	33627-33628	a	_	
213-12	33629-33632	CHR	_	
213-13	33633-33639	sample	_	
213-14	33639-33640	,	_	
213-15	33641-33649	although	_	
213-16	33650-33655	prior	_	
213-17	33656-33665	SFC-based	_	
213-18	33666-33670	work	_	
213-19	33671-33674	has	_	
213-20	33675-33683	observed	_	
213-21	33684-33692	aberrant	_	
213-22	33693-33705	connectivity	_	
213-23	33706-33708	in	_	
213-24	33709-33712	CHR	_	
213-25	33713-33724	individuals	_	
213-26	33724-33725	.	_	

#Text=By applying the GIG-ICA method to whole-brain DFC derived from resting-state fMRI data, we investigated group differences among HC, CHR and ESZ groups.
214-1	33726-33728	By	_	
214-2	33729-33737	applying	_	
214-3	33738-33741	the	_	
214-4	33742-33749	GIG-ICA	_	
214-5	33750-33756	method	_	
214-6	33757-33759	to	_	
214-7	33760-33771	whole-brain	_	
214-8	33772-33775	DFC	_	
214-9	33776-33783	derived	_	
214-10	33784-33788	from	_	
214-11	33789-33802	resting-state	_	
214-12	33803-33807	fMRI	_	
214-13	33808-33812	data	_	
214-14	33812-33813	,	_	
214-15	33814-33816	we	_	
214-16	33817-33829	investigated	_	
214-17	33830-33835	group	_	
214-18	33836-33847	differences	_	
214-19	33848-33853	among	_	
214-20	33854-33856	HC	_	
214-21	33856-33857	,	_	
214-22	33858-33861	CHR	_	
214-23	33862-33865	and	_	
214-24	33866-33869	ESZ	_	
214-25	33870-33876	groups	_	
214-26	33876-33877	.	_	

#Text=We found that multiple FCs in the dominant state altered in CHR and ESZ groups.
215-1	33878-33880	We	_	
215-2	33881-33886	found	_	
215-3	33887-33891	that	_	
215-4	33892-33900	multiple	_	
215-5	33901-33904	FCs	_	
215-6	33905-33907	in	_	
215-7	33908-33911	the	_	
215-8	33912-33920	dominant	_	
215-9	33921-33926	state	_	
215-10	33927-33934	altered	_	
215-11	33935-33937	in	_	
215-12	33938-33941	CHR	_	
215-13	33942-33945	and	_	
215-14	33946-33949	ESZ	_	
215-15	33950-33956	groups	_	
215-16	33956-33957	.	_	

#Text=The primary abnormal FCs included the connections within cerebellum, between temporal cortex and cerebellum, between frontal cortex and thalamus, between supplementary motor area and parahippocampal gyrus, between supplementary motor area and temporal cortex, between postcentral and temporal cortex, between parahippocampal gyrus and temporal cortex, and between Hesch1’s gyrus and cerebellum.
216-1	33958-33961	The	_	
216-2	33962-33969	primary	_	
216-3	33970-33978	abnormal	_	
216-4	33979-33982	FCs	_	
216-5	33983-33991	included	_	
216-6	33992-33995	the	_	
216-7	33996-34007	connections	_	
216-8	34008-34014	within	_	
216-9	34015-34025	cerebellum	_	
216-10	34025-34026	,	_	
216-11	34027-34034	between	_	
216-12	34035-34043	temporal	_	
216-13	34044-34050	cortex	_	
216-14	34051-34054	and	_	
216-15	34055-34065	cerebellum	_	
216-16	34065-34066	,	_	
216-17	34067-34074	between	_	
216-18	34075-34082	frontal	_	
216-19	34083-34089	cortex	_	
216-20	34090-34093	and	_	
216-21	34094-34102	thalamus	_	
216-22	34102-34103	,	_	
216-23	34104-34111	between	_	
216-24	34112-34125	supplementary	_	
216-25	34126-34131	motor	_	
216-26	34132-34136	area	_	
216-27	34137-34140	and	_	
216-28	34141-34156	parahippocampal	_	
216-29	34157-34162	gyrus	_	
216-30	34162-34163	,	_	
216-31	34164-34171	between	_	
216-32	34172-34185	supplementary	_	
216-33	34186-34191	motor	_	
216-34	34192-34196	area	_	
216-35	34197-34200	and	_	
216-36	34201-34209	temporal	_	
216-37	34210-34216	cortex	_	
216-38	34216-34217	,	_	
216-39	34218-34225	between	_	
216-40	34226-34237	postcentral	_	
216-41	34238-34241	and	_	
216-42	34242-34250	temporal	_	
216-43	34251-34257	cortex	_	
216-44	34257-34258	,	_	
216-45	34259-34266	between	_	
216-46	34267-34282	parahippocampal	_	
216-47	34283-34288	gyrus	_	
216-48	34289-34292	and	_	
216-49	34293-34301	temporal	_	
216-50	34302-34308	cortex	_	
216-51	34308-34309	,	_	
216-52	34310-34313	and	_	
216-53	34314-34321	between	_	
216-54	34322-34328	Hesch1	_	
216-55	34328-34329	’	_	
216-56	34329-34330	s	_	
216-57	34331-34336	gyrus	_	
216-58	34337-34340	and	_	
216-59	34341-34351	cerebellum	_	
216-60	34351-34352	.	_	

#Text=Our findings are in agreement with previous studies using task-related or resting-state fMRI data, which also observed abnormalities in CHR and schizophrenia groups in the frontal lobes, temporal lobes, cerebellum, thalamus, hippocampus, postcentral gyrus, sensory motor cortex and Heschl’s gyrus.
217-1	34353-34356	Our	_	
217-2	34357-34365	findings	_	
217-3	34366-34369	are	_	
217-4	34370-34372	in	_	
217-5	34373-34382	agreement	_	
217-6	34383-34387	with	_	
217-7	34388-34396	previous	_	
217-8	34397-34404	studies	_	
217-9	34405-34410	using	_	
217-10	34411-34423	task-related	_	
217-11	34424-34426	or	_	
217-12	34427-34440	resting-state	_	
217-13	34441-34445	fMRI	_	
217-14	34446-34450	data	_	
217-15	34450-34451	,	_	
217-16	34452-34457	which	_	
217-17	34458-34462	also	_	
217-18	34463-34471	observed	_	
217-19	34472-34485	abnormalities	_	
217-20	34486-34488	in	_	
217-21	34489-34492	CHR	_	
217-22	34493-34496	and	_	
217-23	34497-34510	schizophrenia	_	
217-24	34511-34517	groups	_	
217-25	34518-34520	in	_	
217-26	34521-34524	the	_	
217-27	34525-34532	frontal	_	
217-28	34533-34538	lobes	_	
217-29	34538-34539	,	_	
217-30	34540-34548	temporal	_	
217-31	34549-34554	lobes	_	
217-32	34554-34555	,	_	
217-33	34556-34566	cerebellum	_	
217-34	34566-34567	,	_	
217-35	34568-34576	thalamus	_	
217-36	34576-34577	,	_	
217-37	34578-34589	hippocampus	_	
217-38	34589-34590	,	_	
217-39	34591-34602	postcentral	_	
217-40	34603-34608	gyrus	_	
217-41	34608-34609	,	_	
217-42	34610-34617	sensory	_	
217-43	34618-34623	motor	_	
217-44	34624-34630	cortex	_	
217-45	34631-34634	and	_	
217-46	34635-34641	Heschl	_	
217-47	34641-34642	’	_	
217-48	34642-34643	s	_	
217-49	34644-34649	gyrus	_	
217-50	34649-34650	.	_	

#Text=While cerebellum dysfunction has been suggested to be relevant to certain characteristics in some neuropsychiatric disorders including SZ, our findings also underscore the cerebellar abnormality of resting-state brain connectivity in CHR and ESZ individuals.
218-1	34651-34656	While	_	
218-2	34657-34667	cerebellum	_	
218-3	34668-34679	dysfunction	_	
218-4	34680-34683	has	_	
218-5	34684-34688	been	_	
218-6	34689-34698	suggested	_	
218-7	34699-34701	to	_	
218-8	34702-34704	be	_	
218-9	34705-34713	relevant	_	
218-10	34714-34716	to	_	
218-11	34717-34724	certain	_	
218-12	34725-34740	characteristics	_	
218-13	34741-34743	in	_	
218-14	34744-34748	some	_	
218-15	34749-34765	neuropsychiatric	_	
218-16	34766-34775	disorders	_	
218-17	34776-34785	including	_	
218-18	34786-34788	SZ	_	
218-19	34788-34789	,	_	
218-20	34790-34793	our	_	
218-21	34794-34802	findings	_	
218-22	34803-34807	also	_	
218-23	34808-34818	underscore	_	
218-24	34819-34822	the	_	
218-25	34823-34833	cerebellar	_	
218-26	34834-34845	abnormality	_	
218-27	34846-34848	of	_	
218-28	34849-34862	resting-state	_	
218-29	34863-34868	brain	_	
218-30	34869-34881	connectivity	_	
218-31	34882-34884	in	_	
218-32	34885-34888	CHR	_	
218-33	34889-34892	and	_	
218-34	34893-34896	ESZ	_	
218-35	34897-34908	individuals	_	
218-36	34908-34909	.	_	

#Text=Importantly, our previous studies using the similar dynamic connectivity analysis framework also revealed significant group differences in cerebellum-related connectivity among bipolar disorder with psychosis, schizoaffective disorder and schizophrenia.
219-1	34910-34921	Importantly	_	
219-2	34921-34922	,	_	
219-3	34923-34926	our	_	
219-4	34927-34935	previous	_	
219-5	34936-34943	studies	_	
219-6	34944-34949	using	_	
219-7	34950-34953	the	_	
219-8	34954-34961	similar	_	
219-9	34962-34969	dynamic	_	
219-10	34970-34982	connectivity	_	
219-11	34983-34991	analysis	_	
219-12	34992-35001	framework	_	
219-13	35002-35006	also	_	
219-14	35007-35015	revealed	_	
219-15	35016-35027	significant	_	
219-16	35028-35033	group	_	
219-17	35034-35045	differences	_	
219-18	35046-35048	in	_	
219-19	35049-35067	cerebellum-related	_	
219-20	35068-35080	connectivity	_	
219-21	35081-35086	among	_	
219-22	35087-35094	bipolar	_	
219-23	35095-35103	disorder	_	
219-24	35104-35108	with	_	
219-25	35109-35118	psychosis	_	
219-26	35118-35119	,	_	
219-27	35120-35135	schizoaffective	_	
219-28	35136-35144	disorder	_	
219-29	35145-35148	and	_	
219-30	35149-35162	schizophrenia	_	
219-31	35162-35163	.	_	

#Text=Interestingly, our results from the dominant connectivity state suggest that ESZ patients showed greater connectivity changes than CHR individuals, and in general CHR individuals had an intermediate FC pattern between HCs and ESZ patients.
220-1	35164-35177	Interestingly	_	
220-2	35177-35178	,	_	
220-3	35179-35182	our	_	
220-4	35183-35190	results	_	
220-5	35191-35195	from	_	
220-6	35196-35199	the	_	
220-7	35200-35208	dominant	_	
220-8	35209-35221	connectivity	_	
220-9	35222-35227	state	_	
220-10	35228-35235	suggest	_	
220-11	35236-35240	that	_	
220-12	35241-35244	ESZ	_	
220-13	35245-35253	patients	_	
220-14	35254-35260	showed	_	
220-15	35261-35268	greater	_	
220-16	35269-35281	connectivity	_	
220-17	35282-35289	changes	_	
220-18	35290-35294	than	_	
220-19	35295-35298	CHR	_	
220-20	35299-35310	individuals	_	
220-21	35310-35311	,	_	
220-22	35312-35315	and	_	
220-23	35316-35318	in	_	
220-24	35319-35326	general	_	
220-25	35327-35330	CHR	_	
220-26	35331-35342	individuals	_	
220-27	35343-35346	had	_	
220-28	35347-35349	an	_	
220-29	35350-35362	intermediate	_	
220-30	35363-35365	FC	_	
220-31	35366-35373	pattern	_	
220-32	35374-35381	between	_	
220-33	35382-35385	HCs	_	
220-34	35386-35389	and	_	
220-35	35390-35393	ESZ	_	
220-36	35394-35402	patients	_	
220-37	35402-35403	.	_	

#Text=Measured by the mean connectivity strength, most of the identified FCs (25 of 30 FCs) in the CHR group fell in between those of the HC and ESZ groups.
221-1	35404-35412	Measured	_	
221-2	35413-35415	by	_	
221-3	35416-35419	the	_	
221-4	35420-35424	mean	_	
221-5	35425-35437	connectivity	_	
221-6	35438-35446	strength	_	
221-7	35446-35447	,	_	
221-8	35448-35452	most	_	
221-9	35453-35455	of	_	
221-10	35456-35459	the	_	
221-11	35460-35470	identified	_	
221-12	35471-35474	FCs	_	
221-13	35475-35476	(	_	
221-14	35476-35478	25	_	
221-15	35479-35481	of	_	
221-16	35482-35484	30	_	
221-17	35485-35488	FCs	_	
221-18	35488-35489	)	_	
221-19	35490-35492	in	_	
221-20	35493-35496	the	_	
221-21	35497-35500	CHR	_	
221-22	35501-35506	group	_	
221-23	35507-35511	fell	_	
221-24	35512-35514	in	_	
221-25	35515-35522	between	_	
221-26	35523-35528	those	_	
221-27	35529-35531	of	_	
221-28	35532-35535	the	_	
221-29	35536-35538	HC	_	
221-30	35539-35542	and	_	
221-31	35543-35546	ESZ	_	
221-32	35547-35553	groups	_	
221-33	35553-35554	.	_	

#Text=This may reflect large abnormalities in the subset of CHRs who are destined to transition to psychosis, with other CHRs showing normal FC patterns, or it may reflect attenuated FC abnormalities across most CHR individuals that worsen to the levels seen in ESZ patients during the transition to psychosis and its immediate aftermath.
222-1	35555-35559	This	_	
222-2	35560-35563	may	_	
222-3	35564-35571	reflect	_	
222-4	35572-35577	large	_	
222-5	35578-35591	abnormalities	_	
222-6	35592-35594	in	_	
222-7	35595-35598	the	_	
222-8	35599-35605	subset	_	
222-9	35606-35608	of	_	
222-10	35609-35613	CHRs	_	
222-11	35614-35617	who	_	
222-12	35618-35621	are	_	
222-13	35622-35630	destined	_	
222-14	35631-35633	to	_	
222-15	35634-35644	transition	_	
222-16	35645-35647	to	_	
222-17	35648-35657	psychosis	_	
222-18	35657-35658	,	_	
222-19	35659-35663	with	_	
222-20	35664-35669	other	_	
222-21	35670-35674	CHRs	_	
222-22	35675-35682	showing	_	
222-23	35683-35689	normal	_	
222-24	35690-35692	FC	_	
222-25	35693-35701	patterns	_	
222-26	35701-35702	,	_	
222-27	35703-35705	or	_	
222-28	35706-35708	it	_	
222-29	35709-35712	may	_	
222-30	35713-35720	reflect	_	
222-31	35721-35731	attenuated	_	
222-32	35732-35734	FC	_	
222-33	35735-35748	abnormalities	_	
222-34	35749-35755	across	_	
222-35	35756-35760	most	_	
222-36	35761-35764	CHR	_	
222-37	35765-35776	individuals	_	
222-38	35777-35781	that	_	
222-39	35782-35788	worsen	_	
222-40	35789-35791	to	_	
222-41	35792-35795	the	_	
222-42	35796-35802	levels	_	
222-43	35803-35807	seen	_	
222-44	35808-35810	in	_	
222-45	35811-35814	ESZ	_	
222-46	35815-35823	patients	_	
222-47	35824-35830	during	_	
222-48	35831-35834	the	_	
222-49	35835-35845	transition	_	
222-50	35846-35848	to	_	
222-51	35849-35858	psychosis	_	
222-52	35859-35862	and	_	
222-53	35863-35866	its	_	
222-54	35867-35876	immediate	_	
222-55	35877-35886	aftermath	_	
222-56	35886-35887	.	_	

#Text=Unfortunately, the absence of sufficient clinical follow-up data in our CHR sample prevents us from distinguishing these possibilities.
223-1	35888-35901	Unfortunately	_	
223-2	35901-35902	,	_	
223-3	35903-35906	the	_	
223-4	35907-35914	absence	_	
223-5	35915-35917	of	_	
223-6	35918-35928	sufficient	_	
223-7	35929-35937	clinical	_	
223-8	35938-35947	follow-up	_	
223-9	35948-35952	data	_	
223-10	35953-35955	in	_	
223-11	35956-35959	our	_	
223-12	35960-35963	CHR	_	
223-13	35964-35970	sample	_	
223-14	35971-35979	prevents	_	
223-15	35980-35982	us	_	
223-16	35983-35987	from	_	
223-17	35988-36002	distinguishing	_	
223-18	36003-36008	these	_	
223-19	36009-36022	possibilities	_	
223-20	36022-36023	.	_	

#Text=Examined by two-sample t-tests, the ESZ group exhibited significant alterations compared to both HC and CHR groups in some FCs, which primarily involved the within-cerebellum connections, the connections between frontal gyri and thalamus, as well as the connections between temporal gyri and cerebellum.
224-1	36024-36032	Examined	_	
224-2	36033-36035	by	_	
224-3	36036-36046	two-sample	_	
224-4	36047-36054	t-tests	_	
224-5	36054-36055	,	_	
224-6	36056-36059	the	_	
224-7	36060-36063	ESZ	_	
224-8	36064-36069	group	_	
224-9	36070-36079	exhibited	_	
224-10	36080-36091	significant	_	
224-11	36092-36103	alterations	_	
224-12	36104-36112	compared	_	
224-13	36113-36115	to	_	
224-14	36116-36120	both	_	
224-15	36121-36123	HC	_	
224-16	36124-36127	and	_	
224-17	36128-36131	CHR	_	
224-18	36132-36138	groups	_	
224-19	36139-36141	in	_	
224-20	36142-36146	some	_	
224-21	36147-36150	FCs	_	
224-22	36150-36151	,	_	
224-23	36152-36157	which	_	
224-24	36158-36167	primarily	_	
224-25	36168-36176	involved	_	
224-26	36177-36180	the	_	
224-27	36181-36198	within-cerebellum	_	
224-28	36199-36210	connections	_	
224-29	36210-36211	,	_	
224-30	36212-36215	the	_	
224-31	36216-36227	connections	_	
224-32	36228-36235	between	_	
224-33	36236-36243	frontal	_	
224-34	36244-36248	gyri	_	
224-35	36249-36252	and	_	
224-36	36253-36261	thalamus	_	
224-37	36261-36262	,	_	
224-38	36263-36265	as	_	
224-39	36266-36270	well	_	
224-40	36271-36273	as	_	
224-41	36274-36277	the	_	
224-42	36278-36289	connections	_	
224-43	36290-36297	between	_	
224-44	36298-36306	temporal	_	
224-45	36307-36311	gyri	_	
224-46	36312-36315	and	_	
224-47	36316-36326	cerebellum	_	
224-48	36326-36327	.	_	

#Text=So, these abnormalities may not be apparent until early in the course of schizophrenia.
225-1	36328-36330	So	_	
225-2	36330-36331	,	_	
225-3	36332-36337	these	_	
225-4	36338-36351	abnormalities	_	
225-5	36352-36355	may	_	
225-6	36356-36359	not	_	
225-7	36360-36362	be	_	
225-8	36363-36371	apparent	_	
225-9	36372-36377	until	_	
225-10	36378-36383	early	_	
225-11	36384-36386	in	_	
225-12	36387-36390	the	_	
225-13	36391-36397	course	_	
225-14	36398-36400	of	_	
225-15	36401-36414	schizophrenia	_	
225-16	36414-36415	.	_	

#Text=Measured by the mean connectivity strength, the within-cerebellum connections as well as the connections between the frontal gyri and the thalamus showed a decreased trend from the HC group to the CHR group to the ESZ group, while the connections between the temporal gyri and the cerebellum increased across the three groups.
226-1	36416-36424	Measured	_	
226-2	36425-36427	by	_	
226-3	36428-36431	the	_	
226-4	36432-36436	mean	_	
226-5	36437-36449	connectivity	_	
226-6	36450-36458	strength	_	
226-7	36458-36459	,	_	
226-8	36460-36463	the	_	
226-9	36464-36481	within-cerebellum	_	
226-10	36482-36493	connections	_	
226-11	36494-36496	as	_	
226-12	36497-36501	well	_	
226-13	36502-36504	as	_	
226-14	36505-36508	the	_	
226-15	36509-36520	connections	_	
226-16	36521-36528	between	_	
226-17	36529-36532	the	_	
226-18	36533-36540	frontal	_	
226-19	36541-36545	gyri	_	
226-20	36546-36549	and	_	
226-21	36550-36553	the	_	
226-22	36554-36562	thalamus	_	
226-23	36563-36569	showed	_	
226-24	36570-36571	a	_	
226-25	36572-36581	decreased	_	
226-26	36582-36587	trend	_	
226-27	36588-36592	from	_	
226-28	36593-36596	the	_	
226-29	36597-36599	HC	_	
226-30	36600-36605	group	_	
226-31	36606-36608	to	_	
226-32	36609-36612	the	_	
226-33	36613-36616	CHR	_	
226-34	36617-36622	group	_	
226-35	36623-36625	to	_	
226-36	36626-36629	the	_	
226-37	36630-36633	ESZ	_	
226-38	36634-36639	group	_	
226-39	36639-36640	,	_	
226-40	36641-36646	while	_	
226-41	36647-36650	the	_	
226-42	36651-36662	connections	_	
226-43	36663-36670	between	_	
226-44	36671-36674	the	_	
226-45	36675-36683	temporal	_	
226-46	36684-36688	gyri	_	
226-47	36689-36692	and	_	
226-48	36693-36696	the	_	
226-49	36697-36707	cerebellum	_	
226-50	36708-36717	increased	_	
226-51	36718-36724	across	_	
226-52	36725-36728	the	_	
226-53	36729-36734	three	_	
226-54	36735-36741	groups	_	
226-55	36741-36742	.	_	

#Text=Previous work also showed hypoconnectivity in CHR individuals between thalamus and prefrontal areas, which is more prominent in those who converted to full-blown illness.
227-1	36743-36751	Previous	_	
227-2	36752-36756	work	_	
227-3	36757-36761	also	_	
227-4	36762-36768	showed	_	
227-5	36769-36785	hypoconnectivity	_	
227-6	36786-36788	in	_	
227-7	36789-36792	CHR	_	
227-8	36793-36804	individuals	_	
227-9	36805-36812	between	_	
227-10	36813-36821	thalamus	_	
227-11	36822-36825	and	_	
227-12	36826-36836	prefrontal	_	
227-13	36837-36842	areas	_	
227-14	36842-36843	,	_	
227-15	36844-36849	which	_	
227-16	36850-36852	is	_	
227-17	36853-36857	more	_	
227-18	36858-36867	prominent	_	
227-19	36868-36870	in	_	
227-20	36871-36876	those	_	
227-21	36877-36880	who	_	
227-22	36881-36890	converted	_	
227-23	36891-36893	to	_	
227-24	36894-36904	full-blown	_	
227-25	36905-36912	illness	_	
227-26	36912-36913	.	_	

#Text=Especially, five cerebellar crus related connections linking the cerebellar crus and the temporal lobe showed negative strengths in HC and CHR groups, but showed significant impairments (loss of negative connectivity) in ESZ group tested by two-sample t-tests.
228-1	36914-36924	Especially	_	
228-2	36924-36925	,	_	
228-3	36926-36930	five	_	
228-4	36931-36941	cerebellar	_	
228-5	36942-36946	crus	_	
228-6	36947-36954	related	_	
228-7	36955-36966	connections	_	
228-8	36967-36974	linking	_	
228-9	36975-36978	the	_	
228-10	36979-36989	cerebellar	_	
228-11	36990-36994	crus	_	
228-12	36995-36998	and	_	
228-13	36999-37002	the	_	
228-14	37003-37011	temporal	_	
228-15	37012-37016	lobe	_	
228-16	37017-37023	showed	_	
228-17	37024-37032	negative	_	
228-18	37033-37042	strengths	_	
228-19	37043-37045	in	_	
228-20	37046-37048	HC	_	
228-21	37049-37052	and	_	
228-22	37053-37056	CHR	_	
228-23	37057-37063	groups	_	
228-24	37063-37064	,	_	
228-25	37065-37068	but	_	
228-26	37069-37075	showed	_	
228-27	37076-37087	significant	_	
228-28	37088-37099	impairments	_	
228-29	37100-37101	(	_	
228-30	37101-37105	loss	_	
228-31	37106-37108	of	_	
228-32	37109-37117	negative	_	
228-33	37118-37130	connectivity	_	
228-34	37130-37131	)	_	
228-35	37132-37134	in	_	
228-36	37135-37138	ESZ	_	
228-37	37139-37144	group	_	
228-38	37145-37151	tested	_	
228-39	37152-37154	by	_	
228-40	37155-37165	two-sample	_	
228-41	37166-37173	t-tests	_	
228-42	37173-37174	.	_	

#Text=Habas et al have shown that cerebellar crus I and II make a significant contribution to parallel cortico-cerebellar loops that are involved in executive control, salience detection, episodic memory and self-reflection.
229-1	37175-37180	Habas	_	
229-2	37181-37183	et	_	
229-3	37184-37186	al	_	
229-4	37187-37191	have	_	
229-5	37192-37197	shown	_	
229-6	37198-37202	that	_	
229-7	37203-37213	cerebellar	_	
229-8	37214-37218	crus	_	
229-9	37219-37220	I	_	
229-10	37221-37224	and	_	
229-11	37225-37227	II	_	
229-12	37228-37232	make	_	
229-13	37233-37234	a	_	
229-14	37235-37246	significant	_	
229-15	37247-37259	contribution	_	
229-16	37260-37262	to	_	
229-17	37263-37271	parallel	_	
229-18	37272-37290	cortico-cerebellar	_	
229-19	37291-37296	loops	_	
229-20	37297-37301	that	_	
229-21	37302-37305	are	_	
229-22	37306-37314	involved	_	
229-23	37315-37317	in	_	
229-24	37318-37327	executive	_	
229-25	37328-37335	control	_	
229-26	37335-37336	,	_	
229-27	37337-37345	salience	_	
229-28	37346-37355	detection	_	
229-29	37355-37356	,	_	
229-30	37357-37365	episodic	_	
229-31	37366-37372	memory	_	
229-32	37373-37376	and	_	
229-33	37377-37392	self-reflection	_	
229-34	37392-37393	.	_	

#Text=Our findings is also consistent with misconnection in a cortico-cerebellar-thalamo-cortical (CCTC) network, underlying the pathophysiology of schizophrenia.
230-1	37394-37397	Our	_	
230-2	37398-37406	findings	_	
230-3	37407-37409	is	_	
230-4	37410-37414	also	_	
230-5	37415-37425	consistent	_	
230-6	37426-37430	with	_	
230-7	37431-37444	misconnection	_	
230-8	37445-37447	in	_	
230-9	37448-37449	a	_	
230-10	37450-37485	cortico-cerebellar-thalamo-cortical	_	
230-11	37486-37487	(	_	
230-12	37487-37491	CCTC	_	
230-13	37491-37492	)	_	
230-14	37493-37500	network	_	
230-15	37500-37501	,	_	
230-16	37502-37512	underlying	_	
230-17	37513-37516	the	_	
230-18	37517-37532	pathophysiology	_	
230-19	37533-37535	of	_	
230-20	37536-37549	schizophrenia	_	
230-21	37549-37550	.	_	

#Text=Furthermore, CHR and ESZ groups shared common impairments with respect to 12 connections that were mainly associated with the supplementary motor area, parahippocampal gyrus, temporal cortex, postcentral gyrus, cerebellum, frontal gyrus, and thalamus.
231-1	37551-37562	Furthermore	_	
231-2	37562-37563	,	_	
231-3	37564-37567	CHR	_	
231-4	37568-37571	and	_	
231-5	37572-37575	ESZ	_	
231-6	37576-37582	groups	_	
231-7	37583-37589	shared	_	
231-8	37590-37596	common	_	
231-9	37597-37608	impairments	_	
231-10	37609-37613	with	_	
231-11	37614-37621	respect	_	
231-12	37622-37624	to	_	
231-13	37625-37627	12	_	
231-14	37628-37639	connections	_	
231-15	37640-37644	that	_	
231-16	37645-37649	were	_	
231-17	37650-37656	mainly	_	
231-18	37657-37667	associated	_	
231-19	37668-37672	with	_	
231-20	37673-37676	the	_	
231-21	37677-37690	supplementary	_	
231-22	37691-37696	motor	_	
231-23	37697-37701	area	_	
231-24	37701-37702	,	_	
231-25	37703-37718	parahippocampal	_	
231-26	37719-37724	gyrus	_	
231-27	37724-37725	,	_	
231-28	37726-37734	temporal	_	
231-29	37735-37741	cortex	_	
231-30	37741-37742	,	_	
231-31	37743-37754	postcentral	_	
231-32	37755-37760	gyrus	_	
231-33	37760-37761	,	_	
231-34	37762-37772	cerebellum	_	
231-35	37772-37773	,	_	
231-36	37774-37781	frontal	_	
231-37	37782-37787	gyrus	_	
231-38	37787-37788	,	_	
231-39	37789-37792	and	_	
231-40	37793-37801	thalamus	_	
231-41	37801-37802	.	_	

#Text=In these connections, 9 connections showed a deceasing trend in strength in the CHR and ESZ groups than the HC group, while 3 connections had an increasing trend in the CHR and ESZ groups compared to the HC group.
232-1	37803-37805	In	_	
232-2	37806-37811	these	_	
232-3	37812-37823	connections	_	
232-4	37823-37824	,	_	
232-5	37825-37826	9	_	
232-6	37827-37838	connections	_	
232-7	37839-37845	showed	_	
232-8	37846-37847	a	_	
232-9	37848-37857	deceasing	_	
232-10	37858-37863	trend	_	
232-11	37864-37866	in	_	
232-12	37867-37875	strength	_	
232-13	37876-37878	in	_	
232-14	37879-37882	the	_	
232-15	37883-37886	CHR	_	
232-16	37887-37890	and	_	
232-17	37891-37894	ESZ	_	
232-18	37895-37901	groups	_	
232-19	37902-37906	than	_	
232-20	37907-37910	the	_	
232-21	37911-37913	HC	_	
232-22	37914-37919	group	_	
232-23	37919-37920	,	_	
232-24	37921-37926	while	_	
232-25	37927-37928	3	_	
232-26	37929-37940	connections	_	
232-27	37941-37944	had	_	
232-28	37945-37947	an	_	
232-29	37948-37958	increasing	_	
232-30	37959-37964	trend	_	
232-31	37965-37967	in	_	
232-32	37968-37971	the	_	
232-33	37972-37975	CHR	_	
232-34	37976-37979	and	_	
232-35	37980-37983	ESZ	_	
232-36	37984-37990	groups	_	
232-37	37991-37999	compared	_	
232-38	38000-38002	to	_	
232-39	38003-38006	the	_	
232-40	38007-38009	HC	_	
232-41	38010-38015	group	_	
232-42	38015-38016	.	_	

#Text=Specifically, compared to the HC group, CHR and ESZ groups showed enhanced negative connectivity strengths between the right middle frontal gyrus (including orbital part) and the right thalamus, and diminished positive connectivity strengths between the left/right parahippocampal gyrus and the right temporal pole.
233-1	38017-38029	Specifically	_	
233-2	38029-38030	,	_	
233-3	38031-38039	compared	_	
233-4	38040-38042	to	_	
233-5	38043-38046	the	_	
233-6	38047-38049	HC	_	
233-7	38050-38055	group	_	
233-8	38055-38056	,	_	
233-9	38057-38060	CHR	_	
233-10	38061-38064	and	_	
233-11	38065-38068	ESZ	_	
233-12	38069-38075	groups	_	
233-13	38076-38082	showed	_	
233-14	38083-38091	enhanced	_	
233-15	38092-38100	negative	_	
233-16	38101-38113	connectivity	_	
233-17	38114-38123	strengths	_	
233-18	38124-38131	between	_	
233-19	38132-38135	the	_	
233-20	38136-38141	right	_	
233-21	38142-38148	middle	_	
233-22	38149-38156	frontal	_	
233-23	38157-38162	gyrus	_	
233-24	38163-38164	(	_	
233-25	38164-38173	including	_	
233-26	38174-38181	orbital	_	
233-27	38182-38186	part	_	
233-28	38186-38187	)	_	
233-29	38188-38191	and	_	
233-30	38192-38195	the	_	
233-31	38196-38201	right	_	
233-32	38202-38210	thalamus	_	
233-33	38210-38211	,	_	
233-34	38212-38215	and	_	
233-35	38216-38226	diminished	_	
233-36	38227-38235	positive	_	
233-37	38236-38248	connectivity	_	
233-38	38249-38258	strengths	_	
233-39	38259-38266	between	_	
233-40	38267-38270	the	_	
233-41	38271-38275	left	_	
233-42	38275-38276	/	_	
233-43	38276-38281	right	_	
233-44	38282-38297	parahippocampal	_	
233-45	38298-38303	gyrus	_	
233-46	38304-38307	and	_	
233-47	38308-38311	the	_	
233-48	38312-38317	right	_	
233-49	38318-38326	temporal	_	
233-50	38327-38331	pole	_	
233-51	38331-38332	.	_	

#Text=In addition, CHR and ESZ groups also had enhanced negative functional connectivity strengths between the right supplementary motor area and left parahippocampal gyrus as well as between the right supplementary motor area and the left temporal pole (middle temporal gyrus).
234-1	38333-38335	In	_	
234-2	38336-38344	addition	_	
234-3	38344-38345	,	_	
234-4	38346-38349	CHR	_	
234-5	38350-38353	and	_	
234-6	38354-38357	ESZ	_	
234-7	38358-38364	groups	_	
234-8	38365-38369	also	_	
234-9	38370-38373	had	_	
234-10	38374-38382	enhanced	_	
234-11	38383-38391	negative	_	
234-12	38392-38402	functional	_	
234-13	38403-38415	connectivity	_	
234-14	38416-38425	strengths	_	
234-15	38426-38433	between	_	
234-16	38434-38437	the	_	
234-17	38438-38443	right	_	
234-18	38444-38457	supplementary	_	
234-19	38458-38463	motor	_	
234-20	38464-38468	area	_	
234-21	38469-38472	and	_	
234-22	38473-38477	left	_	
234-23	38478-38493	parahippocampal	_	
234-24	38494-38499	gyrus	_	
234-25	38500-38502	as	_	
234-26	38503-38507	well	_	
234-27	38508-38510	as	_	
234-28	38511-38518	between	_	
234-29	38519-38522	the	_	
234-30	38523-38528	right	_	
234-31	38529-38542	supplementary	_	
234-32	38543-38548	motor	_	
234-33	38549-38553	area	_	
234-34	38554-38557	and	_	
234-35	38558-38561	the	_	
234-36	38562-38566	left	_	
234-37	38567-38575	temporal	_	
234-38	38576-38580	pole	_	
234-39	38581-38582	(	_	
234-40	38582-38588	middle	_	
234-41	38589-38597	temporal	_	
234-42	38598-38603	gyrus	_	
234-43	38603-38604	)	_	
234-44	38604-38605	.	_	

#Text=These abnormalities may reflect the vulnerability to develop psychosis irrespective of whether a psychotic disorder has actually developed.
235-1	38606-38611	These	_	
235-2	38612-38625	abnormalities	_	
235-3	38626-38629	may	_	
235-4	38630-38637	reflect	_	
235-5	38638-38641	the	_	
235-6	38642-38655	vulnerability	_	
235-7	38656-38658	to	_	
235-8	38659-38666	develop	_	
235-9	38667-38676	psychosis	_	
235-10	38677-38689	irrespective	_	
235-11	38690-38692	of	_	
235-12	38693-38700	whether	_	
235-13	38701-38702	a	_	
235-14	38703-38712	psychotic	_	
235-15	38713-38721	disorder	_	
235-16	38722-38725	has	_	
235-17	38726-38734	actually	_	
235-18	38735-38744	developed	_	
235-19	38744-38745	.	_	

#Text=Additionally, the CHR group also exhibited a group-specific abnormality in the connections between the medial part of the superior frontal gyrus and the calcarine cortex.
236-1	38746-38758	Additionally	_	
236-2	38758-38759	,	_	
236-3	38760-38763	the	_	
236-4	38764-38767	CHR	_	
236-5	38768-38773	group	_	
236-6	38774-38778	also	_	
236-7	38779-38788	exhibited	_	
236-8	38789-38790	a	_	
236-9	38791-38805	group-specific	_	
236-10	38806-38817	abnormality	_	
236-11	38818-38820	in	_	
236-12	38821-38824	the	_	
236-13	38825-38836	connections	_	
236-14	38837-38844	between	_	
236-15	38845-38848	the	_	
236-16	38849-38855	medial	_	
236-17	38856-38860	part	_	
236-18	38861-38863	of	_	
236-19	38864-38867	the	_	
236-20	38868-38876	superior	_	
236-21	38877-38884	frontal	_	
236-22	38885-38890	gyrus	_	
236-23	38891-38894	and	_	
236-24	38895-38898	the	_	
236-25	38899-38908	calcarine	_	
236-26	38909-38915	cortex	_	
236-27	38915-38916	.	_	

#Text=Furthermore, FC-symptom correlations supported the clinical relevance of three connections.
237-1	38917-38928	Furthermore	_	
237-2	38928-38929	,	_	
237-3	38930-38940	FC-symptom	_	
237-4	38941-38953	correlations	_	
237-5	38954-38963	supported	_	
237-6	38964-38967	the	_	
237-7	38968-38976	clinical	_	
237-8	38977-38986	relevance	_	
237-9	38987-38989	of	_	
237-10	38990-38995	three	_	
237-11	38996-39007	connections	_	
237-12	39007-39008	.	_	

#Text=Two hypoconnectivities (with decreasing strength across the HC, CHR and ESZ groups) between right supplementary motor area and left parahippocampal gyrus and between right parahippocampal gyrus and right temporal pole were negatively correlated with SOPS positive symptom scores in CHR individuals.
238-1	39009-39012	Two	_	
238-2	39013-39031	hypoconnectivities	_	
238-3	39032-39033	(	_	
238-4	39033-39037	with	_	
238-5	39038-39048	decreasing	_	
238-6	39049-39057	strength	_	
238-7	39058-39064	across	_	
238-8	39065-39068	the	_	
238-9	39069-39071	HC	_	
238-10	39071-39072	,	_	
238-11	39073-39076	CHR	_	
238-12	39077-39080	and	_	
238-13	39081-39084	ESZ	_	
238-14	39085-39091	groups	_	
238-15	39091-39092	)	_	
238-16	39093-39100	between	_	
238-17	39101-39106	right	_	
238-18	39107-39120	supplementary	_	
238-19	39121-39126	motor	_	
238-20	39127-39131	area	_	
238-21	39132-39135	and	_	
238-22	39136-39140	left	_	
238-23	39141-39156	parahippocampal	_	
238-24	39157-39162	gyrus	_	
238-25	39163-39166	and	_	
238-26	39167-39174	between	_	
238-27	39175-39180	right	_	
238-28	39181-39196	parahippocampal	_	
238-29	39197-39202	gyrus	_	
238-30	39203-39206	and	_	
238-31	39207-39212	right	_	
238-32	39213-39221	temporal	_	
238-33	39222-39226	pole	_	
238-34	39227-39231	were	_	
238-35	39232-39242	negatively	_	
238-36	39243-39253	correlated	_	
238-37	39254-39258	with	_	
238-38	39259-39263	SOPS	_	
238-39	39264-39272	positive	_	
238-40	39273-39280	symptom	_	
238-41	39281-39287	scores	_	
238-42	39288-39290	in	_	
238-43	39291-39294	CHR	_	
238-44	39295-39306	individuals	_	
238-45	39306-39307	.	_	

#Text=One hyperconnectivity (with increasing strength from the HC group to CHR group to ESZ group) linking right temporal pole and left cerebellum was positively correlated with PANSS negative symptom scores in ESZ patients.
239-1	39308-39311	One	_	
239-2	39312-39329	hyperconnectivity	_	
239-3	39330-39331	(	_	
239-4	39331-39335	with	_	
239-5	39336-39346	increasing	_	
239-6	39347-39355	strength	_	
239-7	39356-39360	from	_	
239-8	39361-39364	the	_	
239-9	39365-39367	HC	_	
239-10	39368-39373	group	_	
239-11	39374-39376	to	_	
239-12	39377-39380	CHR	_	
239-13	39381-39386	group	_	
239-14	39387-39389	to	_	
239-15	39390-39393	ESZ	_	
239-16	39394-39399	group	_	
239-17	39399-39400	)	_	
239-18	39401-39408	linking	_	
239-19	39409-39414	right	_	
239-20	39415-39423	temporal	_	
239-21	39424-39428	pole	_	
239-22	39429-39432	and	_	
239-23	39433-39437	left	_	
239-24	39438-39448	cerebellum	_	
239-25	39449-39452	was	_	
239-26	39453-39463	positively	_	
239-27	39464-39474	correlated	_	
239-28	39475-39479	with	_	
239-29	39480-39485	PANSS	_	
239-30	39486-39494	negative	_	
239-31	39495-39502	symptom	_	
239-32	39503-39509	scores	_	
239-33	39510-39512	in	_	
239-34	39513-39516	ESZ	_	
239-35	39517-39525	patients	_	
239-36	39525-39526	.	_	

#Text=Moreover, since DFC can discover multiple inherent connectivity states, our findings suggested that the non-dominant group-specific connectivity states including GS 2, GS 3, GS 4 and GS 5 showed a more similar pattern between the CHR group and ESZ group than between the HC group and CHR (or ESZ) group, indicating that these states could be disease-related.
240-1	39527-39535	Moreover	_	
240-2	39535-39536	,	_	
240-3	39537-39542	since	_	
240-4	39543-39546	DFC	_	
240-5	39547-39550	can	_	
240-6	39551-39559	discover	_	
240-7	39560-39568	multiple	_	
240-8	39569-39577	inherent	_	
240-9	39578-39590	connectivity	_	
240-10	39591-39597	states	_	
240-11	39597-39598	,	_	
240-12	39599-39602	our	_	
240-13	39603-39611	findings	_	
240-14	39612-39621	suggested	_	
240-15	39622-39626	that	_	
240-16	39627-39630	the	_	
240-17	39631-39643	non-dominant	_	
240-18	39644-39658	group-specific	_	
240-19	39659-39671	connectivity	_	
240-20	39672-39678	states	_	
240-21	39679-39688	including	_	
240-22	39689-39691	GS	_	
240-23	39692-39693	2	_	
240-24	39693-39694	,	_	
240-25	39695-39697	GS	_	
240-26	39698-39699	3	_	
240-27	39699-39700	,	_	
240-28	39701-39703	GS	_	
240-29	39704-39705	4	_	
240-30	39706-39709	and	_	
240-31	39710-39712	GS	_	
240-32	39713-39714	5	_	
240-33	39715-39721	showed	_	
240-34	39722-39723	a	_	
240-35	39724-39728	more	_	
240-36	39729-39736	similar	_	
240-37	39737-39744	pattern	_	
240-38	39745-39752	between	_	
240-39	39753-39756	the	_	
240-40	39757-39760	CHR	_	
240-41	39761-39766	group	_	
240-42	39767-39770	and	_	
240-43	39771-39774	ESZ	_	
240-44	39775-39780	group	_	
240-45	39781-39785	than	_	
240-46	39786-39793	between	_	
240-47	39794-39797	the	_	
240-48	39798-39800	HC	_	
240-49	39801-39806	group	_	
240-50	39807-39810	and	_	
240-51	39811-39814	CHR	_	
240-52	39815-39816	(	_	
240-53	39816-39818	or	_	
240-54	39819-39822	ESZ	_	
240-55	39822-39823	)	_	
240-56	39824-39829	group	_	
240-57	39829-39830	,	_	
240-58	39831-39841	indicating	_	
240-59	39842-39846	that	_	
240-60	39847-39852	these	_	
240-61	39853-39859	states	_	
240-62	39860-39865	could	_	
240-63	39866-39868	be	_	
240-64	39869-39884	disease-related	_	
240-65	39884-39885	.	_	

#Text=In our study, we applied GIG-ICA to dynamic connectivity of each group separately in order to estimate the group-specific connectivity states.
241-1	39886-39888	In	_	
241-2	39889-39892	our	_	
241-3	39893-39898	study	_	
241-4	39898-39899	,	_	
241-5	39900-39902	we	_	
241-6	39903-39910	applied	_	
241-7	39911-39918	GIG-ICA	_	
241-8	39919-39921	to	_	
241-9	39922-39929	dynamic	_	
241-10	39930-39942	connectivity	_	
241-11	39943-39945	of	_	
241-12	39946-39950	each	_	
241-13	39951-39956	group	_	
241-14	39957-39967	separately	_	
241-15	39968-39970	in	_	
241-16	39971-39976	order	_	
241-17	39977-39979	to	_	
241-18	39980-39988	estimate	_	
241-19	39989-39992	the	_	
241-20	39993-40007	group-specific	_	
241-21	40008-40020	connectivity	_	
241-22	40021-40027	states	_	
241-23	40027-40028	.	_	

#Text=Our results using the permutation test support that the identified group differences in the dominant state are valid.
242-1	40029-40032	Our	_	
242-2	40033-40040	results	_	
242-3	40041-40046	using	_	
242-4	40047-40050	the	_	
242-5	40051-40062	permutation	_	
242-6	40063-40067	test	_	
242-7	40068-40075	support	_	
242-8	40076-40080	that	_	
242-9	40081-40084	the	_	
242-10	40085-40095	identified	_	
242-11	40096-40101	group	_	
242-12	40102-40113	differences	_	
242-13	40114-40116	in	_	
242-14	40117-40120	the	_	
242-15	40121-40129	dominant	_	
242-16	40130-40135	state	_	
242-17	40136-40139	are	_	
242-18	40140-40145	valid	_	
242-19	40145-40146	.	_	

#Text=In the supplementary materials, we also report the results obtained from performing GIG-ICA on the temporally concatenated dynamic connectivity of all subjects of the three groups to estimate the group-level and then subject-level connectivity states.
243-1	40147-40149	In	_	
243-2	40150-40153	the	_	
243-3	40154-40167	supplementary	_	
243-4	40168-40177	materials	_	
243-5	40177-40178	,	_	
243-6	40179-40181	we	_	
243-7	40182-40186	also	_	
243-8	40187-40193	report	_	
243-9	40194-40197	the	_	
243-10	40198-40205	results	_	
243-11	40206-40214	obtained	_	
243-12	40215-40219	from	_	
243-13	40220-40230	performing	_	
243-14	40231-40238	GIG-ICA	_	
243-15	40239-40241	on	_	
243-16	40242-40245	the	_	
243-17	40246-40256	temporally	_	
243-18	40257-40269	concatenated	_	
243-19	40270-40277	dynamic	_	
243-20	40278-40290	connectivity	_	
243-21	40291-40293	of	_	
243-22	40294-40297	all	_	
243-23	40298-40306	subjects	_	
243-24	40307-40309	of	_	
243-25	40310-40313	the	_	
243-26	40314-40319	three	_	
243-27	40320-40326	groups	_	
243-28	40327-40329	to	_	
243-29	40330-40338	estimate	_	
243-30	40339-40342	the	_	
243-31	40343-40354	group-level	_	
243-32	40355-40358	and	_	
243-33	40359-40363	then	_	
243-34	40364-40377	subject-level	_	
243-35	40378-40390	connectivity	_	
243-36	40391-40397	states	_	
243-37	40397-40398	.	_	

#Text=Fig.
244-1	40399-40402	Fig	_	
244-2	40402-40403	.	_	

#Text=S3A–B indicate that the five reliable group-level connectivity states estimated from all subjects of the three groups showed comparable patterns with the states estimated from seprate group.
245-1	40404-40409	S3A–B	_	
245-2	40410-40418	indicate	_	
245-3	40419-40423	that	_	
245-4	40424-40427	the	_	
245-5	40428-40432	five	_	
245-6	40433-40441	reliable	_	
245-7	40442-40453	group-level	_	
245-8	40454-40466	connectivity	_	
245-9	40467-40473	states	_	
245-10	40474-40483	estimated	_	
245-11	40484-40488	from	_	
245-12	40489-40492	all	_	
245-13	40493-40501	subjects	_	
245-14	40502-40504	of	_	
245-15	40505-40508	the	_	
245-16	40509-40514	three	_	
245-17	40515-40521	groups	_	
245-18	40522-40528	showed	_	
245-19	40529-40539	comparable	_	
245-20	40540-40548	patterns	_	
245-21	40549-40553	with	_	
245-22	40554-40557	the	_	
245-23	40558-40564	states	_	
245-24	40565-40574	estimated	_	
245-25	40575-40579	from	_	
245-26	40580-40587	seprate	_	
245-27	40588-40593	group	_	
245-28	40593-40594	.	_	

#Text=Furthermore, the p-values in ANCOVA of all connections (Fig.
246-1	40595-40606	Furthermore	_	
246-2	40606-40607	,	_	
246-3	40608-40611	the	_	
246-4	40612-40620	p-values	_	
246-5	40621-40623	in	_	
246-6	40624-40630	ANCOVA	_	
246-7	40631-40633	of	_	
246-8	40634-40637	all	_	
246-9	40638-40649	connections	_	
246-10	40650-40651	(	_	
246-11	40651-40654	Fig	_	
246-12	40654-40655	.	_	

#Text=S3C) had a similar pattern to the p-values that were calculated based on the dominant SSs obtained from performing separate GIG-ICA on each group.
247-1	40656-40659	S3C	_	
247-2	40659-40660	)	_	
247-3	40661-40664	had	_	
247-4	40665-40666	a	_	
247-5	40667-40674	similar	_	
247-6	40675-40682	pattern	_	
247-7	40683-40685	to	_	
247-8	40686-40689	the	_	
247-9	40690-40698	p-values	_	
247-10	40699-40703	that	_	
247-11	40704-40708	were	_	
247-12	40709-40719	calculated	_	
247-13	40720-40725	based	_	
247-14	40726-40728	on	_	
247-15	40729-40732	the	_	
247-16	40733-40741	dominant	_	
247-17	40742-40745	SSs	_	
247-18	40746-40754	obtained	_	
247-19	40755-40759	from	_	
247-20	40760-40770	performing	_	
247-21	40771-40779	separate	_	
247-22	40780-40787	GIG-ICA	_	
247-23	40788-40790	on	_	
247-24	40791-40795	each	_	
247-25	40796-40801	group	_	
247-26	40801-40802	.	_	

#Text=Among the FCs with group differences (p < 0.0005) shown in Fig.
248-1	40803-40808	Among	_	
248-2	40809-40812	the	_	
248-3	40813-40816	FCs	_	
248-4	40817-40821	with	_	
248-5	40822-40827	group	_	
248-6	40828-40839	differences	_	
248-7	40840-40841	(	_	
248-8	40841-40842	p	_	
248-9	40843-40844	<	_	
248-10	40845-40851	0.0005	_	
248-11	40851-40852	)	_	
248-12	40853-40858	shown	_	
248-13	40859-40861	in	_	
248-14	40862-40865	Fig	_	
248-15	40865-40866	.	_	

#Text=S3D, 24 FCs were overlapping with the 30 FCs identified using the separate GIG-ICA one each group.
249-1	40867-40870	S3D	_	
249-2	40870-40871	,	_	
249-3	40872-40874	24	_	
249-4	40875-40878	FCs	_	
249-5	40879-40883	were	_	
249-6	40884-40895	overlapping	_	
249-7	40896-40900	with	_	
249-8	40901-40904	the	_	
249-9	40905-40907	30	_	
249-10	40908-40911	FCs	_	
249-11	40912-40922	identified	_	
249-12	40923-40928	using	_	
249-13	40929-40932	the	_	
249-14	40933-40941	separate	_	
249-15	40942-40949	GIG-ICA	_	
249-16	40950-40953	one	_	
249-17	40954-40958	each	_	
249-18	40959-40964	group	_	
249-19	40964-40965	.	_	

#Text=The ANCOVA results of the 24 FCs are included in Table S4.
250-1	40966-40969	The	_	
250-2	40970-40976	ANCOVA	_	
250-3	40977-40984	results	_	
250-4	40985-40987	of	_	
250-5	40988-40991	the	_	
250-6	40992-40994	24	_	
250-7	40995-40998	FCs	_	
250-8	40999-41002	are	_	
250-9	41003-41011	included	_	
250-10	41012-41014	in	_	
250-11	41015-41020	Table	_	
250-12	41021-41023	S4	_	
250-13	41023-41024	.	_	

#Text=For each of the 24 FCs, the inter-group differences between any pair of groups (supplementary Fig.
251-1	41025-41028	For	_	
251-2	41029-41033	each	_	
251-3	41034-41036	of	_	
251-4	41037-41040	the	_	
251-5	41041-41043	24	_	
251-6	41044-41047	FCs	_	
251-7	41047-41048	,	_	
251-8	41049-41052	the	_	
251-9	41053-41064	inter-group	_	
251-10	41065-41076	differences	_	
251-11	41077-41084	between	_	
251-12	41085-41088	any	_	
251-13	41089-41093	pair	_	
251-14	41094-41096	of	_	
251-15	41097-41103	groups	_	
251-16	41104-41105	(	_	
251-17	41105-41118	supplementary	_	
251-18	41119-41122	Fig	_	
251-19	41122-41123	.	_	

#Text=S4) were highly consistent to that found using the separate GIG-ICA.
252-1	41124-41126	S4	_	
252-2	41126-41127	)	_	
252-3	41128-41132	were	_	
252-4	41133-41139	highly	_	
252-5	41140-41150	consistent	_	
252-6	41151-41153	to	_	
252-7	41154-41158	that	_	
252-8	41159-41164	found	_	
252-9	41165-41170	using	_	
252-10	41171-41174	the	_	
252-11	41175-41183	separate	_	
252-12	41184-41191	GIG-ICA	_	
252-13	41191-41192	.	_	

#Text=The present work has several limitations. (1) We lack sufficient clinical follow-up of CHR individuals to permit evaluation of whether DFC abnormalities predict conversion to psychosis.
253-1	41193-41196	The	_	
253-2	41197-41204	present	_	
253-3	41205-41209	work	_	
253-4	41210-41213	has	_	
253-5	41214-41221	several	_	
253-6	41222-41233	limitations	_	
253-7	41233-41234	.	_	
253-8	41235-41236	(	_	
253-9	41236-41237	1	_	
253-10	41237-41238	)	_	
253-11	41239-41241	We	_	
253-12	41242-41246	lack	_	
253-13	41247-41257	sufficient	_	
253-14	41258-41266	clinical	_	
253-15	41267-41276	follow-up	_	
253-16	41277-41279	of	_	
253-17	41280-41283	CHR	_	
253-18	41284-41295	individuals	_	
253-19	41296-41298	to	_	
253-20	41299-41305	permit	_	
253-21	41306-41316	evaluation	_	
253-22	41317-41319	of	_	
253-23	41320-41327	whether	_	
253-24	41328-41331	DFC	_	
253-25	41332-41345	abnormalities	_	
253-26	41346-41353	predict	_	
253-27	41354-41364	conversion	_	
253-28	41365-41367	to	_	
253-29	41368-41377	psychosis	_	
253-30	41377-41378	.	_	

#Text=However, our framework can be potentially applied for individual-subject classification (or prediction) in future work where the clinical follow-up data of CHR subjects are available.
254-1	41379-41386	However	_	
254-2	41386-41387	,	_	
254-3	41388-41391	our	_	
254-4	41392-41401	framework	_	
254-5	41402-41405	can	_	
254-6	41406-41408	be	_	
254-7	41409-41420	potentially	_	
254-8	41421-41428	applied	_	
254-9	41429-41432	for	_	
254-10	41433-41451	individual-subject	_	
254-11	41452-41466	classification	_	
254-12	41467-41468	(	_	
254-13	41468-41470	or	_	
254-14	41471-41481	prediction	_	
254-15	41481-41482	)	_	
254-16	41483-41485	in	_	
254-17	41486-41492	future	_	
254-18	41493-41497	work	_	
254-19	41498-41503	where	_	
254-20	41504-41507	the	_	
254-21	41508-41516	clinical	_	
254-22	41517-41526	follow-up	_	
254-23	41527-41531	data	_	
254-24	41532-41534	of	_	
254-25	41535-41538	CHR	_	
254-26	41539-41547	subjects	_	
254-27	41548-41551	are	_	
254-28	41552-41561	available	_	
254-29	41561-41562	.	_	

#Text=One possible strategy is to use features from the dominant state that shows a comparable pattern across subjects.
255-1	41563-41566	One	_	
255-2	41567-41575	possible	_	
255-3	41576-41584	strategy	_	
255-4	41585-41587	is	_	
255-5	41588-41590	to	_	
255-6	41591-41594	use	_	
255-7	41595-41603	features	_	
255-8	41604-41608	from	_	
255-9	41609-41612	the	_	
255-10	41613-41621	dominant	_	
255-11	41622-41627	state	_	
255-12	41628-41632	that	_	
255-13	41633-41638	shows	_	
255-14	41639-41640	a	_	
255-15	41641-41651	comparable	_	
255-16	41652-41659	pattern	_	
255-17	41660-41666	across	_	
255-18	41667-41675	subjects	_	
255-19	41675-41676	.	_	

#Text=Based on the altered connectivities in the dominant connectivity state, a classifier/model can be built using converted and unconverted CHR subjects’ data.
256-1	41677-41682	Based	_	
256-2	41683-41685	on	_	
256-3	41686-41689	the	_	
256-4	41690-41697	altered	_	
256-5	41698-41712	connectivities	_	
256-6	41713-41715	in	_	
256-7	41716-41719	the	_	
256-8	41720-41728	dominant	_	
256-9	41729-41741	connectivity	_	
256-10	41742-41747	state	_	
256-11	41747-41748	,	_	
256-12	41749-41750	a	_	
256-13	41751-41761	classifier	_	
256-14	41761-41762	/	_	
256-15	41762-41767	model	_	
256-16	41768-41771	can	_	
256-17	41772-41774	be	_	
256-18	41775-41780	built	_	
256-19	41781-41786	using	_	
256-20	41787-41796	converted	_	
256-21	41797-41800	and	_	
256-22	41801-41812	unconverted	_	
256-23	41813-41816	CHR	_	
256-24	41817-41825	subjects	_	
256-25	41825-41826	’	_	
256-26	41827-41831	data	_	
256-27	41831-41832	.	_	

#Text=Then, for a new/testing CHR subject, the related dominant subject-specific connectivity state can be computed from the individual-subject’s dynamic connectivity patterns.
257-1	41833-41837	Then	_	
257-2	41837-41838	,	_	
257-3	41839-41842	for	_	
257-4	41843-41844	a	_	
257-5	41845-41848	new	_	
257-6	41848-41849	/	_	
257-7	41849-41856	testing	_	
257-8	41857-41860	CHR	_	
257-9	41861-41868	subject	_	
257-10	41868-41869	,	_	
257-11	41870-41873	the	_	
257-12	41874-41881	related	_	
257-13	41882-41890	dominant	_	
257-14	41891-41907	subject-specific	_	
257-15	41908-41920	connectivity	_	
257-16	41921-41926	state	_	
257-17	41927-41930	can	_	
257-18	41931-41933	be	_	
257-19	41934-41942	computed	_	
257-20	41943-41947	from	_	
257-21	41948-41951	the	_	
257-22	41952-41970	individual-subject	_	
257-23	41970-41971	’	_	
257-24	41971-41972	s	_	
257-25	41973-41980	dynamic	_	
257-26	41981-41993	connectivity	_	
257-27	41994-42002	patterns	_	
257-28	42002-42003	.	_	

#Text=Finally, the new CHR subject with features from its dominant state can be classified by the well-trained model.
258-1	42004-42011	Finally	_	
258-2	42011-42012	,	_	
258-3	42013-42016	the	_	
258-4	42017-42020	new	_	
258-5	42021-42024	CHR	_	
258-6	42025-42032	subject	_	
258-7	42033-42037	with	_	
258-8	42038-42046	features	_	
258-9	42047-42051	from	_	
258-10	42052-42055	its	_	
258-11	42056-42064	dominant	_	
258-12	42065-42070	state	_	
258-13	42071-42074	can	_	
258-14	42075-42077	be	_	
258-15	42078-42088	classified	_	
258-16	42089-42091	by	_	
258-17	42092-42095	the	_	
258-18	42096-42108	well-trained	_	
258-19	42109-42114	model	_	
258-20	42114-42115	.	_	

#Text=The other alternative strategy is to employ all states, similar to the previous work from our group.
259-1	42116-42119	The	_	
259-2	42120-42125	other	_	
259-3	42126-42137	alternative	_	
259-4	42138-42146	strategy	_	
259-5	42147-42149	is	_	
259-6	42150-42152	to	_	
259-7	42153-42159	employ	_	
259-8	42160-42163	all	_	
259-9	42164-42170	states	_	
259-10	42170-42171	,	_	
259-11	42172-42179	similar	_	
259-12	42180-42182	to	_	
259-13	42183-42186	the	_	
259-14	42187-42195	previous	_	
259-15	42196-42200	work	_	
259-16	42201-42205	from	_	
259-17	42206-42209	our	_	
259-18	42210-42215	group	_	
259-19	42215-42216	.	_	

#Text=In this strategy, two groups of the group-level connectivity states (including all the dominant and non-dominant states) from both converted CHR group and unconverted CHR group can be used as the common regressors.
260-1	42217-42219	In	_	
260-2	42220-42224	this	_	
260-3	42225-42233	strategy	_	
260-4	42233-42234	,	_	
260-5	42235-42238	two	_	
260-6	42239-42245	groups	_	
260-7	42246-42248	of	_	
260-8	42249-42252	the	_	
260-9	42253-42264	group-level	_	
260-10	42265-42277	connectivity	_	
260-11	42278-42284	states	_	
260-12	42285-42286	(	_	
260-13	42286-42295	including	_	
260-14	42296-42299	all	_	
260-15	42300-42303	the	_	
260-16	42304-42312	dominant	_	
260-17	42313-42316	and	_	
260-18	42317-42329	non-dominant	_	
260-19	42330-42336	states	_	
260-20	42336-42337	)	_	
260-21	42338-42342	from	_	
260-22	42343-42347	both	_	
260-23	42348-42357	converted	_	
260-24	42358-42361	CHR	_	
260-25	42362-42367	group	_	
260-26	42368-42371	and	_	
260-27	42372-42383	unconverted	_	
260-28	42384-42387	CHR	_	
260-29	42388-42393	group	_	
260-30	42394-42397	can	_	
260-31	42398-42400	be	_	
260-32	42401-42405	used	_	
260-33	42406-42408	as	_	
260-34	42409-42412	the	_	
260-35	42413-42419	common	_	
260-36	42420-42430	regressors	_	
260-37	42430-42431	.	_	

#Text=By representing each window-related connectivity matrix as a linear combination of the common regressors and then averaging the beta-values across all windows, each subject will have same number of features.
261-1	42432-42434	By	_	
261-2	42435-42447	representing	_	
261-3	42448-42452	each	_	
261-4	42453-42467	window-related	_	
261-5	42468-42480	connectivity	_	
261-6	42481-42487	matrix	_	
261-7	42488-42490	as	_	
261-8	42491-42492	a	_	
261-9	42493-42499	linear	_	
261-10	42500-42511	combination	_	
261-11	42512-42514	of	_	
261-12	42515-42518	the	_	
261-13	42519-42525	common	_	
261-14	42526-42536	regressors	_	
261-15	42537-42540	and	_	
261-16	42541-42545	then	_	
261-17	42546-42555	averaging	_	
261-18	42556-42559	the	_	
261-19	42560-42571	beta-values	_	
261-20	42572-42578	across	_	
261-21	42579-42582	all	_	
261-22	42583-42590	windows	_	
261-23	42590-42591	,	_	
261-24	42592-42596	each	_	
261-25	42597-42604	subject	_	
261-26	42605-42609	will	_	
261-27	42610-42614	have	_	
261-28	42615-42619	same	_	
261-29	42620-42626	number	_	
261-30	42627-42629	of	_	
261-31	42630-42638	features	_	
261-32	42638-42639	.	_	

#Text=So, these features can be used to train a classifier based on the training subjects and yield the classification labels for testing subjects.
262-1	42640-42642	So	_	
262-2	42642-42643	,	_	
262-3	42644-42649	these	_	
262-4	42650-42658	features	_	
262-5	42659-42662	can	_	
262-6	42663-42665	be	_	
262-7	42666-42670	used	_	
262-8	42671-42673	to	_	
262-9	42674-42679	train	_	
262-10	42680-42681	a	_	
262-11	42682-42692	classifier	_	
262-12	42693-42698	based	_	
262-13	42699-42701	on	_	
262-14	42702-42705	the	_	
262-15	42706-42714	training	_	
262-16	42715-42723	subjects	_	
262-17	42724-42727	and	_	
262-18	42728-42733	yield	_	
262-19	42734-42737	the	_	
262-20	42738-42752	classification	_	
262-21	42753-42759	labels	_	
262-22	42760-42763	for	_	
262-23	42764-42771	testing	_	
262-24	42772-42780	subjects	_	
262-25	42780-42781	.	_	

#Text=We will investigate this issue in the future when more data are available. (2) The fMRI data used in our study was relatively short (i.e., six minutes).
263-1	42782-42784	We	_	
263-2	42785-42789	will	_	
263-3	42790-42801	investigate	_	
263-4	42802-42806	this	_	
263-5	42807-42812	issue	_	
263-6	42813-42815	in	_	
263-7	42816-42819	the	_	
263-8	42820-42826	future	_	
263-9	42827-42831	when	_	
263-10	42832-42836	more	_	
263-11	42837-42841	data	_	
263-12	42842-42845	are	_	
263-13	42846-42855	available	_	
263-14	42855-42856	.	_	
263-15	42857-42858	(	_	
263-16	42858-42859	2	_	
263-17	42859-42860	)	_	
263-18	42861-42864	The	_	
263-19	42865-42869	fMRI	_	
263-20	42870-42874	data	_	
263-21	42875-42879	used	_	
263-22	42880-42882	in	_	
263-23	42883-42886	our	_	
263-24	42887-42892	study	_	
263-25	42893-42896	was	_	
263-26	42897-42907	relatively	_	
263-27	42908-42913	short	_	
263-28	42914-42915	(	_	
263-29	42915-42918	i.e	_	
263-30	42918-42919	.	_	
263-31	42919-42920	,	_	
263-32	42921-42924	six	_	
263-33	42925-42932	minutes	_	
263-34	42932-42933	)	_	
263-35	42933-42934	.	_	

#Text=Some work used data from a longer scanning to investigate dynamics; however, many studies have already shown that different connectivity states can be robustly and replicably captured in a similarly short period such as five minutes. (3) The number of ICs in the framework was adjustable, and a change in this parameter may influence the states and the identified biomarkers.
264-1	42935-42939	Some	_	
264-2	42940-42944	work	_	
264-3	42945-42949	used	_	
264-4	42950-42954	data	_	
264-5	42955-42959	from	_	
264-6	42960-42961	a	_	
264-7	42962-42968	longer	_	
264-8	42969-42977	scanning	_	
264-9	42978-42980	to	_	
264-10	42981-42992	investigate	_	
264-11	42993-43001	dynamics	_	
264-12	43001-43002	;	_	
264-13	43003-43010	however	_	
264-14	43010-43011	,	_	
264-15	43012-43016	many	_	
264-16	43017-43024	studies	_	
264-17	43025-43029	have	_	
264-18	43030-43037	already	_	
264-19	43038-43043	shown	_	
264-20	43044-43048	that	_	
264-21	43049-43058	different	_	
264-22	43059-43071	connectivity	_	
264-23	43072-43078	states	_	
264-24	43079-43082	can	_	
264-25	43083-43085	be	_	
264-26	43086-43094	robustly	_	
264-27	43095-43098	and	_	
264-28	43099-43109	replicably	_	
264-29	43110-43118	captured	_	
264-30	43119-43121	in	_	
264-31	43122-43123	a	_	
264-32	43124-43133	similarly	_	
264-33	43134-43139	short	_	
264-34	43140-43146	period	_	
264-35	43147-43151	such	_	
264-36	43152-43154	as	_	
264-37	43155-43159	five	_	
264-38	43160-43167	minutes	_	
264-39	43167-43168	.	_	
264-40	43169-43170	(	_	
264-41	43170-43171	3	_	
264-42	43171-43172	)	_	
264-43	43173-43176	The	_	
264-44	43177-43183	number	_	
264-45	43184-43186	of	_	
264-46	43187-43190	ICs	_	
264-47	43191-43193	in	_	
264-48	43194-43197	the	_	
264-49	43198-43207	framework	_	
264-50	43208-43211	was	_	
264-51	43212-43222	adjustable	_	
264-52	43222-43223	,	_	
264-53	43224-43227	and	_	
264-54	43228-43229	a	_	
264-55	43230-43236	change	_	
264-56	43237-43239	in	_	
264-57	43240-43244	this	_	
264-58	43245-43254	parameter	_	
264-59	43255-43258	may	_	
264-60	43259-43268	influence	_	
264-61	43269-43272	the	_	
264-62	43273-43279	states	_	
264-63	43280-43283	and	_	
264-64	43284-43287	the	_	
264-65	43288-43298	identified	_	
264-66	43299-43309	biomarkers	_	
264-67	43309-43310	.	_	

#Text=We selected the number of ICs according to previous work, which preserved enough variance from each subject’s DFC and resulted in reliable GSs under multiple ICA runs.
265-1	43311-43313	We	_	
265-2	43314-43322	selected	_	
265-3	43323-43326	the	_	
265-4	43327-43333	number	_	
265-5	43334-43336	of	_	
265-6	43337-43340	ICs	_	
265-7	43341-43350	according	_	
265-8	43351-43353	to	_	
265-9	43354-43362	previous	_	
265-10	43363-43367	work	_	
265-11	43367-43368	,	_	
265-12	43369-43374	which	_	
265-13	43375-43384	preserved	_	
265-14	43385-43391	enough	_	
265-15	43392-43400	variance	_	
265-16	43401-43405	from	_	
265-17	43406-43410	each	_	
265-18	43411-43418	subject	_	
265-19	43418-43419	’	_	
265-20	43419-43420	s	_	
265-21	43421-43424	DFC	_	
265-22	43425-43428	and	_	
265-23	43429-43437	resulted	_	
265-24	43438-43440	in	_	
265-25	43441-43449	reliable	_	
265-26	43450-43453	GSs	_	
265-27	43454-43459	under	_	
265-28	43460-43468	multiple	_	
265-29	43469-43472	ICA	_	
265-30	43473-43477	runs	_	
265-31	43477-43478	.	_	

#Text=However, other settings may deserve study. (4) We used the canonical AAL template-defined ROIs to compute the whole-brain FC, as the template provides clear parcellation and explicit description on whole-brain regions.
266-1	43479-43486	However	_	
266-2	43486-43487	,	_	
266-3	43488-43493	other	_	
266-4	43494-43502	settings	_	
266-5	43503-43506	may	_	
266-6	43507-43514	deserve	_	
266-7	43515-43520	study	_	
266-8	43520-43521	.	_	
266-9	43522-43523	(	_	
266-10	43523-43524	4	_	
266-11	43524-43525	)	_	
266-12	43526-43528	We	_	
266-13	43529-43533	used	_	
266-14	43534-43537	the	_	
266-15	43538-43547	canonical	_	
266-16	43548-43551	AAL	_	
266-17	43552-43568	template-defined	_	
266-18	43569-43573	ROIs	_	
266-19	43574-43576	to	_	
266-20	43577-43584	compute	_	
266-21	43585-43588	the	_	
266-22	43589-43600	whole-brain	_	
266-23	43601-43603	FC	_	
266-24	43603-43604	,	_	
266-25	43605-43607	as	_	
266-26	43608-43611	the	_	
266-27	43612-43620	template	_	
266-28	43621-43629	provides	_	
266-29	43630-43635	clear	_	
266-30	43636-43648	parcellation	_	
266-31	43649-43652	and	_	
266-32	43653-43661	explicit	_	
266-33	43662-43673	description	_	
266-34	43674-43676	on	_	
266-35	43677-43688	whole-brain	_	
266-36	43689-43696	regions	_	
266-37	43696-43697	.	_	

#Text=In the future, we will also consider using ROIs obtained from ICA, clustering techniques, and previous fMRI studies. (5) In light of the relatively small sample sizes available for this study, we included CHR individuals who were treated with antipsychotic medication at the time of testing.
267-1	43698-43700	In	_	
267-2	43701-43704	the	_	
267-3	43705-43711	future	_	
267-4	43711-43712	,	_	
267-5	43713-43715	we	_	
267-6	43716-43720	will	_	
267-7	43721-43725	also	_	
267-8	43726-43734	consider	_	
267-9	43735-43740	using	_	
267-10	43741-43745	ROIs	_	
267-11	43746-43754	obtained	_	
267-12	43755-43759	from	_	
267-13	43760-43763	ICA	_	
267-14	43763-43764	,	_	
267-15	43765-43775	clustering	_	
267-16	43776-43786	techniques	_	
267-17	43786-43787	,	_	
267-18	43788-43791	and	_	
267-19	43792-43800	previous	_	
267-20	43801-43805	fMRI	_	
267-21	43806-43813	studies	_	
267-22	43813-43814	.	_	
267-23	43815-43816	(	_	
267-24	43816-43817	5	_	
267-25	43817-43818	)	_	
267-26	43819-43821	In	_	
267-27	43822-43827	light	_	
267-28	43828-43830	of	_	
267-29	43831-43834	the	_	
267-30	43835-43845	relatively	_	
267-31	43846-43851	small	_	
267-32	43852-43858	sample	_	
267-33	43859-43864	sizes	_	
267-34	43865-43874	available	_	
267-35	43875-43878	for	_	
267-36	43879-43883	this	_	
267-37	43884-43889	study	_	
267-38	43889-43890	,	_	
267-39	43891-43893	we	_	
267-40	43894-43902	included	_	
267-41	43903-43906	CHR	_	
267-42	43907-43918	individuals	_	
267-43	43919-43922	who	_	
267-44	43923-43927	were	_	
267-45	43928-43935	treated	_	
267-46	43936-43940	with	_	
267-47	43941-43954	antipsychotic	_	
267-48	43955-43965	medication	_	
267-49	43966-43968	at	_	
267-50	43969-43972	the	_	
267-51	43973-43977	time	_	
267-52	43978-43980	of	_	
267-53	43981-43988	testing	_	
267-54	43988-43989	.	_	

#Text=Given that only a minority of CHR individuals were taking antipsychotic medication, this was unlikely to confound our results.
268-1	43990-43995	Given	_	
268-2	43996-44000	that	_	
268-3	44001-44005	only	_	
268-4	44006-44007	a	_	
268-5	44008-44016	minority	_	
268-6	44017-44019	of	_	
268-7	44020-44023	CHR	_	
268-8	44024-44035	individuals	_	
268-9	44036-44040	were	_	
268-10	44041-44047	taking	_	
268-11	44048-44061	antipsychotic	_	
268-12	44062-44072	medication	_	
268-13	44072-44073	,	_	
268-14	44074-44078	this	_	
268-15	44079-44082	was	_	
268-16	44083-44091	unlikely	_	
268-17	44092-44094	to	_	
268-18	44095-44103	confound	_	
268-19	44104-44107	our	_	
268-20	44108-44115	results	_	
268-21	44115-44116	.	_	

#Text=Nonetheless, we also performed the same DFC analyses using the unmedicated CHR individuals to explore.
269-1	44117-44128	Nonetheless	_	
269-2	44128-44129	,	_	
269-3	44130-44132	we	_	
269-4	44133-44137	also	_	
269-5	44138-44147	performed	_	
269-6	44148-44151	the	_	
269-7	44152-44156	same	_	
269-8	44157-44160	DFC	_	
269-9	44161-44169	analyses	_	
269-10	44170-44175	using	_	
269-11	44176-44179	the	_	
269-12	44180-44191	unmedicated	_	
269-13	44192-44195	CHR	_	
269-14	44196-44207	individuals	_	
269-15	44208-44210	to	_	
269-16	44211-44218	explore	_	
269-17	44218-44219	.	_	

#Text=Results in supplementary materials showed that the patterns remain consistent with the findings described above.
270-1	44220-44227	Results	_	
270-2	44228-44230	in	_	
270-3	44231-44244	supplementary	_	
270-4	44245-44254	materials	_	
270-5	44255-44261	showed	_	
270-6	44262-44266	that	_	
270-7	44267-44270	the	_	
270-8	44271-44279	patterns	_	
270-9	44280-44286	remain	_	
270-10	44287-44297	consistent	_	
270-11	44298-44302	with	_	
270-12	44303-44306	the	_	
270-13	44307-44315	findings	_	
270-14	44316-44325	described	_	
270-15	44326-44331	above	_	
270-16	44331-44332	.	_	

#Text=In addition, data of CHR individuals with different syndromes were analyzed.
271-1	44333-44335	In	_	
271-2	44336-44344	addition	_	
271-3	44344-44345	,	_	
271-4	44346-44350	data	_	
271-5	44351-44353	of	_	
271-6	44354-44357	CHR	_	
271-7	44358-44369	individuals	_	
271-8	44370-44374	with	_	
271-9	44375-44384	different	_	
271-10	44385-44394	syndromes	_	
271-11	44395-44399	were	_	
271-12	44400-44408	analyzed	_	
271-13	44408-44409	.	_	

#Text=Due to the unbalanced number in different syndrome-related groups, we cannot investigate if CHR subjects with different syndromes have significant different brain connectivity.
272-1	44410-44413	Due	_	
272-2	44414-44416	to	_	
272-3	44417-44420	the	_	
272-4	44421-44431	unbalanced	_	
272-5	44432-44438	number	_	
272-6	44439-44441	in	_	
272-7	44442-44451	different	_	
272-8	44452-44468	syndrome-related	_	
272-9	44469-44475	groups	_	
272-10	44475-44476	,	_	
272-11	44477-44479	we	_	
272-12	44480-44486	cannot	_	
272-13	44487-44498	investigate	_	
272-14	44499-44501	if	_	
272-15	44502-44505	CHR	_	
272-16	44506-44514	subjects	_	
272-17	44515-44519	with	_	
272-18	44520-44529	different	_	
272-19	44530-44539	syndromes	_	
272-20	44540-44544	have	_	
272-21	44545-44556	significant	_	
272-22	44557-44566	different	_	
272-23	44567-44572	brain	_	
272-24	44573-44585	connectivity	_	
272-25	44585-44586	.	_	

#Text=We plan to explore this issue when more data are available. (6) The association relationship (correlations) between connectivity strengths and symptom scores cannot pass correction for multiple comparisons probably due to the small sample size.
273-1	44587-44589	We	_	
273-2	44590-44594	plan	_	
273-3	44595-44597	to	_	
273-4	44598-44605	explore	_	
273-5	44606-44610	this	_	
273-6	44611-44616	issue	_	
273-7	44617-44621	when	_	
273-8	44622-44626	more	_	
273-9	44627-44631	data	_	
273-10	44632-44635	are	_	
273-11	44636-44645	available	_	
273-12	44645-44646	.	_	
273-13	44647-44648	(	_	
273-14	44648-44649	6	_	
273-15	44649-44650	)	_	
273-16	44651-44654	The	_	
273-17	44655-44666	association	_	
273-18	44667-44679	relationship	_	
273-19	44680-44681	(	_	
273-20	44681-44693	correlations	_	
273-21	44693-44694	)	_	
273-22	44695-44702	between	_	
273-23	44703-44715	connectivity	_	
273-24	44716-44725	strengths	_	
273-25	44726-44729	and	_	
273-26	44730-44737	symptom	_	
273-27	44738-44744	scores	_	
273-28	44745-44751	cannot	_	
273-29	44752-44756	pass	_	
273-30	44757-44767	correction	_	
273-31	44768-44771	for	_	
273-32	44772-44780	multiple	_	
273-33	44781-44792	comparisons	_	
273-34	44793-44801	probably	_	
273-35	44802-44805	due	_	
273-36	44806-44808	to	_	
273-37	44809-44812	the	_	
273-38	44813-44818	small	_	
273-39	44819-44825	sample	_	
273-40	44826-44830	size	_	
273-41	44830-44831	.	_	

#Text=So, the association results should be validated in future. (7) Similar to a previous functional connectivity study in CHR individuals, we regressed out the global mean signal when preprocessing, since global signal is assumed to reflect a combination of resting-state fluctuations, physiological noise (e.g. respiratory and cardiac noise), and other noise signals with non-neural origin.
274-1	44832-44834	So	_	
274-2	44834-44835	,	_	
274-3	44836-44839	the	_	
274-4	44840-44851	association	_	
274-5	44852-44859	results	_	
274-6	44860-44866	should	_	
274-7	44867-44869	be	_	
274-8	44870-44879	validated	_	
274-9	44880-44882	in	_	
274-10	44883-44889	future	_	
274-11	44889-44890	.	_	
274-12	44891-44892	(	_	
274-13	44892-44893	7	_	
274-14	44893-44894	)	_	
274-15	44895-44902	Similar	_	
274-16	44903-44905	to	_	
274-17	44906-44907	a	_	
274-18	44908-44916	previous	_	
274-19	44917-44927	functional	_	
274-20	44928-44940	connectivity	_	
274-21	44941-44946	study	_	
274-22	44947-44949	in	_	
274-23	44950-44953	CHR	_	
274-24	44954-44965	individuals	_	
274-25	44965-44966	,	_	
274-26	44967-44969	we	_	
274-27	44970-44979	regressed	_	
274-28	44980-44983	out	_	
274-29	44984-44987	the	_	
274-30	44988-44994	global	_	
274-31	44995-44999	mean	_	
274-32	45000-45006	signal	_	
274-33	45007-45011	when	_	
274-34	45012-45025	preprocessing	_	
274-35	45025-45026	,	_	
274-36	45027-45032	since	_	
274-37	45033-45039	global	_	
274-38	45040-45046	signal	_	
274-39	45047-45049	is	_	
274-40	45050-45057	assumed	_	
274-41	45058-45060	to	_	
274-42	45061-45068	reflect	_	
274-43	45069-45070	a	_	
274-44	45071-45082	combination	_	
274-45	45083-45085	of	_	
274-46	45086-45099	resting-state	_	
274-47	45100-45112	fluctuations	_	
274-48	45112-45113	,	_	
274-49	45114-45127	physiological	_	
274-50	45128-45133	noise	_	
274-51	45134-45135	(	_	
274-52	45135-45138	e.g	_	
274-53	45138-45139	.	_	
274-54	45140-45151	respiratory	_	
274-55	45152-45155	and	_	
274-56	45156-45163	cardiac	_	
274-57	45164-45169	noise	_	
274-58	45169-45170	)	_	
274-59	45170-45171	,	_	
274-60	45172-45175	and	_	
274-61	45176-45181	other	_	
274-62	45182-45187	noise	_	
274-63	45188-45195	signals	_	
274-64	45196-45200	with	_	
274-65	45201-45211	non-neural	_	
274-66	45212-45218	origin	_	
274-67	45218-45219	.	_	

#Text=Regressing out global mean has been shown to facilitate the detection of localized neuronal signals and improve the specificity of functional connectivity analysis, although it could result in increased negative correlations.
275-1	45220-45230	Regressing	_	
275-2	45231-45234	out	_	
275-3	45235-45241	global	_	
275-4	45242-45246	mean	_	
275-5	45247-45250	has	_	
275-6	45251-45255	been	_	
275-7	45256-45261	shown	_	
275-8	45262-45264	to	_	
275-9	45265-45275	facilitate	_	
275-10	45276-45279	the	_	
275-11	45280-45289	detection	_	
275-12	45290-45292	of	_	
275-13	45293-45302	localized	_	
275-14	45303-45311	neuronal	_	
275-15	45312-45319	signals	_	
275-16	45320-45323	and	_	
275-17	45324-45331	improve	_	
275-18	45332-45335	the	_	
275-19	45336-45347	specificity	_	
275-20	45348-45350	of	_	
275-21	45351-45361	functional	_	
275-22	45362-45374	connectivity	_	
275-23	45375-45383	analysis	_	
275-24	45383-45384	,	_	
275-25	45385-45393	although	_	
275-26	45394-45396	it	_	
275-27	45397-45402	could	_	
275-28	45403-45409	result	_	
275-29	45410-45412	in	_	
275-30	45413-45422	increased	_	
275-31	45423-45431	negative	_	
275-32	45432-45444	correlations	_	
275-33	45444-45445	.	_	

#Text=Considering that regressing out global mean is a controversial issue, we will investigate its impact in the future. (8) Since the non-dominant group-level states were not very corresponding across the three groups (as shown in Fig. 2, Fig. 3 and Table 2), estimating and comparing the associated non-dominant subject-specific states should be carefully conducted.
276-1	45446-45457	Considering	_	
276-2	45458-45462	that	_	
276-3	45463-45473	regressing	_	
276-4	45474-45477	out	_	
276-5	45478-45484	global	_	
276-6	45485-45489	mean	_	
276-7	45490-45492	is	_	
276-8	45493-45494	a	_	
276-9	45495-45508	controversial	_	
276-10	45509-45514	issue	_	
276-11	45514-45515	,	_	
276-12	45516-45518	we	_	
276-13	45519-45523	will	_	
276-14	45524-45535	investigate	_	
276-15	45536-45539	its	_	
276-16	45540-45546	impact	_	
276-17	45547-45549	in	_	
276-18	45550-45553	the	_	
276-19	45554-45560	future	_	
276-20	45560-45561	.	_	
276-21	45562-45563	(	_	
276-22	45563-45564	8	_	
276-23	45564-45565	)	_	
276-24	45566-45571	Since	_	
276-25	45572-45575	the	_	
276-26	45576-45588	non-dominant	_	
276-27	45589-45600	group-level	_	
276-28	45601-45607	states	_	
276-29	45608-45612	were	_	
276-30	45613-45616	not	_	
276-31	45617-45621	very	_	
276-32	45622-45635	corresponding	_	
276-33	45636-45642	across	_	
276-34	45643-45646	the	_	
276-35	45647-45652	three	_	
276-36	45653-45659	groups	_	
276-37	45660-45661	(	_	
276-38	45661-45663	as	_	
276-39	45664-45669	shown	_	
276-40	45670-45672	in	_	
276-41	45673-45676	Fig	_	
276-42	45676-45677	.	_	
276-43	45678-45679	2	_	
276-44	45679-45680	,	_	
276-45	45681-45684	Fig	_	
276-46	45684-45685	.	_	
276-47	45686-45687	3	_	
276-48	45688-45691	and	_	
276-49	45692-45697	Table	_	
276-50	45698-45699	2	_	
276-51	45699-45700	)	_	
276-52	45700-45701	,	_	
276-53	45702-45712	estimating	_	
276-54	45713-45716	and	_	
276-55	45717-45726	comparing	_	
276-56	45727-45730	the	_	
276-57	45731-45741	associated	_	
276-58	45742-45754	non-dominant	_	
276-59	45755-45771	subject-specific	_	
276-60	45772-45778	states	_	
276-61	45779-45785	should	_	
276-62	45786-45788	be	_	
276-63	45789-45798	carefully	_	
276-64	45799-45808	conducted	_	
276-65	45808-45809	.	_	

#Text=In fact, the non-dominant states may only be comparable between the CHR group and ESZ group, but not comparable between the HC group and CHR (or ESZ) group, due to that they may be disease-related.
277-1	45810-45812	In	_	
277-2	45813-45817	fact	_	
277-3	45817-45818	,	_	
277-4	45819-45822	the	_	
277-5	45823-45835	non-dominant	_	
277-6	45836-45842	states	_	
277-7	45843-45846	may	_	
277-8	45847-45851	only	_	
277-9	45852-45854	be	_	
277-10	45855-45865	comparable	_	
277-11	45866-45873	between	_	
277-12	45874-45877	the	_	
277-13	45878-45881	CHR	_	
277-14	45882-45887	group	_	
277-15	45888-45891	and	_	
277-16	45892-45895	ESZ	_	
277-17	45896-45901	group	_	
277-18	45901-45902	,	_	
277-19	45903-45906	but	_	
277-20	45907-45910	not	_	
277-21	45911-45921	comparable	_	
277-22	45922-45929	between	_	
277-23	45930-45933	the	_	
277-24	45934-45936	HC	_	
277-25	45937-45942	group	_	
277-26	45943-45946	and	_	
277-27	45947-45950	CHR	_	
277-28	45951-45952	(	_	
277-29	45952-45954	or	_	
277-30	45955-45958	ESZ	_	
277-31	45958-45959	)	_	
277-32	45960-45965	group	_	
277-33	45965-45966	,	_	
277-34	45967-45970	due	_	
277-35	45971-45973	to	_	
277-36	45974-45978	that	_	
277-37	45979-45983	they	_	
277-38	45984-45987	may	_	
277-39	45988-45990	be	_	
277-40	45991-46006	disease-related	_	
277-41	46006-46007	.	_	

#Text=Hence, we do not include analyses on the non-dominant subject-specific states in the present study.
278-1	46008-46013	Hence	_	
278-2	46013-46014	,	_	
278-3	46015-46017	we	_	
278-4	46018-46020	do	_	
278-5	46021-46024	not	_	
278-6	46025-46032	include	_	
278-7	46033-46041	analyses	_	
278-8	46042-46044	on	_	
278-9	46045-46048	the	_	
278-10	46049-46061	non-dominant	_	
278-11	46062-46078	subject-specific	_	
278-12	46079-46085	states	_	
278-13	46086-46088	in	_	
278-14	46089-46092	the	_	
278-15	46093-46100	present	_	
278-16	46101-46106	study	_	
278-17	46106-46107	.	_	

#Text=By applying a novel DFC method, we found widespread connectivity alterations in both CHR and ESZ groups, and ESZ patients generally showed more connectivity differences with larger changes relative to controls than CHR individuals.
279-1	46108-46110	By	_	
279-2	46111-46119	applying	_	
279-3	46120-46121	a	_	
279-4	46122-46127	novel	_	
279-5	46128-46131	DFC	_	
279-6	46132-46138	method	_	
279-7	46138-46139	,	_	
279-8	46140-46142	we	_	
279-9	46143-46148	found	_	
279-10	46149-46159	widespread	_	
279-11	46160-46172	connectivity	_	
279-12	46173-46184	alterations	_	
279-13	46185-46187	in	_	
279-14	46188-46192	both	_	
279-15	46193-46196	CHR	_	
279-16	46197-46200	and	_	
279-17	46201-46204	ESZ	_	
279-18	46205-46211	groups	_	
279-19	46211-46212	,	_	
279-20	46213-46216	and	_	
279-21	46217-46220	ESZ	_	
279-22	46221-46229	patients	_	
279-23	46230-46239	generally	_	
279-24	46240-46246	showed	_	
279-25	46247-46251	more	_	
279-26	46252-46264	connectivity	_	
279-27	46265-46276	differences	_	
279-28	46277-46281	with	_	
279-29	46282-46288	larger	_	
279-30	46289-46296	changes	_	
279-31	46297-46305	relative	_	
279-32	46306-46308	to	_	
279-33	46309-46317	controls	_	
279-34	46318-46322	than	_	
279-35	46323-46326	CHR	_	
279-36	46327-46338	individuals	_	
279-37	46338-46339	.	_	

#Text=The functional abnormalities are generally consistent with the CCTC network postulated to underlie the core cognitive deficit of schizophrenia.
280-1	46340-46343	The	_	
280-2	46344-46354	functional	_	
280-3	46355-46368	abnormalities	_	
280-4	46369-46372	are	_	
280-5	46373-46382	generally	_	
280-6	46383-46393	consistent	_	
280-7	46394-46398	with	_	
280-8	46399-46402	the	_	
280-9	46403-46407	CCTC	_	
280-10	46408-46415	network	_	
280-11	46416-46426	postulated	_	
280-12	46427-46429	to	_	
280-13	46430-46438	underlie	_	
280-14	46439-46442	the	_	
280-15	46443-46447	core	_	
280-16	46448-46457	cognitive	_	
280-17	46458-46465	deficit	_	
280-18	46466-46468	of	_	
280-19	46469-46482	schizophrenia	_	
280-20	46482-46483	.	_	

#Text=Furthermore, the CHR group also showed group-specific impairments, indicating that some connections’ alterations differentiated CHR and ESZ groups.
281-1	46484-46495	Furthermore	_	
281-2	46495-46496	,	_	
281-3	46497-46500	the	_	
281-4	46501-46504	CHR	_	
281-5	46505-46510	group	_	
281-6	46511-46515	also	_	
281-7	46516-46522	showed	_	
281-8	46523-46537	group-specific	_	
281-9	46538-46549	impairments	_	
281-10	46549-46550	,	_	
281-11	46551-46561	indicating	_	
281-12	46562-46566	that	_	
281-13	46567-46571	some	_	
281-14	46572-46583	connections	_	
281-15	46583-46584	’	_	
281-16	46585-46596	alterations	_	
281-17	46597-46611	differentiated	_	
281-18	46612-46615	CHR	_	
281-19	46616-46619	and	_	
281-20	46620-46623	ESZ	_	
281-21	46624-46630	groups	_	
281-22	46630-46631	.	_	

#Text=An important future research direction is to examine the extent to which the aberrant FCs identified in CHR individuals are predictive of subsequent transition to a full-blown psychotic disorder.
282-1	46632-46634	An	_	
282-2	46635-46644	important	_	
282-3	46645-46651	future	_	
282-4	46652-46660	research	_	
282-5	46661-46670	direction	_	
282-6	46671-46673	is	_	
282-7	46674-46676	to	_	
282-8	46677-46684	examine	_	
282-9	46685-46688	the	_	
282-10	46689-46695	extent	_	
282-11	46696-46698	to	_	
282-12	46699-46704	which	_	
282-13	46705-46708	the	_	
282-14	46709-46717	aberrant	_	
282-15	46718-46721	FCs	_	
282-16	46722-46732	identified	_	
282-17	46733-46735	in	_	
282-18	46736-46739	CHR	_	
282-19	46740-46751	individuals	_	
282-20	46752-46755	are	_	
282-21	46756-46766	predictive	_	
282-22	46767-46769	of	_	
282-23	46770-46780	subsequent	_	
282-24	46781-46791	transition	_	
282-25	46792-46794	to	_	
282-26	46795-46796	a	_	
282-27	46797-46807	full-blown	_	
282-28	46808-46817	psychotic	_	
282-29	46818-46826	disorder	_	
282-30	46826-46827	.	_	

#Text=Supplementary Material
#Text=This is a PDF file of an unedited manuscript that has been accepted for publication.
283-1	46828-46841	Supplementary	_	
283-2	46842-46850	Material	_	
283-3	46851-46855	This	_	
283-4	46856-46858	is	_	
283-5	46859-46860	a	_	
283-6	46861-46864	PDF	_	
283-7	46865-46869	file	_	
283-8	46870-46872	of	_	
283-9	46873-46875	an	_	
283-10	46876-46884	unedited	_	
283-11	46885-46895	manuscript	_	
283-12	46896-46900	that	_	
283-13	46901-46904	has	_	
283-14	46905-46909	been	_	
283-15	46910-46918	accepted	_	
283-16	46919-46922	for	_	
283-17	46923-46934	publication	_	
283-18	46934-46935	.	_	

#Text=As a service to our customers we are providing this early version of the manuscript.
284-1	46936-46938	As	_	
284-2	46939-46940	a	_	
284-3	46941-46948	service	_	
284-4	46949-46951	to	_	
284-5	46952-46955	our	_	
284-6	46956-46965	customers	_	
284-7	46966-46968	we	_	
284-8	46969-46972	are	_	
284-9	46973-46982	providing	_	
284-10	46983-46987	this	_	
284-11	46988-46993	early	_	
284-12	46994-47001	version	_	
284-13	47002-47004	of	_	
284-14	47005-47008	the	_	
284-15	47009-47019	manuscript	_	
284-16	47019-47020	.	_	

#Text=The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form.
285-1	47021-47024	The	_	
285-2	47025-47035	manuscript	_	
285-3	47036-47040	will	_	
285-4	47041-47048	undergo	_	
285-5	47049-47060	copyediting	_	
285-6	47060-47061	,	_	
285-7	47062-47073	typesetting	_	
285-8	47073-47074	,	_	
285-9	47075-47078	and	_	
285-10	47079-47085	review	_	
285-11	47086-47088	of	_	
285-12	47089-47092	the	_	
285-13	47093-47102	resulting	_	
285-14	47103-47108	proof	_	
285-15	47109-47115	before	_	
285-16	47116-47118	it	_	
285-17	47119-47121	is	_	
285-18	47122-47131	published	_	
285-19	47132-47134	in	_	
285-20	47135-47138	its	_	
285-21	47139-47144	final	_	
285-22	47145-47152	citable	_	
285-23	47153-47157	form	_	
285-24	47157-47158	.	_	

#Text=Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
286-1	47159-47165	Please	_	
286-2	47166-47170	note	_	
286-3	47171-47175	that	_	
286-4	47176-47182	during	_	
286-5	47183-47186	the	_	
286-6	47187-47197	production	_	
286-7	47198-47205	process	_	
286-8	47206-47212	errors	_	
286-9	47213-47216	may	_	
286-10	47217-47219	be	_	
286-11	47220-47230	discovered	_	
286-12	47231-47236	which	_	
286-13	47237-47242	could	_	
286-14	47243-47249	affect	_	
286-15	47250-47253	the	_	
286-16	47254-47261	content	_	
286-17	47261-47262	,	_	
286-18	47263-47266	and	_	
286-19	47267-47270	all	_	
286-20	47271-47276	legal	_	
286-21	47277-47288	disclaimers	_	
286-22	47289-47293	that	_	
286-23	47294-47299	apply	_	
286-24	47300-47302	to	_	
286-25	47303-47306	the	_	
286-26	47307-47314	journal	_	
286-27	47315-47322	pertain	_	
286-28	47322-47323	.	_	

#Text=The Chronnectome: Replicability of Dynamic Connectivity Patterns in 7500 Resting fMRI Datasets
#Text=Tracking whole-brain connectivity dynamics in the resting state
#Text=Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis
#Text=A new learning algorithm for blind signal separation
#Text=A unitary model of schizophrenia: Bleuler’s “fragmented phrene” as schizencephaly
#Text=The role of the cerebellum in schizophrenia
#Text=Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk
#Text=Spontaneous low-frequency blood oxygenation level-dependent fluctuations and functional connectivity analysis of the ‘resting’ brain
#Text=Human brain networks in health and disease
#Text=An information-maximization approach to blind separation and blind deconvolution
#Text=Distinguishing prodromal from first-episode psychosis using neuroanatomical single-subject pattern recognition
#Text=Neural correlates of visuospatial working memory in the ‘at-risk mental state’
#Text=Neural correlates of movement generation in the ‘at-risk mental state’
#Text=The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging
#Text=Multisubject independent component analysis of fMRI: a decade of intrinsic networks, default mode, and neurodiagnostic discovery
#Text=The Chronnectome: Time-Varying Connectivity Networks as the Next Frontier in fMRI Data Discovery
#Text=Prediction of psychosis in youth at high clinical risk
#Text=Anticorrelations in resting state networks without global signal regression
#Text=Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings
#Text=Frequencies contributing to functional connectivity in the cerebral cortex in “resting-state” data
#Text=A whole brain fMRI atlas generated via spatially constrained spectral clustering
#Text=Dynamic functional connectivity analysis reveals transient states of dysconnectivity in schizophrenia
#Text=Dynamic brain functional connectivity modulated by resting-state networks
#Text=Group information guided ICA for fMRI data analysis
#Text=Identification of subject specific and functional consistent ROIs using semi-supervised learning
#Text=Identifying dynamic functional connectivity biomarkers using GIG-ICA: application to schizophrenia, schizoaffective disorder and psychotic bipolar disorder
#Text=Identifying brain dynamic network states via GIG-ICA: Application to schizophrenia, bipolar and schizoaffective disorders
#Text=Interaction among subsystems within default mode network diminished in schizophrenia patients: A dynamic connectivity approach
#Text=Exploring neural dysfunction in ‘clinical high risk’ for psychosis: a quantitative review of fMRI studies
#Text=Comparison of multi-subject ICA methods for analysis of fMRI data
#Text=The human brain is intrinsically organized into dynamic, anticorrelated functional networks
#Text=The global signal and observed anticorrelated resting state brain networks
#Text=Sparse inverse covariance estimation with the graphical lasso
#Text=Deficient Suppression of Default Mode Regions during Working Memory in Individuals with Early Psychosis and at Clinical High-Risk for Psychosis
#Text=Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk
#Text=Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis
#Text=Resting-state cerebellar-cerebral networks are differently affected in first-episode, drug-naive schizophrenia patients and unaffected siblings
#Text=Distinct cerebellar contributions to intrinsic connectivity networks
#Text=Functional connectivity networks with and without global signal correction
#Text=Resting-state networks show dynamic functional connectivity in awake humans and anesthetized macaques
#Text=Structural brain alterations in individuals at ultra-high risk for psychosis: a review of magnetic resonance imaging studies and future directions
#Text=Regional brain atrophy and functional disconnection in Broca’s area in individuals at ultra-high risk for psychosis and schizophrenia
#Text=The positive and negative syndrome scale (PANSS) for schizophrenia
#Text=Diagnosing schizophrenia in the initial prodromal phase
#Text=Is the cerebellum relevant in the circuitry of neuropsychiatric disorders?
287-1	47324-47327	The	_	
287-2	47328-47340	Chronnectome	_	
287-3	47340-47341	:	_	
287-4	47342-47355	Replicability	_	
287-5	47356-47358	of	_	
287-6	47359-47366	Dynamic	_	
287-7	47367-47379	Connectivity	_	
287-8	47380-47388	Patterns	_	
287-9	47389-47391	in	_	
287-10	47392-47396	7500	_	
287-11	47397-47404	Resting	_	
287-12	47405-47409	fMRI	_	
287-13	47410-47418	Datasets	_	
287-14	47419-47427	Tracking	_	
287-15	47428-47439	whole-brain	_	
287-16	47440-47452	connectivity	_	
287-17	47453-47461	dynamics	_	
287-18	47462-47464	in	_	
287-19	47465-47468	the	_	
287-20	47469-47476	resting	_	
287-21	47477-47482	state	_	
287-22	47483-47490	Altered	_	
287-23	47491-47501	prefrontal	_	
287-24	47502-47505	and	_	
287-25	47506-47517	hippocampal	_	
287-26	47518-47526	function	_	
287-27	47527-47533	during	_	
287-28	47534-47540	verbal	_	
287-29	47541-47549	encoding	_	
287-30	47550-47553	and	_	
287-31	47554-47565	recognition	_	
287-32	47566-47568	in	_	
287-33	47569-47575	people	_	
287-34	47576-47580	with	_	
287-35	47581-47590	prodromal	_	
287-36	47591-47599	symptoms	_	
287-37	47600-47602	of	_	
287-38	47603-47612	psychosis	_	
287-39	47613-47614	A	_	
287-40	47615-47618	new	_	
287-41	47619-47627	learning	_	
287-42	47628-47637	algorithm	_	
287-43	47638-47641	for	_	
287-44	47642-47647	blind	_	
287-45	47648-47654	signal	_	
287-46	47655-47665	separation	_	
287-47	47666-47667	A	_	
287-48	47668-47675	unitary	_	
287-49	47676-47681	model	_	
287-50	47682-47684	of	_	
287-51	47685-47698	schizophrenia	_	
287-52	47698-47699	:	_	
287-53	47700-47707	Bleuler	_	
287-54	47707-47708	’	_	
287-55	47708-47709	s	_	
287-56	47710-47711	“	_	
287-57	47711-47721	fragmented	_	
287-58	47722-47728	phrene	_	
287-59	47728-47729	”	_	
287-60	47730-47732	as	_	
287-61	47733-47747	schizencephaly	_	
287-62	47748-47751	The	_	
287-63	47752-47756	role	_	
287-64	47757-47759	of	_	
287-65	47760-47763	the	_	
287-66	47764-47774	cerebellum	_	
287-67	47775-47777	in	_	
287-68	47778-47791	schizophrenia	_	
287-69	47792-47803	Association	_	
287-70	47804-47806	of	_	
287-71	47807-47815	Thalamic	_	
287-72	47816-47831	Dysconnectivity	_	
287-73	47832-47835	and	_	
287-74	47836-47846	Conversion	_	
287-75	47847-47849	to	_	
287-76	47850-47859	Psychosis	_	
287-77	47860-47862	in	_	
287-78	47863-47868	Youth	_	
287-79	47869-47872	and	_	
287-80	47873-47878	Young	_	
287-81	47879-47885	Adults	_	
287-82	47886-47888	at	_	
287-83	47889-47897	Elevated	_	
287-84	47898-47906	Clinical	_	
287-85	47907-47911	Risk	_	
287-86	47912-47923	Spontaneous	_	
287-87	47924-47937	low-frequency	_	
287-88	47938-47943	blood	_	
287-89	47944-47955	oxygenation	_	
287-90	47956-47971	level-dependent	_	
287-91	47972-47984	fluctuations	_	
287-92	47985-47988	and	_	
287-93	47989-47999	functional	_	
287-94	48000-48012	connectivity	_	
287-95	48013-48021	analysis	_	
287-96	48022-48024	of	_	
287-97	48025-48028	the	_	
287-98	48029-48030	‘	_	
287-99	48030-48037	resting	_	
287-100	48037-48038	’	_	
287-101	48039-48044	brain	_	
287-102	48045-48050	Human	_	
287-103	48051-48056	brain	_	
287-104	48057-48065	networks	_	
287-105	48066-48068	in	_	
287-106	48069-48075	health	_	
287-107	48076-48079	and	_	
287-108	48080-48087	disease	_	
287-109	48088-48090	An	_	
287-110	48091-48115	information-maximization	_	
287-111	48116-48124	approach	_	
287-112	48125-48127	to	_	
287-113	48128-48133	blind	_	
287-114	48134-48144	separation	_	
287-115	48145-48148	and	_	
287-116	48149-48154	blind	_	
287-117	48155-48168	deconvolution	_	
287-118	48169-48183	Distinguishing	_	
287-119	48184-48193	prodromal	_	
287-120	48194-48198	from	_	
287-121	48199-48212	first-episode	_	
287-122	48213-48222	psychosis	_	
287-123	48223-48228	using	_	
287-124	48229-48244	neuroanatomical	_	
287-125	48245-48259	single-subject	_	
287-126	48260-48267	pattern	_	
287-127	48268-48279	recognition	_	
287-128	48280-48286	Neural	_	
287-129	48287-48297	correlates	_	
287-130	48298-48300	of	_	
287-131	48301-48313	visuospatial	_	
287-132	48314-48321	working	_	
287-133	48322-48328	memory	_	
287-134	48329-48331	in	_	
287-135	48332-48335	the	_	
287-136	48336-48337	‘	_	
287-137	48337-48344	at-risk	_	
287-138	48345-48351	mental	_	
287-139	48352-48357	state	_	
287-140	48357-48358	’	_	
287-141	48359-48365	Neural	_	
287-142	48366-48376	correlates	_	
287-143	48377-48379	of	_	
287-144	48380-48388	movement	_	
287-145	48389-48399	generation	_	
287-146	48400-48402	in	_	
287-147	48403-48406	the	_	
287-148	48407-48408	‘	_	
287-149	48408-48415	at-risk	_	
287-150	48416-48422	mental	_	
287-151	48423-48428	state	_	
287-152	48428-48429	’	_	
287-153	48430-48433	The	_	
287-154	48434-48444	cerebellum	_	
287-155	48445-48448	and	_	
287-156	48449-48458	cognitive	_	
287-157	48459-48467	function	_	
287-158	48467-48468	:	_	
287-159	48469-48471	25	_	
287-160	48472-48477	years	_	
287-161	48478-48480	of	_	
287-162	48481-48488	insight	_	
287-163	48489-48493	from	_	
287-164	48494-48501	anatomy	_	
287-165	48502-48505	and	_	
287-166	48506-48518	neuroimaging	_	
287-167	48519-48531	Multisubject	_	
287-168	48532-48543	independent	_	
287-169	48544-48553	component	_	
287-170	48554-48562	analysis	_	
287-171	48563-48565	of	_	
287-172	48566-48570	fMRI	_	
287-173	48570-48571	:	_	
287-174	48572-48573	a	_	
287-175	48574-48580	decade	_	
287-176	48581-48583	of	_	
287-177	48584-48593	intrinsic	_	
287-178	48594-48602	networks	_	
287-179	48602-48603	,	_	
287-180	48604-48611	default	_	
287-181	48612-48616	mode	_	
287-182	48616-48617	,	_	
287-183	48618-48621	and	_	
287-184	48622-48637	neurodiagnostic	_	
287-185	48638-48647	discovery	_	
287-186	48648-48651	The	_	
287-187	48652-48664	Chronnectome	_	
287-188	48664-48665	:	_	
287-189	48666-48678	Time-Varying	_	
287-190	48679-48691	Connectivity	_	
287-191	48692-48700	Networks	_	
287-192	48701-48703	as	_	
287-193	48704-48707	the	_	
287-194	48708-48712	Next	_	
287-195	48713-48721	Frontier	_	
287-196	48722-48724	in	_	
287-197	48725-48729	fMRI	_	
287-198	48730-48734	Data	_	
287-199	48735-48744	Discovery	_	
287-200	48745-48755	Prediction	_	
287-201	48756-48758	of	_	
287-202	48759-48768	psychosis	_	
287-203	48769-48771	in	_	
287-204	48772-48777	youth	_	
287-205	48778-48780	at	_	
287-206	48781-48785	high	_	
287-207	48786-48794	clinical	_	
287-208	48795-48799	risk	_	
287-209	48800-48816	Anticorrelations	_	
287-210	48817-48819	in	_	
287-211	48820-48827	resting	_	
287-212	48828-48833	state	_	
287-213	48834-48842	networks	_	
287-214	48843-48850	without	_	
287-215	48851-48857	global	_	
287-216	48858-48864	signal	_	
287-217	48865-48875	regression	_	
287-218	48876-48884	Impaired	_	
287-219	48885-48895	cerebellar	_	
287-220	48896-48906	functional	_	
287-221	48907-48919	connectivity	_	
287-222	48920-48922	in	_	
287-223	48923-48936	schizophrenia	_	
287-224	48937-48945	patients	_	
287-225	48946-48949	and	_	
287-226	48950-48955	their	_	
287-227	48956-48963	healthy	_	
287-228	48964-48972	siblings	_	
287-229	48973-48984	Frequencies	_	
287-230	48985-48997	contributing	_	
287-231	48998-49000	to	_	
287-232	49001-49011	functional	_	
287-233	49012-49024	connectivity	_	
287-234	49025-49027	in	_	
287-235	49028-49031	the	_	
287-236	49032-49040	cerebral	_	
287-237	49041-49047	cortex	_	
287-238	49048-49050	in	_	
287-239	49051-49052	“	_	
287-240	49052-49065	resting-state	_	
287-241	49065-49066	”	_	
287-242	49067-49071	data	_	
287-243	49072-49073	A	_	
287-244	49074-49079	whole	_	
287-245	49080-49085	brain	_	
287-246	49086-49090	fMRI	_	
287-247	49091-49096	atlas	_	
287-248	49097-49106	generated	_	
287-249	49107-49110	via	_	
287-250	49111-49120	spatially	_	
287-251	49121-49132	constrained	_	
287-252	49133-49141	spectral	_	
287-253	49142-49152	clustering	_	
287-254	49153-49160	Dynamic	_	
287-255	49161-49171	functional	_	
287-256	49172-49184	connectivity	_	
287-257	49185-49193	analysis	_	
287-258	49194-49201	reveals	_	
287-259	49202-49211	transient	_	
287-260	49212-49218	states	_	
287-261	49219-49221	of	_	
287-262	49222-49237	dysconnectivity	_	
287-263	49238-49240	in	_	
287-264	49241-49254	schizophrenia	_	
287-265	49255-49262	Dynamic	_	
287-266	49263-49268	brain	_	
287-267	49269-49279	functional	_	
287-268	49280-49292	connectivity	_	
287-269	49293-49302	modulated	_	
287-270	49303-49305	by	_	
287-271	49306-49319	resting-state	_	
287-272	49320-49328	networks	_	
287-273	49329-49334	Group	_	
287-274	49335-49346	information	_	
287-275	49347-49353	guided	_	
287-276	49354-49357	ICA	_	
287-277	49358-49361	for	_	
287-278	49362-49366	fMRI	_	
287-279	49367-49371	data	_	
287-280	49372-49380	analysis	_	
287-281	49381-49395	Identification	_	
287-282	49396-49398	of	_	
287-283	49399-49406	subject	_	
287-284	49407-49415	specific	_	
287-285	49416-49419	and	_	
287-286	49420-49430	functional	_	
287-287	49431-49441	consistent	_	
287-288	49442-49446	ROIs	_	
287-289	49447-49452	using	_	
287-290	49453-49468	semi-supervised	_	
287-291	49469-49477	learning	_	
287-292	49478-49489	Identifying	_	
287-293	49490-49497	dynamic	_	
287-294	49498-49508	functional	_	
287-295	49509-49521	connectivity	_	
287-296	49522-49532	biomarkers	_	
287-297	49533-49538	using	_	
287-298	49539-49546	GIG-ICA	_	
287-299	49546-49547	:	_	
287-300	49548-49559	application	_	
287-301	49560-49562	to	_	
287-302	49563-49576	schizophrenia	_	
287-303	49576-49577	,	_	
287-304	49578-49593	schizoaffective	_	
287-305	49594-49602	disorder	_	
287-306	49603-49606	and	_	
287-307	49607-49616	psychotic	_	
287-308	49617-49624	bipolar	_	
287-309	49625-49633	disorder	_	
287-310	49634-49645	Identifying	_	
287-311	49646-49651	brain	_	
287-312	49652-49659	dynamic	_	
287-313	49660-49667	network	_	
287-314	49668-49674	states	_	
287-315	49675-49678	via	_	
287-316	49679-49686	GIG-ICA	_	
287-317	49686-49687	:	_	
287-318	49688-49699	Application	_	
287-319	49700-49702	to	_	
287-320	49703-49716	schizophrenia	_	
287-321	49716-49717	,	_	
287-322	49718-49725	bipolar	_	
287-323	49726-49729	and	_	
287-324	49730-49745	schizoaffective	_	
287-325	49746-49755	disorders	_	
287-326	49756-49767	Interaction	_	
287-327	49768-49773	among	_	
287-328	49774-49784	subsystems	_	
287-329	49785-49791	within	_	
287-330	49792-49799	default	_	
287-331	49800-49804	mode	_	
287-332	49805-49812	network	_	
287-333	49813-49823	diminished	_	
287-334	49824-49826	in	_	
287-335	49827-49840	schizophrenia	_	
287-336	49841-49849	patients	_	
287-337	49849-49850	:	_	
287-338	49851-49852	A	_	
287-339	49853-49860	dynamic	_	
287-340	49861-49873	connectivity	_	
287-341	49874-49882	approach	_	
287-342	49883-49892	Exploring	_	
287-343	49893-49899	neural	_	
287-344	49900-49911	dysfunction	_	
287-345	49912-49914	in	_	
287-346	49915-49916	‘	_	
287-347	49916-49924	clinical	_	
287-348	49925-49929	high	_	
287-349	49930-49934	risk	_	
287-350	49934-49935	’	_	
287-351	49936-49939	for	_	
287-352	49940-49949	psychosis	_	
287-353	49949-49950	:	_	
287-354	49951-49952	a	_	
287-355	49953-49965	quantitative	_	
287-356	49966-49972	review	_	
287-357	49973-49975	of	_	
287-358	49976-49980	fMRI	_	
287-359	49981-49988	studies	_	
287-360	49989-49999	Comparison	_	
287-361	50000-50002	of	_	
287-362	50003-50016	multi-subject	_	
287-363	50017-50020	ICA	_	
287-364	50021-50028	methods	_	
287-365	50029-50032	for	_	
287-366	50033-50041	analysis	_	
287-367	50042-50044	of	_	
287-368	50045-50049	fMRI	_	
287-369	50050-50054	data	_	
287-370	50055-50058	The	_	
287-371	50059-50064	human	_	
287-372	50065-50070	brain	_	
287-373	50071-50073	is	_	
287-374	50074-50087	intrinsically	_	
287-375	50088-50097	organized	_	
287-376	50098-50102	into	_	
287-377	50103-50110	dynamic	_	
287-378	50110-50111	,	_	
287-379	50112-50126	anticorrelated	_	
287-380	50127-50137	functional	_	
287-381	50138-50146	networks	_	
287-382	50147-50150	The	_	
287-383	50151-50157	global	_	
287-384	50158-50164	signal	_	
287-385	50165-50168	and	_	
287-386	50169-50177	observed	_	
287-387	50178-50192	anticorrelated	_	
287-388	50193-50200	resting	_	
287-389	50201-50206	state	_	
287-390	50207-50212	brain	_	
287-391	50213-50221	networks	_	
287-392	50222-50228	Sparse	_	
287-393	50229-50236	inverse	_	
287-394	50237-50247	covariance	_	
287-395	50248-50258	estimation	_	
287-396	50259-50263	with	_	
287-397	50264-50267	the	_	
287-398	50268-50277	graphical	_	
287-399	50278-50283	lasso	_	
287-400	50284-50293	Deficient	_	
287-401	50294-50305	Suppression	_	
287-402	50306-50308	of	_	
287-403	50309-50316	Default	_	
287-404	50317-50321	Mode	_	
287-405	50322-50329	Regions	_	
287-406	50330-50336	during	_	
287-407	50337-50344	Working	_	
287-408	50345-50351	Memory	_	
287-409	50352-50354	in	_	
287-410	50355-50366	Individuals	_	
287-411	50367-50371	with	_	
287-412	50372-50377	Early	_	
287-413	50378-50387	Psychosis	_	
287-414	50388-50391	and	_	
287-415	50392-50394	at	_	
287-416	50395-50403	Clinical	_	
287-417	50404-50413	High-Risk	_	
287-418	50414-50417	for	_	
287-419	50418-50427	Psychosis	_	
287-420	50428-50438	Predicting	_	
287-421	50439-50448	psychosis	_	
287-422	50448-50449	:	_	
287-423	50450-50463	meta-analysis	_	
287-424	50464-50466	of	_	
287-425	50467-50477	transition	_	
287-426	50478-50486	outcomes	_	
287-427	50487-50489	in	_	
287-428	50490-50501	individuals	_	
287-429	50502-50504	at	_	
287-430	50505-50509	high	_	
287-431	50510-50518	clinical	_	
287-432	50519-50523	risk	_	
287-433	50524-50532	Abnormal	_	
287-434	50533-50543	prefrontal	_	
287-435	50544-50554	activation	_	
287-436	50555-50563	directly	_	
287-437	50564-50571	related	_	
287-438	50572-50574	to	_	
287-439	50575-50587	pre-synaptic	_	
287-440	50588-50596	striatal	_	
287-441	50597-50605	dopamine	_	
287-442	50606-50617	dysfunction	_	
287-443	50618-50620	in	_	
287-444	50621-50627	people	_	
287-445	50628-50630	at	_	
287-446	50631-50639	clinical	_	
287-447	50640-50644	high	_	
287-448	50645-50649	risk	_	
287-449	50650-50653	for	_	
287-450	50654-50663	psychosis	_	
287-451	50664-50677	Resting-state	_	
287-452	50678-50697	cerebellar-cerebral	_	
287-453	50698-50706	networks	_	
287-454	50707-50710	are	_	
287-455	50711-50722	differently	_	
287-456	50723-50731	affected	_	
287-457	50732-50734	in	_	
287-458	50735-50748	first-episode	_	
287-459	50748-50749	,	_	
287-460	50750-50760	drug-naive	_	
287-461	50761-50774	schizophrenia	_	
287-462	50775-50783	patients	_	
287-463	50784-50787	and	_	
287-464	50788-50798	unaffected	_	
287-465	50799-50807	siblings	_	
287-466	50808-50816	Distinct	_	
287-467	50817-50827	cerebellar	_	
287-468	50828-50841	contributions	_	
287-469	50842-50844	to	_	
287-470	50845-50854	intrinsic	_	
287-471	50855-50867	connectivity	_	
287-472	50868-50876	networks	_	
287-473	50877-50887	Functional	_	
287-474	50888-50900	connectivity	_	
287-475	50901-50909	networks	_	
287-476	50910-50914	with	_	
287-477	50915-50918	and	_	
287-478	50919-50926	without	_	
287-479	50927-50933	global	_	
287-480	50934-50940	signal	_	
287-481	50941-50951	correction	_	
287-482	50952-50965	Resting-state	_	
287-483	50966-50974	networks	_	
287-484	50975-50979	show	_	
287-485	50980-50987	dynamic	_	
287-486	50988-50998	functional	_	
287-487	50999-51011	connectivity	_	
287-488	51012-51014	in	_	
287-489	51015-51020	awake	_	
287-490	51021-51027	humans	_	
287-491	51028-51031	and	_	
287-492	51032-51044	anesthetized	_	
287-493	51045-51053	macaques	_	
287-494	51054-51064	Structural	_	
287-495	51065-51070	brain	_	
287-496	51071-51082	alterations	_	
287-497	51083-51085	in	_	
287-498	51086-51097	individuals	_	
287-499	51098-51100	at	_	
287-500	51101-51111	ultra-high	_	
287-501	51112-51116	risk	_	
287-502	51117-51120	for	_	
287-503	51121-51130	psychosis	_	
287-504	51130-51131	:	_	
287-505	51132-51133	a	_	
287-506	51134-51140	review	_	
287-507	51141-51143	of	_	
287-508	51144-51152	magnetic	_	
287-509	51153-51162	resonance	_	
287-510	51163-51170	imaging	_	
287-511	51171-51178	studies	_	
287-512	51179-51182	and	_	
287-513	51183-51189	future	_	
287-514	51190-51200	directions	_	
287-515	51201-51209	Regional	_	
287-516	51210-51215	brain	_	
287-517	51216-51223	atrophy	_	
287-518	51224-51227	and	_	
287-519	51228-51238	functional	_	
287-520	51239-51252	disconnection	_	
287-521	51253-51255	in	_	
287-522	51256-51261	Broca	_	
287-523	51261-51262	’	_	
287-524	51262-51263	s	_	
287-525	51264-51268	area	_	
287-526	51269-51271	in	_	
287-527	51272-51283	individuals	_	
287-528	51284-51286	at	_	
287-529	51287-51297	ultra-high	_	
287-530	51298-51302	risk	_	
287-531	51303-51306	for	_	
287-532	51307-51316	psychosis	_	
287-533	51317-51320	and	_	
287-534	51321-51334	schizophrenia	_	
287-535	51335-51338	The	_	
287-536	51339-51347	positive	_	
287-537	51348-51351	and	_	
287-538	51352-51360	negative	_	
287-539	51361-51369	syndrome	_	
287-540	51370-51375	scale	_	
287-541	51376-51377	(	_	
287-542	51377-51382	PANSS	_	
287-543	51382-51383	)	_	
287-544	51384-51387	for	_	
287-545	51388-51401	schizophrenia	_	
287-546	51402-51412	Diagnosing	_	
287-547	51413-51426	schizophrenia	_	
287-548	51427-51429	in	_	
287-549	51430-51433	the	_	
287-550	51434-51441	initial	_	
287-551	51442-51451	prodromal	_	
287-552	51452-51457	phase	_	
287-553	51458-51460	Is	_	
287-554	51461-51464	the	_	
287-555	51465-51475	cerebellum	_	
287-556	51476-51484	relevant	_	
287-557	51485-51487	in	_	
287-558	51488-51491	the	_	
287-559	51492-51501	circuitry	_	
287-560	51502-51504	of	_	
287-561	51505-51521	neuropsychiatric	_	
287-562	51522-51531	disorders	_	
287-563	51531-51532	?	_	

#Text=Principal components of functional connectivity: a new approach to study dynamic brain connectivity during rest
#Text=Dynamic functional connectomics signatures for characterization and differentiation of PTSD patients
#Text=Automatic identification of functional clusters in FMRI data using spatial dependence
#Text=
#Text=Higher Dimensional Meta-State Analysis Reveals Reduced Resting fMRI Connectivity Dynamism in Schizophrenia Patients
#Text=Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability
#Text=Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing
#Text=Sensory dysfunction is correlated to cerebellar volume reduction in early schizophrenia
#Text=The impact of global signal regression on resting state correlations: are anti-correlated networks introduced?
288-1	51533-51542	Principal	_	
288-2	51543-51553	components	_	
288-3	51554-51556	of	_	
288-4	51557-51567	functional	_	
288-5	51568-51580	connectivity	_	
288-6	51580-51581	:	_	
288-7	51582-51583	a	_	
288-8	51584-51587	new	_	
288-9	51588-51596	approach	_	
288-10	51597-51599	to	_	
288-11	51600-51605	study	_	
288-12	51606-51613	dynamic	_	
288-13	51614-51619	brain	_	
288-14	51620-51632	connectivity	_	
288-15	51633-51639	during	_	
288-16	51640-51644	rest	_	
288-17	51645-51652	Dynamic	_	
288-18	51653-51663	functional	_	
288-19	51664-51676	connectomics	_	
288-20	51677-51687	signatures	_	
288-21	51688-51691	for	_	
288-22	51692-51708	characterization	_	
288-23	51709-51712	and	_	
288-24	51713-51728	differentiation	_	
288-25	51729-51731	of	_	
288-26	51732-51736	PTSD	_	
288-27	51737-51745	patients	_	
288-28	51746-51755	Automatic	_	
288-29	51756-51770	identification	_	
288-30	51771-51773	of	_	
288-31	51774-51784	functional	_	
288-32	51785-51793	clusters	_	
288-33	51794-51796	in	_	
288-34	51797-51801	FMRI	_	
288-35	51802-51806	data	_	
288-36	51807-51812	using	_	
288-37	51813-51820	spatial	_	
288-38	51821-51831	dependence	_	
288-39	51833-51839	Higher	_	
288-40	51840-51851	Dimensional	_	
288-41	51852-51862	Meta-State	_	
288-42	51863-51871	Analysis	_	
288-43	51872-51879	Reveals	_	
288-44	51880-51887	Reduced	_	
288-45	51888-51895	Resting	_	
288-46	51896-51900	fMRI	_	
288-47	51901-51913	Connectivity	_	
288-48	51914-51922	Dynamism	_	
288-49	51923-51925	in	_	
288-50	51926-51939	Schizophrenia	_	
288-51	51940-51948	Patients	_	
288-52	51949-51958	Prodromal	_	
288-53	51959-51969	assessment	_	
288-54	51970-51974	with	_	
288-55	51975-51978	the	_	
288-56	51979-51989	structured	_	
288-57	51990-51999	interview	_	
288-58	52000-52003	for	_	
288-59	52004-52013	prodromal	_	
288-60	52014-52023	syndromes	_	
288-61	52024-52027	and	_	
288-62	52028-52031	the	_	
288-63	52032-52037	scale	_	
288-64	52038-52040	of	_	
288-65	52041-52050	prodromal	_	
288-66	52051-52059	symptoms	_	
288-67	52059-52060	:	_	
288-68	52061-52071	predictive	_	
288-69	52072-52080	validity	_	
288-70	52080-52081	,	_	
288-71	52082-52092	interrater	_	
288-72	52093-52104	reliability	_	
288-73	52104-52105	,	_	
288-74	52106-52109	and	_	
288-75	52110-52118	training	_	
288-76	52119-52121	to	_	
288-77	52122-52133	reliability	_	
288-78	52134-52141	Imaging	_	
288-79	52142-52156	frontostriatal	_	
288-80	52157-52165	function	_	
288-81	52166-52168	in	_	
288-82	52169-52184	ultra-high-risk	_	
288-83	52184-52185	,	_	
288-84	52186-52191	early	_	
288-85	52191-52192	,	_	
288-86	52193-52196	and	_	
288-87	52197-52204	chronic	_	
288-88	52205-52218	schizophrenia	_	
288-89	52219-52225	during	_	
288-90	52226-52235	executive	_	
288-91	52236-52246	processing	_	
288-92	52247-52254	Sensory	_	
288-93	52255-52266	dysfunction	_	
288-94	52267-52269	is	_	
288-95	52270-52280	correlated	_	
288-96	52281-52283	to	_	
288-97	52284-52294	cerebellar	_	
288-98	52295-52301	volume	_	
288-99	52302-52311	reduction	_	
288-100	52312-52314	in	_	
288-101	52315-52320	early	_	
288-102	52321-52334	schizophrenia	_	
288-103	52335-52338	The	_	
288-104	52339-52345	impact	_	
288-105	52346-52348	of	_	
288-106	52349-52355	global	_	
288-107	52356-52362	signal	_	
288-108	52363-52373	regression	_	
288-109	52374-52376	on	_	
288-110	52377-52384	resting	_	
288-111	52385-52390	state	_	
288-112	52391-52403	correlations	_	
288-113	52403-52404	:	_	
288-114	52405-52408	are	_	
288-115	52409-52424	anti-correlated	_	
288-116	52425-52433	networks	_	
288-117	52434-52444	introduced	_	
288-118	52444-52445	?	_	

#Text=The interaction of working memory and emotion in persons clinically at risk for psychosis: An fMRI pilot study
#Text=Classification of schizophrenia and bipolar patients using static and dynamic resting-state fMRI brain connectivity
#Text=Dynamic connectivity states estimated from resting fMRI Identify differences among Schizophrenia, bipolar disorder, and healthy control subjects
#Text=Brain Connectivity Abnormalities Predating the Onset of Psychosis Correlation With the Effect of Medication
#Text=Increased neural response related to neutral faces in individuals at risk for psychosis
#Text=Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum
#Text=Altered resting-state connectivity in subjects at ultra-high risk for psychosis: an fMRI study
#Text=Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk?
289-1	52446-52449	The	_	
289-2	52450-52461	interaction	_	
289-3	52462-52464	of	_	
289-4	52465-52472	working	_	
289-5	52473-52479	memory	_	
289-6	52480-52483	and	_	
289-7	52484-52491	emotion	_	
289-8	52492-52494	in	_	
289-9	52495-52502	persons	_	
289-10	52503-52513	clinically	_	
289-11	52514-52516	at	_	
289-12	52517-52521	risk	_	
289-13	52522-52525	for	_	
289-14	52526-52535	psychosis	_	
289-15	52535-52536	:	_	
289-16	52537-52539	An	_	
289-17	52540-52544	fMRI	_	
289-18	52545-52550	pilot	_	
289-19	52551-52556	study	_	
289-20	52557-52571	Classification	_	
289-21	52572-52574	of	_	
289-22	52575-52588	schizophrenia	_	
289-23	52589-52592	and	_	
289-24	52593-52600	bipolar	_	
289-25	52601-52609	patients	_	
289-26	52610-52615	using	_	
289-27	52616-52622	static	_	
289-28	52623-52626	and	_	
289-29	52627-52634	dynamic	_	
289-30	52635-52648	resting-state	_	
289-31	52649-52653	fMRI	_	
289-32	52654-52659	brain	_	
289-33	52660-52672	connectivity	_	
289-34	52673-52680	Dynamic	_	
289-35	52681-52693	connectivity	_	
289-36	52694-52700	states	_	
289-37	52701-52710	estimated	_	
289-38	52711-52715	from	_	
289-39	52716-52723	resting	_	
289-40	52724-52728	fMRI	_	
289-41	52729-52737	Identify	_	
289-42	52738-52749	differences	_	
289-43	52750-52755	among	_	
289-44	52756-52769	Schizophrenia	_	
289-45	52769-52770	,	_	
289-46	52771-52778	bipolar	_	
289-47	52779-52787	disorder	_	
289-48	52787-52788	,	_	
289-49	52789-52792	and	_	
289-50	52793-52800	healthy	_	
289-51	52801-52808	control	_	
289-52	52809-52817	subjects	_	
289-53	52818-52823	Brain	_	
289-54	52824-52836	Connectivity	_	
289-55	52837-52850	Abnormalities	_	
289-56	52851-52860	Predating	_	
289-57	52861-52864	the	_	
289-58	52865-52870	Onset	_	
289-59	52871-52873	of	_	
289-60	52874-52883	Psychosis	_	
289-61	52884-52895	Correlation	_	
289-62	52896-52900	With	_	
289-63	52901-52904	the	_	
289-64	52905-52911	Effect	_	
289-65	52912-52914	of	_	
289-66	52915-52925	Medication	_	
289-67	52926-52935	Increased	_	
289-68	52936-52942	neural	_	
289-69	52943-52951	response	_	
289-70	52952-52959	related	_	
289-71	52960-52962	to	_	
289-72	52963-52970	neutral	_	
289-73	52971-52976	faces	_	
289-74	52977-52979	in	_	
289-75	52980-52991	individuals	_	
289-76	52992-52994	at	_	
289-77	52995-52999	risk	_	
289-78	53000-53003	for	_	
289-79	53004-53013	psychosis	_	
289-80	53014-53026	Pre-clinical	_	
289-81	53027-53033	models	_	
289-82	53034-53036	of	_	
289-83	53037-53055	neurodevelopmental	_	
289-84	53056-53065	disorders	_	
289-85	53065-53066	:	_	
289-86	53067-53072	focus	_	
289-87	53073-53075	on	_	
289-88	53076-53079	the	_	
289-89	53080-53090	cerebellum	_	
289-90	53091-53098	Altered	_	
289-91	53099-53112	resting-state	_	
289-92	53113-53125	connectivity	_	
289-93	53126-53128	in	_	
289-94	53129-53137	subjects	_	
289-95	53138-53140	at	_	
289-96	53141-53151	ultra-high	_	
289-97	53152-53156	risk	_	
289-98	53157-53160	for	_	
289-99	53161-53170	psychosis	_	
289-100	53170-53171	:	_	
289-101	53172-53174	an	_	
289-102	53175-53179	fMRI	_	
289-103	53180-53185	study	_	
289-104	53186-53188	Do	_	
289-105	53189-53197	Subjects	_	
289-106	53198-53200	at	_	
289-107	53201-53209	Clinical	_	
289-108	53210-53214	High	_	
289-109	53215-53219	Risk	_	
289-110	53220-53223	for	_	
289-111	53224-53233	Psychosis	_	
289-112	53234-53240	Differ	_	
289-113	53241-53245	from	_	
289-114	53246-53251	those	_	
289-115	53252-53256	with	_	
289-116	53257-53258	a	_	
289-117	53259-53266	Genetic	_	
289-118	53267-53271	High	_	
289-119	53272-53276	Risk	_	
289-120	53276-53277	?	_	

#Text=- A Systematic Review of Structural and Functional Brain Abnormalities
#Text=Network modelling methods for FMRI
#Text=Influence of ROI selection on resting state functional connectivity: an individualized approach for resting state fMRI analysis
#Text=Contributions and challenges for network models in cognitive neuroscience
#Text=Which fMRI clustering gives good brain parcellations?
290-1	53278-53279	-	_	
290-2	53280-53281	A	_	
290-3	53282-53292	Systematic	_	
290-4	53293-53299	Review	_	
290-5	53300-53302	of	_	
290-6	53303-53313	Structural	_	
290-7	53314-53317	and	_	
290-8	53318-53328	Functional	_	
290-9	53329-53334	Brain	_	
290-10	53335-53348	Abnormalities	_	
290-11	53349-53356	Network	_	
290-12	53357-53366	modelling	_	
290-13	53367-53374	methods	_	
290-14	53375-53378	for	_	
290-15	53379-53383	FMRI	_	
290-16	53384-53393	Influence	_	
290-17	53394-53396	of	_	
290-18	53397-53400	ROI	_	
290-19	53401-53410	selection	_	
290-20	53411-53413	on	_	
290-21	53414-53421	resting	_	
290-22	53422-53427	state	_	
290-23	53428-53438	functional	_	
290-24	53439-53451	connectivity	_	
290-25	53451-53452	:	_	
290-26	53453-53455	an	_	
290-27	53456-53470	individualized	_	
290-28	53471-53479	approach	_	
290-29	53480-53483	for	_	
290-30	53484-53491	resting	_	
290-31	53492-53497	state	_	
290-32	53498-53502	fMRI	_	
290-33	53503-53511	analysis	_	
290-34	53512-53525	Contributions	_	
290-35	53526-53529	and	_	
290-36	53530-53540	challenges	_	
290-37	53541-53544	for	_	
290-38	53545-53552	network	_	
290-39	53553-53559	models	_	
290-40	53560-53562	in	_	
290-41	53563-53572	cognitive	_	
290-42	53573-53585	neuroscience	_	
290-43	53586-53591	Which	_	
290-44	53592-53596	fMRI	_	
290-45	53597-53607	clustering	_	
290-46	53608-53613	gives	_	
290-47	53614-53618	good	_	
290-48	53619-53624	brain	_	
290-49	53625-53638	parcellations	_	
290-50	53638-53639	?	_	

#Text=Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
#Text=Exploring the brain network: a review on resting-state fMRI functional connectivity
#Text=Intrinsic Functional Connectivity As a Tool For Human Connectomics: Theory, Properties, and Optimization
#Text=Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P)
#Text=Patients with first-episode, drug-naive schizophrenia and subjects at ultra-high risk of psychosis shared increased cerebellar-default mode network connectivity at rest
#Text=BrainNet Viewer: a network visualization tool for human brain connectomics
#Text=Mutually temporally independent connectivity patterns: A new framework to study the dynamics of brain connectivity at rest with application to explain group difference based on gender
#Text=DPARSF: A MATLAB Toolbox for “Pipeline” Data Analysis of Resting-State fMRI
#Text=The role of the cerebellum in schizophrenia: from cognition to molecular pathways
#Text=Altered Fronto-Temporal Functional Connectivity in Individuals at Ultra-High-Risk of Developing Psychosis
#Text=Assessing dynamic brain graphs of time-varying connectivity in fMRI data: Application to healthy controls and patients with schizophrenia
#Text=Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group
#Text=Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States
#Text=Towards a statistical test for functional connectivity dynamics
#Text=Disease and the brain’s dark energy
#Text=The oscillating brain: complex and reliable
#Text=The schematic drawing of analysis steps.
291-1	53640-53649	Automated	_	
291-2	53650-53660	anatomical	_	
291-3	53661-53669	labeling	_	
291-4	53670-53672	of	_	
291-5	53673-53684	activations	_	
291-6	53685-53687	in	_	
291-7	53688-53691	SPM	_	
291-8	53692-53697	using	_	
291-9	53698-53699	a	_	
291-10	53700-53711	macroscopic	_	
291-11	53712-53722	anatomical	_	
291-12	53723-53735	parcellation	_	
291-13	53736-53738	of	_	
291-14	53739-53742	the	_	
291-15	53743-53746	MNI	_	
291-16	53747-53750	MRI	_	
291-17	53751-53765	single-subject	_	
291-18	53766-53771	brain	_	
291-19	53772-53781	Exploring	_	
291-20	53782-53785	the	_	
291-21	53786-53791	brain	_	
291-22	53792-53799	network	_	
291-23	53799-53800	:	_	
291-24	53801-53802	a	_	
291-25	53803-53809	review	_	
291-26	53810-53812	on	_	
291-27	53813-53826	resting-state	_	
291-28	53827-53831	fMRI	_	
291-29	53832-53842	functional	_	
291-30	53843-53855	connectivity	_	
291-31	53856-53865	Intrinsic	_	
291-32	53866-53876	Functional	_	
291-33	53877-53889	Connectivity	_	
291-34	53890-53892	As	_	
291-35	53893-53894	a	_	
291-36	53895-53899	Tool	_	
291-37	53900-53903	For	_	
291-38	53904-53909	Human	_	
291-39	53910-53922	Connectomics	_	
291-40	53922-53923	:	_	
291-41	53924-53930	Theory	_	
291-42	53930-53931	,	_	
291-43	53932-53942	Properties	_	
291-44	53942-53943	,	_	
291-45	53944-53947	and	_	
291-46	53948-53960	Optimization	_	
291-47	53961-53969	Training	_	
291-48	53970-53973	and	_	
291-49	53974-53981	quality	_	
291-50	53982-53991	assurance	_	
291-51	53992-53996	with	_	
291-52	53997-54000	the	_	
291-53	54001-54011	Structured	_	
291-54	54012-54020	Clinical	_	
291-55	54021-54030	Interview	_	
291-56	54031-54034	for	_	
291-57	54035-54041	DSM-IV	_	
291-58	54042-54043	(	_	
291-59	54043-54049	SCID-I	_	
291-60	54049-54050	/	_	
291-61	54050-54051	P	_	
291-62	54051-54052	)	_	
291-63	54053-54061	Patients	_	
291-64	54062-54066	with	_	
291-65	54067-54080	first-episode	_	
291-66	54080-54081	,	_	
291-67	54082-54092	drug-naive	_	
291-68	54093-54106	schizophrenia	_	
291-69	54107-54110	and	_	
291-70	54111-54119	subjects	_	
291-71	54120-54122	at	_	
291-72	54123-54133	ultra-high	_	
291-73	54134-54138	risk	_	
291-74	54139-54141	of	_	
291-75	54142-54151	psychosis	_	
291-76	54152-54158	shared	_	
291-77	54159-54168	increased	_	
291-78	54169-54187	cerebellar-default	_	
291-79	54188-54192	mode	_	
291-80	54193-54200	network	_	
291-81	54201-54213	connectivity	_	
291-82	54214-54216	at	_	
291-83	54217-54221	rest	_	
291-84	54222-54230	BrainNet	_	
291-85	54231-54237	Viewer	_	
291-86	54237-54238	:	_	
291-87	54239-54240	a	_	
291-88	54241-54248	network	_	
291-89	54249-54262	visualization	_	
291-90	54263-54267	tool	_	
291-91	54268-54271	for	_	
291-92	54272-54277	human	_	
291-93	54278-54283	brain	_	
291-94	54284-54296	connectomics	_	
291-95	54297-54305	Mutually	_	
291-96	54306-54316	temporally	_	
291-97	54317-54328	independent	_	
291-98	54329-54341	connectivity	_	
291-99	54342-54350	patterns	_	
291-100	54350-54351	:	_	
291-101	54352-54353	A	_	
291-102	54354-54357	new	_	
291-103	54358-54367	framework	_	
291-104	54368-54370	to	_	
291-105	54371-54376	study	_	
291-106	54377-54380	the	_	
291-107	54381-54389	dynamics	_	
291-108	54390-54392	of	_	
291-109	54393-54398	brain	_	
291-110	54399-54411	connectivity	_	
291-111	54412-54414	at	_	
291-112	54415-54419	rest	_	
291-113	54420-54424	with	_	
291-114	54425-54436	application	_	
291-115	54437-54439	to	_	
291-116	54440-54447	explain	_	
291-117	54448-54453	group	_	
291-118	54454-54464	difference	_	
291-119	54465-54470	based	_	
291-120	54471-54473	on	_	
291-121	54474-54480	gender	_	
291-122	54481-54487	DPARSF	_	
291-123	54487-54488	:	_	
291-124	54489-54490	A	_	
291-125	54491-54497	MATLAB	_	
291-126	54498-54505	Toolbox	_	
291-127	54506-54509	for	_	
291-128	54510-54511	“	_	
291-129	54511-54519	Pipeline	_	
291-130	54519-54520	”	_	
291-131	54521-54525	Data	_	
291-132	54526-54534	Analysis	_	
291-133	54535-54537	of	_	
291-134	54538-54551	Resting-State	_	
291-135	54552-54556	fMRI	_	
291-136	54557-54560	The	_	
291-137	54561-54565	role	_	
291-138	54566-54568	of	_	
291-139	54569-54572	the	_	
291-140	54573-54583	cerebellum	_	
291-141	54584-54586	in	_	
291-142	54587-54600	schizophrenia	_	
291-143	54600-54601	:	_	
291-144	54602-54606	from	_	
291-145	54607-54616	cognition	_	
291-146	54617-54619	to	_	
291-147	54620-54629	molecular	_	
291-148	54630-54638	pathways	_	
291-149	54639-54646	Altered	_	
291-150	54647-54662	Fronto-Temporal	_	
291-151	54663-54673	Functional	_	
291-152	54674-54686	Connectivity	_	
291-153	54687-54689	in	_	
291-154	54690-54701	Individuals	_	
291-155	54702-54704	at	_	
291-156	54705-54720	Ultra-High-Risk	_	
291-157	54721-54723	of	_	
291-158	54724-54734	Developing	_	
291-159	54735-54744	Psychosis	_	
291-160	54745-54754	Assessing	_	
291-161	54755-54762	dynamic	_	
291-162	54763-54768	brain	_	
291-163	54769-54775	graphs	_	
291-164	54776-54778	of	_	
291-165	54779-54791	time-varying	_	
291-166	54792-54804	connectivity	_	
291-167	54805-54807	in	_	
291-168	54808-54812	fMRI	_	
291-169	54813-54817	data	_	
291-170	54817-54818	:	_	
291-171	54819-54830	Application	_	
291-172	54831-54833	to	_	
291-173	54834-54841	healthy	_	
291-174	54842-54850	controls	_	
291-175	54851-54854	and	_	
291-176	54855-54863	patients	_	
291-177	54864-54868	with	_	
291-178	54869-54882	schizophrenia	_	
291-179	54883-54892	Psychosis	_	
291-180	54893-54903	prediction	_	
291-181	54903-54904	:	_	
291-182	54905-54907	12	_	
291-183	54907-54908	-	_	
291-184	54908-54913	month	_	
291-185	54914-54920	follow	_	
291-186	54921-54923	up	_	
291-187	54924-54926	of	_	
291-188	54927-54928	a	_	
291-189	54929-54938	high-risk	_	
291-190	54939-54940	(	_	
291-191	54940-54941	“	_	
291-192	54941-54950	prodromal	_	
291-193	54950-54951	”	_	
291-194	54951-54952	)	_	
291-195	54953-54958	group	_	
291-196	54959-54966	Mapping	_	
291-197	54967-54970	the	_	
291-198	54971-54976	onset	_	
291-199	54977-54979	of	_	
291-200	54980-54989	psychosis	_	
291-201	54989-54990	:	_	
291-202	54991-54994	the	_	
291-203	54995-55008	Comprehensive	_	
291-204	55009-55019	Assessment	_	
291-205	55020-55022	of	_	
291-206	55023-55030	At-Risk	_	
291-207	55031-55037	Mental	_	
291-208	55038-55044	States	_	
291-209	55045-55052	Towards	_	
291-210	55053-55054	a	_	
291-211	55055-55066	statistical	_	
291-212	55067-55071	test	_	
291-213	55072-55075	for	_	
291-214	55076-55086	functional	_	
291-215	55087-55099	connectivity	_	
291-216	55100-55108	dynamics	_	
291-217	55109-55116	Disease	_	
291-218	55117-55120	and	_	
291-219	55121-55124	the	_	
291-220	55125-55130	brain	_	
291-221	55130-55131	’	_	
291-222	55131-55132	s	_	
291-223	55133-55137	dark	_	
291-224	55138-55144	energy	_	
291-225	55145-55148	The	_	
291-226	55149-55160	oscillating	_	
291-227	55161-55166	brain	_	
291-228	55166-55167	:	_	
291-229	55168-55175	complex	_	
291-230	55176-55179	and	_	
291-231	55180-55188	reliable	_	
291-232	55189-55192	The	_	
291-233	55193-55202	schematic	_	
291-234	55203-55210	drawing	_	
291-235	55211-55213	of	_	
291-236	55214-55222	analysis	_	
291-237	55223-55228	steps	_	
291-238	55228-55229	.	_	

#Text=A: Estimation of dynamic functional connectivity (DFC) of individual subject (e.g., the kth subject) using a sliding time-window method based on regions of interests (ROIs).
292-1	55230-55231	A	_	
292-2	55231-55232	:	_	
292-3	55233-55243	Estimation	_	
292-4	55244-55246	of	_	
292-5	55247-55254	dynamic	_	
292-6	55255-55265	functional	_	
292-7	55266-55278	connectivity	_	
292-8	55279-55280	(	_	
292-9	55280-55283	DFC	_	
292-10	55283-55284	)	_	
292-11	55285-55287	of	_	
292-12	55288-55298	individual	_	
292-13	55299-55306	subject	_	
292-14	55307-55308	(	_	
292-15	55308-55311	e.g	_	
292-16	55311-55312	.	_	
292-17	55312-55313	,	_	
292-18	55314-55317	the	_	
292-19	55318-55321	kth	_	
292-20	55322-55329	subject	_	
292-21	55329-55330	)	_	
292-22	55331-55336	using	_	
292-23	55337-55338	a	_	
292-24	55339-55346	sliding	_	
292-25	55347-55358	time-window	_	
292-26	55359-55365	method	_	
292-27	55366-55371	based	_	
292-28	55372-55374	on	_	
292-29	55375-55382	regions	_	
292-30	55383-55385	of	_	
292-31	55386-55395	interests	_	
292-32	55396-55397	(	_	
292-33	55397-55401	ROIs	_	
292-34	55401-55402	)	_	
292-35	55402-55403	.	_	

#Text=For each subject, a window-by-connectivity matrix (e.g., Xk) is obtained to reflect its DFC.
293-1	55404-55407	For	_	
293-2	55408-55412	each	_	
293-3	55413-55420	subject	_	
293-4	55420-55421	,	_	
293-5	55422-55423	a	_	
293-6	55424-55446	window-by-connectivity	_	
293-7	55447-55453	matrix	_	
293-8	55454-55455	(	_	
293-9	55455-55458	e.g	_	
293-10	55458-55459	.	_	
293-11	55459-55460	,	_	
293-12	55461-55463	Xk	_	
293-13	55463-55464	)	_	
293-14	55465-55467	is	_	
293-15	55468-55476	obtained	_	
293-16	55477-55479	to	_	
293-17	55480-55487	reflect	_	
293-18	55488-55491	its	_	
293-19	55492-55495	DFC	_	
293-20	55495-55496	.	_	

#Text=B: Computation of group-level connectivity states.
294-1	55497-55498	B	_	
294-2	55498-55499	:	_	
294-3	55500-55511	Computation	_	
294-4	55512-55514	of	_	
294-5	55515-55526	group-level	_	
294-6	55527-55539	connectivity	_	
294-7	55540-55546	states	_	
294-8	55546-55547	.	_	

#Text=For each group, the window direction-concatenated dynamic connectivity matrix X from all N subjects was decomposed by ICA to obtain M group-level states (GSs) and the subject-specific fluctuations (SFs) of these states.
295-1	55548-55551	For	_	
295-2	55552-55556	each	_	
295-3	55557-55562	group	_	
295-4	55562-55563	,	_	
295-5	55564-55567	the	_	
295-6	55568-55574	window	_	
295-7	55575-55597	direction-concatenated	_	
295-8	55598-55605	dynamic	_	
295-9	55606-55618	connectivity	_	
295-10	55619-55625	matrix	_	
295-11	55626-55627	X	_	
295-12	55628-55632	from	_	
295-13	55633-55636	all	_	
295-14	55637-55638	N	_	
295-15	55639-55647	subjects	_	
295-16	55648-55651	was	_	
295-17	55652-55662	decomposed	_	
295-18	55663-55665	by	_	
295-19	55666-55669	ICA	_	
295-20	55670-55672	to	_	
295-21	55673-55679	obtain	_	
295-22	55680-55681	M	_	
295-23	55682-55693	group-level	_	
295-24	55694-55700	states	_	
295-25	55701-55702	(	_	
295-26	55702-55705	GSs	_	
295-27	55705-55706	)	_	
295-28	55707-55710	and	_	
295-29	55711-55714	the	_	
295-30	55715-55731	subject-specific	_	
295-31	55732-55744	fluctuations	_	
295-32	55745-55746	(	_	
295-33	55746-55749	SFs	_	
295-34	55749-55750	)	_	
295-35	55751-55753	of	_	
295-36	55754-55759	these	_	
295-37	55760-55766	states	_	
295-38	55766-55767	.	_	

#Text=C: Computation of individual-subject’s connectivity states.
296-1	55768-55769	C	_	
296-2	55769-55770	:	_	
296-3	55771-55782	Computation	_	
296-4	55783-55785	of	_	
296-5	55786-55804	individual-subject	_	
296-6	55804-55805	’	_	
296-7	55805-55806	s	_	
296-8	55807-55819	connectivity	_	
296-9	55820-55826	states	_	
296-10	55826-55827	.	_	

#Text=Based on the dominant group-level state (i.e., Sl) and individual-subject’s dynamic functional connectivity matrix (e.g., Xk), the dominant subject-specific state (SS, e.g., 
#Text=) of each subject can be computed.
297-1	55828-55833	Based	_	
297-2	55834-55836	on	_	
297-3	55837-55840	the	_	
297-4	55841-55849	dominant	_	
297-5	55850-55861	group-level	_	
297-6	55862-55867	state	_	
297-7	55868-55869	(	_	
297-8	55869-55872	i.e	_	
297-9	55872-55873	.	_	
297-10	55873-55874	,	_	
297-11	55875-55877	Sl	_	
297-12	55877-55878	)	_	
297-13	55879-55882	and	_	
297-14	55883-55901	individual-subject	_	
297-15	55901-55902	’	_	
297-16	55902-55903	s	_	
297-17	55904-55911	dynamic	_	
297-18	55912-55922	functional	_	
297-19	55923-55935	connectivity	_	
297-20	55936-55942	matrix	_	
297-21	55943-55944	(	_	
297-22	55944-55947	e.g	_	
297-23	55947-55948	.	_	
297-24	55948-55949	,	_	
297-25	55950-55952	Xk	_	
297-26	55952-55953	)	_	
297-27	55953-55954	,	_	
297-28	55955-55958	the	_	
297-29	55959-55967	dominant	_	
297-30	55968-55984	subject-specific	_	
297-31	55985-55990	state	_	
297-32	55991-55992	(	_	
297-33	55992-55994	SS	_	
297-34	55994-55995	,	_	
297-35	55996-55999	e.g	_	
297-36	55999-56000	.	_	
297-37	56000-56001	,	_	
297-38	56003-56004	)	_	
297-39	56005-56007	of	_	
297-40	56008-56012	each	_	
297-41	56013-56020	subject	_	
297-42	56021-56024	can	_	
297-43	56025-56027	be	_	
297-44	56028-56036	computed	_	
297-45	56036-56037	.	_	

#Text=The corresponding group-level connectivity states (GSs) in matrix form, rendered form, and their inter-group correlations for healthy control (HC), clinical high-risk (CHR) and early illness schizophrenia (ESZ) groups.
298-1	56038-56041	The	_	
298-2	56042-56055	corresponding	_	
298-3	56056-56067	group-level	_	
298-4	56068-56080	connectivity	_	
298-5	56081-56087	states	_	
298-6	56088-56089	(	_	
298-7	56089-56092	GSs	_	
298-8	56092-56093	)	_	
298-9	56094-56096	in	_	
298-10	56097-56103	matrix	_	
298-11	56104-56108	form	_	
298-12	56108-56109	,	_	
298-13	56110-56118	rendered	_	
298-14	56119-56123	form	_	
298-15	56123-56124	,	_	
298-16	56125-56128	and	_	
298-17	56129-56134	their	_	
298-18	56135-56146	inter-group	_	
298-19	56147-56159	correlations	_	
298-20	56160-56163	for	_	
298-21	56164-56171	healthy	_	
298-22	56172-56179	control	_	
298-23	56180-56181	(	_	
298-24	56181-56183	HC	_	
298-25	56183-56184	)	_	
298-26	56184-56185	,	_	
298-27	56186-56194	clinical	_	
298-28	56195-56204	high-risk	_	
298-29	56205-56206	(	_	
298-30	56206-56209	CHR	_	
298-31	56209-56210	)	_	
298-32	56211-56214	and	_	
298-33	56215-56220	early	_	
298-34	56221-56228	illness	_	
298-35	56229-56242	schizophrenia	_	
298-36	56243-56244	(	_	
298-37	56244-56247	ESZ	_	
298-38	56247-56248	)	_	
298-39	56249-56255	groups	_	
298-40	56255-56256	.	_	

#Text=Each rendered GS is another view of the associated GS matrix, shown using the BrainNet Viewer toolbox with the same sparsity.
299-1	56257-56261	Each	_	
299-2	56262-56270	rendered	_	
299-3	56271-56273	GS	_	
299-4	56274-56276	is	_	
299-5	56277-56284	another	_	
299-6	56285-56289	view	_	
299-7	56290-56292	of	_	
299-8	56293-56296	the	_	
299-9	56297-56307	associated	_	
299-10	56308-56310	GS	_	
299-11	56311-56317	matrix	_	
299-12	56317-56318	,	_	
299-13	56319-56324	shown	_	
299-14	56325-56330	using	_	
299-15	56331-56334	the	_	
299-16	56335-56343	BrainNet	_	
299-17	56344-56350	Viewer	_	
299-18	56351-56358	toolbox	_	
299-19	56359-56363	with	_	
299-20	56364-56367	the	_	
299-21	56368-56372	same	_	
299-22	56373-56381	sparsity	_	
299-23	56381-56382	.	_	

#Text=The red and blue lines represent positive and negative values, respectively.
300-1	56383-56386	The	_	
300-2	56387-56390	red	_	
300-3	56391-56394	and	_	
300-4	56395-56399	blue	_	
300-5	56400-56405	lines	_	
300-6	56406-56415	represent	_	
300-7	56416-56424	positive	_	
300-8	56425-56428	and	_	
300-9	56429-56437	negative	_	
300-10	56438-56444	values	_	
300-11	56444-56445	,	_	
300-12	56446-56458	respectively	_	
300-13	56458-56459	.	_	

#Text=The first column corresponds to the dominant GS.
301-1	56460-56463	The	_	
301-2	56464-56469	first	_	
301-3	56470-56476	column	_	
301-4	56477-56488	corresponds	_	
301-5	56489-56491	to	_	
301-6	56492-56495	the	_	
301-7	56496-56504	dominant	_	
301-8	56505-56507	GS	_	
301-9	56507-56508	.	_	

#Text=The last row shows the correlation matrix of three matched GSs from three groups.
302-1	56509-56512	The	_	
302-2	56513-56517	last	_	
302-3	56518-56521	row	_	
302-4	56522-56527	shows	_	
302-5	56528-56531	the	_	
302-6	56532-56543	correlation	_	
302-7	56544-56550	matrix	_	
302-8	56551-56553	of	_	
302-9	56554-56559	three	_	
302-10	56560-56567	matched	_	
302-11	56568-56571	GSs	_	
302-12	56572-56576	from	_	
302-13	56577-56582	three	_	
302-14	56583-56589	groups	_	
302-15	56589-56590	.	_	

#Text=The overall similarity between the matched GSs is also shown along with each correlation matrix.
303-1	56591-56594	The	_	
303-2	56595-56602	overall	_	
303-3	56603-56613	similarity	_	
303-4	56614-56621	between	_	
303-5	56622-56625	the	_	
303-6	56626-56633	matched	_	
303-7	56634-56637	GSs	_	
303-8	56638-56640	is	_	
303-9	56641-56645	also	_	
303-10	56646-56651	shown	_	
303-11	56652-56657	along	_	
303-12	56658-56662	with	_	
303-13	56663-56667	each	_	
303-14	56668-56679	correlation	_	
303-15	56680-56686	matrix	_	
303-16	56686-56687	.	_	

#Text=The mean correlation matrix of the matched GSs across 100 permutation runs for each state.
304-1	56688-56691	The	_	
304-2	56692-56696	mean	_	
304-3	56697-56708	correlation	_	
304-4	56709-56715	matrix	_	
304-5	56716-56718	of	_	
304-6	56719-56722	the	_	
304-7	56723-56730	matched	_	
304-8	56731-56734	GSs	_	
304-9	56735-56741	across	_	
304-10	56742-56745	100	_	
304-11	56746-56757	permutation	_	
304-12	56758-56762	runs	_	
304-13	56763-56766	for	_	
304-14	56767-56771	each	_	
304-15	56772-56777	state	_	
304-16	56777-56778	.	_	

#Text=The overall similarity between the matched GSs is also shown along with each correlation matrix.
305-1	56779-56782	The	_	
305-2	56783-56790	overall	_	
305-3	56791-56801	similarity	_	
305-4	56802-56809	between	_	
305-5	56810-56813	the	_	
305-6	56814-56821	matched	_	
305-7	56822-56825	GSs	_	
305-8	56826-56828	is	_	
305-9	56829-56833	also	_	
305-10	56834-56839	shown	_	
305-11	56840-56845	along	_	
305-12	56846-56850	with	_	
305-13	56851-56855	each	_	
305-14	56856-56867	correlation	_	
305-15	56868-56874	matrix	_	
305-16	56874-56875	.	_	

#Text=Values of subject-specific fluctuations (SFs) in the concatenated windows of all subjects for each state.
306-1	56876-56882	Values	_	
306-2	56883-56885	of	_	
306-3	56886-56902	subject-specific	_	
306-4	56903-56915	fluctuations	_	
306-5	56916-56917	(	_	
306-6	56917-56920	SFs	_	
306-7	56920-56921	)	_	
306-8	56922-56924	in	_	
306-9	56925-56928	the	_	
306-10	56929-56941	concatenated	_	
306-11	56942-56949	windows	_	
306-12	56950-56952	of	_	
306-13	56953-56956	all	_	
306-14	56957-56965	subjects	_	
306-15	56966-56969	for	_	
306-16	56970-56974	each	_	
306-17	56975-56980	state	_	
306-18	56980-56981	.	_	

#Text=A–C: The functional connectivity matrix of the mean dominant subject-specific FC state (SS) across subjects and its visualized pattern for the healthy control (HC), clinical high-risk (CHR) and early illness schizophrenia (ESZ) group, respectively.
307-1	56982-56985	A–C	_	
307-2	56985-56986	:	_	
307-3	56987-56990	The	_	
307-4	56991-57001	functional	_	
307-5	57002-57014	connectivity	_	
307-6	57015-57021	matrix	_	
307-7	57022-57024	of	_	
307-8	57025-57028	the	_	
307-9	57029-57033	mean	_	
307-10	57034-57042	dominant	_	
307-11	57043-57059	subject-specific	_	
307-12	57060-57062	FC	_	
307-13	57063-57068	state	_	
307-14	57069-57070	(	_	
307-15	57070-57072	SS	_	
307-16	57072-57073	)	_	
307-17	57074-57080	across	_	
307-18	57081-57089	subjects	_	
307-19	57090-57093	and	_	
307-20	57094-57097	its	_	
307-21	57098-57108	visualized	_	
307-22	57109-57116	pattern	_	
307-23	57117-57120	for	_	
307-24	57121-57124	the	_	
307-25	57125-57132	healthy	_	
307-26	57133-57140	control	_	
307-27	57141-57142	(	_	
307-28	57142-57144	HC	_	
307-29	57144-57145	)	_	
307-30	57145-57146	,	_	
307-31	57147-57155	clinical	_	
307-32	57156-57165	high-risk	_	
307-33	57166-57167	(	_	
307-34	57167-57170	CHR	_	
307-35	57170-57171	)	_	
307-36	57172-57175	and	_	
307-37	57176-57181	early	_	
307-38	57182-57189	illness	_	
307-39	57190-57203	schizophrenia	_	
307-40	57204-57205	(	_	
307-41	57205-57208	ESZ	_	
307-42	57208-57209	)	_	
307-43	57210-57215	group	_	
307-44	57215-57216	,	_	
307-45	57217-57229	respectively	_	
307-46	57229-57230	.	_	

#Text=In A–C, the red and blue lines represent the positive and negative strengths, respectively.
308-1	57231-57233	In	_	
308-2	57234-57237	A–C	_	
308-3	57237-57238	,	_	
308-4	57239-57242	the	_	
308-5	57243-57246	red	_	
308-6	57247-57250	and	_	
308-7	57251-57255	blue	_	
308-8	57256-57261	lines	_	
308-9	57262-57271	represent	_	
308-10	57272-57275	the	_	
308-11	57276-57284	positive	_	
308-12	57285-57288	and	_	
308-13	57289-57297	negative	_	
308-14	57298-57307	strengths	_	
308-15	57307-57308	,	_	
308-16	57309-57321	respectively	_	
308-17	57321-57322	.	_	

#Text=D: Left: Statistical map (−log10 (p) values) obtained by performing analysis of covariance (ANCOVA) with age and gender as covariates on each connection in the dominant SSs of three groups.
309-1	57323-57324	D	_	
309-2	57324-57325	:	_	
309-3	57326-57330	Left	_	
309-4	57330-57331	:	_	
309-5	57332-57343	Statistical	_	
309-6	57344-57347	map	_	
309-7	57348-57349	(	_	
309-8	57349-57350	−	_	
309-9	57350-57355	log10	_	
309-10	57356-57357	(	_	
309-11	57357-57358	p	_	
309-12	57358-57359	)	_	
309-13	57360-57366	values	_	
309-14	57366-57367	)	_	
309-15	57368-57376	obtained	_	
309-16	57377-57379	by	_	
309-17	57380-57390	performing	_	
309-18	57391-57399	analysis	_	
309-19	57400-57402	of	_	
309-20	57403-57413	covariance	_	
309-21	57414-57415	(	_	
309-22	57415-57421	ANCOVA	_	
309-23	57421-57422	)	_	
309-24	57423-57427	with	_	
309-25	57428-57431	age	_	
309-26	57432-57435	and	_	
309-27	57436-57442	gender	_	
309-28	57443-57445	as	_	
309-29	57446-57456	covariates	_	
309-30	57457-57459	on	_	
309-31	57460-57464	each	_	
309-32	57465-57475	connection	_	
309-33	57476-57478	in	_	
309-34	57479-57482	the	_	
309-35	57483-57491	dominant	_	
309-36	57492-57495	SSs	_	
309-37	57496-57498	of	_	
309-38	57499-57504	three	_	
309-39	57505-57511	groups	_	
309-40	57511-57512	.	_	

#Text=Right: The visualized pattern of the 30 FCs showing significant group difference (p < 0.05 with Bonferroni correction, i.e., p < 0.05/6670).
310-1	57513-57518	Right	_	
310-2	57518-57519	:	_	
310-3	57520-57523	The	_	
310-4	57524-57534	visualized	_	
310-5	57535-57542	pattern	_	
310-6	57543-57545	of	_	
310-7	57546-57549	the	_	
310-8	57550-57552	30	_	
310-9	57553-57556	FCs	_	
310-10	57557-57564	showing	_	
310-11	57565-57576	significant	_	
310-12	57577-57582	group	_	
310-13	57583-57593	difference	_	
310-14	57594-57595	(	_	
310-15	57595-57596	p	_	
310-16	57597-57598	<	_	
310-17	57599-57603	0.05	_	
310-18	57604-57608	with	_	
310-19	57609-57619	Bonferroni	_	
310-20	57620-57630	correction	_	
310-21	57630-57631	,	_	
310-22	57632-57635	i.e	_	
310-23	57635-57636	.	_	
310-24	57636-57637	,	_	
310-25	57638-57639	p	_	
310-26	57640-57641	<	_	
310-27	57642-57646	0.05	_	
310-28	57646-57647	/	_	
310-29	57647-57651	6670	_	
310-30	57651-57652	)	_	
310-31	57652-57653	.	_	

#Text=The thickness of the line reflecting one edge reflects the associated F-value.
311-1	57654-57657	The	_	
311-2	57658-57667	thickness	_	
311-3	57668-57670	of	_	
311-4	57671-57674	the	_	
311-5	57675-57679	line	_	
311-6	57680-57690	reflecting	_	
311-7	57691-57694	one	_	
311-8	57695-57699	edge	_	
311-9	57700-57708	reflects	_	
311-10	57709-57712	the	_	
311-11	57713-57723	associated	_	
311-12	57724-57731	F-value	_	
311-13	57731-57732	.	_	

#Text=The colors of the nodes and edges in the subfigure D are organized by their modules in the AAL template provided by the BrainNet Viewer software.
312-1	57733-57736	The	_	
312-2	57737-57743	colors	_	
312-3	57744-57746	of	_	
312-4	57747-57750	the	_	
312-5	57751-57756	nodes	_	
312-6	57757-57760	and	_	
312-7	57761-57766	edges	_	
312-8	57767-57769	in	_	
312-9	57770-57773	the	_	
312-10	57774-57783	subfigure	_	
312-11	57784-57785	D	_	
312-12	57786-57789	are	_	
312-13	57790-57799	organized	_	
312-14	57800-57802	by	_	
312-15	57803-57808	their	_	
312-16	57809-57816	modules	_	
312-17	57817-57819	in	_	
312-18	57820-57823	the	_	
312-19	57824-57827	AAL	_	
312-20	57828-57836	template	_	
312-21	57837-57845	provided	_	
312-22	57846-57848	by	_	
312-23	57849-57852	the	_	
312-24	57853-57861	BrainNet	_	
312-25	57862-57868	Viewer	_	
312-26	57869-57877	software	_	
312-27	57877-57878	.	_	

#Text=Nodes belonging to the same module and edges linking such nodes are shown using the same color.
313-1	57879-57884	Nodes	_	
313-2	57885-57894	belonging	_	
313-3	57895-57897	to	_	
313-4	57898-57901	the	_	
313-5	57902-57906	same	_	
313-6	57907-57913	module	_	
313-7	57914-57917	and	_	
313-8	57918-57923	edges	_	
313-9	57924-57931	linking	_	
313-10	57932-57936	such	_	
313-11	57937-57942	nodes	_	
313-12	57943-57946	are	_	
313-13	57947-57952	shown	_	
313-14	57953-57958	using	_	
313-15	57959-57962	the	_	
313-16	57963-57967	same	_	
313-17	57968-57973	color	_	
313-18	57973-57974	.	_	

#Text=Edges linking two nodes belonging to different modules are shown in grey color.
314-1	57975-57980	Edges	_	
314-2	57981-57988	linking	_	
314-3	57989-57992	two	_	
314-4	57993-57998	nodes	_	
314-5	57999-58008	belonging	_	
314-6	58009-58011	to	_	
314-7	58012-58021	different	_	
314-8	58022-58029	modules	_	
314-9	58030-58033	are	_	
314-10	58034-58039	shown	_	
314-11	58040-58042	in	_	
314-12	58043-58047	grey	_	
314-13	58048-58053	color	_	
314-14	58053-58054	.	_	

#Text=A: Two-sample t-test results of the identified 30 FCs in the dominant subject-specific FC state (SS).
315-1	58055-58056	A	_	
315-2	58056-58057	:	_	
315-3	58058-58068	Two-sample	_	
315-4	58069-58075	t-test	_	
315-5	58076-58083	results	_	
315-6	58084-58086	of	_	
315-7	58087-58090	the	_	
315-8	58091-58101	identified	_	
315-9	58102-58104	30	_	
315-10	58105-58108	FCs	_	
315-11	58109-58111	in	_	
315-12	58112-58115	the	_	
315-13	58116-58124	dominant	_	
315-14	58125-58141	subject-specific	_	
315-15	58142-58144	FC	_	
315-16	58145-58150	state	_	
315-17	58151-58152	(	_	
315-18	58152-58154	SS	_	
315-19	58154-58155	)	_	
315-20	58155-58156	.	_	

#Text=The result of each FC is shown in one sub-figure, the title of which denotes the associated two regions of interest (ROIs).
316-1	58157-58160	The	_	
316-2	58161-58167	result	_	
316-3	58168-58170	of	_	
316-4	58171-58175	each	_	
316-5	58176-58178	FC	_	
316-6	58179-58181	is	_	
316-7	58182-58187	shown	_	
316-8	58188-58190	in	_	
316-9	58191-58194	one	_	
316-10	58195-58205	sub-figure	_	
316-11	58205-58206	,	_	
316-12	58207-58210	the	_	
316-13	58211-58216	title	_	
316-14	58217-58219	of	_	
316-15	58220-58225	which	_	
316-16	58226-58233	denotes	_	
316-17	58234-58237	the	_	
316-18	58238-58248	associated	_	
316-19	58249-58252	two	_	
316-20	58253-58260	regions	_	
316-21	58261-58263	of	_	
316-22	58264-58272	interest	_	
316-23	58273-58274	(	_	
316-24	58274-58278	ROIs	_	
316-25	58278-58279	)	_	
316-26	58279-58280	.	_	

#Text=For each of the 30 FCs, connectivity strengths of all subjects in one group are shown using one boxplot.
317-1	58281-58284	For	_	
317-2	58285-58289	each	_	
317-3	58290-58292	of	_	
317-4	58293-58296	the	_	
317-5	58297-58299	30	_	
317-6	58300-58303	FCs	_	
317-7	58303-58304	,	_	
317-8	58305-58317	connectivity	_	
317-9	58318-58327	strengths	_	
317-10	58328-58330	of	_	
317-11	58331-58334	all	_	
317-12	58335-58343	subjects	_	
317-13	58344-58346	in	_	
317-14	58347-58350	one	_	
317-15	58351-58356	group	_	
317-16	58357-58360	are	_	
317-17	58361-58366	shown	_	
317-18	58367-58372	using	_	
317-19	58373-58376	one	_	
317-20	58377-58384	boxplot	_	
317-21	58384-58385	.	_	

#Text=Any pair of groups showing a significant difference (two-sample t-test, p < 0.05 with Bonferroni correction) is denoted using a blue line with a star (*) between them.
318-1	58386-58389	Any	_	
318-2	58390-58394	pair	_	
318-3	58395-58397	of	_	
318-4	58398-58404	groups	_	
318-5	58405-58412	showing	_	
318-6	58413-58414	a	_	
318-7	58415-58426	significant	_	
318-8	58427-58437	difference	_	
318-9	58438-58439	(	_	
318-10	58439-58449	two-sample	_	
318-11	58450-58456	t-test	_	
318-12	58456-58457	,	_	
318-13	58458-58459	p	_	
318-14	58460-58461	<	_	
318-15	58462-58466	0.05	_	
318-16	58467-58471	with	_	
318-17	58472-58482	Bonferroni	_	
318-18	58483-58493	correction	_	
318-19	58493-58494	)	_	
318-20	58495-58497	is	_	
318-21	58498-58505	denoted	_	
318-22	58506-58511	using	_	
318-23	58512-58513	a	_	
318-24	58514-58518	blue	_	
318-25	58519-58523	line	_	
318-26	58524-58528	with	_	
318-27	58529-58530	a	_	
318-28	58531-58535	star	_	
318-29	58536-58537	(	_	
318-30	58537-58538	*	_	
318-31	58538-58539	)	_	
318-32	58540-58547	between	_	
318-33	58548-58552	them	_	
318-34	58552-58553	.	_	

#Text=P-values of two-sample t-tests (HC vs.
319-1	58554-58562	P-values	_	
319-2	58563-58565	of	_	
319-3	58566-58576	two-sample	_	
319-4	58577-58584	t-tests	_	
319-5	58585-58586	(	_	
319-6	58586-58588	HC	_	
319-7	58589-58591	vs	_	
319-8	58591-58592	.	_	

#Text=CHR, HC vs.
320-1	58593-58596	CHR	_	
320-2	58596-58597	,	_	
320-3	58598-58600	HC	_	
320-4	58601-58603	vs	_	
320-5	58603-58604	.	_	

#Text=ESZ and CHR vs.
321-1	58605-58608	ESZ	_	
321-2	58609-58612	and	_	
321-3	58613-58616	CHR	_	
321-4	58617-58619	vs	_	
321-5	58619-58620	.	_	

#Text=ESZ) are also shown in the title.
322-1	58621-58624	ESZ	_	
322-2	58624-58625	)	_	
322-3	58626-58629	are	_	
322-4	58630-58634	also	_	
322-5	58635-58640	shown	_	
322-6	58641-58643	in	_	
322-7	58644-58647	the	_	
322-8	58648-58653	title	_	
322-9	58653-58654	.	_	

#Text=B: Significant correlations (with p < 0.05) between the FC strengths and the symptom scores for the clinical high-risk (CHR) or early illness schizophrenia (ESZ) group.
323-1	58655-58656	B	_	
323-2	58656-58657	:	_	
323-3	58658-58669	Significant	_	
323-4	58670-58682	correlations	_	
323-5	58683-58684	(	_	
323-6	58684-58688	with	_	
323-7	58689-58690	p	_	
323-8	58691-58692	<	_	
323-9	58693-58697	0.05	_	
323-10	58697-58698	)	_	
323-11	58699-58706	between	_	
323-12	58707-58710	the	_	
323-13	58711-58713	FC	_	
323-14	58714-58723	strengths	_	
323-15	58724-58727	and	_	
323-16	58728-58731	the	_	
323-17	58732-58739	symptom	_	
323-18	58740-58746	scores	_	
323-19	58747-58750	for	_	
323-20	58751-58754	the	_	
323-21	58755-58763	clinical	_	
323-22	58764-58773	high-risk	_	
323-23	58774-58775	(	_	
323-24	58775-58778	CHR	_	
323-25	58778-58779	)	_	
323-26	58780-58782	or	_	
323-27	58783-58788	early	_	
323-28	58789-58796	illness	_	
323-29	58797-58810	schizophrenia	_	
323-30	58811-58812	(	_	
323-31	58812-58815	ESZ	_	
323-32	58815-58816	)	_	
323-33	58817-58822	group	_	
323-34	58822-58823	.	_	

#Text=A: p-value map obtained from performing ANCOVA on each FC’s strengths in the dominant subject-specific states of the original/real three groups.
324-1	58824-58825	A	_	
324-2	58825-58826	:	_	
324-3	58827-58834	p-value	_	
324-4	58835-58838	map	_	
324-5	58839-58847	obtained	_	
324-6	58848-58852	from	_	
324-7	58853-58863	performing	_	
324-8	58864-58870	ANCOVA	_	
324-9	58871-58873	on	_	
324-10	58874-58878	each	_	
324-11	58879-58881	FC	_	
324-12	58881-58882	’	_	
324-13	58882-58883	s	_	
324-14	58884-58893	strengths	_	
324-15	58894-58896	in	_	
324-16	58897-58900	the	_	
324-17	58901-58909	dominant	_	
324-18	58910-58926	subject-specific	_	
324-19	58927-58933	states	_	
324-20	58934-58936	of	_	
324-21	58937-58940	the	_	
324-22	58941-58949	original	_	
324-23	58949-58950	/	_	
324-24	58950-58954	real	_	
324-25	58955-58960	three	_	
324-26	58961-58967	groups	_	
324-27	58967-58968	.	_	

#Text=B: All FCs’ associated −log10 (p) map from the permutation test, where the p values (i.e., the frequencies or tail probabilities) were computed based on ANCOVA results of the dominant state from 1000 permutations.
325-1	58969-58970	B	_	
325-2	58970-58971	:	_	
325-3	58972-58975	All	_	
325-4	58976-58979	FCs	_	
325-5	58979-58980	’	_	
325-6	58981-58991	associated	_	
325-7	58992-58993	−	_	
325-8	58993-58998	log10	_	
325-9	58999-59000	(	_	
325-10	59000-59001	p	_	
325-11	59001-59002	)	_	
325-12	59003-59006	map	_	
325-13	59007-59011	from	_	
325-14	59012-59015	the	_	
325-15	59016-59027	permutation	_	
325-16	59028-59032	test	_	
325-17	59032-59033	,	_	
325-18	59034-59039	where	_	
325-19	59040-59043	the	_	
325-20	59044-59045	p	_	
325-21	59046-59052	values	_	
325-22	59053-59054	(	_	
325-23	59054-59057	i.e	_	
325-24	59057-59058	.	_	
325-25	59058-59059	,	_	
325-26	59060-59063	the	_	
325-27	59064-59075	frequencies	_	
325-28	59076-59078	or	_	
325-29	59079-59083	tail	_	
325-30	59084-59097	probabilities	_	
325-31	59097-59098	)	_	
325-32	59099-59103	were	_	
325-33	59104-59112	computed	_	
325-34	59113-59118	based	_	
325-35	59119-59121	on	_	
325-36	59122-59128	ANCOVA	_	
325-37	59129-59136	results	_	
325-38	59137-59139	of	_	
325-39	59140-59143	the	_	
325-40	59144-59152	dominant	_	
325-41	59153-59158	state	_	
325-42	59159-59163	from	_	
325-43	59164-59168	1000	_	
325-44	59169-59181	permutations	_	
325-45	59181-59182	.	_	

#Text=C: All FCs’ associated p-value map from the permutation test.
326-1	59183-59184	C	_	
326-2	59184-59185	:	_	
326-3	59186-59189	All	_	
326-4	59190-59193	FCs	_	
326-5	59193-59194	’	_	
326-6	59195-59205	associated	_	
326-7	59206-59213	p-value	_	
326-8	59214-59217	map	_	
326-9	59218-59222	from	_	
326-10	59223-59226	the	_	
326-11	59227-59238	permutation	_	
326-12	59239-59243	test	_	
326-13	59243-59244	.	_	

#Text=D: Adjusted p-value map of the dominant sate for the permutation test using the step-down minP method.
327-1	59245-59246	D	_	
327-2	59246-59247	:	_	
327-3	59248-59256	Adjusted	_	
327-4	59257-59264	p-value	_	
327-5	59265-59268	map	_	
327-6	59269-59271	of	_	
327-7	59272-59275	the	_	
327-8	59276-59284	dominant	_	
327-9	59285-59289	sate	_	
327-10	59290-59293	for	_	
327-11	59294-59297	the	_	
327-12	59298-59309	permutation	_	
327-13	59310-59314	test	_	
327-14	59315-59320	using	_	
327-15	59321-59324	the	_	
327-16	59325-59334	step-down	_	
327-17	59335-59339	minP	_	
327-18	59340-59346	method	_	
327-19	59346-59347	.	_	

#Text=E: p-values of the identified 30 FCs using the original three groups after Bonferroni correction (p < 0.05).
328-1	59348-59349	E	_	
328-2	59349-59350	:	_	
328-3	59351-59359	p-values	_	
328-4	59360-59362	of	_	
328-5	59363-59366	the	_	
328-6	59367-59377	identified	_	
328-7	59378-59380	30	_	
328-8	59381-59384	FCs	_	
328-9	59385-59390	using	_	
328-10	59391-59394	the	_	
328-11	59395-59403	original	_	
328-12	59404-59409	three	_	
328-13	59410-59416	groups	_	
328-14	59417-59422	after	_	
328-15	59423-59433	Bonferroni	_	
328-16	59434-59444	correction	_	
328-17	59445-59446	(	_	
328-18	59446-59447	p	_	
328-19	59448-59449	<	_	
328-20	59450-59454	0.05	_	
328-21	59454-59455	)	_	
328-22	59455-59456	.	_	

#Text=F: Adjusted p-values of the identified 58 FCs showing group difference after correction with p < 0.05 based on the adjusted p-values.
329-1	59457-59458	F	_	
329-2	59458-59459	:	_	
329-3	59460-59468	Adjusted	_	
329-4	59469-59477	p-values	_	
329-5	59478-59480	of	_	
329-6	59481-59484	the	_	
329-7	59485-59495	identified	_	
329-8	59496-59498	58	_	
329-9	59499-59502	FCs	_	
329-10	59503-59510	showing	_	
329-11	59511-59516	group	_	
329-12	59517-59527	difference	_	
329-13	59528-59533	after	_	
329-14	59534-59544	correction	_	
329-15	59545-59549	with	_	
329-16	59550-59551	p	_	
329-17	59552-59553	<	_	
329-18	59554-59558	0.05	_	
329-19	59559-59564	based	_	
329-20	59565-59567	on	_	
329-21	59568-59571	the	_	
329-22	59572-59580	adjusted	_	
329-23	59581-59589	p-values	_	
329-24	59589-59590	.	_	

#Text=G: Adjusted p-values of the identified 357 FCs showing group difference after correction with p < 0.01 based on the adjusted p-values.
330-1	59591-59592	G	_	
330-2	59592-59593	:	_	
330-3	59594-59602	Adjusted	_	
330-4	59603-59611	p-values	_	
330-5	59612-59614	of	_	
330-6	59615-59618	the	_	
330-7	59619-59629	identified	_	
330-8	59630-59633	357	_	
330-9	59634-59637	FCs	_	
330-10	59638-59645	showing	_	
330-11	59646-59651	group	_	
330-12	59652-59662	difference	_	
330-13	59663-59668	after	_	
330-14	59669-59679	correction	_	
330-15	59680-59684	with	_	
330-16	59685-59686	p	_	
330-17	59687-59688	<	_	
330-18	59689-59693	0.01	_	
330-19	59694-59699	based	_	
330-20	59700-59702	on	_	
330-21	59703-59706	the	_	
330-22	59707-59715	adjusted	_	
330-23	59716-59724	p-values	_	
330-24	59724-59725	.	_	

#Text=Subject and clinical characteristics.
331-1	59726-59733	Subject	_	
331-2	59734-59737	and	_	
331-3	59738-59746	clinical	_	
331-4	59747-59762	characteristics	_	
331-5	59762-59763	.	_	

#Text=HCs(n=70)\tCHR individuals(n=53)\tESZ patients(n=58)\t \t\t \t\tMean\tSD\tMean\tSD\tMean\tSD\t \tAge (Years)\t21.9\t5.6\t20.4\t4.5\t21.8\t3.8\t \tPANSS Positive Symptoms\t–\t–\t–\t–\t13.7\t4.8\t \tPANSS Negative Symptoms\t–\t–\t–\t–\t17.4\t6.6\t \tPANSS General Symptoms\t–\t–\t–\t–\t32.9\t8.9\t \tSOPS Positive Symptoms\t–\t–\t9.4\t4.5\t–\t–\t \tSOPS Negative Symptoms\t–\t–\t12.2\t5.8\t–\t–\t \tSOPS General Symptoms\t–\t–\t8.1\t4.5\t–\t–\t \tSOPS Disorganization Symptoms\t–\t–\t5.4\t3.4\t–\t–\t \tMaximum translation motion displacement (mm)\t0.8\t0.6\t1.1\t1.4\t1.2\t1.3\t \tMaximum rotation motion displacement (degree)\t0.8\t1.0\t1.0\t0.9\t0.9\t0.8\t \t\t \t\tn\t%\tn\t%\tn\t%\t \t\t \tMale\t41\t59%\t32\t62%\t38\t65%\t \t
#Text=SD, standard deviation; HCs, healthy controls; CHR, clinical high-risk; ESZ, early illness schizophrenia; PANSS, Positive and Negative Syndrome Scale; SOPS, Scale of Prodromal Symptoms.
332-1	59765-59768	HCs	_	
332-2	59768-59769	(	_	
332-3	59769-59770	n	_	
332-4	59770-59771	=	_	
332-5	59771-59773	70	_	
332-6	59773-59774	)	_	
332-7	59775-59778	CHR	_	
332-8	59779-59790	individuals	_	
332-9	59790-59791	(	_	
332-10	59791-59792	n	_	
332-11	59792-59793	=	_	
332-12	59793-59795	53	_	
332-13	59795-59796	)	_	
332-14	59797-59800	ESZ	_	
332-15	59801-59809	patients	_	
332-16	59809-59810	(	_	
332-17	59810-59811	n	_	
332-18	59811-59812	=	_	
332-19	59812-59814	58	_	
332-20	59814-59815	)	_	
332-21	59822-59826	Mean	_	
332-22	59827-59829	SD	_	
332-23	59830-59834	Mean	_	
332-24	59835-59837	SD	_	
332-25	59838-59842	Mean	_	
332-26	59843-59845	SD	_	
332-27	59848-59851	Age	_	
332-28	59852-59853	(	_	
332-29	59853-59858	Years	_	
332-30	59858-59859	)	_	
332-31	59860-59864	21.9	_	
332-32	59865-59868	5.6	_	
332-33	59869-59873	20.4	_	
332-34	59874-59877	4.5	_	
332-35	59878-59882	21.8	_	
332-36	59883-59886	3.8	_	
332-37	59889-59894	PANSS	_	
332-38	59895-59903	Positive	_	
332-39	59904-59912	Symptoms	_	
332-40	59913-59914	–	_	
332-41	59915-59916	–	_	
332-42	59917-59918	–	_	
332-43	59919-59920	–	_	
332-44	59921-59925	13.7	_	
332-45	59926-59929	4.8	_	
332-46	59932-59937	PANSS	_	
332-47	59938-59946	Negative	_	
332-48	59947-59955	Symptoms	_	
332-49	59956-59957	–	_	
332-50	59958-59959	–	_	
332-51	59960-59961	–	_	
332-52	59962-59963	–	_	
332-53	59964-59968	17.4	_	
332-54	59969-59972	6.6	_	
332-55	59975-59980	PANSS	_	
332-56	59981-59988	General	_	
332-57	59989-59997	Symptoms	_	
332-58	59998-59999	–	_	
332-59	60000-60001	–	_	
332-60	60002-60003	–	_	
332-61	60004-60005	–	_	
332-62	60006-60010	32.9	_	
332-63	60011-60014	8.9	_	
332-64	60017-60021	SOPS	_	
332-65	60022-60030	Positive	_	
332-66	60031-60039	Symptoms	_	
332-67	60040-60041	–	_	
332-68	60042-60043	–	_	
332-69	60044-60047	9.4	_	
332-70	60048-60051	4.5	_	
332-71	60052-60053	–	_	
332-72	60054-60055	–	_	
332-73	60058-60062	SOPS	_	
332-74	60063-60071	Negative	_	
332-75	60072-60080	Symptoms	_	
332-76	60081-60082	–	_	
332-77	60083-60084	–	_	
332-78	60085-60089	12.2	_	
332-79	60090-60093	5.8	_	
332-80	60094-60095	–	_	
332-81	60096-60097	–	_	
332-82	60100-60104	SOPS	_	
332-83	60105-60112	General	_	
332-84	60113-60121	Symptoms	_	
332-85	60122-60123	–	_	
332-86	60124-60125	–	_	
332-87	60126-60129	8.1	_	
332-88	60130-60133	4.5	_	
332-89	60134-60135	–	_	
332-90	60136-60137	–	_	
332-91	60140-60144	SOPS	_	
332-92	60145-60160	Disorganization	_	
332-93	60161-60169	Symptoms	_	
332-94	60170-60171	–	_	
332-95	60172-60173	–	_	
332-96	60174-60177	5.4	_	
332-97	60178-60181	3.4	_	
332-98	60182-60183	–	_	
332-99	60184-60185	–	_	
332-100	60188-60195	Maximum	_	
332-101	60196-60207	translation	_	
332-102	60208-60214	motion	_	
332-103	60215-60227	displacement	_	
332-104	60228-60229	(	_	
332-105	60229-60231	mm	_	
332-106	60231-60232	)	_	
332-107	60233-60236	0.8	_	
332-108	60237-60240	0.6	_	
332-109	60241-60244	1.1	_	
332-110	60245-60248	1.4	_	
332-111	60249-60252	1.2	_	
332-112	60253-60256	1.3	_	
332-113	60259-60266	Maximum	_	
332-114	60267-60275	rotation	_	
332-115	60276-60282	motion	_	
332-116	60283-60295	displacement	_	
332-117	60296-60297	(	_	
332-118	60297-60303	degree	_	
332-119	60303-60304	)	_	
332-120	60305-60308	0.8	_	
332-121	60309-60312	1.0	_	
332-122	60313-60316	1.0	_	
332-123	60317-60320	0.9	_	
332-124	60321-60324	0.9	_	
332-125	60325-60328	0.8	_	
332-126	60335-60336	n	_	
332-127	60337-60338	%	_	
332-128	60339-60340	n	_	
332-129	60341-60342	%	_	
332-130	60343-60344	n	_	
332-131	60345-60346	%	_	
332-132	60352-60356	Male	_	
332-133	60357-60359	41	_	
332-134	60360-60363	59%	_	
332-135	60364-60366	32	_	
332-136	60367-60370	62%	_	
332-137	60371-60373	38	_	
332-138	60374-60377	65%	_	
332-139	60381-60383	SD	_	
332-140	60383-60384	,	_	
332-141	60385-60393	standard	_	
332-142	60394-60403	deviation	_	
332-143	60403-60404	;	_	
332-144	60405-60408	HCs	_	
332-145	60408-60409	,	_	
332-146	60410-60417	healthy	_	
332-147	60418-60426	controls	_	
332-148	60426-60427	;	_	
332-149	60428-60431	CHR	_	
332-150	60431-60432	,	_	
332-151	60433-60441	clinical	_	
332-152	60442-60451	high-risk	_	
332-153	60451-60452	;	_	
332-154	60453-60456	ESZ	_	
332-155	60456-60457	,	_	
332-156	60458-60463	early	_	
332-157	60464-60471	illness	_	
332-158	60472-60485	schizophrenia	_	
332-159	60485-60486	;	_	
332-160	60487-60492	PANSS	_	
332-161	60492-60493	,	_	
332-162	60494-60502	Positive	_	
332-163	60503-60506	and	_	
332-164	60507-60515	Negative	_	
332-165	60516-60524	Syndrome	_	
332-166	60525-60530	Scale	_	
332-167	60530-60531	;	_	
332-168	60532-60536	SOPS	_	
332-169	60536-60537	,	_	
332-170	60538-60543	Scale	_	
332-171	60544-60546	of	_	
332-172	60547-60556	Prodromal	_	
332-173	60557-60565	Symptoms	_	
332-174	60565-60566	.	_	

#Text=The maximum translation motion displacement was computed as the maximum translation across all axes (x-axis, y-axis and z-axis) and the whole scanning.
333-1	60567-60570	The	_	
333-2	60571-60578	maximum	_	
333-3	60579-60590	translation	_	
333-4	60591-60597	motion	_	
333-5	60598-60610	displacement	_	
333-6	60611-60614	was	_	
333-7	60615-60623	computed	_	
333-8	60624-60626	as	_	
333-9	60627-60630	the	_	
333-10	60631-60638	maximum	_	
333-11	60639-60650	translation	_	
333-12	60651-60657	across	_	
333-13	60658-60661	all	_	
333-14	60662-60666	axes	_	
333-15	60667-60668	(	_	
333-16	60668-60674	x-axis	_	
333-17	60674-60675	,	_	
333-18	60676-60682	y-axis	_	
333-19	60683-60686	and	_	
333-20	60687-60693	z-axis	_	
333-21	60693-60694	)	_	
333-22	60695-60698	and	_	
333-23	60699-60702	the	_	
333-24	60703-60708	whole	_	
333-25	60709-60717	scanning	_	
333-26	60717-60718	.	_	

#Text=The maximum rotation motion displacement was computed as the maximum rotation across the pitch, roll and yaw and the whole scanning.
334-1	60719-60722	The	_	
334-2	60723-60730	maximum	_	
334-3	60731-60739	rotation	_	
334-4	60740-60746	motion	_	
334-5	60747-60759	displacement	_	
334-6	60760-60763	was	_	
334-7	60764-60772	computed	_	
334-8	60773-60775	as	_	
334-9	60776-60779	the	_	
334-10	60780-60787	maximum	_	
334-11	60788-60796	rotation	_	
334-12	60797-60803	across	_	
334-13	60804-60807	the	_	
334-14	60808-60813	pitch	_	
334-15	60813-60814	,	_	
334-16	60815-60819	roll	_	
334-17	60820-60823	and	_	
334-18	60824-60827	yaw	_	
334-19	60828-60831	and	_	
334-20	60832-60835	the	_	
334-21	60836-60841	whole	_	
334-22	60842-60850	scanning	_	
334-23	60850-60851	.	_	

#Text=The statistical results from the two-tailed two-sample t-tests that investigated the differences in similarity relationship of GSs based on the 100 permutation runs.
335-1	60852-60855	The	_	
335-2	60856-60867	statistical	_	
335-3	60868-60875	results	_	
335-4	60876-60880	from	_	
335-5	60881-60884	the	_	
335-6	60885-60895	two-tailed	_	
335-7	60896-60906	two-sample	_	
335-8	60907-60914	t-tests	_	
335-9	60915-60919	that	_	
335-10	60920-60932	investigated	_	
335-11	60933-60936	the	_	
335-12	60937-60948	differences	_	
335-13	60949-60951	in	_	
335-14	60952-60962	similarity	_	
335-15	60963-60975	relationship	_	
335-16	60976-60978	of	_	
335-17	60979-60982	GSs	_	
335-18	60983-60988	based	_	
335-19	60989-60991	on	_	
335-20	60992-60995	the	_	
335-21	60996-60999	100	_	
335-22	61000-61011	permutation	_	
335-23	61012-61016	runs	_	
335-24	61016-61017	.	_	

#Text=GS 1\tGS 2\tGS 3\tGS 4\tGS 5\t \tp-value of two-sample t-test between rHC–CHR and rHC–ESZ\t0.008\t0.096\t3.040e–06\t0.011\t0.265\t \tT-value of two-sample t-test between rHC–CHR and rHC–ESZ\t−2.671\t1.671\t−4.805\t2.571\t−1.117\t \tp-value of two-sample t-test between rCHR–ESZ and rHC–CHR\t0.001\t2.257e–16\t1.253e–63\t1.196e–06\t2.493e–21\t \tT-value of two-sample t-test between rCHR–ESZ and rHC–CHR\t3.314\t8.971\t25.176\t5.0111\t10.684\t \tp-value of two-sample t-test between rCHR–ESZ and rHC–ESZ\t0.242\t7.551e–21\t5.632e–58\t1.019e–16\t9.893e–20\t \tT-value of two-sample t-test between rCHR–ESZ and rHC–ESZ\t1.173\t10.521\t23.055\t9.094\t10.141\t \t
#Text=The 30 identified FCs reflecting significant group difference in analysis of covariance (ANCOVA) (p < 0.05 with Bonferroni correction) based on the dominant subject-specific connectivity states (SSs).
336-1	61019-61021	GS	_	
336-2	61022-61023	1	_	
336-3	61024-61026	GS	_	
336-4	61027-61028	2	_	
336-5	61029-61031	GS	_	
336-6	61032-61033	3	_	
336-7	61034-61036	GS	_	
336-8	61037-61038	4	_	
336-9	61039-61041	GS	_	
336-10	61042-61043	5	_	
336-11	61046-61053	p-value	_	
336-12	61054-61056	of	_	
336-13	61057-61067	two-sample	_	
336-14	61068-61074	t-test	_	
336-15	61075-61082	between	_	
336-16	61083-61090	rHC–CHR	_	
336-17	61091-61094	and	_	
336-18	61095-61102	rHC–ESZ	_	
336-19	61103-61108	0.008	_	
336-20	61109-61114	0.096	_	
336-21	61115-61121	3.040e	_	
336-22	61121-61122	–	_	
336-23	61122-61124	06	_	
336-24	61125-61130	0.011	_	
336-25	61131-61136	0.265	_	
336-26	61139-61146	T-value	_	
336-27	61147-61149	of	_	
336-28	61150-61160	two-sample	_	
336-29	61161-61167	t-test	_	
336-30	61168-61175	between	_	
336-31	61176-61183	rHC–CHR	_	
336-32	61184-61187	and	_	
336-33	61188-61195	rHC–ESZ	_	
336-34	61196-61197	−	_	
336-35	61197-61202	2.671	_	
336-36	61203-61208	1.671	_	
336-37	61209-61210	−	_	
336-38	61210-61215	4.805	_	
336-39	61216-61221	2.571	_	
336-40	61222-61223	−	_	
336-41	61223-61228	1.117	_	
336-42	61231-61238	p-value	_	
336-43	61239-61241	of	_	
336-44	61242-61252	two-sample	_	
336-45	61253-61259	t-test	_	
336-46	61260-61267	between	_	
336-47	61268-61276	rCHR–ESZ	_	
336-48	61277-61280	and	_	
336-49	61281-61288	rHC–CHR	_	
336-50	61289-61294	0.001	_	
336-51	61295-61301	2.257e	_	
336-52	61301-61302	–	_	
336-53	61302-61304	16	_	
336-54	61305-61311	1.253e	_	
336-55	61311-61312	–	_	
336-56	61312-61314	63	_	
336-57	61315-61321	1.196e	_	
336-58	61321-61322	–	_	
336-59	61322-61324	06	_	
336-60	61325-61331	2.493e	_	
336-61	61331-61332	–	_	
336-62	61332-61334	21	_	
336-63	61337-61344	T-value	_	
336-64	61345-61347	of	_	
336-65	61348-61358	two-sample	_	
336-66	61359-61365	t-test	_	
336-67	61366-61373	between	_	
336-68	61374-61382	rCHR–ESZ	_	
336-69	61383-61386	and	_	
336-70	61387-61394	rHC–CHR	_	
336-71	61395-61400	3.314	_	
336-72	61401-61406	8.971	_	
336-73	61407-61413	25.176	_	
336-74	61414-61420	5.0111	_	
336-75	61421-61427	10.684	_	
336-76	61430-61437	p-value	_	
336-77	61438-61440	of	_	
336-78	61441-61451	two-sample	_	
336-79	61452-61458	t-test	_	
336-80	61459-61466	between	_	
336-81	61467-61475	rCHR–ESZ	_	
336-82	61476-61479	and	_	
336-83	61480-61487	rHC–ESZ	_	
336-84	61488-61493	0.242	_	
336-85	61494-61500	7.551e	_	
336-86	61500-61501	–	_	
336-87	61501-61503	21	_	
336-88	61504-61510	5.632e	_	
336-89	61510-61511	–	_	
336-90	61511-61513	58	_	
336-91	61514-61520	1.019e	_	
336-92	61520-61521	–	_	
336-93	61521-61523	16	_	
336-94	61524-61530	9.893e	_	
336-95	61530-61531	–	_	
336-96	61531-61533	20	_	
336-97	61536-61543	T-value	_	
336-98	61544-61546	of	_	
336-99	61547-61557	two-sample	_	
336-100	61558-61564	t-test	_	
336-101	61565-61572	between	_	
336-102	61573-61581	rCHR–ESZ	_	
336-103	61582-61585	and	_	
336-104	61586-61593	rHC–ESZ	_	
336-105	61594-61599	1.173	_	
336-106	61600-61606	10.521	_	
336-107	61607-61613	23.055	_	
336-108	61614-61619	9.094	_	
336-109	61620-61626	10.141	_	
336-110	61630-61633	The	_	
336-111	61634-61636	30	_	
336-112	61637-61647	identified	_	
336-113	61648-61651	FCs	_	
336-114	61652-61662	reflecting	_	
336-115	61663-61674	significant	_	
336-116	61675-61680	group	_	
336-117	61681-61691	difference	_	
336-118	61692-61694	in	_	
336-119	61695-61703	analysis	_	
336-120	61704-61706	of	_	
336-121	61707-61717	covariance	_	
336-122	61718-61719	(	_	
336-123	61719-61725	ANCOVA	_	
336-124	61725-61726	)	_	
336-125	61727-61728	(	_	
336-126	61728-61729	p	_	
336-127	61730-61731	<	_	
336-128	61732-61736	0.05	_	
336-129	61737-61741	with	_	
336-130	61742-61752	Bonferroni	_	
336-131	61753-61763	correction	_	
336-132	61763-61764	)	_	
336-133	61765-61770	based	_	
336-134	61771-61773	on	_	
336-135	61774-61777	the	_	
336-136	61778-61786	dominant	_	
336-137	61787-61803	subject-specific	_	
336-138	61804-61816	connectivity	_	
336-139	61817-61823	states	_	
336-140	61824-61825	(	_	
336-141	61825-61828	SSs	_	
336-142	61828-61829	)	_	
336-143	61829-61830	.	_	

#Text=Indexes (IDs) and names of two regions of interest (ROIs) associated with each FC, the F-value, p-value in ANCOVA of the FC are included.
337-1	61831-61838	Indexes	_	
337-2	61839-61840	(	_	
337-3	61840-61843	IDs	_	
337-4	61843-61844	)	_	
337-5	61845-61848	and	_	
337-6	61849-61854	names	_	
337-7	61855-61857	of	_	
337-8	61858-61861	two	_	
337-9	61862-61869	regions	_	
337-10	61870-61872	of	_	
337-11	61873-61881	interest	_	
337-12	61882-61883	(	_	
337-13	61883-61887	ROIs	_	
337-14	61887-61888	)	_	
337-15	61889-61899	associated	_	
337-16	61900-61904	with	_	
337-17	61905-61909	each	_	
337-18	61910-61912	FC	_	
337-19	61912-61913	,	_	
337-20	61914-61917	the	_	
337-21	61918-61925	F-value	_	
337-22	61925-61926	,	_	
337-23	61927-61934	p-value	_	
337-24	61935-61937	in	_	
337-25	61938-61944	ANCOVA	_	
337-26	61945-61947	of	_	
337-27	61948-61951	the	_	
337-28	61952-61954	FC	_	
337-29	61955-61958	are	_	
337-30	61959-61967	included	_	
337-31	61967-61968	.	_	

#Text=ROI ID\tROI name\tROI ID\tROI name\tF-value\tp-value\t \t91\tCerebellum-Crus1-L\t102\tCerebellum-7b-R\t20.45\t1.03e–08\t \t82\tTemporal-Sup-R\t103\tCerebellum-8-L\t20.21\t1.26e–08\t \t82\tTemporal-Sup-R\t101\tCerebellum-7b-L\t19.35\t2.54e–08\t \t82\tTemporal-Sup-R\t104\tCerebellum-8-R\t17.88\t8.54e–08\t \t4\tFrontal-Sup-R\t77\tThalamus-L\t17.22\t1.48e–07\t \t20\tSupp-Motor-Area-R\t39\tParaHippocampal-L\t16.61\t2.47e–07\t \t79\tHeschl-L\t91\tCerebellum-Crus1-L\t15.66\t5.53e–07\t \t88\tTemporal-Pole-Mid-R\t93\tCerebellum-Crus2-L\t15.31\t7.43e–07\t \t88\tTemporal-Pole-Mid-R\t115\tVermis-9\t15.07\t9.08e–07\t \t8\tFrontal-Mid-R\t78\tThalamus-R\t14.92\t1.03e–06\t \t4\tFrontal-Sup-R\t78\tThalamus-R\t14.70\t1.25e–06\t \t91\tCerebellum-Crus1-L\t94\tCerebellum-Crus2-R\t14.58\t1.38e–06\t \t82\tTemporal-Sup-R\t87\tTemporal-Pole-Mid-L\t14.30\t1.75e–06\t \t82\tTemporal-Sup-R\t91\tCerebellum-Crus1-L\t14.07\t2.15e–06\t \t20\tSupp-Motor-Area-R\t87\tTemporal-Pole-Mid-L\t13.84\t2.61e–06\t \t86\tTemporal-Mid-R\t93\tCerebellum-Crus2-L\t13.72\t2.90e–06\t \t79\tHeschl-L\t93\tCerebellum-Crus2-L\t13.71\t2.92e–06\t \t81\tTemporal-Sup-L\t101\tCerebellum-7b-L\t13.70\t2.96e–06\t \t57\tPostcentral-L\t87\tTemporal-Pole-Mid-L\t13.32\t4.11e–06\t \t17\tRolandic-Oper-L\t86\tTemporal-Mid-R\t13.32\t4.12e–06\t \t7\tFrontal-Mid-L\t78\tThalamus-R\t13.32\t4.12e–06\t \t39\tParaHippocampal-L\t84\tTemporal-Pole-Sup-R\t13.25\t4.37e–06\t \t40\tParaHippocampal-R\t84\tTemporal-Pole-Sup-R\t13.19\t4.58e–06\t \t24\tFrontal-Sup-Medial-R\t43\tCalcarine-L\t13.18\t4.64e–06\t \t69\tParacentral-Lobule-L\t101\tCerebellum-7b-L\t13.07\t5.10e–06\t \t82\tTemporal-Sup-R\t102\tCerebellum-7b-R\t12.94\t5.72e–06\t \t10\tFrontal-Mid-Orb-R\t78\tThalamus-R\t12.83\t6.30e–06\t \t57\tPostcentral-L\t86\tTemporal-Mid-R\t12.74\t6.80e–06\t \t85\tTemporal-Mid-L\t106\tCerebellum-9-R\t12.73\t6.87e–06\t \t23\tFrontal-Sup-Medial-L\t43\tCalcarine-L\t12.65\t7.38e–06
338-1	61969-61972	ROI	_	
338-2	61973-61975	ID	_	
338-3	61976-61979	ROI	_	
338-4	61980-61984	name	_	
338-5	61985-61988	ROI	_	
338-6	61989-61991	ID	_	
338-7	61992-61995	ROI	_	
338-8	61996-62000	name	_	
338-9	62001-62008	F-value	_	
338-10	62009-62016	p-value	_	
338-11	62019-62021	91	_	
338-12	62022-62038	Cerebellum-Crus1	_	
338-13	62038-62039	-	_	
338-14	62039-62040	L	_	
338-15	62041-62044	102	_	
338-16	62045-62055	Cerebellum	_	
338-17	62055-62056	-	_	
338-18	62056-62060	7b-R	_	
338-19	62061-62066	20.45	_	
338-20	62067-62072	1.03e	_	
338-21	62072-62073	–	_	
338-22	62073-62075	08	_	
338-23	62078-62080	82	_	
338-24	62081-62095	Temporal-Sup-R	_	
338-25	62096-62099	103	_	
338-26	62100-62110	Cerebellum	_	
338-27	62110-62111	-	_	
338-28	62111-62112	8	_	
338-29	62112-62113	-	_	
338-30	62113-62114	L	_	
338-31	62115-62120	20.21	_	
338-32	62121-62126	1.26e	_	
338-33	62126-62127	–	_	
338-34	62127-62129	08	_	
338-35	62132-62134	82	_	
338-36	62135-62149	Temporal-Sup-R	_	
338-37	62150-62153	101	_	
338-38	62154-62164	Cerebellum	_	
338-39	62164-62165	-	_	
338-40	62165-62169	7b-L	_	
338-41	62170-62175	19.35	_	
338-42	62176-62181	2.54e	_	
338-43	62181-62182	–	_	
338-44	62182-62184	08	_	
338-45	62187-62189	82	_	
338-46	62190-62204	Temporal-Sup-R	_	
338-47	62205-62208	104	_	
338-48	62209-62219	Cerebellum	_	
338-49	62219-62220	-	_	
338-50	62220-62221	8	_	
338-51	62221-62222	-	_	
338-52	62222-62223	R	_	
338-53	62224-62229	17.88	_	
338-54	62230-62235	8.54e	_	
338-55	62235-62236	–	_	
338-56	62236-62238	08	_	
338-57	62241-62242	4	_	
338-58	62243-62256	Frontal-Sup-R	_	
338-59	62257-62259	77	_	
338-60	62260-62270	Thalamus-L	_	
338-61	62271-62276	17.22	_	
338-62	62277-62282	1.48e	_	
338-63	62282-62283	–	_	
338-64	62283-62285	07	_	
338-65	62288-62290	20	_	
338-66	62291-62308	Supp-Motor-Area-R	_	
338-67	62309-62311	39	_	
338-68	62312-62329	ParaHippocampal-L	_	
338-69	62330-62335	16.61	_	
338-70	62336-62341	2.47e	_	
338-71	62341-62342	–	_	
338-72	62342-62344	07	_	
338-73	62347-62349	79	_	
338-74	62350-62358	Heschl-L	_	
338-75	62359-62361	91	_	
338-76	62362-62378	Cerebellum-Crus1	_	
338-77	62378-62379	-	_	
338-78	62379-62380	L	_	
338-79	62381-62386	15.66	_	
338-80	62387-62392	5.53e	_	
338-81	62392-62393	–	_	
338-82	62393-62395	07	_	
338-83	62398-62400	88	_	
338-84	62401-62420	Temporal-Pole-Mid-R	_	
338-85	62421-62423	93	_	
338-86	62424-62440	Cerebellum-Crus2	_	
338-87	62440-62441	-	_	
338-88	62441-62442	L	_	
338-89	62443-62448	15.31	_	
338-90	62449-62454	7.43e	_	
338-91	62454-62455	–	_	
338-92	62455-62457	07	_	
338-93	62460-62462	88	_	
338-94	62463-62482	Temporal-Pole-Mid-R	_	
338-95	62483-62486	115	_	
338-96	62487-62493	Vermis	_	
338-97	62493-62494	-	_	
338-98	62494-62495	9	_	
338-99	62496-62501	15.07	_	
338-100	62502-62507	9.08e	_	
338-101	62507-62508	–	_	
338-102	62508-62510	07	_	
338-103	62513-62514	8	_	
338-104	62515-62528	Frontal-Mid-R	_	
338-105	62529-62531	78	_	
338-106	62532-62542	Thalamus-R	_	
338-107	62543-62548	14.92	_	
338-108	62549-62554	1.03e	_	
338-109	62554-62555	–	_	
338-110	62555-62557	06	_	
338-111	62560-62561	4	_	
338-112	62562-62575	Frontal-Sup-R	_	
338-113	62576-62578	78	_	
338-114	62579-62589	Thalamus-R	_	
338-115	62590-62595	14.70	_	
338-116	62596-62601	1.25e	_	
338-117	62601-62602	–	_	
338-118	62602-62604	06	_	
338-119	62607-62609	91	_	
338-120	62610-62626	Cerebellum-Crus1	_	
338-121	62626-62627	-	_	
338-122	62627-62628	L	_	
338-123	62629-62631	94	_	
338-124	62632-62648	Cerebellum-Crus2	_	
338-125	62648-62649	-	_	
338-126	62649-62650	R	_	
338-127	62651-62656	14.58	_	
338-128	62657-62662	1.38e	_	
338-129	62662-62663	–	_	
338-130	62663-62665	06	_	
338-131	62668-62670	82	_	
338-132	62671-62685	Temporal-Sup-R	_	
338-133	62686-62688	87	_	
338-134	62689-62708	Temporal-Pole-Mid-L	_	
338-135	62709-62714	14.30	_	
338-136	62715-62720	1.75e	_	
338-137	62720-62721	–	_	
338-138	62721-62723	06	_	
338-139	62726-62728	82	_	
338-140	62729-62743	Temporal-Sup-R	_	
338-141	62744-62746	91	_	
338-142	62747-62763	Cerebellum-Crus1	_	
338-143	62763-62764	-	_	
338-144	62764-62765	L	_	
338-145	62766-62771	14.07	_	
338-146	62772-62777	2.15e	_	
338-147	62777-62778	–	_	
338-148	62778-62780	06	_	
338-149	62783-62785	20	_	
338-150	62786-62803	Supp-Motor-Area-R	_	
338-151	62804-62806	87	_	
338-152	62807-62826	Temporal-Pole-Mid-L	_	
338-153	62827-62832	13.84	_	
338-154	62833-62838	2.61e	_	
338-155	62838-62839	–	_	
338-156	62839-62841	06	_	
338-157	62844-62846	86	_	
338-158	62847-62861	Temporal-Mid-R	_	
338-159	62862-62864	93	_	
338-160	62865-62881	Cerebellum-Crus2	_	
338-161	62881-62882	-	_	
338-162	62882-62883	L	_	
338-163	62884-62889	13.72	_	
338-164	62890-62895	2.90e	_	
338-165	62895-62896	–	_	
338-166	62896-62898	06	_	
338-167	62901-62903	79	_	
338-168	62904-62912	Heschl-L	_	
338-169	62913-62915	93	_	
338-170	62916-62932	Cerebellum-Crus2	_	
338-171	62932-62933	-	_	
338-172	62933-62934	L	_	
338-173	62935-62940	13.71	_	
338-174	62941-62946	2.92e	_	
338-175	62946-62947	–	_	
338-176	62947-62949	06	_	
338-177	62952-62954	81	_	
338-178	62955-62969	Temporal-Sup-L	_	
338-179	62970-62973	101	_	
338-180	62974-62984	Cerebellum	_	
338-181	62984-62985	-	_	
338-182	62985-62989	7b-L	_	
338-183	62990-62995	13.70	_	
338-184	62996-63001	2.96e	_	
338-185	63001-63002	–	_	
338-186	63002-63004	06	_	
338-187	63007-63009	57	_	
338-188	63010-63023	Postcentral-L	_	
338-189	63024-63026	87	_	
338-190	63027-63046	Temporal-Pole-Mid-L	_	
338-191	63047-63052	13.32	_	
338-192	63053-63058	4.11e	_	
338-193	63058-63059	–	_	
338-194	63059-63061	06	_	
338-195	63064-63066	17	_	
338-196	63067-63082	Rolandic-Oper-L	_	
338-197	63083-63085	86	_	
338-198	63086-63100	Temporal-Mid-R	_	
338-199	63101-63106	13.32	_	
338-200	63107-63112	4.12e	_	
338-201	63112-63113	–	_	
338-202	63113-63115	06	_	
338-203	63118-63119	7	_	
338-204	63120-63133	Frontal-Mid-L	_	
338-205	63134-63136	78	_	
338-206	63137-63147	Thalamus-R	_	
338-207	63148-63153	13.32	_	
338-208	63154-63159	4.12e	_	
338-209	63159-63160	–	_	
338-210	63160-63162	06	_	
338-211	63165-63167	39	_	
338-212	63168-63185	ParaHippocampal-L	_	
338-213	63186-63188	84	_	
338-214	63189-63208	Temporal-Pole-Sup-R	_	
338-215	63209-63214	13.25	_	
338-216	63215-63220	4.37e	_	
338-217	63220-63221	–	_	
338-218	63221-63223	06	_	
338-219	63226-63228	40	_	
338-220	63229-63246	ParaHippocampal-R	_	
338-221	63247-63249	84	_	
338-222	63250-63269	Temporal-Pole-Sup-R	_	
338-223	63270-63275	13.19	_	
338-224	63276-63281	4.58e	_	
338-225	63281-63282	–	_	
338-226	63282-63284	06	_	
338-227	63287-63289	24	_	
338-228	63290-63310	Frontal-Sup-Medial-R	_	
338-229	63311-63313	43	_	
338-230	63314-63325	Calcarine-L	_	
338-231	63326-63331	13.18	_	
338-232	63332-63337	4.64e	_	
338-233	63337-63338	–	_	
338-234	63338-63340	06	_	
338-235	63343-63345	69	_	
338-236	63346-63366	Paracentral-Lobule-L	_	
338-237	63367-63370	101	_	
338-238	63371-63381	Cerebellum	_	
338-239	63381-63382	-	_	
338-240	63382-63386	7b-L	_	
338-241	63387-63392	13.07	_	
338-242	63393-63398	5.10e	_	
338-243	63398-63399	–	_	
338-244	63399-63401	06	_	
338-245	63404-63406	82	_	
338-246	63407-63421	Temporal-Sup-R	_	
338-247	63422-63425	102	_	
338-248	63426-63436	Cerebellum	_	
338-249	63436-63437	-	_	
338-250	63437-63441	7b-R	_	
338-251	63442-63447	12.94	_	
338-252	63448-63453	5.72e	_	
338-253	63453-63454	–	_	
338-254	63454-63456	06	_	
338-255	63459-63461	10	_	
338-256	63462-63479	Frontal-Mid-Orb-R	_	
338-257	63480-63482	78	_	
338-258	63483-63493	Thalamus-R	_	
338-259	63494-63499	12.83	_	
338-260	63500-63505	6.30e	_	
338-261	63505-63506	–	_	
338-262	63506-63508	06	_	
338-263	63511-63513	57	_	
338-264	63514-63527	Postcentral-L	_	
338-265	63528-63530	86	_	
338-266	63531-63545	Temporal-Mid-R	_	
338-267	63546-63551	12.74	_	
338-268	63552-63557	6.80e	_	
338-269	63557-63558	–	_	
338-270	63558-63560	06	_	
338-271	63563-63565	85	_	
338-272	63566-63580	Temporal-Mid-L	_	
338-273	63581-63584	106	_	
338-274	63585-63595	Cerebellum	_	
338-275	63595-63596	-	_	
338-276	63596-63597	9	_	
338-277	63597-63598	-	_	
338-278	63598-63599	R	_	
338-279	63600-63605	12.73	_	
338-280	63606-63611	6.87e	_	
338-281	63611-63612	–	_	
338-282	63612-63614	06	_	
338-283	63617-63619	23	_	
338-284	63620-63640	Frontal-Sup-Medial-L	_	
338-285	63641-63643	43	_	
338-286	63644-63655	Calcarine-L	_	
338-287	63656-63661	12.65	_	
338-288	63662-63667	7.38e	_	
338-289	63667-63668	–	_	
338-290	63668-63670	06	_	
